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Abstract 
 
Population growth and associated food security has led to pressure on the livestock production 
industries to increase both production output and production sustainability. The 2006 EU ban on the 
use of non-therapeutic antibiotics had created a need for alternative measures to support the health 
and growth of livestock. In recent years there has been increasing evidence that broilers may be 
experience high levels of oxidative stress. This has been linked with an emerging problem with poultry 
muscle meat myopathies such as woody breast, white stripe and spaghetti meat. 
 Pre-biotics are one area being explored to fill this void. Xylanase is an exogenous enzyme routinely 
used in broiler production to reduce the anti-nutritional effects of non-starch polysaccharides present 
in viscous feed grains. It has been speculated that xylanase may also act as a prebiotic by hydrolysing 
long-chain polysaccharides in the diet into oligosaccharides that can be utilized for fermentation by 
microbiota in the hind gut. Subsequently, fermentation products can have antimicrobial and energy 
sparing effects that may be able to enhance broiler performance and gut health. Oligosaccharides 
have also been shown to have antioxidant properties. 
A series of bird trials and in vitro studies were conducted to investigate the effect of xylanase, 
arabinoxylans and xylo-oligosaccharides on the performance, gut health and oxidative status of 
broilers. . Initially a bird trial investigated the effect of an arabinoxylan extract, with and without the 
addition of xylanase. This study showed performance benefits of supplementing broilers with an 
arabinoxylan extract with birds consistently gaining more weight than the other treatments 
(significant during days 21-28) and finally weighing on average over 100g more than the other 
treatments. Pre-treating the AX extract seemed to negate any performance benefits, possibly due to a 
mixing or distribution effect of the pre-treatment process.  
iv 
 
A second bird trial investigated the effect of two XOS products derived from different base materials 
with and without the addition of xylanase in a 3x2 factorial study. This study revealed very few 
performance effect but did show that xylanase inclusion increased the tibial breaking strength at day 
21 and increased calcium digestibility at day 42.  
An in vitro study investigated novel antioxidant assays as a way to measure the oxidative status of 
broilers and the antioxidative properties of broiler feed and various commercial oligosaccharides. This 
study provided initial indications for optimizing the use of this assay in broilers and showed that all of 
the XOS products investigated had some antioxidative capacity.  
A final bird trial investigated the dose response of Signis®, a commercial XOS and xylanase 
supplement. This study compared a commercially recommended dose of 0.1g/kg Signis® with a dose 
of 0.2g/kg. This study showed significantly improved body weight gain, average bird weight for both 
doses of Signis® compared to the control and significantly improved feed conversion ratio for the 
0.2g/kg dose compared to the control and 0.1g/kg dose. This study did not find any significant 
difference in digesta viscosity, suggesting that the performance enhancing effects of XOS/xylanase 
may be due to alternative mechanisms such as the production of xylanase by bacteria in the GIT. 
This project demonstrated that broilers can gain performance benefits from the supplementation of 
an AX extract without the addition of xylanase, suggesting that broilers may be able to ferment AX 
independently and that although broilers may not be able to produce endogenous xylanase, the 
microbiota within the intestinal tract may be able to and that viscosity and cell wall effects may not be 
responsible for all beneficial effects of XOS/xylanase supplementation.  
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Chapter 1 Review of the literature 
1.1 Introduction 
Global population growth and associated food insecurity has increased demand for sustainable, 
inexpensive meat protein. This has placed pressure on the poultry industry to meet this demand. In 
2015 global poultry production stood at 111,000 thousand metric tons, however the industry is 
predicted to reach over 131,255 metric tons by 2025. 1Historically, the poultry industry has 
supported production with the use of non-therapeutic anti-biotics for growth promotion and disease 
prevention (Onrust et al., 2015). Following the 2006 EU ban on the use of non-therapeutic antibiotics, 
the industry has been driven to seek alternative approaches to enhance bird health and support 
growth performance.  Gut health and oxidative status are two inextricably linked areas of broiler 
health that have been found to have a profound effect on health and performance (Enberg et 
al.,1996; Sihvo et al., 2013; Ismail et al., 2013; Sugiharto, 2014; Estevez, 2015).  
Identifying ways to improve oxidative status and gut health is vital for the rapid growth of the 
industry. One approach to improving gut health is the provision of pre-biotics. Pre-biotics are 
substances that provide a nutrient source for selected beneficial microbes within the gut. Encouraging 
proliferation of beneficial bacteria can have a protective and restorative effect on the host’s immune 
system, potentially preventing pathogenic disease and therefore improving production performance 
(Enberg et al., 1996).  
Improving the oxidative status of broilers can also have wide reaching benefits. One of the main 
detrimental effects of oxidative stress in broilers is the loss of integrity of tight junctions within the 
intestinal epithelium (Gangwar et al., 2017). When these tight junctions are damaged, leakage can 
occur, translocating gut microbiota, potentially leading to systemic infection. As such, ensuring the 
microbial population of the gut is optimized, can also have a protective effect on the host by 
preventing systemic pathogenic infection (Latorre et al., 2018). Additionally, both poor gut health and 
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oxidative stress are likely to impinge on animal welfare, potentially causing pain and suffering at an 
individual level.  
Oligosaccharides are compounds that have recently been investigated for their pre-biotic properties 
(Wichienchot and Chinachoti, 2011). Oligosaccharides have also been confirmed to possess 
antioxidant properties (Hou et al., 2015; Zhou et al., 2018). As such, oligosaccharides could represent 
a viable supplement to support two key areas of poultry health.  
The overarching aim of this project is to investigate the efficacy of xylo-oligosaccharides and/or 
xylanase in supporting the performance, gut health, and oxidative status of broilers.  
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1.2 Population growth 
Between 1950 and 2017 the global population rose by around 5 billion people (Population Reference 
Bureau, 2019) and is expected to continue this exponential growth, with some predications estimating 
the global population will top 10 billion by the end of the century. This vast increase in population 
naturally creates an increased need for food, especially protein sources. It is becoming widely 
recognized that the population increase, extended life expectancy and the associated food insecurity is 
a major global concern (FAO, 2015).  
1.3 Growth of the Poultry Industry 
In response to the need for cost efficient and abundant protein, global poultry production increased by 
53% between 1995 and 2005 (Scanes, 2007). This increase was achieved due to several factors, 
including genetic manipulation, selective breeding, improved management and a better understanding 
of optimal nutrition for broilers. This has led to a 30% reduction in the feed conversion ratio of the 
modern broiler chicken when compared to its 1957 equivalent (Havenstein et al, 2003) (figure 1.1).  
 
Figure 1.1 A comparison of broiler chicken development from 1957-2005 (Zuidhof et al., 2014)  
The UK alone currently slaughters over 20 million broilers a week (DEFRA, 2020). Poultry production 
has also been streamlined, with modern intensive systems requiring 30% less land, and a 30% lower 
carbon footprint and energy usage than 50 years ago (Burton et al., 2016).  
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Poultry meat continues to grow in popularity (Magdelaine at al., 2008), due to cultural acceptability, 
low price points and the nutritional advantages of poultry meat over other meats (Magdelaine et al., 
2008). In the last 15 years, poultry meat production has risen by nearly 44 million metric tons, reaching 
production of over 125 million metric tons by 2019 (Shahbandeh, 2019).  In the UK alone, consumption 
of poultry meat doubled in the 20 years between 1987 and 2007 (Foods ethics Council, 2007). Reasons 
for this include increased awareness of nutrition for health, benefits of low-fat white meat and reduced 
price and availability of meat (Magdelaine et al., 2008). 
In the quest for sustainable agriculture and protein production, species such as cattle and sheep are 
considered to be less sustainable and possibly even damaging to the environment due to the 
methane production resulting from enteric fermentation as well as the large time, space and 
resources required to raise them to slaughter age (Desjardins et al., 2012). Recent years have seen a 
rise in the popularity of vegan diets, whilst this market is growing it is unlikely to replace meat protein 
due to a large majority of consumers being averse to meat-free diets. Research into alternative 
protein sources for the human food market is now also prevalent, with increased interest in insect 
and plant-based proteins. Novel proteins are often unpopular with consumers, with many people 
being unwilling or unable to give up traditional meat protein (Burton et al., 2016).  
Chicken is one of the most viable options for a sustainable animal protein, which can be produced in 
large quantities (Neeteson-van Nieuwenhoven et al., 2016). This is due to several factors. Broilers 
(meat chickens) are bred to reach slaughter weight 35-42 post hatch, and as such, are incredibly 
efficient at turning feed into muscle, thus maximising the feed investment. Broilers also have minimal 
space requirements and produce far less hazardous waste than other production species.  
There is also growing use of chicken manure as a commercial fertilizer due to its high nitrogen, 
potassium and phosphorus content (Vandecasteele et al., 2013), therefore improving industry 
sustainability. In recent years it is becoming more recognized that the industry is utilizing high quality 
diet ingredients that could be utilized by the human sector. As omnivores, chickens can and will eat a 
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very wide range of food (Sturkie, 1965).  This has led to increased research into alternative poultry 
diets, that utilize ingredients that are not suitable or palatable to humans such as industrial by-
products and insect proteins. This is particularly useful in improving the sustainability of the industry, 
allowing high quality meat protein for human consumption whilst reducing industrial waste (Burton et 
al., 2016).  
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1.4 The Avian Digestive Tract 
Chickens share many similarities in digestive strategy with other monogastrics such and pigs and 
humans. The avian digestive tract is a relatively simple, but highly efficient structure. As a result of 
evolution, avian species developed lightweight, fast transit systems that allowed flight and thus 
predator escape, while maximising utilisation of a wide range of nutritional materials. 
 
1.4.1 The Alimentary canal 
The alimentary canal is the entire digestive organ of the chicken. It runs from the beak, where 
ingestion occurs, down to the cloaca, where waste is excreted. The entire alimentary canal can be up 
to 6 times the length of the total bird length (Scholey, 2012). The length of the individual tract 
components varies by age and can be dependent upon variables such as diet. For example, Sturkie 
(1965) reports an association between fibrous and viscous diets and larger alimentary tracts.  
As a precocial species, chickens have highly developed digestive systems at point of hatch. The 
alimentary tract can account for 25% of the total live weight at hatch, reducing to only 5% by 56 days 
of age (Larbier and Leclercq, 1994). 
The mechanical, enzymatic and chemical processes of digestion occur throughout the entire tract, 
however, the process of nutrient absorption occurs only in the small intestine where nutrients are 
absorbed through the wall of the tract into the circulatory system for transport throughout the body 
(Larbier and Leclercq, 1994; Scholey, 2012). The majority of the tract is lined with mucus membranes, 
layers of muscle that run lengthwise and glandular tissue that secretes digestive enzymes. Digesta can 
transit the tract in as little as 2-4 hours but can take up to 10 hours depending on feed composition 
and form. This allows highly efficient uptake of nutrients (Scholey, 2012). 
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1.4.2 The Mouth Structure 
Food is taken into the alimentary canal via the beak of the bird. In the absence of lips and cheeks, 
chickens possess dense horny skin that covers the mandible and incisive bones (Lorenzoni, 2010). This 
provides structure to the mouth. Chicken do not possess teeth, with the exception of a small bony 
ridge on the beak that only remains for a few days post hatch and aids exit from the egg. There is no 
specific distinction between the mouth and pharynx of the chicken and there is no soft palate present 
(Duke, 1986; Lorenzoni, 2010). As such, the combination of the mouth and pharynx is sometimes 
referred to as the oropharynx (Lorenzoni, 2010; Jacobs and Pescatore, 2013). The dorsal surface of 
the oropharynx contains a common orifice for the two Eustachian tubes (Bradley, 1960). 
The dense, hard palate that forms the mouth has a long narrow median slit that intersects the nasal 
cavity (Larbier and Leclercq, 1994). The hard palate has five rows of hard conical papillae that point 
backwards. A number of salivary glands line the hard palate, secreting limited quantities of digestive 
enzymes including amylase.  
The majority of feed is ingested whole and very little maceration occurs in the beak. Feed is 
transferred to the pharynx via mechanical movement of the head in an upward and forward direction 
(Hill, 1976). Water is ingested in a similar manner, but with the beak closed. Water flows directly into 
the oesophagus when the head is raised.  
Situated in the beak, the tongue contains few intrinsic muscles and is ridged and narrow. In cross 
section, the tongue is triangular and pointed. The tongue is attached to the hyoid bone, which 
providing the framework for the tongue to transfer ingested substances to the oesophagus (Hill, 
1976).Chickens possess very few taste buds and as such taste is likely to play only a very small role in 
feed consumption (Scott et al., 1976). 
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1.4.3 Salivary Glands 
A thick layer of stratified squamous epithelium covers the surface of the mouth structure. The hard 
palate has salivary gland running its entire length and the maxillary, palatine and sphenopterygoid 
glands lead to an area on the dorsal palate at the bottom of the papillae (Lorenzoni, 2010; Kleyn, 
2013). The combined glands form a mass of glandular tissue beneath the epithelium. Most of this 
glandular tissue contains lymphoid tissue (Husveth, 2011). The ventral and dorsal palates meet in an 
area known as the lateral cheek where the buccal gland is located (Denbow, 2000). Saliva acts as a 
lubricant to ingested feed. Unlike many other species, only minimal amylase is secreted with the 
saliva (Denbow, 2000; Lorenzoni, 2010; Kleyn, 2013).  
 
1.4.4 Pharynx and Tongue 
The roof of the pharynx houses more salivary glands (Kleyn, 2013). These glands mainly secrete 
mucus, containing muco-proteins and both sulphated and non-sulphated muco-polysaccharides to 
lubricate ingested feed(Kleyn, 2013).During swallowing, feed is grabbed by the beak and the tongue 
used to manoeuvre the feed to the roof of the mouth where mucus is added to form a sticky bolus 
(Kleyn, 2013).The tongue is used to manoeuvre the ingested feed towards the oesophagus 
(Lorenzoni, 2010; Kleyn, 2013).  
 
1.4.5 Oesophagus and Crop 
The oesophagus does not possess a sphincter and the walls of the oesophagus are very thin. The 
oesophagus is split into two indistinct regions – cervical (upper section) and thoracic (lower) 
(Lorenzoni, 2010; Kleyn, 2013). The cervical section dilates and opens into the bird’s crop. The crop is 
an expanding diverticulum structure that acts as a storage vessel for ingested feed (Lorenzoni, 2010; 
Kleyn, 2013).  Mucous is produced in the oesophagus and crop to provide lubrication for ingested 
matter (Scholey, 2012). From the crop, digesta is passed to the proventriculus. 
9 
 
 
1.4.6 Proventriculus 
The proventriculus is the glandular stomach of the chicken (Lorenzoni 2010; Kleyn, 2013).  The organ 
is lined with papillae and multi-lobular glands which give the proventriculus its granular appearance. 
These papillae possess oxynticopeptic cells that produce and secrete hydrochloric acid and proteolytic 
enzymes in the form of pepsin (Lorenzoni, 2010; Kleyn, 2013). The proventriculus leads directly to the 
ventriculus or gizzard. The gizzard represents the muscular stomach, and here mixing and grinding 
occurs. The external surface of the gizzard is composed of smooth muscle (Kleyn, 2013). The internal 
wall of the gizzard is covered with a thick cuticle membrane that is secreted by mucosal glands 
beneath the surface. This cuticle is folded longitudinally and provides protection to the organ from 
mechanical friction created by the grinding of digesta (Lorenzoni, 2010). Grinding the digesta is 
achieved by two pairs of opposing muscles that contract in turn to create a grinding motion. There is a 
small pyloric section of the gizzard that again contains mucosal glands as well as villi. Here mucus is 
secreted to lubricate the passage of digesta from the gizzard to the duodenum, and passage of 
digesta controlled by the pyloric sphincter.  
 
1.4.7 Small intestine 
The small intestine is composed of three distinct parts, the duodenum, jejunum and ileum. The small 
intestine of an adult broiler would measure approximately 120-140cm in length from the gizzard to 
ileal-caecal junction. 
The duodenum forms the cranial portion of the small intestine (Kleyn, 2013) and the gizzard-duodenal 
junction forms an active filter that prevents larger ingested particles from entering the duodenum. It 
is compiled of a descending and ascending loop that surround the pancreas. The pancreas is a 
secretory organ. Both pancreatic and bile ducts open into the top of the duodenal loop. Pancreatic 
secretions can be broken down into two components: aqueous and enzymatic. Aqueous secretions 
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contain high concentrations of bicarbonate ions that neutralise chime and optimize pancreatic 
enzymatic activity (Scholey, 2012). Secretions contain enzymes including peptidases, amylases, 
saccharidases and lipases for the enzymatic degradation of proteins, carbohydrates, and lipids 
respectively. Digestive enzymes are secreted as proenzymes, where the presence of ingesta converts 
proenzymes to their active status. 
Secretin is a peptide hormone that influences the secretion of pancreatic juice. Secretin is produced 
in the intestinal wall along with cholecystokinin-pancreozyme (CCK-PZ). Secretin release is stimulated 
by gastric hydrochloric acid and food reaching the duodenum. CCK-PZ is then released following 
stimulation from amino acids, peptides and fats from the ingesta into the duodenal loop (Duke, 
1986b). The presence of secretin triggers an initial secretion of aqueous and enzymatic components 
from the pancreas.  
 Enterocytes line the entire intestinal lumen. These are arranged into villi and microvilli - finger like 
projections that are continually replaced by cells migrating from the crypts of Lieberkühn (situated 
between villi) throughout the lifespan of the chicken (Lorenzoni, 2010). The crypts of Lieberkühn also 
secrete mucus, as Brunner’s glands (found in humans) are absent in birds. These villi create a very 
large surface area which confers increased absorptive ability to uptake nutrients and water 
(Lorenzoni, 2010). 
Liver bile enters the duodenum via two ducts (from the caudal end) at a pH of 6. This acts as an 
emulsifier and facilitates the action of pancreatic lipase and lipid absorption. Synthesis and secretion 
of bile develops with age and therefore lipid digestion improves throughout the lifespan of the bird 
(Larbier and Le Clercq, 1994). 
The pancreatic and bile ducts enter the caudal end of the ascending loop of the duodenum and marks 
the start of the jejunum, which runs until the Meckel’s diverticulum where the jejunum nominally 
becomes referred to as the ileum. The jejunum and ileum are similar in function, length and structure. 
These two portions of the small intestine are the major absorptive sites of the intestinal tract (Larbier 
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and LeClercq, 1994). Digesta is propelled through the small intestine via peristalsis and segmentation 
movement. As in the duodenum, the jejunum and ileum are lined with villi, covered with delicate 
absorptive tissue. The absorptive cells are large, cylindrical structures containing a basal nuclei and an 
apical membrane covered in microvilli (Hill, 1976). Villi contain undifferentiated cells that have the 
ability to undergo mitotic division and form the precursors to absorptive cells. These can in turn 
migrate either up the villus or down into the neighbouring crypts of Lieberkühn as required by the 
bird. 
 
1.4.8 Large Intestine – Caeca and Colon 
The large intestine of an adult broiler is approximately 20cm in length (Calhoun, 1954). The caeca are 
a pair of blind ended sacs that sit at the junction of the small and large intestine. The caeca provide a 
home to a host of microorganisms which enjoy a symbiotic relationship with the bird. The microbial 
population degrade undigested nutrients via fermentation and produce metabolites during this 
process that can in part be absorbed by the caeca. Metabolites can also play a vital role in the balance 
and maintenance of the microbial population of the gut as a whole. Metabolites such as butyrate are 
available as a nutrient source for bacterial populations which are thought to be beneficial to the 
health of the bird (Bedford and Gong, 2018). 
The ileo-caecal-colonic junction is a sphincter that controls the flow of chime between the colon and 
caeca. Retro peristalsis is utilized. The sphincter relaxes when the ileum distends to allow colonic 
movement. Once movement is possible, the colon distends and contracts to move digesta towards 
the caeca or cloaca (depending on peristaltic direction). As commercial broilers have constant access 
to food and water, the caeca replenish frequently with evacuation occurring from a strong distal end 
contraction. The frequency of caecal emptying varies with pH, electrolyte activity, diet and caecal 
distention (Scholey, 2012). Nutrient digestion is minimal in the large intestine (Larbier and Le Clercq, 
1994). A schematic of the chicken gastrointestinal tract is shown in figure 1.2. 
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Figure 1.2 – Gastrointestinal tract of the chicken 
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1.5 Antibiotic growth promotors 
In recent decades the broiler production industry has routinely utilized antimicrobial compounds at 
sub therapeutic doses as both a prophylaxis for disease and as a growth promoter (Singer and 
Hofacre, 2006). This usage has allowed the industry to improve production output and reduce disease 
related losses. However, in 2006, the EU enacted a ban on the use of antibiotics for any purpose 
other than therapeutic uses (European Commission, 2005) due to concerns surrounding widespread 
antimicrobial cross resistance and multiple antibiotic resistance to pathogenic bacteria in both 
humans and animals (Hajati and Rezaei, 2010).  
The historical use of antimicrobials allowed the industry to utilize sub-optimal ingredients and ration 
formulations without negative effects on performance or liveability. Studies from the 1960’s showed 
that maize inclusion in broiler diets could be replaced with barley and rye, if the birds were 
supplemented with sufficient levels of antibiotics (Bedford, 2019) . The addition of antibiotic growth 
promotors (AGP) compensated for numerous anti-nutritional factors and often sub-optimal 
management and environmental conditions (Enberg et al., 2000; Mehdi et al., 2018). The EU ban 
forced producers to seek alternative strategies to support the health and growth of broilers. One of 
the main benefits of AGP was considered to be the modulation of intestinal microbiota. The exact 
mechanism remains unclear, but Dibner and Richards, (2005) suggest that AGP work by modulating 
microbiota diversity and relative abundance in the GIT to provide optimal conditions for bird growth 
(Bedford, 2000; Fung et al., 2013).   
The ban, and the widespread opinion that the current ban is likely to be extended to prevention of 
any antibiotic use, has led to an exponential growth in research looking at the health and microbial 
population of the GIT.  
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1.6 Gut Health 
Ensuring effective poultry production relies on a number of factors including; genetic potential of the 
birds, optimal nutrition, good management and environmental conditions and disease prevention 
(Szollosi et al, 2014; Sugiharto, 2016). However, the genetic potential of the birds can only be 
achieved by the efficient conversion of fuel into its key components for maximum nutrient 
absorption. One method of optimising this conversion is to maximise gut health potential (Sugiharto, 
2014). 
The gut is a pivotal, multi-faceted organ. It regulates the uptake of nutrients and how these nutrients 
are metabolised and utilised, as well as being the largest immunological organ in the body of most 
animals (Kogut, 2013). Paradoxically, the gut is also one of the main sites for exposure to external and 
environmental pathogens (Yegani and Korver, 2014). It has been understood for some time now that 
the microbial population of the gut can play a substantial role in the performance and health status of 
animals (Choct, 2007; Awad et al., 2009), with associated financial implications on the poultry sector. 
The gut has been shown to be involved in body weight and energy homeostasis and on the 
development and maturation of both the adaptive and innate immune systems (Kogut, 2008, 
Sugiharto, 2014, Muir et al., 2000, Brisbin et al., 2008).   The microbial populations of the  gut are 
highly diverse in chickens, with each species producing different metabolic products such as 
fermentation acids and various gases (Onrust et al., 2015). 
As such, the development of strategies to manipulate the microbial community of the gut are key to 
supporting gut health.  
 The gut has three primary interactions 
1. The intestinal epithelium and associated neuroendocrine connections 
2. The immune system 
3. Commensal microbiota 
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The study of gut health has its origins in human medicine. Studying health of the avian gut is a highly 
complex amalgam of disciplines including microbiology, nutrition, immunology, and physiology. The 
results of poor gut health may be detrimental, impacting not only on the welfare of the bird, but also 
on the efficacy of production (Yegani and Korver, 2008). Reasons cited for poor gut health include 
stress (oxidative and environmental), dietary protein sources which are poorly digestible, diseases 
such as coccidiosis, and the routine use of antimicrobial drugs such as antibiotics (Dibner and 
Richards, 2005). The mitigation of these issues can only be achieved by a holistic approach which has 
to be a combined effort from farmers, scientists, nutritionists, and commercial feed companies. 
Of additional note is the impact that the gut health of broilers can have on human health. Pathogenic 
gastrointestinal diseases of the chicken such as Salmonella, Campylobacter, Listeria, and Clostridium 
can also infect humans, causing severe gastroenteritis and even death. As such, preventing the 
colonisation of these pathogens in the gut of the chicken can also prevent human disease (Eeckhaut 
et al., 2008). Gastrointestinal pathogens such as these can often survive in the chicken during life  
without causing outward signs of illness Post-mortem, pathogens can easily transfer into the human 
food chain.  
An influx of poultry gut health research has been seen in recent years, mainly due to the perceived 
impact on production. However, more recently research has shifted toward examining the role of 
poultry gut health as a limiting factor in the sustainable production of food to feed an exponentially 
expanding population (Burton et al, 2016; Roosendaal and Wahlstrom, 2016; Van der Aar et al., 2016) 
 
1.7 Gastrointestinal dysbiosis 
The historical use of antibiotic growth promoters and subsequent ban in 2006 has led to gut health 
problems in broilers such as gastrointestinal dysbiosis  - an imbalance of gastrointestinal bacteria 
(Onrust et al., 2015).  Controlling this dysbiosis without the use of antimicrobials is difficult and 
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requires thorough knowledge and understanding of the microbial populations within the gut, and the 
interactions between these microbes and the gut mucosa of the host (Onrust et al., 2015). 
The microbial composition of the gastrointestinal tract is diverse and variable. Variation can occur for 
numerous reasons including host diet, health status, biosecurity, housing and environmental 
conditions (Onrust et al., 2015). Dysbiosis occurs when there is an overgrowth of a given 
microorganism, causing competitive exclusion of other microbial species (Belisarius and Faintuch, 
2018). This causes an imbalance of microbiota and therefore microbial function. Gut microbiota exert 
vital functions that in combination maintain homeostasis (Peterson et al., 2015; Belizario and 
Faintuch, 2018). These vital functions include regulation of innate and adaptive immune function, 
digestion, xenobiotic metabolism and numerous signalling pathways (Peterson et al., 2015). There can 
be a number of causative factors that affect dysbiosis including the use of antibiotics, antifungals, 
poor diet, disease, and oxidative status (Peterson et al., 2015; Belizario and Faintuch, 2018; 
Dumitrescu et al., 2018).  
 
1.8 The role of the gut epithelial in gut health 
The internal gut wall (luminal side) is covered with epithelial cells with absorptive properties that 
facilitate both nutrient and water uptake (Eeckhaut et al., 2008). This provides a semipermeable wall 
between the lumen and the body cavity. This wall is comprised of epithelial cells, intersected with 
tight junctions that serve as a connection between the epithelial cells (Eeckhaut et al., 2008).  
The permeability of the epithelial lining can be affected by things such as luminal signalling and cell 
death. Luminal signalling can increase permeability by loosening the tight junctions which can 
adversely affect the host. The loss of integrity caused by this increased permeability can allow an 
efflux of host proteins into the gut, potentially leading to toxins and microorganisms reaching the 
luminal side of the gut epithelium, resulting in a condition termed “leaky gut” (Eeckhaut et al., 2008). 
Oxidative stress has been shown to damage tight junctions (Anderson and Itallie, 1995).  Studies 
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suggest that interaction between the mucosa and enteric microbes can result in the production of 
reactive oxygen species and consequently lead to oxidative stress (Naidoo et al., 2008). Damage 
caused to the intestinal epithelium can deleteriously affect and destroy the barrier function and tight 
junctions, leaving the gut vulnerable to pathological disease, and the host open to systemic infection 
from the microbial population of the gut (Mishra and Jha, 2019). 
 
1.9 The Gut-brain axis 
It has become recognized recently that a vital pathway exists between the gut and the brain (Calefi et 
al., 2016; Dumitrescu et al., 2018). This so-called “gut-brain axis” is responsible for physiological 
regulation and signalling pathways. Communication between the gut microbiota, enteric nervous 
system and the brain acts as an interface between the host and its environment (Carabotti et al., 
2015) (Figure 1.3). The gut-brain axis is a humeral pathway between the intestinal epithelium, portal 
and systemic circulations, the blood-brain barrier, neuroendocrine-immune network and nervous 
system (Dumitrescu et al., 2018). In broilers the gut-brain axis has been found to mediate and 
modulate behavioural and immune responses, meaning that the effects of environmental stressors 
such as heat stress and stocking density can ultimately affect gut immune and gut health parameters 
(Calefi et al., 2016; Rana, 2018). It is therefore possible that modulating the GIT with pre or probiotics 
may have more implications than just improving gut health. 
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Figure 1.3 - Schematic of the gut-brain axis (Rana, 2018) 
 
1.10 Gut permeability 
The GIT plays a key role in protecting the host from enteric pathogens (Vicuna et al., 2015). Therefore, 
integrity of this barrier function is vital to prevent disease and maintain optimal production. The 
mucosal layer comprises of tight junctions situated between epithelial cells and gut-associated 
lymphoid tissue. This barrier maintains homeostasis between dietary antigens, enteric pathogens and 
beneficial microbiota (Van Der Hulst et al., 1998). Damage or disruption to barrier integrity can result 
in increased permeability and loss of barrier function. Yarandi et al., (2016) reported that increased 
gut permeability can facilitate systemic translocation of gut bacteria and/or the metabolites of gut 
microbiota  from the intestinal lumen. The exposure of epithelial or mucosal cells to this bacteria or 
metabolic products can trigger an immune response and subsequent production of pro-inflammatory 
cytokines. Stress (including oxidative) can lead to the hypothalamus-pituitary axis being activated and 
subsequent excessive release of corticotropin-releasing factor. Consequently, this hormone can 
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modulate local activation of mast cells in the intestinal wall, releasing cytokines that cause increased 
permeability of the gut epithelium (Yarandi et al., 2016) (Figure 1.4). Increasingly, there is a link being 
made between the gut’s microbiota and oxidative stress. 
 
 
Figure 1.4 Two-way interaction between gut microbiota, gut permeability and the central nervous 
system (adapted from Yarandi et al., 2016) 
 
 
1.11 Oxidative stress 
1.11.1 Free radicals and reactive oxygen species 
Oxidative stress can be defined as an imbalance in the production of reactive oxygen species (ROS) 
and free radicals and the antioxidant defences of the body (Betteridge, 2000). Free radicals are 
naturally occurring, highly unstable molecules that are formed during normal aerobic metabolism 
(Sies, 1996). They are a chemical species that possess an outer electron orbital and a single unpaired 
electron that increase the reactivity of an atom or molecule (Dugan and Choi, 1999; Betteridge, 
2000). Most ROS are unstable and will donate the unpaired electron to neighbouring molecules or 
seek a hydrogen atom in order to pair it with their free electron (Dugan and Choi, 1999). However, 
some ROS can persist for extended periods of time. The process of reactivity allows oxygen to 
participate in high-energy electron transfer and production of adenosine-5-triphosphate (ATP) via 
oxidative phosphorylation. Whilst this process is vital in the evolution of multicellular organisms, it 
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also has the propensity to attack biological molecules such as lipids, proteins, and DNA (Burton and 
Jauniaux, 2011). Exposure to exogenous free radicals is also possible through environmental contact 
with air pollution, sunlight and substances such as cigarette smoke (Burton and Jauniaux, 2011).  
The production of endogenous free radicals is intrinsic to normal metabolic process such as cell 
respiration, phagocytosis of foreign bodies, lipid synthesis and metal metabolism and in low and 
moderate numbers, they actually play a number of beneficial roles (Gagne, 2014; Pizzion et al., 2017). 
Free radicals are required in order to synthesize various cellular structures and are also used by the 
host’s immune system to mount a defence (Pizzion et al., 2017). Phagocytes both synthesize and 
store free radicals and use them to overcome invading pathogens (Pizzion et al., 2017). Some cellular 
signalling pathways are also regulated by free radicals including endothelial cells, fibroblasts, vascular 
smooth muscle cells, thyroid cells and cardiac myocytes (Pizzion et al., 2017). Conversely, free radicals 
play a vital role in the innate immune system, effectively mitigating inflammation (Dumitrescu et al., 
2018). One of the most elucidated free radical signalling molecules is nitric oxide. Nitric oxide acts as a 
cell-to-cell messenger that modulates blood flow and is vital for normal neural activity (Pizzion et al., 
2017). Additionally, nitric oxide is involved in the elimination of intra-cellular pathogens and tumour 
forming cells. As such, free radicals remain vital for the health and wellbeing of the host, however in 
excess they can be highly damaging, and this balance needs to be maintained. 
1.11.2 Oxidative Stress 
When free radical production overwhelms intrinsic anti-oxidative defences, oxidative stress may 
occur. Oxidative stress is a damaging process that effects a number of cellular structures including 
membranes, lipids, proteins, lipoproteins and DNA (Pizzino et al., 2017). Polyunsaturated fatty acids 
(PUFA) are at particular risk. Oxidative damage to PUFA is classified as lipid peroxidation, and this 
process is particularly damaging as it triggers a self-perpetuating chain reaction. At higher levels, 
indiscriminate damage to biological molecules including cytotoxicity, genotoxicity, carcinogenesis and 
cell death (tissue damage) may occur (Burton and Jauniaux, 2011; Gagne, 2014). An example of this 
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process is when hydroxyl radicals and peroxynitrite arise in excess causing lipid peroxidation. This 
damages cell membranes and lipoproteins and subsequently leads to the formation of 
malaondialdehyde (MDA) and conjugated diene compounds. These are known to be mutagenic and 
cytotoxic. Due to this process being a radical chain reaction, lipid peroxidation will promptly spread to 
affect large quantities of lipidic molecules (Pizzino et al., 2017). Likewise, proteins damaged by 
oxidative stress have been found to undergo morphological and conformational changes that can 
cause loss and/or damage to their enzyme production and activity (Pizzino et al., 2017). 
DNA is particularly at risk to lesions caused by oxidative stress. Nishida et al., (2013), found that 
oxidative stress can be responsible for mutagenesis and loss of epigenetic tagging or information.  If 
oxidative stress is not detected and controlled it has been found to be a causative factor in a number 
of degenerative and chronic diseases in humans such as cancer, cardiovascular disease, various 
neurological diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, rheumatoid arthritis, kidney 
disease, and depression (Pizzino et al., 2017).   
Conversely, oxidative stress also plays a role in maintaining homeostasis of the central nervous system 
(Dumitrescu et al., 2018). Oxidative stress levels are monitored and when present in excess, trigger a 
negative feedback reaction to attempt to return to manageable levels. The level of free radicals 
circulating in the body is controlled by antioxidants, originating both from internal (produced in 
response to the presence of ROS )and external processes (such as heat stress) and sources  such as 
oxidised lipids in the food supply.(Mironczuk-Chodakowska et al., 2018). 
 
1.11.3 The effect of oxidative stress in broilers 
The main causes of oxidative stress in broilers appear to be heat stress and diet composition although 
there is also a pre-disposition in some birds as a result of heavy genetic selection (Fellenberg and 
Speisky, 2006; Sihvo et al., 2013). However, the challenging conditions of commercial production such 
as growth rate, stocking density, heat requirements, handling, pre-slaughter stress and the provision 
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of oxidized oils within the ration all increase the possibility of oxidative stress occurring (Enberg et al., 
1996; Sihvo et al., 2013; Ismail et al., 2013; Estevez, 2015). Oxidative stress not only effects the bird, 
but also negatively impacts the quality, palatability and nutritional of the meat (Estevez, 2015; Grady 
et al., 1996). It is also of importance to the producers as it as has been shown to cause inhibited 
growth in broilers (Fellenberg and Speisky, 2006). 
Heat stress is widely documented to increase lipid oxidation and downstream negative effects on 
meat (Fellenberg and Speisky, 2006; Zhang et al., 2011; Sihvo et al., 2013; Ismail et al., 2013). 
However, reducing the ambient temperature of animal houses and reducing stocking density are not 
generally practical due to the loss of growth performance from the increased energy required for 
thermoregulation.  
Diet composition is the other well-cited cause of oxidative stress (Manilla and Husveth, 1999). The 
dietary inclusion of either fish meal or oil has historically been used for poultry diets as a protein and 
energy source due to its superior amino acid profile and lack of anti-nutritive factors (Frempong et al., 
2019). However, the oil component of broiler diets is the most prone to oxidation and therefore the 
most prominent dietary cause of oxidative stress. 
 
 
1.11.4 The effect of oxidative stress on poultry gut health 
The continual genetic selection of broilers has enabled modern birds to absorb substantial quantities 
of nutrients via the intestinal epithelium (Mishra and Jha, 2019). Reactive oxygen species are 
generated by intestinal epithelial cells as a by-product of normal oxygen metabolism and are also 
produced in direct response to enteric commensal bacteria. Oxidative stress in broilers can be a result 
of nutritional, environmental or pathological factors, all of which can negatively impact performance 
and health as well as meat and egg quality (Fellenburg and Speisky, 2006).  
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Tight junctions are situated between intestinal epithelial cells acting as a barrier to prevent 
microorganism invasion (Anderson and Itallie, 1995).  Studies suggest that interaction between the 
mucosa and enteric microbes can result in the production of reactive oxygen species and 
consequently oxidative stress (Naidoo et al., 2008). Damage caused to the intestinal epithelium can 
damage or destroy the barrier function and tight junctions, leaving the gut vulnerable to pathological 
disease and the host open to systemic infection from the microbial population of the gut (Mishra and 
Jha, 2019). It is also suggested that oxidative stress can affect the composition and functionality of the 
microbial community in the gut (Dumitrescu et al., 2018). As anaerobes thrive in the presence of 
electron acceptors (such as free radicals), it can increase the possibility of potentially pathogenic 
bacteria reaching systemic circulation (Dumitrescu et al., 2018).  
 
1.11.5 Oxidative effects on chicken meat 
 Oxidative stress is also thought to have profound effects on meat quality and shelf-life. Post-mortem, 
chicken meat is particularly vulnerable to oxidative processes due to the degree of unsaturated lipids 
within the muscle. Post-mortem oxidation (lipid and protein) dramatically affects the shelf life and 
quality of the final meat product. Modern production means that meat is often transported large 
distances for sale and as such, reduced shelf life represents significant financial losses. A number of 
external factors can also affect the levels of oxidative reactions. Physiological damage and 
psychological stress prior to and during the slaughter process may have an effect on the oxidation of 
poultry meat (Min and Ahn, 2005). Likewise, meat handling (aging, tenderizing, shortening, deboning), 
storage (temperature, time and oxygen exposure) and preparation (deboning, adding additives and 
cooking) can accelerate this process. Rancidity and poor flavour are generally attributed to the effects 
of lipid and protein oxidation (Min and Ahn, 2005, Lund et al., 2011) and these are obviously 
undesirable to the end consumer. 
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 White striping, spaghetti breast and woody breast are emerging challenges facing the broiler 
industry. These novel myopathies started to appear around 10 years ago and until that point were 
entirely unknown (Petracci et al., 2019). The financial impact of these are expected to result in $200 
million to $1 billion economic losses to the US broiler industry alone (Huang and Ahn, 2018), as they 
make the meat unacceptable and it is downgraded for pet food use. Whilst the mechanism for these 
conditions is largely still poorly understood, all three conditions have been linked to the oxidative 
status of the bird (Petracci et al., 2019). 
 
1.11.6 White striping  
White striping the presence of distinctive white striation throughout the breast meat. The pectoralis 
major is most commonly affected, but white striping is sometimes seen in the pectoralis minor 
(Petracci et al., 2019). White striping has been widely associated with increased growth rate and body 
weight (Kuttappan et al., 2012).  Under microscopic examination breast meat affected with white 
stripe reveal accumulation of lipids, lysis of muscle fibres, inflammation, loss of cross striation and 
proliferation of connective tissue (Kuttappan et al., 2013; Huang and Ahn, 2018). Affected meat has 
been found to show reduced marinade uptake, increased water loss during cooking and reduced 
consumer acceptance (Kuttappan et al., 2013; Mudalai et al., 2014). Whilst there is no threat to 
human health from consumption of affected meat, the tabloids and other press have published 
reports of affected meat containing up to 224% more fat than unaffected, further reducing consumer 
acceptance. White striping has been reported to affect up to 50% of British breast meat (Petracci et 
al., 2019). Causative factors are thought to include rapid growth and body weight gain, heavy genetic 
selection for fast growing strains, genetic mutations and oxidative stress (Petracci et al., 2019). 
 
 
25 
 
1.11.7 Spaghetti meat 
It is still debated whether spaghetti breast/meat is related to white striping (Petracci et al., 2019). 
However, this myopathy is characterized by a separation of bundles of muscle fibres, generally 
located in the in the cranial region of the breast muscle (Baldi et al., 2018; Soglia et al., 2018) (figure 
1.6). Intramuscular connective tissue comprises of three sections; endomysium, perimysium and 
epimysium that cover individual muscle fibres and the entire muscle (Huang and Ahn, 2018). In the 
presence of spaghetti meat, the connective tissue of the endomysium and perimysium progressively 
decrease in density. As such, the bundles of muscle fibres disintegrate and become soft with the 
appearance of spaghetti (Huang and Ahn et al., 2018). It is still unclear whether this condition occurs 
pre or post-mortem but is thought to effect around 20% of British chicken breast (Petracci et al., 
2019). As with white stripe, the causative factors are generally considered to be rapid growth, genetic 
selection/changes and/or oxidative stress (Petracci et al., 2019; Kuttappan et al., 2012).  
 
Figure 1.6 – The spaghetti breast myopathy found in broiler meat 
 
1.11.8 Woody breast 
As with white stripe and spaghetti meat, woody breast is generally considered to be caused by heavy 
genetic selection for fast growing strains, and by oxidative stress (Huang and Ahn, 2018). Woody 
breast is characterized by hard and rigid muscle that can appear as bulged and display a surface 
haemorrhage and/or a pale-yellow viscous exudate on the surface of the muscle (Mazzoni et al., 
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2015). The pH of the meat is also higher than found in a normal muscle tissue and extensive lipidosis 
and fibrillar collagen deposition is present (Chatterjee et al., 2016). Woody breast begins as focal 
legions before spreading as a diffuse form throughout the breast as the age of the bird increases 
(Soglia et al., 2016). 
 
1.12 Nutritional interventions to improve gut health and oxidative status 
1.12.1 Antioxidants 
Antioxidants are substances or compounds that prevent or inhibit the damaging effect of excess free 
radicals (Gagne, 2014). Antioxidants can be categorized in several ways. Firstly, antioxidants can be of 
either endogenous or exogenous origin. Can be either naturally occurring or synthetic (Fellenburg and 
Speisky, 2006). However, the most common method of categorization is either enzymatic or non-
enzymatic. Enzymatic antioxidants work by degradation and removal of free radicals (Nimse and Pal, 
2015). They convert reactive oxygen species to hydrogen peroxide and then to water during a multi-
step process utilizing cofactors including copper, zinc, iron and manganese (Dugan and Choi 1999, 
Nimse and Pal, 2015). Non-enzymatic antioxidants include substances such as vitamin C, E, plant 
polyphenols, carotenoids and glutathione (Nimse and Pal, 2015). These work by interrupting the chain 
reactions of free radicals.  
Alternatively, antioxidants can be categorized their solubility in either water or lipids. The water-
soluble antioxidants such as vitamin C are predominantly found within cellular fluids including cytosol 
or cytoplasmic matrix. Whilst the lipid-soluble antioxidants such as carotenoids, vitamin E and lipoic 
acid are generally found within the cell membrane (Nimse and Pal, 2015; Mironczuk-Chodakowska et 
al., 2018). 
 Finally, antioxidants can be categorized by molecular size.  Small-molecule antioxidants such as 
vitamin C and E, carotenoids and glutathione are responsible for neutralizing radical oxygen species 
(scavenging) and then removing them. Whereas large molecule antioxidants (the enzymes and some 
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sacrificial proteins such as albumin) absorb reactive oxygen species, preventing the attack of essential 
proteins (Nimse and Pal., 2015; Mironczuk-Chodakowska et al., 2018) (Figure 1.8). 
 
Figure 1.8 - The biologic mechanisms of antioxidant protection (Source: de la Vega-Monroy, 2013) 
Picture not included due to lack of permission 
 
1.12.2 The effect of dietary antioxidants on broilers 
As dietary antioxidants are absorbed in the gut, they have the potential to assert a systemic effect on 
the bird (Fellenburg and Speisky, 2006). Supplementing broilers with antioxidants has been found to 
have a number of beneficial effects, not only on the birds, but also on the meat entering the human 
food chain (Fellenburg and Speisky, 2006). When looking at the literature for broilers, vitamin E is 
possibly the most heavily studied exogenous antioxidant. Deficiencies of vitamin E have been shown 
to cause a large number of negative effects, including breast meat being more susceptible to 
membrane lipo-peroxidation   Supplementing broilers with the antioxidant glutathione peroxidase 
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and Selenium has been shown to protect capillary cells from the potential damage of lipo-peroxyl 
radicals (Noguchi et al., 1973). Vitamin E residing within the membrane can then serve as a second 
line of antioxidant defence, averting propagation of the lipo-peroxidative chain. If the bird is deficient 
in either vitamin E or Se, antioxidant mechanisms fail to work and could therefore allow lipo-
peroxidation and its deleterious disease effects to ensue (Noguchi et al., 1973).  
Of the synthetic antioxidants ethoxyquin, butylated hydroxytolulene (BHT) and butylated 
hydroxyanisole are probably the most commonly used in the animal feed industry (Fellenburg and 
Speisky, 2006; Salami et al., 2015). Ethoxyquin has been demonstrated to produce significant 
increases in BWG before 4 weeks of age (Waldroup et al., 1961, Wang et al., 1997), and reduced level 
of tissue lipid peroxidation. Dibner et al.,(1996) demonstrated the benefits of supplementing broilers 
with  ethoxyquin, showing increased villus length and surface area in the small intestine of birds fed 
oxidised fat. Likewise, ethoxyquin is believed to prevent the oxidation of the lipids and lipid soluble  
portion of the feed ration (Cabel and Waldroup, 1989). 
BHT is a monophenolic fat-soluble antioxidant that is stable at high temperatures. BHT has been 
shown to have numerous beneficial effects, including chemoprevention (Hocman, 1988),protective 
effects against hepacarcinogenocity (Williams and Latropoulos, 1996) and protection against some 
classes of mycotoxins (Larsen et al., 1985) Singh et al. (2019) demonstrated the efficacy of BHT for 
ameliorating aflatoxicosis. These authors fed broilers fed a maize-rice-soy diet with maize infected 
with aflatoxin (form of mycotoxin). It was found that birds given BHT at 1000ppm and 2000ppm 
showed significantly increased BWG, FCR and improved metabolic responses to aflatoxin exposure. 
BHT is often fed in combination with BHA as they work synergistically together (Salami et al., 2015). In 
combination BHT and BHA act as chain reaction terminators and are particularly effective at 
preventing the lipid oxidation of fats/oils present in broiler diets. BHT and BHA  has been 
demonstrated to have protective effect the final meat product (Fellenburg and Speisky, 2006). Lin et 
al. (1989) demonstrated that birds fed diets supplemented with a mixture of BHT and BHA showed 
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significantly increased BWG during production and the chicken meat had better oxidative stability 
compared to a control diet without antioxidants.  
 
1.12.3 Probiotics 
A normal gastrointestinal tract has a mix of bacteria, both beneficial and potentially pathogenic in 
nature. In optimum conditions, this balance would be tipped towards a higher percentage of 
beneficial microbes. Unfortunately, in modern commercial broiler production, conditions are rarely 
optimal, and therefore a number of challenges exist leading to sub-optimal gut health. Chicks begin 
life with a sterile GIT and bacterial colonisation occurs post hatch. Commercial broilers are hatched in 
a hatchery, away from the parent birds. Due to stringent hygiene standards in a commercial hatchery 
and the fumigation or washing of eggs, there is limited contact and exposure to the commensal 
bacteria of the parent that would naturally start the initial colonization of the chicks GIT (Varmuzova 
et al., 2016). Likewise, it has been shown that the stress of transport and move to new housing can 
negatively affect the microbial balance of the gut. Research has shown that exposing chicks to 
probiotic bacteria can aid optimal bacterial colonisation of the GIT (Pan and Yu, 2014). 
 The term probiotic is derived from the Greek ‘for life’. Currently pro-biotic is used to cover any 
bacteria deemed to provide a positive effect on health. 
The World Health Organization defines probiotics as “live microorganisms which when administered 
in adequate amounts confer a health benefit on the host”(WHO, 2002) ; in order to be labelled a 
probiotic, scientific evidence for health benefit has to be documented. Probiotics are often a mono or 
mixed culture of live microorganisms, which are often of lactic acid bacteria descent. These include 
bifido bacteria, lactobacilli or lactococcus, streptococcus and a variety of yeast species. These 
indigenous bacteria are considered beneficial to gut health due to their ability to inhibit growth of 
pathogenic bacteria (Patterson and Burkholder, 2003). Mechanisms by which this is achieved include; 
outcompeting pathogenic bacteria for resources such as nutrients and space, decreasing the pH of 
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the gut causing environmental acidification via rapid production of volatile fatty acids (VFAs) such as 
acetate or lactate, or by producing compounds which can act as an antimicrobial, such as bacitracin 
(Hill et al, 2014), thereby inhibiting the growth of potentially pathogenic bacteria. It has also been 
found that administration of probiotics can also stimulate the immune system (Dong et al., 2012). 
Alternative strategies to stimulate these indigenous beneficial bacteria are by providing a substrate to 
essentially selectively provide nutrients to the beneficial bacteria, thus improving their chances of 
increased colonization. This can be achieved through the use of prebiotics. 
1.12.4 Prebiotics 
Prebiotics are one of the primary groups of compounds that are being considered as potential 
alternatives to antimicrobials. Prebiotics have been defined as “a non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria in the colon” (Roberfroid et al., 2010). 
Unlike probiotics, prebiotics are compounds that can be metabolized by one or a limited number of 
beneficial bacteria in the gut, inferring a competitive advantage to the given bacteria. It has been 
suggested that providing probiotics alone may be less successful, as without nourishment the live 
microorganisms may not survive well enough to infer any benefit. One option identified is to 
supplement the diet with both pro and prebiotics in the form of a symbiotic. Thus, providing some of 
the nutritional requirements of the microorganisms at the same time as adding the bacteria, in order 
to aid their colonization in the hindgut. 
Prebiotics are thought to have the following modes of action; 
1. Lower the intestinal pH by stimulating bacterial production of VFAs (Chio et al, 1994) 
2. Inhibiting and/or preventing colonization of pathogenic bacteria (Bengmark, 2001). 
3. Modifying metabolic activity of indigenous intestinal flora. 
4. Stimulation of the immune system 
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Prebiotics provide a selective substrate for microflora in the gastrointestinal tract. This substrate 
provides nutrients that can be metabolized by selected organisms considered beneficial to gut health, 
thus allowing beneficial gut micro flora to flourish and aid their colonization in the hindgut (Hajati and 
Rezaei, 2010). Microbes that are considered to be beneficial to the host enjoy a mutualistic 
relationship with the host providing anaerobic shelter and nutrients for the bacteria. In return, these 
beneficial bacteria produce enzymes that aid degradation of various complex molecules including 
polysaccharides (Onrust, 2015).  
Prebiotics are generally carbohydrate based, including inulin, lactulose and oligosaccharides such as 
fructo-oligosaccharides and galacto-oligosaccharides (Hernandez-Hernandez et al., 2012). These 
prebiotics have the ability to aid the proliferation of lactobacilli and bifido bacteria. These  bacterial 
species are of particular interest due to their metabolites which include an abundance of short chain 
fatty acids such as lactate and butyrate (Kanauchi et al., 1999). 
1.12.5 Exogenous enzymes 
One strategy for supporting the growth and performance of broilers is the use of exogenous enzymes. 
This practice is the act of supplementing broilers with enzymes that the birds cannot produce 
independently. Exogenous enzymes literally break down larger dietary components into smaller 
pieces. They can allow producers to improve the availability and utilization of nutrients, improve 
intestinal health, gut function, litter quality and  reduce anti-nutritional factors and the environmental 
impact of animal production (Kleyn, 2013). Exogenous enzymes used in broiler production include 
carbohydrases such as xylanase, beta-glucanase that are used to degrade the carbohydrate fraction of 
the feed ration and Phosphatases such as phytase, that is used to release dietary phosphorus, bound 
within phytate in the diet.   There are a wide range of different enzymes on the market for use in 
production animals which serve a variety of purposes. For the purpose of this project only xylanase 
will be discussed in detail. 
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1.12.6 Fibre 
All plant derived animal feed ingredients contain fibre. Dietary fibre is defined as “carbohydrate 
polymers with three of more monomeric units”. These polymers cannot be digested nor absorbed in 
the small intestine of mammals. There are several types of fibre that can all act differently when 
ingested (table 1.1). 
Table 1.1 Types of fibre and dietary sources (adapted from the British Nutrition Foundation, 2020)  
Fibre component Description Dietary sources 
Cellulose Polysaccharides of up to 
10,000 closely packed 
glucose units arranged 
linearly  
Grains, vegetables, fruit, 
cereal grains 
Hemicellulose Polysaccharides containing 
sugars other than glucose 
Cereal grains, legumes 
Lignin A non-carbohydrate 
component associated with 
plant cell walls 
Outer cell walls of cereal 
grains 
Beta-glucans Glucose polymers that have 
branched structure (as 
opposed to linear like 
cellulose) 
Cell walls of oats and barley 
Pectins Non-starch polysaccharides 
common to all cell walls 
Grains, fruit. Vegetables 
legumes and potatoes 
Gums and mucilages Non-starch polysaccharides 
that are gel-forming and 
help keep the structure of 
plants 
Seeds, seaweed extracts 
Resistant starch Starch and the products of 
starch digestion, not 
absorbed by the small 
intestine 
Legumes, potatoes, cereal 
grains 
Oligosaccharides Short chain carbohydrates of 
3-9 monomers. 
Fruits, vegetables,  xylan in 
cereal grains 
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Historically fibre has been avoided in broiler diets due to the perception that it has a diluting effect on 
nutrient availability, reducing feed intake, digestibility and growth performance. However, in recent 
years there has been a paradigm shift towards the industry recognising the value of certain types and 
quantities of fibre in the diet. Choct (2009) demonstrated the value of insoluble dietary fibre as a 
structural component to increase gizzard development and function and a number of other studies 
have demonstrated enhanced nutrient digestibility in birds fed structural components such as fibre, 
whole or coarsely ground grains (Xu et al., 2017; Kheravii et al., 2017; Kimiaeitalab et al., 2017).  
2018. However, not all fibre is beneficial to broilers. Pectins, gums and mucilages are all non-starch 
polysaccharides that tend to have a gel-forming effect in the GOT, increasing the viscosity of digesta 
and reducing nutrient availability (Kimiaeitalab et al., 2017). 
 
1.12.7 Non-starch polysaccharides 
Cereal grains and legumes form the basis of feed rationsof most poultry diets. The fibre component of 
many grains can be comprised mainly of non-starch polysaccharides (NSP) that have been shown to 
elicit significant anti-nutritive effects on monogastric species such as pigs and poultry (Choct, 1997; 
Stef et al., 2010).  NSP levels have been shown to vary from 0.1% in corn flour, up to 37% in wheat 
bran. NSP are derived from the plant cell wall and account for approximately 10% of the whole grain 
in wheat (Pirgozliev et al., 2015). NSP also have a role in the storage of energy (Choct, 1997). NSP can 
be either soluble or insoluble. Both types can have detrimental effects on monogastric livestock 
(Choct, 1997). 
Polysaccharides are polymers of monosaccharides attached by glycoside linkages (Choct, 1997). NSP 
cover a vast range of polysaccharide molecules which comprise of a number of chemical compounds 
including cellulose, arabinoxylans, beta glucans and pectic polysaccharides containing mannans and 
gallactans (Stef et al., 2010) (figure 1.9). 
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Figure 1.9 – The classification of non-starch polysaccharides (Choct et al., 2010,)(Diagram made by 
Desbruslais, 2020) 
 
1.12.8  The anti-nutritive effect of NSP 
The anti-nutritional effects of NSP can be diverse and at time severe (Choct, 1997). The majority of 
detrimental effect of NSP are associated with the viscosity, modulation of the intestinal microbiota 
and physical and morphological effects on the intestinal tract.  
Non-starch polysaccharides can be viscous by nature, with viscosity varying by solubility and 
molecular weight (Choct, 1997). Viscosity effects are mainly caused by the uptake of water in the 
digestive tract by soluble NSP, causing them to become gelatinous and highly viscous (Rosicka-
Kaczmarek et al., 2017). This can in turn reduce the rate of diffusion between endogenous digestive 
enzymes and digesta, reducing active interaction on the mucosal surface (Edwards et al., 1988). The 
glycocalyx of the intestinal brush boarder can interact with NSP, causing thickening to the rate-
limiting unstirred water layer of the intestinal mucosa, which directly inhibits nutrient absorption via 
Non-Starch Polysaccharides 
Cellulose Non-cellulosic 
Polymers 
Pectic Polymers 
Insoluble in water, 
alkali or dilute acids 
Arabinoxylans 
mixed-linked beta 
glucans, mannans, 
galactans, 
xyloglucan, fructans 
Polygalacturonic acids 
which may be 
substituted with 
arabinan, galactan and 
arabinogalactan 
Partially soluble in 
water 
Partially soluble in 
water 
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the intestinal wall (Johnson and Gee, 1981). This in turn can decrease feed intake and body weight 
gain. Cowieson, (2010) suggests that up to 400-450kcal (1.67-1.88 MJ) of digestible energy per kg of 
feed can be lost due to the effects of NSP in corn/soy-based diets.  The increased viscosity of the 
digesta reduces the transit time through the gut, consequently increasing the time in which 
undigested nutrients can be utilized for pathogenic microbial propagation (Raza et al., 2019)  
Prolonged consumption of soluble NSP has been associated with increased secretion of digestive 
juices and an enlargement of digestive organs, generally convoyed with reduced nutrient digestibility 
(Choct, 1997). Insoluble NSP can also prevent the contents of plant cells from being accessed by 
endogenous enzymes, consequently reducing the digestibility of nutrients such as protein and amino 
acids (Halas and Babinszky, 2014). The insoluble NSP can also be responsible for reducing transit time 
in the large intestine, preventing optimal water resorption (Halas and Babinszky, 2014) 
1.12.9 Xylanase 
Xylanases are hydrolytic exogenous enzymes from the glycanase family (Xylanases and B-glucanases). 
Xylanases cleave the β1,4 backbone of the complex plant cell wall polysaccharide xylan (Collins et al., 
2005). Xylanases are found in a number of forms, which vary in mode of action, substrate specificities 
and hydrolytic activities. Xylanases catalyse the endohydrolysis of 1,4 –β-D- xylosidic linkages in xylan 
and are involved in the production of xylose, one of the primary carbon sources for plant metabolism 
(Collins et al., 2005). Xylanases can be derived from a number of sources including bacteria, algae, 
fungi, protozoa, arthropods and gastropods.  
Exogenous xylanase has been routinely added to poultry diets for the last 20 years (Cowieson and 
Masey O’Neil, 2013).  The addition of xylanase has been demonstrated to improve performance by 
between 2-4% when compared to un-supplemented birds.  It has been shown that these 
improvements are consistent when used in diets high in viscous grains such as wheat, oats, barley, rye 
and triticale. However, improvements are less consistent in diets containing sorghum and maize 
(Cowieson and Masey O’Neil, 2013, Bedford and Cowieson, 2012). 
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The mode of action for exogenous xylanase has been extensively studied, but still not fully elucidated. 
Four potential mechanisms have been suggested for the beneficial effects of xylanase on reducing the 
apparent anti-nutritional effects of viscous grain-based diets (Bedford and Schulze, 1998; Wu et al., 
2004 Bedford, 2018). 
1. Viscosity effect – xylanase reduces the viscosity of digesta  by degrading long chain 
polysaccharides via hydrolysis of the soluble high molecular weight pentosans found in 
highly viscous cereal grains (Gonzalez-Ortiz, 2016) 
2. Cage effect (cell wall mechanism) – xylanase degrades the cell wall of cereal grains releasing 
encapsulated nutrients. This increases the diffusion of nutrients, substrates and enzymes 
enabling the host better utilize nutrients in the ration (Bedford and Autio, 1996) 
3. Pre-biotic effect – xylanase degrades AX present in the diet into oligosaccharides which can 
be used a nutrient source by saccharolytic microbes in the gut (Bedford, 2018,Craig, 2019) 
4. Signalling effect – xylanase stimulates microbes in the gut to produce xylanase in situ which 
can subsequently increases the hydrolysis of AX into AXOS and XOS which can then be used as 
a nutrient source by saccharolytic microbes in the gut (Bedford, 2018).  
 
 It is widely agreed that xylanase plays an active role in cleavage and degradation of the cell wall 
matrix in the NSP fraction of viscous grains, reducing xylans in the diet down to xylose (figure 1.10).  
Probably the most demonstrated mechanism of xylanase is the reduction of digesta viscosity (Choct, 
1998). Xylanase aids the degradation of long chain polysaccharides by way of hydrolysis of the soluble 
high molecular weight pentosans found in highly viscous cereal grains. This therefore improves the 
rate of diffusion between substrates and enzymes, allowing endogenous digestive enzymes to access 
nutrients more readily (Bedford, 2000, Cowieson and Massey O’Neill, 2013). This reduction in digesta 
viscosity has been found to stimulate gut motility, increasing the rate of passage, consequently 
allowing birds to consume more ration, and accelerate growth. (Choct, 1997). 
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Figure 1.10: The structure of xylan and its digestion to xylose (Biotech, 2020). 
The second mechanism is a reduction in cell wall effect – also known as a cage factor. This mechanism 
describes how xylanase degrades the plant cell walls, increasing the availability of nutrients previously 
encapsulated in the cell wall matrix (Bedford and Schulze, 1998). 
The third potential mechanism of xylanase explores the potential of xylanase to modulate the 
microbial population of the hindgut.  Bedford and Cowieson, (2012) report that when structural fibre 
is hydrolysed by exogenous xylanase, it yields a reduced molecular weight end product that is rich in 
short-chain xylo-oligomers of 2-5 monomers in length. It has been shown that provision of these xylo-
oligomers into the gastrointestinal tract (GIT) of the bird increases the number of bifido bacteria in 
the caeca (Cowieson and Masey O’Neill, 2013; Courtin et al., 2008). When these oligosaccharides are 
fermented by micro-flora in the caeca and colon, the microbes rapidly produce volatile fatty acids 
(VFA) that cause changes to the short-chain fatty acid profile in the distal GI tract (Cowieson and 
Masey O’Neill, 2013). The additional VFA reduce the environmental pH and inhibit proliferation of 
putrefactive organisms, allowing beneficial microbes to outcompete and flourish (Bedford, 2000). 
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Additionally, the reduction in pH encourages proliferation of enterocytes and it has been suggested it 
may also be directly linked to the mediation of gastric emptying, potentially increasing transit time 
(Choct, 2015, Cowieson and Masey O’Neill, 2013).  
Bedford, (2000) describes the function of xylanase as working in two phases. The ileal phase allows 
enzymes to remove fermentable substrates from the ileum. The caecal phase then degrades the 
sugar products such as xylose and xylo-oligomers, which are the fermented by the caecal bacteria. 
This stimulates volatile fatty acids (VFA) production and the growth of specific bacteria such as 
lactobacilli and bifido bacteria which can be considered beneficial to the bird (Bedford, 2000). The 
final potential mechanism is highly related to the third mechanism and explores the possibility of 
microbiota within the gut producing xylanase in situ , so consequently enhancing the potential effects 
as described above. This has recently been demonstrated by Bautil et al. (2019). These authors 
demonstrated that broilers develop the ability to hydrolyse arabinoxylan with age, and that by 35 
days of age, broilers could achieve up to 24% total tract digestibility for arabinoxylan in the diet. 
 
1.12.10 Xylanase-inhibitors 
 
Xylanase-inhibitors are substances that prevent the function of xylanase (Debyser et al., 1999) 
Two distinct classes of proteinaceous endoxylanase have been identified in cereal grains (Juge et al., 
2004), Triticum aestivum xylanase inhibitor (TAXI) and xylanase inhibitor protein (XIP) 
(Perez-Vendrell and Brufau De Barbera, 2007). XIP has been shown to impose significant inhibition on 
fungal derived xylanases compared to those of bacterial derivation. Whereas TAXI are able to inhibit 
the function of both bacterial and fungal derived xylanase (Juge et al., 2004). The quantity and the 
level of activity of xylanase inhibitors has been shown to vary with different grain varieties and 
cultivars with Rialto and Cadenza wheat both containing high levels of xylanase inhibitors (Perez-
Vendrell and Brufau De Barbera, 2007). 
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In broilers the presence of xylanase inhibitors has been shown to reduce growth performance 
(Madsen et al., 2018). Again, these authors report variation in xylanase inhibitors between different 
wheat varieties.  
1.12.11 Xylans 
Xylans are the main structural polysaccharides within plant cells. Xylans account for around one-third 
of the earth’s renewable organic carbon and are one of the most abundant non starch 
polysaccharides (NSP) in nature (Busse-Wicher et al., 2014; Collins et al., 2005).  Xylans are one of the 
main components of hemicellulose, an organic complex of polymeric carbohydrates; they are 
comprised mainly of the pentose sugars, xylose and arabinose (Collins et al., 2005).  
Xylan, cellulose and lignin form the main polymeric constituents of the plant cell wall (Busse-Wicher 
et al., 2014 Collins et al., 2005; Wong et al., 1988). These three constituents interact via covalent and 
non-covalent linkages. Xylan sits the interface between lignin and cellulose, where its main function is 
thought to be that of plant cell wall elasticity, strength, integrity and fibre cohesion (Busse-Wicher et 
al., 2014; Collins et al., 2005; Wong et al., 1988). The structure of xylan varies between plant species 
with various substitutions to the homopolysaccharide backbone chain. The purpose and pattern of 
decorations upon the xylan backbone are still to be fully elucidated and vary based upon the species 
and cell wall type (Busse-Wicher et al., 2014). However, it is widely thought that one of the main 
functions of the decorations is the prevention of digestion by microbial enzymatic degradation 
(Busse-Wicher et al., 2014). 
 
Arabinoxylan is one of the common forms of xylan and is the main NSP present in wheat (Immerseel 
et al., 2014) - Arabinoxylans are made up of α-L-arabinofuranose residues that attach at branch joints 
to β-(1 4)-linked D-xylopyranose polymeric backbone chains. It is possible for 2- or 3-substituted 
or 2- and 3- di-substituted. These substitutions are not random, however, the distribution of 
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substituted residues along the chain does appear random/ Arabinose residues can also be connected 
to other attached groups such as glucuronic acid residues, acetyl groups and ferulic acid cross links 
(Figure 1.11). Figure 1.12 illustrates the most stable conformations of α-L-arabinofuranose (top) 
and β-(1 4)-linked D-xylopyranose residues. The furanose can, take up other conformations with 
similar energy whereas the chair conformation of the pyranose residue remains fixed. 
Wheat is reported to contain 5-8% arabinoxylans pentosans consisting of arabinose and xylose linked 
with B 1-4 linkages with arabinose side chains at the 02 and/or 03 positions on a xylopyranosyl 
backbone (Choct et al., 2004; Scheller and Ulvskov, 2010). The quantity of arabinose associated with 
the xylose backbone can be expressed as the Ara/Xyl ratio (Immerseel et al., 2014). For wheat this is 
reported to be between 0.47 and 0.56. 
Due to being non-starch polysaccharides, Xylans act as an anti-nutritional factor to some species 
including monogastric agricultural production animals such as pigs and poultry (discussed in section 
1.13.8). 
 
 
 
Figure 1.11 – The structure of Arabinoxylans  
41 
 
1.12.12 Arabinoxylans 
Arabinoxylans (AX) are a soluble fraction of NSP found in many cereal grains. AX are pentosans 
composed of two pentoses (arabinose and xylose) (Choct, 1997).  
AX are abundant in many plants as a constituent part of hemicellulose, one of the components of the 
plant cell wall (Ramkrishna et al., 2015). The molecular structure of AX consists of a linear xylan 
backbone with substituents attached through 02 and 03 atoms of xylosyl residues (Perlin, 1951). 
There are several substituents, the main one being single arabinose residues although hexoses and 
hexuronic acid can also be found (Fincher, 1975). The majority of arabinoxylans in grains are not 
soluble in water due to being attached to cell walls by alkali-labile ester-like cross links as opposed to 
basic physical attachment (Mares and Stone, 1973). However, free arabinoxylans that are not 
attached to the cell wall are able to absorb up to ten times their weight in water, forming highly 
viscous solutions. When exposed to oxidative agents such as H2O2/peroxidase, arabinoxylans can form 
a gel network due to rapid re-establishment of cross-links. It is this reaction that causes the main anti-
nutritional effect on poultry (Choct, 1997). This exerts an anti-nutritional effect on monogastric 
species such as poultry and pigs causing highly viscous conditions in the small intestine. 
1.12.13 Oligosaccharides 
Oligosaccharides are carbohydrates and as such can be categorized by degree of polymerization 
(quantity of monosaccharides units combined). Oligosaccharides are defined by IUB-IUPAC 
nomenclature (IUPAC-IUB, 1980) to possess between 3 and 10 sugar moieties. Other sources classify 
oligosaccharides as having anything up to 19 moieties, however, there appears to be no rationale for 
these differing limits (Voragen, 1998). Non-digestible oligosaccharides (NDOs) are classed as such due 
to the fact that the anomeric C atom (C1 or C2) of the monosaccharide units has a unique 
configuration that renders their osidic bonds unaffected by hydrolytic activity of digestive enzymes 
(Roberfroid and Slavin, 2000). NDOs that have been shown to enhance beneficial bacterial growth in 
the gut are derived from carbohydrates where the monosaccharide unit is glucose, galactose, 
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fructose and xylose (Sako et al., 1999) (Fig.6). As such, these NDOs are considered to have prebiotic 
potential (Hernandez-Hernandez et al., 2012). Oligosaccharides have also been shown to have 
antioxidant properties as discussed in section 1.13.1 (Hou et al., 2015) 
 
 
Figure 1.12 - Monosaccharide components of non-digestible oligosaccharides (Mussatto and 
Mancilha, 2007) 
 
1.12.14 Xylo-oligosaccharides 
Xylo-oligosaccharides (XOS) are a class of oligosaccharides that are currently undergoing an increase 
in research output in numerous species, from humans to chickens (Maesschalck et al., 2015; 
Mussatto and Mancilha, 2007; Selle et al., 2003; Sun et al., 2013).  
 As previously mentioned, a XOS is a sugar oligomer comprised of xylose units. It is present in 
numerous natural sources including fruits, vegetables and cereal crops (Vazquez et al., 2000). 
Arabinoxylans have been identified in all major cereal grains including wheat, rye, barley, oats, 
sorghum maize and millet (Izydorczyk, 2009). When the heteropolymer AX is exposed to hydrolytic 
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degradation, the result is a combination of arabinose-substituted xylo-oligosaccharides (AXOS) and 
non-substituted xylo-oligosaccharides (XOS) (Maesschalck et al., 2015). 
XOS are oligomers made up of xylose units, joined by β-(1-4) linkages (Aachary and Prapulla, 2008). 
Industrial production of XOS is carried out from lignocellulosic materials (LCMs) from sources such as 
forestry, agriculture, industry and urban solid waste (Vazquez et al., 2000). In addition to non-
structural components, LCMs comprise of three polymers: cellulose, lignin and hemicelluloses, 
including xylose, arabinose and mannose (Vazquez et al., 2000). Polymers of xylose (xylan), arabinose 
(arabinan) or mannose (mannan) will account for a substantial portion of the hemicellulose 
depending on the source of the LCM. This portion of the hemicellulose can then be substituted via 
ether or ester bonds. XOS is typically extracted from raw materials including corncobs, sugarcane 
bagasse, straw and DDGS (Isao et al., 1989; Suwa et al., 1999; Vazquez et al., 2000). As these 
materials are by-products of other processes, XOS production can represent increased value as part of 
these processes.  
When XOS is selectively fermented in the hind gut of monogastrics, it has been shown to modulate 
both the composition and activity of the host’s microbiota (Maesschalck et al., 2015). Lactate and 
short-chain fatty acid (SCFA) production following fermentation has been confirmed both in a number 
of studies in both pigs and poultry (Broekaert et al., 2011; Scott et al., 2014).  
 
1.12.15 Oligosaccharides and their use in broilers 
Originally commercially produced as fillers for human food and used as artificial sweeteners, 
oligosaccharides have more recently been utilised in livestock for their prebiotic function. The fibres 
of cereal grains are comprised of carbohydrate polymers that remain resistant to digestive enzymes in 
the small intestine of monogastric species and so reach the hind-gut intact. (Maesschalck et al., 2015). 
However, some or all these polymers are fermented in the distal gut and as such are thought to have 
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beneficial implications on the gut health of broilers due to the provision of a selective substrate for 
beneficial microbes in the GIT (Teng and Kim, 2018).  
Various oligosaccharides have been used in poultry diets including manno-oligosaccharides, galacto-
oligosaccharides (GOS), fructo-oligosaccharides (FOS) and xylo-oligosaccharides. All of these have 
been found to infer beneficial results on the gut health of broilers, though to a greater or lesser 
extent.  
Mannan-Oligosaccharides 
Mannan-oligosaccharides (MOS) (present in the cell wall of yeast), have been found to alter the gut’s 
bacterial population due to the yeast cell wall having high affinity ligand for bacteria which then offers 
a competitive binding site for bacteria (Biggs et al., 2007). Pathogenic bacteria that possess mannose-
specific type-1 fimbriae attach to the MOS instead of binding to the intestinal epithelial allowing the 
bacteria to move through the gut without colonization. It is also thought that oligosaccharides have a 
positive effect on immune function. MOS has been shown to increase Immunoglobulin-A production. 
This production inhibits the attachment and penetration of bacteria within the lumen as well as 
increasing the amount of intestinal mucus present (Biggs et al., 2007). Immunoglobulin A has also 
been shown to prevent inflammation (Biggs et al., 2007) that has the potential to cause damage to 
epithelial tissue. Ao and Choct, (2013) investigated the effect of MOS and FOS on broiler performance 
and gut development. When birds were fed a sorghum and soy-based ration supplemented with 
either MOS or FOS at 1kg per tonne in the starter, and 0.5kg per tonne in the grower and finisher, 
these authors found that both oligosaccharides significantly improved body weight and FCR and birds 
fed MOS showed a trend towards increased bursa weight. MOS supplementation also significantly 
improved flock uniformity. Likewise, Shendare et al., (2008), explored the performance effect of MOS 
and beta-glucans with a maize-based die. These authors found MOS increased body weight by 5.37% 
compared to a control and enhanced FCR by 8.45%. Iji et al., (2001) studied the intestinal structure 
and function of broilers fed sorghum and lupin-based diets supplemented with MOS. This study 
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showed that when supplemented at 5g/kg, MOS significantly increased jejunal villi length and L-
tryptophan uptake by the jejunal brush-border membrane vesicles. These authors also reported small 
increases in body weight in supplemented birds, but no improvement in FR.  
 
Isomalto and fructo oligosaccharides 
 Isomalto-oligosaccharides (IMO), when supplemented at 0.3% significantly increased the quantity of 
butyrate and isobutyrate concentrations in the jejunum (Zhang et al.,2003), However, performance 
was not significantly altered by isomalto-oligosaccharides supplementation compared to a control. 
Chung et al., (2004) compared the growth of broiler caecal isolates grown with either IMO and FOS as 
a sole carbon source. These authors report that FOS significantly increased caecal isolate growth 
compared to IMO. When the caecal isolates and Salmonella were grown in a mixed culture on IMO, 
the salmonella population was decreased with IMO. Likewise, when the caecal isolates were grown 
with Bifido bacteria, FOS significantly increased the growth of the isolates and the Bifido bacteria. This 
study concludes that FOS and IMO show promise for supporting beneficial broiler intestinal microflora 
modification by aiding the proliferation of Bifido bacteria.   
 
1.12.16 The Effect of XOS in broilers 
XOS supplementation has been shown to have numerous benefits for broiler production, on both 
performance and physiological parameters. In 2006, Wu et al. found that XOS inclusion (1,2 and 4 
g/kg) significantly reduced cumulative mortality and feed conversion ratio over a 7-week broiler 
study. These authors also found that when fed at 2g/kg, XOS increased the number of lactobacillus in 
the ileum. More recently, Maesschalck et al. (2015) found that birds fed a wheat/rye-based diet 
supplemented with XOS at 0.2% over 39 days showed significantly improved FCR and increased 
numbers of lactobacilli present in the hind gut as well as significantly increased the length of ileal villi, 
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thus increasing the surface area and absorptive capacity of the ileum compared to the control birds. 
Subsequently, this led to increased concentrations of SCFA. 
A number of studies report that XOS inclusion shows numerical increases in performance parameters 
such as weight gain, feed conversion ratio (FCR) and feed intake (Suo et al., 2015; Dang, 2004, Craig, 
2019). However, improvements are not always statistically significant. Suo et al. (2015) fed a corn/soy 
diet supplemented with XOS at 25, 50, 75 or 100mg/kg. The authors found that 75 and 100mg/kg of 
XOS did improve FCR, but only significant between days 22-42 and 0-42, suggesting that XOS may only 
be having a significant affect during the later periods of broiler production. Likewise, Craig et al. 
(2020) compared supplementing broilers with various carbohydrase enzymes (xylanase, xylanase/ß-
glucanase) to a diet containing XOS (0.025%) or a control. In a 21-day study feeding wheat/soy/corn 
diets, these authors found increased BWG and reduced FCR in the XOS treatment compared to the 
control. The same authors conducted an earlier study (2019) comparing XOS or xylanase 
supplementation to a control. The study used a control diet (wheat/soy ) to compare to a low and 
high dose of xylanase (16000BXU and 32,000BXU) and low and high dose of XOS (0.25g/kg and 1g/kg) 
. The authors found reductions in FCR for both the xylanase and XOS treatments compared to the 
control (Craig, et al., 2019). Ribeira et al., (2018) found that in a 0-28-day study feeding wheat-based 
diets, XOS (Corn cob derived) supplementation at 0.06g/kg significantly increased the final body 
weight of broilers and reduced the cumulative FCR compared to the control, but feed intake and 
digesta viscosity were not affected. This may suggest that the mode of action for XOS may purely be 
microbial modulation, rather than an enzymatic effect on NSPs in this study. However, Ribeira et al., 
(2018), only looking at days 0-28, there may have been effects during the latter stages of broiler 
production as seen in the work of Sue et al. (2015). Ribeira et al., (2018) went on to conduct a second 
0-42 day study utilizing XOS at two inclusion amounts (0.1g/kg and 1g/kg) with a wheat-based diet. 
Here the authors found that final body weights were significantly increased in both experimental 
groups supplemented with XOS, and that the lower inclusion level produced higher body weights. 
Feed intake was also significantly improved in both XOS groups, with the lower inclusion rate again 
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highest, but only in the latter stages of production (D35-42), which agrees with the results of Suo et 
al., 2015). FCR was also significantly improved in the lower inclusion rate group when compared to 
the control. The majority of papers which investigate the microflora of the host  agree that XOS 
supplementation has a positive effect on the microbial population of the gut in broilers. Courtin et al. 
(2008) supplemented a wheat-based diet with XOS at 0.25 and 0.5g/kg and found that two weeks of 
XOS supplementation (extracted from wheat flour) resulted in significantly increased numbers of 
bifido bacteria in the caeca of broilers, however the authors did not find any significant difference in 
the numbers of lactobacilli. A study by Pourabedin et al. (2015) found similar results with significant 
increases in beneficial bacteria in the caeca of birds supplemented with XOS at 2g/kg, however, in this 
case it was lactobacillus genus bacterium that flourished. In some cases, both bifido and lactobacillus 
bacteria have been found to proliferate with XOS inclusion. Ribeira et al. (2018) found that XOS 
supplementation at 0.1g/kg increased the microbial populations of bifido bacterium and lactobacilli. 
As was found in the performance data from this study, a lower XOS inclusion rate (0.1g/kg) produced 
higher levels of beneficial bacterium. The results of Ribeira et al. (2018) suggest that there is likely to 
be an optimal dosage when supplementing broilers and that overdosing can reduce or eliminate the 
beneficial effects of supplementation.  
XOS supplementation has also been shown to increase the production of volatile fatty acids. De 
Maesschalck et al., (2015) showed that supplementing wheat/rye-based diets with XOS at 0.5%  
directly increased production of both butyrate and lactate by the microbial population of the distal 
gut. Likewise, Craig et al., 2020, reported that XOS supplemented at 0.25g/kg and 1g/kg significantly 
increased production of iso-butyric, acetic and iso-valeric acids in the caeca of broilers. A study 
looking at the effect of XOS on broilers showed that supplementing corn/soy diets with 0.2g/kg XOS 
significantly increased the presence of butyrate and acetate in the caeca (Yuan et al., 2018). 
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1.13 Methods for measuring levels of oxidative stress/damage 
Accurate measuring of ROS can be difficult due to their short life span and high reactivity with other 
components. Peroxyl radicals and hydro peroxide are considered relatively stable with a half-life of a 
few seconds to a maximum of a few minutes. However, hydroxyl radicals are highly reactive and have 
a half-life of less than a nanosecond (Pryor, 1986). Due to this it is generally considered more accurate 
to assess the damage caused as a direct result of ROS to lipids, proteins and nucleic acids as described 
in the following sections. 
1.13.1 Measuring protein damage 
Protein damage due to ROS is one of the main concerns, as this is the key component in ROS-
mediated tissue damage. Protein carbonyl are produced as a by-product of oxidation of protein 
backbones and amino acid residues, including lysine, arginine, and threonine by ROS (Berlett and 
Stadtman, 1997). As such, protein carbonyl is often used as a marker for oxidative changes. Protein 
carbonyl can be measured in two ways. The first uses 2, 4-dinitrophenylhydrazine (DNPH) assay 
developed by Levine et al., (1990). Here DNPH reacts with protein carbonyls to form a Schiff base that 
can produce dinitrophenylhydrazone products. The levels of these products can then be measured 
using spectrophotometry at 375 nm and correlated to levels of oxidized proteins. The second method 
uses 2D gel electrophoresis and western blot as described by Marco et al., (2012). Another approach 
to measuring protein oxidation is to detect advanced oxidation proteins products (Witko-Sarsat et al., 
1996). Advanced oxidation protein products are produced via a reaction of plasma proteins and 
chlorinated oxidants such as chloramines. This assay uses either plasma or serum, calibrated with 
chloramine-T. This is mixed with potassium iodide and acetic acid before the absorbance is measured 
using spectrophotometry at 340nm. The main problem with these assays is that they only measure 
one type of oxidative reaction and as such, are unlikely to fully elucidate the full oxidative process, 
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1.13.2 Measuring lipid damage 
Lipid peroxidation is of particular interest to the poultry sector as it thought to be the main 
contributor to breast tissue myopathies such as woody breast, spaghetti meat and white stripe (as 
described in sections 1.10.6, 1.10.7 and 1.10.8)(Salles et al., 2019). Lipid peroxidation is also the 
process responsible for meat rancidity and reduced shelf-life and is believed to be compounded by 
increased levels of oxidative stress during life of the bird (Abasht et al., 2016). Rancidity occurs as a 
result of metabolic transformations of fatty acids and subsequent oxidation of the polyunsaturated fat 
within the meat (Bigolin et al., 2013). Damage to cell membranes by ROS is commonly assessed by 
measuring lipid peroxidation (Katerji et al., 2019). There are numerous assays that can be used to 
assess lipid peroxidation, however, the most commonly used assay in the poultry industry is 
quantifying malondialdehyde (MDA) (Esterbauer et al., 1990). 
 Malondialdehyde is one of the most studied end-products of peroxidation of polyunsaturated fatty 
acids (Esterbauer et al., 1990). In addition to measuring lipid peroxidation, measuring MDA can be 
used to estimate levels of oxidative stress. Typically, this is done using thiobarbituric acid reactive 
substances (TBARS) and can be performed using blood or homogenised tissue. In this assay, MDA 
reacts with TBARS in acid at 100°C to create pink/red-coloured product that can be extracted with 
butanol, then measured using a spectrophotometer at 520-535 nm. Whilst the TBARS method is 
relatively simple, it is possible that aldehydes other than MDA could react with TBARS, generating 
derivatives that could absorb light in the same wavelength range, thus skewing the result (Giustarini 
et al., 2009).  MDA can also be measured via gas chromatography, which removes this risk, however, 
the analytical kit required is more substantial and costly. 
In poultry, drip loss tests are often used to measure the lipid peroxidation of meat (typically breast 
meat). A sample of breast meat is taken immediately post slaughter, weighed individually and placed 
on a grid. After a period of time (24-72 hours) samples are dried with a paper towel and re-weighed. 
Drip loss is expressed as a percentage of the initial sample (Correa et al., 2007). Whilst this method is 
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regularly used by the meat quality industry, it is often considered inaccurate and requires high 
accuracy balances to measure with precision.  
 
1.13.3 Measuring nucleic acid damage 
8-Hydroxy-2’ –deoxyguanosine (8-OHdG) is amongst the major oxidative changes seen in DNA, 
produced by hydroxylation of the deoxyguanosin residues. These residues can be excised from the 
DNA by enzymatic repair systems, which leads to systemic circulation via the blood stream and 
subsequent urinary excretion (Ock et al., 2012). Due to this, 8-OHdG can be measured in either blood 
or urine as a marker for oxidative damage to DNA (Keterji et al., 2019). This can be performed by 
ELISA and immunohistochemical analysis or by oxyDNA-FITC conjugate binding followed by flow 
cytometry with fluorescence (Katerji et al., 2019). Due to birds producing combined urine and faeces 
(excreta), blood must be used to measure thi8s parameter in poultry. 
 
1.13.4 Assessing antioxidant status 
The homeostatic system of the body is equipped with an antioxidant system to regulate and counter-
balance oxidation/ROS and their deleterious effects. This system is referred to as redox homeostasis 
(Katerji et al., 2019).  Oxidative stress can occur when levels of ROS and antioxidants become 
unbalanced. The imbalance of pro and antioxidants can be caused by excess free radical production or 
by excessive antioxidant consumption. As such, antioxidant status can be correlated to the levels of 
oxidation found in clinical samples (Katerji et al., 2019).  Essentially, most methods for assessing 
oxidative/ antioxidant status are looking at the capacity of the individual to quench ROS and thereby 
maintain homeostasis. To date, there no assays that have been specifically validated in broilers to 
assess total antioxidant capacity, however, a number of assays can be used to assess the capacity of 
the blood to quench various individual reactive oxygen species. Unfortunately, this makes assessing 
the true, overall oxidative status of a bird impossible. 
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1.14 Aims and objectives 
The overarching aim of this project was to explore ways of supporting the gut health and production 
parameters of broilers via pre-biotic supplementation. Specifically, the project aims to determine if 
XOS and/or xylanase can support the gut health, oxidative status and performance of broilers. The 
following specific objectives were set to achieve this aim: 
 
1 – To determine if exogenous xylanase and/or xylo-oligosaccharides have a positive effect on the 
production performance of broilers. 
2 – To elucidate the mechanism via which XOS and/or xylanase may improve the performance of 
broilers 
3 – To determine whether xylo-oligosaccharides and or xylanase may improve gut health parameters 
of broilers. 
4 – To determine whether the material from which the XOS is derived influences its efficacy 
5 – To develop and assess a novel method for measuring the oxidative status of broilers and broiler 
feed 
6 - To determine the efficacy of XOS and xylanase in improving the oxidative status of commercial 
broilers 
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Chapter Two: Materials and Methods 
2.1. Introduction 
This chapter provides an overview of the materials and methods used throughout this thesis. Three 
animal trials and one in vitro study were conducted as part of this body of work and are summarised 
in the table below with associated chapters where results are presented (table 2.1).  
Study 1 evaluated an arabinoxylan extract derived from distillers wet grains with solubles, made by 
the University of Huddersfield. The study used three diets (control, Control + AX and control + AX pre-
treated with xylanase) to evaluate the effect of the product on broiler chickens. Study 2 compared 
two different xylo-oligosaccharides derived from different base materials with and without 
commercial xylanase in a 3x2 factorial study to evaluate the general effect of XOS inclusion upon both 
performance and physiological parameters. Study 3 evaluated novel oxidation assays and validated 
these assays in broilers. Study 4 was a dose response trial looking at the effect of increasing the dose 
of a commercial corn XOS + xylanase product. All animal trials were conducted at the Poultry 
Research Unit at Nottingham Trent University’s Brackenhurst campus, UK. Ethical approval was 
granted via the university ethics committee and approval numbers are provided in the individual 
material and methods sections for each study. 
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Table 2.1 - Outline of studies conducted 
Study Investigation Chapter 
1 The effect of feeding a distillers dried grains with solubles AX extract 
upon the performance and gut health of broilers 
3 
2 A comparison of two XOS products derived from different base 
materials  
4 
3 Validation of two novel methodologies for assessing the oxidative 
status of broilers and broiler feed 
5 
4 Investigation of dose response for a corn based XOS +Xyl 6 
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2.2 Birds and Management 
Institutional and UK national NC3R ARRIVE guidelines for the care, use and reporting of animals in 
research (Kilkenny et al., 2010) were followed at all times. The University’s College of Arts and Science 
ethical review committee approved all experimental procedures utilizing animals. 
For all studies, day old, male Ross 308 broiler chicks were obtained from PD Hook Hatcheries Ltd, 
Oxfordshire. Upon arrival at the Poultry Research Unit (PRU) the chicks were allocated pens 
approximately 0.64m2. The chicks were raised in a thermostatically controlled poultry room with an 
initial temperature of 32°C, which was reduced daily to 21°C by day 21. The room was then 
maintained at 21°C for the remainder of each trial. Lighting was controlled with 1 hour of darkness 
from day 1, which was then increased by 1-hour increments until day 6. 6 hours of darkness was then 
maintained until the end of the trial with 15-minute dusk and dawn periods. Wood shavings were 
provided as a substrate in the pens (3cm thick). Additional shavings were added as required 
throughout the trials. Water was continually available via nipple drinker lines and the experimental 
diets were provided ad libitum in open troughs throughout the trial. The bird room was checked twice 
daily to monitor bird welfare and environmental conditions. Environment was altered according to 
bird behaviour. Bird mortality was recorded daily in addition to the bird weight and reason if culled 
(for example due to deformities or illness). 
 
2.3 Diet Formulation and Feed Preparation – study 1, 2 and 4 
For study 1, mash diets were manufactured on-site by PRU staff. Three phases of diet were used, 
starter from day 1-14, grower, day 14-21 and finisher day 21-35.  Diet formulation was undertaken by 
a commercial nutritionist and diets manufactured by NTU. Dry ingredients were weighed in a top pan 
balance (Mettler, Toledo, Leicester, UK) as per the diet production specifications sheet. Dry 
ingredients were mixed for 5 minutes in a ribbon mixer (Regal Bennet, Goole, UK) in batches of no 
more than 100KG. Oil was added, and the diet was mixed for a further five minutes before being 
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weighed into individual bags for each pan. Diet specification and calculated nutritional content are 
presented in the relevant chapters. 1kg samples of each diet treatment were reserved for proximate 
analysis and stored at -20°C. Nutritional composition was confirmed by laboratory analysis and are 
described later in this chapter. 
The basal mash diets for study 2 and 4 were produced by Target feeds, Shropshire UK. The diets were 
formulated by a commercial nutritionist to meet the age and strain of the birds. 
 
2.4 Sampling and Preparation Methods 
2.4.1 Bird Performance Measurements – study 1, 2 and 4 
In all studies, feed was weighed into pre-weighed bags that were labelled with designated pen 
number. Each pen of birds was fed from the designated bag. Additional feed of the same formulation 
was added if required throughout the trial. Feed intake was recorded weekly, by tipping back 
remaining feed into the original bag and weighing. Feed intake per bird was calculated from the 
difference between the starting amount and the amount remaining on each weigh day divided by the 
number of birds in the pen to give an average feed intake per bird.  
Birds were individually weighed at the start of trial to ensure equal distribution between treatments. 
Birds were then weighed by pen at the start of the study (d0) and then weekly to calculate average 
bird weight (BW) (total pen weight/ number of birds). Body weight gain (BWG) and feed conversion 
ratio (FCR) were calculated weekly.  
Birds were sampled according to trial needs, (as detailed in chapter 3,4 and 6) on days 7, 21, 35and 
42. Prior to sampling birds were humanely euthanized via cervical dislocation by trained operatives in 
a separate room in line with the guidelines of the Scientific procedures Act (ASPCA, 1986). Birds were 
weighed individually. Feed conversion ratio (FCR) was determined by pen by dividing the total feed 
intake by the total weight gain. 
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2.4.2 Blood Sampling – Studies 1, 2, 3&4 
Immediately post-mortem the bird was dissected, and a blood sample was collected from the cavity 
(surrounding the heart muscle) in a clean syringe and placed in a blood tube containing EDTA as an 
anti-coagulant. The samples were centrifuged at 3000RPM for 10 minutes (Thermo Scientific, 
Megafuge 8, Fisher, UK), before the plasma was removed and collected into clean tubes. Samples 
were stored at -20°C for analysis. 
 
2.4.3 Digesta Sampling – Studies 1, 2 & 3 
Prior to digesta collection, birds were sequentially fed in order to stimulate eating and had access to 
feed for 1 hour before sampling to ensure adequate gut fill. After euthanasia, digesta was collected by 
careful digital pressure along the distal end of the small intestine (identified as the portion of gut 
between the Meckel’s diverticulum and the ileal-caecal-colonic junction). Digesta was pooled per pen 
(when multiple birds sampled) into labelled pots and weighed. Digesta samples were stored at -20° 
until required. Samples were later freeze dried (LTE Scientific, Oldham, UK) for 7 days before being re-
weighed and then ground manually with a pestle and mortar to homogeneity fine powder. Ground 
samples were analysed for digestibility analysis described later in this chapter. 
 
2.4.4 Bone Samples – Study 2 
Tibia bones were excised from the feet at the tibial-tarsal junction, and from the femur at tibio-
femoral junction using a scalpel. The cartilage caps were retained on the tibia. The tibias were de-
fleshed using a scalpel and they were stored individually in labelled bags at -20°C until analysis could 
take place. Prior to further analysis, bones were thawed to room temperature to prevent false 
readings from bones being partially frozen and therefore more brittle. 
57 
 
 
2.4.5 Histology Samples – Study 2 
The ileum was excised from the bird from the ileo-caecal-colonic junction to the Meckel’s 
diverticulum as described in section 2.5.18. A 3cm section was taken from the end proximal to 
Meckel’s diverticulum and fixed in a pot containing approximately 20ml of Bouin’s fixative (Fisher 
Scientific, UK) for 8 hours. After 8h the samples were transferred into 70% Industrial methylated spirit 
and stored at room temperature until processing. 
2.5 Analytical procedures 
2.5.1 Dry matter  
Dry matter was analysed for diet as follows. 5-10g of diet was weighed on an analytical balance into 
pre-weighed crucibles and dried in a forced air oven at 105°C until constant weight. The dried 
samples were reweighed, following cooling in a desiccator. Dry matter content was then calculated 
with the following formula.  
  
Moisture content (%) = fresh sample weight (g) – dry sample weight (g)   x100 
                                                               Fresh sample weight 
Dry Matter (%) = 100 – moisture content (%) 
 
2.5.2 Crude Protein – Study 1, 2 and 4 
Diets were analysed for nitrogen content using a Dumatherm Nitrogen analyser (Gerhardt, UK). AS 
nitrogen is a compound unique to protein, it can be used as a direct measure of amino acid (protein 
status). Diets were weighed and pelleted in foil. The Dumas method of combustion for nitrogen 
analysis was used. The unknown sample is burned in an oxygen rich atmosphere at high temperature. 
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The machine then analyses the resulting gases. Results are expressed as mg of nitrogen, then 
converted into percentage of protein present in the sample. 
 
2.5.3 Crude Fat (ether extraction) - study 1, 2 and 4 
A SOXTHERM® fat crude fat analyser (Gerhardt, UK) was used to quantify the fat content of the diets. 
Extraction flasks containing boiling stones were pre-weighed on an analytical balance. 5g of diet was 
weighed into extraction thimbles (Whatman, USA) which were then placed inside the flasks and 
petroleum ether added as a solvent. A 2-hour cycle was used. Following the extraction cycle the flasks 
were heated in a fume hood to ensure all solvent had evaporated. Flasks were then placed in an oven 
(105°C) for 2 hours until a constant weight was achieved. Flasks containing the extracted fat and 
boiling stones were cooled in a desiccator and then re-weighed. Fat content was calculated using the 
following formula: 
% extractable fat = [M2-M1÷ M0] X 100 
Where:  
M0 = sample weight (g) 
M1 = weight of flask + boiling stones (g) 
M3 = weight of flask= fat + boiling stones (g) 
 
2.5.4 Ash Content study 1,2 and 4 
Ash content of diets and digesta was measured by weighing 5-10g of dried samples into pre-weighed 
crucibles. Crucibles were then placed in a muffle furnace (Nabertherm, Germany) for 14 hours at 
650°C.  Samples were then cooled in a desiccator and re-weighed . Ash weight was calculated by 
subtracting ashed weight from the original weight then expressing this as a percentage. Results were 
corrected for dry matter. 
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2.5.5 Titanium Dioxide Analysis – study 1,2 and 3 
Titanium dioxide was added at 0.5% to all diets as an inert marker for digestibility measures. Ti02 was 
measured in the diets and digesta using a UV spectrophotometer following the methodology of Short 
et al., (1996). Standard titanium solution (0.5mg ml) was made by dissolving 250mg Ti02 in 100ml 
concentrated H2SO4 (Fisher Scientific, UK) before adding 500ml of distilled water. 1-10ml of the Ti02 
standard was placed in pre-labelled 100ml volumetric flasks. Concentrated H²SO⁴ was then added to 
each flask to bring the total volume to 10ml. 10ml of 30% hydrogen peroxide (Fisher Scientific, UK) 
was added before the flasks were brought to volume with distilled water. Samples were measured on 
a UV spectrophotometer (Cecil, CE 1011, USA) at 410nm to confirm standard curve. The standard 
solution was stored in amber bottles in darkness until required. 
0.3-0.5g of feed or digesta (freeze dried) were weighed in triplicate (diet) and duplicate (digesta) into 
ceramic crucibles and ashed in a muffle furnace (SNOL, Germany) for 14 hours at 650°C. Once cooled 
the samples had 10ml 7.4M H2SO4 added and were boiled on a hotplate for 2 hours. An additional 5ml 
7.4M H2SO4was added to each crucible and the samples were continually heated until completely 
dissolved. 
Once cooled the samples diluted with 10ml of distilled water then quantitatively filtered into 100ml 
volumetric flasks through Whatman 541 hardened ashless filter papers. 10ml of 30% hydrogen 
peroxide was added to each flask which was then brought to volume with distilled water. The 
absorbance of the samples was measured after thorough mixing at 410nm using a UV 
spectrophotometer (Cecil, CE 1011, USA). A standard curve was measured each day from the 
standard solutions previously described. The coefficient used to determine TiO2 concentration was 
derived from the regression analysis of the standard curve . The amount of TiO2 in the solutions was 
calculated by: 
TiO2/mg = Absorbance x 10 
              Coefficient x sample weight (mg) 
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2.5.6 Calcium and Phosphorus Analysis– study 1,2 and 4 
Calcium and phosphorus content of diets and digesta was analysed via inductively coupled plasma 
optical emission spectrometry (ICP-OES) (Optima 2100 DV, Perkin Elmer, USA). Glass wear was acid 
washed in 1% nitric acid overnight to remove mineral contamination. 0.5g of sample was incubated at 
room temperature in duplicate with 10ml aqua regia (1-part HNO3 - 3 parts HCl) in 50ml conical flasks 
for 16h. Samples were then heated for 90 minutes before a further 5ml aqua regia was added to each 
flask. The samples were heated for a further 60 minutes. Once cooled the samples were filtered 
through Whatman 541 hardened ashless filter papers into 50ml volumetric flasks. Ultrapure water 
was then used to bring flasks to volume. Samples were mixed then decanted into 15ml tubes. 
Ca standards (10-1000ppm) and P standards (0-350ppm) were prepared by diluting 1000ppm ICP-OES 
standards (Fisher Scientific, UK) with ultra-pure water before being analysed. Ca and P contents were 
measured at wavelengths of 317.933nm  (Ca) and 213.617nm (P). The emission intensities of both 
samples and standards were recorded. The standard curves were determined by plotting Ca and P 
emission intensities against the standards (figures 2.1, and 2.2). The concentration of Ca and P (ppm) 
was calculated in the following way: 
Mineral conc. (ppm) = Dilution volume (ml) x MEI-Intercept 
                                                                                    Sample weight              Gradient 
Mineral conc. (g/kg) = Mineral conc. (ppm) ÷ 1000 
Where: 
Mineral conc. = mineral concentration of Ca or P 
Dilution volume = final volume in which samples were dissolved. i.e. 50ml 
Sample weight = weight of sample analysed  
MEI = Ca or P mineral emission intensity analysed by ICP-OES 
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Intercept = intercept of the standard curve of Ca or P 
Gradient = gradient of the standard curve of Ca or P 
 
Figure 2.1 – Example of a standard curve for Ca emission intensity 
 
 
Figure 2.2 - Example of a standard curve for P emission intensity  
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2.5.7. Apparent Metabolizable Energy 
 Gross energy (GE) of the feed and excreta was sent to a commercial lab and measured using bomb 
calorimetry. Excreta was manually collected from depopulated pens, with care taken to obtain clean, 
bedding free samples. Titanium content of the diet and ileal digesta was determined as described in 
section 2.5.5. Apparent metabolizable energy (AME) was calculated by: GE diet-(GE digesta*(TiO2 in 
the diet/TiO2 in excreta)).  
 
2.5.8 Nitrogen retention 
Nitrogen content of diet and digesta was analysed by Dumas as described in section 2.5.2. Nitrogen 
retention was calculated using the following equation. Nitrogen per g of diet – Nitrogen per g of 
digesta * (Diet TiO2/Digesta TiO2) 
 
2.5.9 Apparent metabolizable energy corrected for nitrogen 
Both apparent metabolizable energy (AME) and nitrogen were analysed on a dry matter basis. AME 
corrected for nitrogen (AMEn) was calculated by the method of JHill and Anderson (1958) using 
34.4MJ per g of dietary nitrogen.   
 
2.5.10 Nutrient Digestibility – Study 1, 2 and 3 
Titanium dioxide concentration in the diets and digesta was determined by UV spectrophotometry as 
described in section 2.5.5, after the method of Short et al., (1996). Ca and P content of diets and 
digesta was determined by ICP-OES as described in the previous section. The following calculations 
were utilized to determine an ileal digestibility coefficient and quantity of nutrient digested, following 
the methodology of Mutucumarana et al, (2014).  
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The apparent ileal digestibility coefficient = 1 - (Ca or P in digesta x TiO2 in diet) 
                                                                          (TiO2 digesta x Ca/P diet)             
Ca or P digested = apparent ileal digestibility coefficient x Ca or P in diet 
 
2.5.11 Gastrointestinal pH – Study 1 
Birds were fed sequentially to ensure adequate gut fill and no differences in intestinal pH resulting 
from periods of empty tract prior to measurement of gut pH. Immediately post-mortem birds were 
dissected  And a digital pH meter (fully calibrated to manufactures calibration specifications)  
(Mettler-Toledo, UK) with piercing tip attachment was inserted into the ileum at the Meckel’s 
diverticulum and into the centre of one caeca ( from the ileal-caecal-colonic junction) in the method 
described by Morgan et al., (2014). The measurement was repeated in triplicate for each site. In-
between birds, the tip was rinsed in ultra-pure water to reduce cross contamination. The mean of the 
three measurements per section of tract was calculated. 
 
 2.5.12 Mucin Layer Thickness Analysis 
Mucin layer thickness was measured as described by Smirnov et al. (2004). A 10mm section of 
jejunum was incised from the Meckel’s end of the tract and weighed (4D.P). The tissue was gently 
flushed with distilled water and then placed in 10g/l Alcian blue (160mmol/l sucrose with 50mmol 
sodium acetate) for 2 hours. The tissue was then washed in 250mmol/l sucrose to remove excess dye. 
The bound dye was then extracted using 10g/l docusate sodium salt overnight at room temperature. 
The supernatant was centrifuged at 700 x g for 10 minutes to remove particulate matter. The 
absorbance was then read at 620nm on a spectrophotometer against a standard curve of diluted 
Alcian blue. (Jenway 7315, Bibby Scientific Ltd, UK). Results are expressed as µg Alcian blue released 
per gram of tissue.  
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2.5.13 Immunoglobulin Analysis – study 1,2 and 3 
IGA and IGM quantification ELISA kits (Bethyl, UK) were used as per the manufacturer’s instructions.  
A standard curve is prepared by diluting a IgM/IgA standard in set dilutions. IgM or IgA present in the 
unknown sample was captured by anti-chicken IgM/IgA that has been pre-adsorbed on the surface of 
the microtiter wells on the ELISA plates. Once any IgM/IgA present in the unknown sample had bound 
to the surface anti-bodies, any unbound proteins were washed away. A biotinylated detection 
antibody was added to each well to bind with the captured immunoglobulin. A streoavidin-conjugated 
horseradish peroxidase was added to catalyse a colorimetric reaction. A blue product was produced 
that then changes to yellow when a stop solution of dilute sulfuric acid was added. Plates were read 
in a plate reader (thermo fisher, UK) at 390nm(IgA) and 450nm (IgM). The absorbance measured is 
proportional to the amount of IgM/IgA present in the sample. Results were  calculated using the 
standard curve. The amount of immunoglobulin present was calculated by comparing the absorbance 
results of the unknown samples with the values on the standard curve (figure 2.5 and 2.6). 
 
Figure 2.3 - Example of typical standard curve for IgA 
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Figure 2.4 - Example of standard curve for IgM 
 
2.5.14 Bone morphometry and strength – study 2 
Tibias were fully defrosted and then manually de-fleshed. Tibia’s were then weighed on an analytical 
balance (Sartorius, UK) to determine bone weight. Tibial length and width were then measured using 
Vernier callipers. Tibial strength was the measured using a 3-point bend TA-XT Plus Texture Analyser 
(Stable Micro System, UK), formatted with a 50kg load cell and test speed of 1.0mm/s following the 
method of Shaw et al. (2010). Bones were placed on a frame adjusted to bone size which varied by 
age (d21 and d42). Identical orientation was always ensured. Peak force was measured in newtons 
and then recorded. 
 
2.5.15 Ileal weight full and empty – study 1 and 2 
Immediately post-mortem the birds were dissected, and the ileum incised from the ileo-caecal-
colonic junction and Meckel’s diverticulum. Care was taken to ensure the ileal content was retained. 
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The ileum was weighed on a 4d.p balance (Acculab, UK) and recorded. The ileal contents were then 
removed as described in section 2.4.3. The empty tract was then re-weighed.  
 
2.5.16 Caeca weight – study 1, 2 and 3 
The caeca were removed as a pair. They were then carefully separated at the ileo-caecal-colonic 
junction and weighed individually. The caeca weights were then combined to give both individual and 
pair weights per pen. 
 
2.5.17 16S Sequencing study 2 and 4 
The V4 hypervariable region of the 16S rRNA gene was amplified from genomic DNA using forward 
primer 515F: GTGCCAGCMGCCGCGGTAA and reverse primer 806R: GGACTACHVGGGTWTCTAAT 
(Earth Microbiome, 2015), using the 2X KAPA HiFi Hotstart ReadyMix and primers. 
PCR amplification was performed using 25 µl reaction mixtures of 2.5 µl microbial DNA (5ng/ul); 5 ul 
Amplicon PCR Forward Primer (1uM); 5ul Amplicon PCR Reverse Primer (1 µm) and 12.5 µl 2X KAPA 
HiFi HotStart ReadyMix (KAPA-Germany). This was added into a 96 well plate fully sealed. PCR was 
performed in a thermal cycler (Techne, TC-512, UK) using the following program: 95°C for 3 minutes; 
25 cycles of :95°C for 30 seconds; 55°C for 30 seconds;72°C for 30 seconds 72°C for 5 minutes. The 
PCR products were run through 1.5% agarose gel electrophoresis and bands analysed to check the 
amplicon quality. Gels were run at 100 volts for 45 minutes after loading 2 µl of loading dye. (Cleaver, 
MP-250v, UK), and 5 µl of amplicon. Gels were viewed under UV light (Syngene, G: Box, USA). The 16S 
V4 amplicon was prepared using 20 µl of AMPure XP beads and then incubated at room temperature 
for 5 minutes. The 96 well plate was then placed on a magnetic stand (FastGene MagnaStand, YS, 
Germany) for 120 seconds or until the supernatant had cleared. The supernatant was then discarded, 
and the beads washed twice with 80% ethanol. The beads were then allowed to air-dry at room 
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temperature for 10 minutes. The amplicon was then suspended in 52.5 µl of 10mM Tris pH 8.5 and 
gently mixed. The sample was then incubated at room temperature for 2 minutes. 50 µl of the clear 
supernatant was then transferred onto a fresh 96 well PCR plate. 
Index PCR was performed as follows: 5 µl of DNA was moved on to a fresh plate and the index 1 and 2 
primers added. The plate containing the re-suspended PCR product was placed in a TruSeq index 
plate fixture (Illumina, USA). 5 µl of DNA amplicon, 5 µl of Nextera XT Index Primer 1 (N71-12) 
horizontally, 5 µl Nextera XT Index primer 2 (s51-8) vertically, 25 µl 0f 2x KAPA HiFi HotStart 
ReadyMix, and 10 µl PCR grade water were gently mixed then the plate covered with Microseal. This 
was then centrifuged at 1000 x g at 20°C for 1 minute then PCR performed again on a thermo cycler: 
95°C for 3 minutes, 8 cycles of 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 30 seconds, 72°C 
for 5 minutes, then finally held at 4°C. The index PCR product was then cleaned up as before and 56 µl 
of AMPure XP beads added to each well. Each well was then mixed by gently pipetting the mixture up 
and down with a multi-channel pipette. This was incubated at room-temperature for 5 minutes. Once 
again, the plate was placed on a magnetic stand for 2 minutes or until the supernatant had cleared. 
The bead was then removed, and the supernatant discarded. Beads were washed with 80% ethanol 
twice, then the excess ethanol removed, and the beads air-dried. 27.5 µl 0f 10 mM Tris (pH8.5) was 
added to each well and incubated at room temperature for 2 minutes. 25 µl of the supernatant from 
each well was then carefully moved to a fresh plate. For validation purposes 1 µl of the library product 
was run on a tape-station DNA 1000 (Agilent, USA) to verify the size. Quantification, normalization, 
and pooling were the performed. 
DNA concentration was calculated in nM based on the size of DNA amplicons as determined by the 
Agilent Tape Station 1000. The library sample was then diluted to 4 nM using Tris pH (8.5). 5µl of 
diluted DNA from each library sample was then pooled. The MiSeq reagent cartridge was removed 
from -15°C storage and thawed at room temperature. DNA was then denatured by combining 5 µl  of 
4nM pooled library sample and 5µl 0.2 N NaOH. This was then briefly vortexed and centrifuged at 280 
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X g at 20°C for 60 seconds. The sample was then incubated at room temperature for 5 minutes. 990 µl 
of pre-chilled hybridization buffer HT1 was added to a tube containing 10 µl of denatured DNA. 5 µl of 
4 nM phiX library sample and 5 µl of 0.2 n NaOH were combined in a micro centrifuge tube and briefly 
vortexed before incubating for 5 minutes at room temperature to denature the phiX library sample 
into individual strands.  990 µl of pre-chilled HT1 (20pM) phiX library was added to the tube 
containing 10 µl denatured phiX library to result in 20 pM phiX. This was then diluted to the same 
loading concentration as the amplicon library sample to equal 8mM by mixing 20 pM denatured 
library and pre-chilled HT1 (360 µl). The amplicon library sample was then set aside on ice until it was 
time to heat denature the mixture immediately prior to loading it into the MiSeq v3 reagent cartridge. 
The mixture was once again incubated at 96°C for 2 minutes using a heat block. The tube was then 
mixed and placed in an ice-water bath. The template allocations of samples were set up in the 
illumina sheet then the combined library and phiX sample was loaded into the Miseq cartridge then 
into the illumine machine using version 3 (300x2) chemistry on the Miseq instrument (illumine Inc., 
USA) according to manufacturer’s instructions. 
Results were then analysed through microbiome analyst software that performed comparative 
diversity analysis and statistical analysis of any differences by either treatment or age. The significance 
level was set to p=>0.05 to match the rest of the statistical analysis used in this thesis. 
 
2.5.18 Peroxynitrite Analysis 
ABEL-TAC™ kits were purchased from Knight Scientific, Plymouth, UK. This assay measures the ability 
of a substance to quench peroxynitrite radicals to determine oxidative status or antioxidant capacity. 
The kit can be used on numerous substances, but for the purpose of this project it was used to 
measure the antioxidant properties of feed and the oxidative status of birds (serum). 
The kit makes peroxynitrite from the reaction between nitric oxide and superoxide which is released 
continually from a 2.5 mmol Lˉˡ solution of 3-morpholino-sydnonimine HCL; C₆H₁₀N₄0₂ . HC1 (SIN-1). A 
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0.5 mmol Vitamin E Analogue (VEA) standard curve is prepared using the reconstituted VEA standard 
provided by the manufacturer.  
A test run was performed to determine a suitable range for the VEA standards using 3 high range 
standards and 3 low range standards, as described in the kit, together with 3 samples to get an 
indication of where the samples fall. Once the standard range has been identified, this is used to 
provide vitamin E equivalent units, to which the samples are compared. 
In brief, 50 µl Pholasin™, 100 µl peroxynitrite, 5 µl of serum sample and 95 µl of kit buffer are added 
to each well of a 96 well microplate with the samples analysed in duplicate. This was placed in the 
luminescent plate reader (Fluostar Omega plate reader, BGM Labtech, UK), which subsequently 
injects 50µl if SIN-1 into each well. The SIN-1 continually releases peroxynitrite. Causing the Pholasin™ 
to glow. The Pholasin™ will emit gradually increasing light that will reach a peak after a few minutes.  
If the sample has any ability to scavenge peroxynitrite radicals it will compete with the Pholasin™ for 
peroxynitrite, resulting in a peak of lower intensity. The point at which peak luminescence occurs 
following the injection of SIN-1 is expressed as a vitamin E analogue equivalent units. The sample 
results are then compared to the curve and linear regression can then be used to convert the times to 
peak luminescence to VEA equivalent units. 
 
2.5.19 ABEL test for Halogenated Oxygen 
This kit measures the ability of a given substance to quench radicals of the halogenated oxygen 
species. This method was used to determine the antioxidant properties of various feed stuffs. The kit 
uses chloramine-T to create halogenated oxygen radicals and the unknown samples can then be 
assessed by measuring the ability of the sample to quench the radicals and comparing to a known 
standard.  
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This test is performed on liquid samples, so initially a suitable solvent must be identified. The kit 
suggests ultra-pure water, acetone or ethanol at either 100% or 50% with 50% ultra-pure water. 
These are recommended as the antioxidant potential of these solvents is known and taken into 
consideration within the kit. The suitability of each solvent was assessed by adding 10 mg of feed 
sample to 1 ml of solvent (or any amount in these ratios). The samples are then placed on rollers for 
20 minutes. After 20 minutes the samples are visually assessed to determine the optimal solvent 
according to how much of the feed has not dissolved. 
On a microplate, 700 µl of assay buffer, 200 µl Pholasin™ and 50 µl of sample were added in 
duplicate. The plate was then placed in the luminescent plate reader (Fluostar Omega plate reader, 
BGM Labtech, UK), which subsequently injected chloramine-T to initiate the reaction. The Pholasin™ 
glows when it comes into contact with the chloramine-T. If the samples have any ability to quench 
halogenated oxygen radicals, the sample competes with the Pholasin™ for the chloramine-T, causing 
the sample to emit less light. The antioxidant capacity of a given sample is expressed in relative light 
units ( light emitted per second (mV)). No sample controls are run on each plate.  
 
2.5.20 ABEL Test for Singlet Oxygen Species 
This kit measures the ability of a feed sample to quench singlet oxygen species.  
Chloramine-T and urea peroxide are used to create singlet oxygen radicals in situ. Pholasin™ then 
reacts to the radicals and emits light. If the unknown sample has any capacity to quench singlet 
oxygen species it will compete with the Pholasin™ for radicals, reducing the light emitted. Results are 
expressed as a percentage inhibition of light. 
To perform the test, 30 µl assay buffer, 40 µl sample, 50 µl Pholasin™ and 40 µl of urea peroxide were 
pipetted onto a microplate. Samples were run in. The plate was loaded into a luminescence plate 
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reader (Fluostar Omega plate reader, BGM Labtech, UK), which subsequently injected 40 µl of 
Chloramine-T in to each well.  
 
2.5.21 Histology – Jejunum and breast tissue 
A 2cm section of jejunum (taken from the Meckel’s end) or a cm cube of breast tissue was dissected 
from 1 bird per pen. The tissue was carefully flushed with distilled water (pH7.4) to avoid damaging 
intestinal architecture then placed in an individual pot of Bouin’s fixative for 6 hours (for birds up to 
14 days old) or 8 hours (for birds over 14 days). Following fixation in Bouin’s, the tissue was 
transferred into 70% IMS and stored at room temperature until processing. 
Samples were removed from the IMS, cut with a scalpel to ensure straight ends and remove any 
damaged areas, and placed into a disposable histology cassette (Thermo Fisher Scientific, UK). The 
cassettes were then placed in a tissue processor (Leica ASP300). The processor sequentially 
submerges the samples as follows (table 2.2) 
Table 2.2 – Tissue processor chemical procedure  
Chemical Duration 
 70% IMS  Overnight 
Fresh 70% IMS  1 hour 
90% IMS  1 hour 
90% IMS 1 hour 
100% IMS  1 hour 
100% IMS  1 hour 
Histoclear  1 hour 
Histoclear  1 hour 
wax 60°C  1 hour 
wax 60°C  1 hour 
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Once removed from the processor, the samples were embedded in paraffin wax using an embedding 
machine (Leica embedding station). The samples were then placed on a cold plate to set and stored in 
the fridge until cutting. 
The wax blocks were trimmed with a single edge razor blade and placed on ice to keep cold. a rotary 
manual microtome (Leica RM2235) at 10 microns thickness into a ribbon of sections. Ribbons were 
placed directly onto the surface of a warm water bath to remove creases. A slide was then dipped 
below the surface to slide the sample onto it. 4 sections of the same sample were added to each slide. 
Once dry the jejunum samples were stained using haematoxylin and eosin staining using staining 
troughs in the order below: 
Xylene – 5 minutes 
1. Histoclear – 5 minutes 
2. 100% alcohol - 2 minutes 
3. 95% alcohol -  2 minutes 
4. 70% alcohol – 2 minutes 
5. Running tap water 
6. Haematoxylin – 10 minutes 
7. Running water until water runs clear 
8. 2 dips in 1% acid IMS  
9. Running tap water 
10. 2 dips in ammoniated water 
11. Running tap water 
12. Eosin – 5 minutes 
13. Running tap water until water runs clear 
14. 70% alcohol – 6x 4 second dips 
15. 95% alcohol – 6 x 4 second dips 
16. 100% alcohol – 1 minutes 
17. Histoclear – 5 minutes 
18. Xylene – 5 minutes 
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Finally, in a fume hood, slides were mounted with DPX mountant and covered with a cover slip. 
Analysis of villi height and crypt depth was done on an Olympus BX51 microscope fitted with an 
Olympus DP71 camera that had an internal measurement function (freshly calibrated). From each 
sample, a villi and crypt were measured (eight Villi and eight crypts per pen). An average of the eight 
measurements was calculated and used for statistical analysis.  
 
2.5.22 Viscosity 
Viscosity of jejunum digesta was measured using a Brookfield cone and plate viscometer (Brookfield 
Engineering laboratories, INC. USA) maintained at chick body temperature (41oC) using a circulating 
water bath. Jejunum digesta was collected post mortem. This was then split into multiple Eppendorf 
tubes and spun at 15,000 RPM for 5 minutes (Sigma 7 Microcentrifuge, Sigma-Aldrich, UK). The 
supernatant was then removed and used for analysis. The viscometer was calibrated with distilled 
water (viscosity 0.66cP). 0.5ml of sample was then pipetted into the cup and the spindle started at 
30rpm. Each sample was repeated 3 times and recorded. The average value for each pen was used for 
statistical analysis. 
 
2.5.23 Texture Analysis 
Breast meat texture was assessed using a TA.XT Plus texture analyser (Stable Microsystems, Guildford, 
UK), set up with a 50KG load cell and compression fixture (Park et al., 2003, Taylor et al., 2003, Shaw 
et al., 2010). The texture analyser was set up to measure force (N) required to maximum 
compression. A 4cm square chunk of fresh (unfrozen) breast meat was placed on the texture analyser 
plate and the compression fixture applied. The machine recorded the maximum compression force 
over three tests per sample. An average was used for statistical analysis.  
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Following this test, the meat was cooked in an oven at 180°C for 15 minutes, until the juices ran clear. 
The cooked  breast meat was then re-tested on the texture analyser with identical settings as 
described in the previous paragraph. 
 
2.5.24 Drip Loss 
The quantity of drip loss from a sample of breast or thigh tissue was measured by weighing a 4cm 
square chunk of meat on the day of slaughter, after 48 hours and again 5 days later. Samples were 
placed on a grid made of plastic pond netting, inside a sealed seed propagator to allow the liquid to 
fall away from the sample. Samples were identified with a cocktail stick with a sticker. The seed 
propagators were sealed with parcel tape and placed in a fridge at 4°C for 5 days. After 48 hours the 
samples were removed and weighed then placed back in the fridge for the remainder of the 5 days. 
The weight lost from each sample was recorded so a drip loss percentage of the original weight could 
be calculated. 
 
2.6 Data Analysis 
Outliers were removed from each data set if they fell above or below 2x the standard deviation of the 
mean. All data was analysed using SPSS software, version 23 for Windows (IBM Statistics, 2018). KS 
testing was applied to determine normality, then either a one-way ANOVA or Kruskal Wallis was 
applied to determine significance. Univariate analysis was used to determine interactions between 
analysed factors. Correlations were analysed by bivariate correlation using Pearson correlation, 
chosen because it computes based on true values and depicts linear relationships. Multiple linear 
regressions were used to determine the unique contribution and relatedness of factors. 
Interpretations of the strength between relationships was based on those of Cohen (1988): small r = 
0.1-0.29, medium r = 0.30-0.39 and large r = 0.50 to 1.0. Statistical significance was declared at 
p<0.05. Statistical significance was declared at p<0.05. 
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Chapter 3 – The effect of XOS from a distiller’s wet grain source on 
the gut health parameters and performance of broilers 
 
3.1 Introduction 
This chapter investigates the effect of a novel arabinoxylan (AX) extract on the performance and gut 
health of broilers.  
Pre and probiotics are one of the key areas being investigated in the effort to support gut health of 
broilers without the use of antimicrobials. Oligosaccharides are a potential prebiotic but as the type of 
oligosaccharide and substance from which an oligosaccharide is extracted can vary hugely, identifying 
specific efficacy from the literature can be difficult.  
Reduced broiler performance due to increased digesta viscosity is commonplace when diets contain 
high levels of non-starch polysaccharides (NSP) due to reduced transit time and subsequent reduced 
feed intake (Jia et al., 2009; Chen et al., 2017). To prevent this, exogenous xylanase is routinely fed to 
improve nutrient utilisation and increase performance. Xylanase hydrolyses the NSP fraction of the 
diet, cleaving the xylan backbone and breaking it into smaller oligosaccharides. The routine use of 
exogenous xylanase in commercial broiler production has been widely shown to improve 
performance parameters by 2-4% (Enberg et al., 2004; Owens et al., 2008; Wu and Ravindran, 2004). 
Xylanase is considered to have four potential modes of action (Bedford, 2018).  
1. Viscosity effect – xylanase reduces the viscosity of digesta (Gonzalez-Ortiz, 2016) 
2. Cage effect (cell wall mechanism) – xylanase degrades the cell wall of cereal grains releasing 
encapsulated nutrients. This increases the diffusion of nutrients, substrates and enzymes 
enabling the host better utilize nutrients in the ration (Bedford and Autio, 1996) 
3. Pre-biotic effect – xylanase degrades AX present in the diet into oligosaccharides that can be 
used a nutrient source by saccharolytic microbes in the gut (Bedford, 2018; Craig, 2019) 
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4. Signalling effect – xylanase stimulates microbes in the gut to produce xylanase in situ 
(Bedford, 2018).  
Distillers dried grains with solubles (DDGS) is a major by-product of cereal-based bio-refineries 
(Alyassin, 2019). During bioethanol production, wheat is ground, mixed with water then heated in a 
high temperature cooking step (Scholey, 2012). Once the resulting mash is cooled to 90-100°C, 
amylase is added to breakdown the starch and reduce the viscosity of the solution. Glucoamylase is 
then added to remove glucose. A fermentation step follows where the mash is further cooled, and 
yeast is added. This is left to ferment for 48-72 hours at 30-35°C. This is then distilled to produce a 
95% ethanol and 5% water solution. The remaining stillage is separated by either centrifugation, or a 
pressing and extrusion process into wet grain and a thin stillage. DDGS is then produced by drying the 
thin stillage to a syrup to remove some of the water content, then remixed with the grain (Scholey, 
2012). In commercial bio-ethanol plants, the distillers wet/dried grains cannot be sampled, or 
separated from the solubles due to a closed production process.  
Chemical engineers at the University of Huddersfield have developed a method using a GUNT CE-640 
(GUNT Technology, Hamburg, Germany) bio-ethanol unit to produce distiller’s wet grains with dried 
solubles, therefore allowing the value of the wet grains and the solubles to be assessed 
independently. The AX manufacturing process is described in detail in the material and methods 
section of this chapter. 
This study was designed to determine whether an AX extract could be manufactured and fed to 
broilers to enhance performance and/or gut health. The rational for this was that supplying an AX 
extract (as opposed to the AX present in the grain) would increase the availability of the AX for 
degradation. The study was designed to use a control treatment to compare to a treatment 
containing AX and a treatment containing AX pre-treated with xylanase.  
The key aims of this study were as follows: 
77 
 
• To investigate the effect of a DWGS derived AX on the gut health and performance 
parameters of broilers 
• To determine whether pre-treating the DWGS AX extract with exogenous xylanase increased 
efficacy of the AX extract in terms  of performance and gut health of the birds 
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3.2 Trial procedure 
3.2.1 Husbandry Conditions 
336-day-old male Ross 308 chicks were sourced from PD Hook Cote hatchery from a flock aged 57 
weeks. Birds were feather sexed on the day of hatch and any poor birds were discarded on arrival. 
Chicks were individually weighed on arrival, then randomly assigned to 48 mesh sided pens, littered 
with a wood shavings substrate. Food and water were provided ad libitum and care taken to ensure 
chicks were eating and drinking as soon as possible. If chicks had not started to eat within 60 mins 
chick paper was added to stimulate food consumption. Husbandry guidelines were followed as 
described in chapter 2 and adhered to the institutional and national guidelines for the care and use of 
animals (Animal Scientific Procedures Act, 1986). Ethical approval was obtained and is recorded as 
project ARE551. 
 
3.2.2 Diet formulation and condition of animals 
AX extract was manufactured and provided dried and ground by the University of Huddersfield. 
Exogenous xylanase (Econase XT) was provided by A.B. Vista. Doubled-milled wheat was sourced from 
Target Feeds (Shropshire, UK) and passed through a 1.4mm sieve to remove any larger particles. 6kg 
of wheat was added into the mash tank of the bio-ethanol unit with 15 litres of water. This was 
heated to 85°C. by direct steam injection. 1.2ml of α-amylase and 3.6ml of gluco-amylase was added 
to induce starch hydrolysis. pH was adjusted to 4.5 with sulphuric acid and the mash was stirred 
continually for 2 hours. Upon completion of the stirring time, the mash was pumped into the 
fermentation tank and 6g of yeast and 0.9ml of anti-foaming agent was added to initiate 
fermentation. The mash was fermented at 25-28°C. for 72 hours. The fermented mash was then 
pumped into the distillation column and distilled for 4 hours to separate the ethanol. The resulting 
slurry was filtered through a cloth to obtain the distillers wet grains (DWG), and the filtrate (solubles). 
The solubles were dried in an oven to produce dry solubles.  A single fermentation batch of 6kg of 
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wheat yielded on average 1275g of wet grains with 16% AX content and 800g of dried solubles with 
11.4% AX content. Therefore, the wet grains were selected for further processing. The wet grains 
were enzymatically treated with xylanase by adding 50ml per kg of wet grains and incubating in a 
shaking water bath at 55°C. for 1 hour (Econase XT, A.B Vista, UK). At the end of this time, the sample 
was submerged into an ice bath to stop enzyme activity. This yielded less than 3% oligosaccharides.  
AX polysaccharides were then extracted via alkaline oxidation with enzymatic purification, yielding a 
44% AX (figure 3.1). AX extract was freeze dried before adding to poultry diets. 
 
Figure 3.1 Chemical extraction of AX extract from distillers’ wet grains, Alyassin, 2019, used with 
permission, A.B. Vista, 2020 
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The four diets were manufactured in-house as a mash diet as per the method in section 2.3.5, with 
treatments detailed in table 3.1. Diets were formulated by a commercial nutritionist (table 3.2) in 3 
phases – starter, grower, and finisher. Analysed values for the individual diets are shown in table 3.3. 
Quantum Blue 5G phytase was added at 0.01% to all treatments. 
 
 
Table 3.1 – Dietary treatments for AX extract trial 
Diet Treatment 
Con Standard broiler diet 
AX Standard broiler diet + 100g/t DDGS 44% AX extract 
AX + 
Xy 
Standard broiler diet + 100g/t DDGS 44% AX extract Pre-treated with xylanase at 
1g/kg 
 
Table 3.2 – Diet Formulation and rate of inclusion for AX extract trial (%) 
Ingredient Starter Grower Finisher 
Wheat 35 35 35 
Corn 23.91 26.58 29.18 
Soybean meal 34.37 31.06 27.55 
Soya oil 2.76 3.85 4.96 
Salt 0.3 0.31 0.31 
Limestone 0.1 0.06 0.03 
Dicalcium Phos, 18%P 2.26 2 1.84 
Sodium Bicarbonate 0.1 0.1 0.1 
Lysine HCl 0.23 0.18 0.18 
DL-Methionine 0.31 0.27 0.26 
Threonine 0.13 0.09 0.08 
Vitamin & Mineral premix 0.5 0.5 0.5 
Quantum Blue 5G Phytase 0.01 0.01 0.01 
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Table 3.3 - Diet proximate analysis for AX extract trial 
Diet Starter 
Con 
Starter 
AX 
Starter 
AX+Xy 
Grower 
Con 
Grower 
AX 
Grower 
AX+ Xy 
Finisher 
Con 
Finisher 
AX 
Finisher 
AX+Xy 
DM (g/kg) 873.1 873.1 876.4 872.2 872.2 874.7 871.3 871.3 870.7 
Ash (g/kg) 5.37 5.51 5.95 5.03 4.68 5.05 4.58 4.96 4.97 
Protein 
(g/kg DM) 
21.42 21.76 22.16 20.21 20.04 20.81 19.02 18.55 20.72 
Total P 
(g/kg DM) 
8.80 7.93 8.39 7.29 8.06 7.58 6.88 6.45 6.72 
Total Ca 
(g/kg DM) 
9.84 9.28 9.03 8.03 8.83 8.61 7.43 6.90 6.93 
Fat (g/kg) 4.41 4.21 4.04 5.48 5.83 5.01 5.85 5.69 5.66 
Ti (g/kg) 4.98 4.95 4.72 N/A N/A N/A 5.01 4.84 4.40 
GE (MJ/kg) 16.27 16.30 16.20 16.55 16.45 16.31 16.69 17.03 16.97 
Phytase 
FTU/kg 
612 990 857 794 501 261 615 1010 989 
 
 
3.2.3 Pre-treatment of AX 
The AX+Xyl was pre-treated with exogenous xylanase as follows; 30.77g of AX and 123.08g of distilled 
water were weighed accurately to 4dp. 0.003g of xylanase was weighed and added to the distilled 
water and mixed. The distilled water and xylanase were then added to the AX and placed on a heated 
magnetic stirrer for 1 hour at 41 degrees C°. with constant stirring. Following this treatment was 
added to the basal diet and mixed in the ribbon mixer to attempt to ensure even distribution. 
 
3.2.4 Treatment schedule / randomisation plan / condition of animals 
A replicate consisted of a pen containing 7 birds, with only birds weighing between 38g and 46g 
placed. The weight of each pen was recorded on day 0 and treatments randomly around the trial 
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room using an online randomiser allocated (by non-involved individual to prevent bias), to reduce any 
possible effects of ventilation and room placement. Pen layout is shown in figure 3.2 and pen 
allocation is shown in table 3.4. 
 
Figure 3.2 - Room plan for AX extract trial 
      
19  20 41  42 
18  21 40  43 
17  22 39  44 
16  23 38  45 
15  24 37  46 
14  25 36  47 
13  26 35  48 
12  27 34   
11  28 33   
10  29 32  1 
9  30 31  2 
8      
  7 6 5 4 3 
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Table 3.4 - Diet allocation for AX extract trial 
pen 
diet 
allocation   pen 
diet 
allocation 
pen 1 D   pen 25 D 
pen 2 C   pen 26 C 
pen 3 B   pen 27 B 
pen 4 A   pen 28 A 
pen 5 D   pen 29 D 
pen 6 C   pen 30 C 
pen 7 B   pen 31 B 
pen 8 A   pen 32 A 
pen 9 D   pen 33 D 
pen 10 C   pen 34 C 
pen 11 B   pen 35 B 
pen 12 A   pen 36 A 
pen 13 D   pen 37 D 
pen 14 C   pen 38 C 
pen 15 B   pen 39 B 
pen 16 A   pen 40 A 
pen 17 D   pen 41 D 
pen 18 C   pen 42 C 
pen 19 B   pen 43 B 
pen 20 A   pen 44 A 
pen 21 D   pen 45 D 
pen 22 C   pen 46 C 
pen 23 B   pen 47 B 
pen 24 A   pen 48 A 
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3.2.6 Study observations 
Bird observations were performed a minimum of twice daily to ensure bird welfare and 
environmental conditions were maintained. Temperature and/or ventilation were adjusted depending 
on bird behaviour. Dead birds were removed and weighed, and any unhealthy birds were culled and 
recorded. Bird feed intake was calculated as per the method detailed in section 2.4.2. Birds were 
weighed weekly by pen on days 0, 7, 14, 21, 28 and 35, as per section 2.4.3.  Each week, remaining 
feed was weighed by pen to calculate feed intake. Feed intake and bird weight were used to calculate 
weekly feed conversion ratio (FCR). 
 
3.2.7 Sample Collection 
On day 7, three birds per pen (collected to remove outliers where possible) were euthanized. Post 
mortem, blood samples were collected (as per section 2.4.2) and placed into tubes containing EDTA 
as an anticoagulant. The blood was centrifuged at 3000RPM for 10 minutes and plasma removed and 
stored at -20°C. Ileal digesta (defined as gut content located between the Meckel’s diverticulum and 
ileal-caecal-colonic junction) was collected (as per section 2.4.3) from all three birds, pooled per pen, 
and frozen for later analysis. A 1 cm section of ileal tissue was collected of mucin layer thickness as 
described in section 2.5.9. One set of caeca per pen was removed at the ileal-caecal-colonic junction, 
weighed as a pair and snap frozen on dry ice.  
On day 35, four birds per pen were euthanized. A post mortem blood sample was collected into EDTA 
tubes as previously described and plasma removed for future immunoglobulin analysis (2.5.10). The 
pH of the ileum and caeca were measured using a spear piercing pH probe (as per section 2.5.8). One 
full ileum per pen was weighed (defined as the section of intestine from the Meckel’s diverticulum to 
the ileal-caecal-colonic junction. Ileal content was then collected in to 100ml pots (as previously 
described) and frozen for further analysis. The empty ileum weighed on a 4dp balance and a 1 cm 
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section of ileal tissue was collected of mucin layer thickness as described in section 2.5.9. One set of 
caeca per pen were collected and weighed   
Digesta was freeze dried and ground with a pestle and mortar before being analysed for titanium 
quantification (as described in section 2.5.5) and digestibility of apparent metabolizable energy, 
apparent metabolizable energy corrected for nitrogen and nitrogen retention (section 2.5.8). 
Diets and ileal digesta were analysed for gross energy by bomb calorimetry and protein content (via 
Dumas) by external labs. Titanium dioxide content of the diet was measured using the method of 
Short et al., 1996 (section 2.5.5). Calcium and phosphorus content of the diets and digesta was 
determined by ICP-OES (section 2.5.6). Ash analysis was determined by ashing a sample in a muffle 
furnace (2.5.4). Dry matter was calculated by drying in an oven for 5 days (section 2.5.1). Digestibility 
of apparent metabolizable energy, apparent metabolizable energy corrected for nitrogen and 
nitrogen retention were calculated using the formulas shown in section 2.5.8. 
 
3.2.8 Statistical analysis of data 
Outliers were removed from data if they fell either two standard deviations above or below the mean. 
Statistical analysis was performed using SPSS v.23. KS testing was used to determine data normality, 
followed by one-way ANOVA analysis as appropriate. Tukey post hoc tests were used to elucidate 
differences in treatment. Correlations were analysed by bivariate correlation using Pearson 
correlation, chosen because it computes based on true values and depicts linear relationships. 
Multiple linear regressions were used to determine the unique contribution and relatedness of 
factors. Interpretations of the strength between relationships was based on those of Cohen (1988): 
small r = 0.1-0.29, medium r = 0.30-0.49 and large r = 0.50 to 1.0. Statistical significance was declared 
at p<0.05.  
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3.3 Results 
3.3.1 Environment 
No environmental abnormalities occurred during this trial. 
3.3.2 Health and Condition 
Mortality data shown in table 3.5 demonstrates that there were no significant concerns regarding the 
health of the birds. There was no statistical significance in mortality between treatments or at any 
age. Total flock mortality for the study was 2.6%, which is considered standard for trials conducted at 
the NTU unit and significantly lower than would be expected in a commercial setting.  
Table 3.5 - Bird mortality for the AX extract trial by week and treatment (per bird) 
Treatment d0-7 d7-14 d14-21 D21-35 Total 
Con 0 0 1 0 1 
AX 0 0 0 0 0 
AX + Xy 0 1 0 0 1 
 
 
3.3.3 Bird Uniformity 
The mean start weights are shown in table 3.6.  There was no statistical significance in the start 
weight of the chicks between treatments. 
Table 3.6 - Average start weights for chicks for the AX extract trial (±SE). 
Treatment d0 BW/bird (g) 
Con 45.9 (0.19) 
AX 45.9 (0.32) 
AX + Xyl 45.3 (0.43) 
P value 0.469 
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3.3.4 Cumulative Performance 
Table 3.7 shows that there was cumulatively no significant difference in BWG and FCR for d0-d35. 
However, there was significantly increased feed intake for the AX treatment compared to the control 
and AX + Xyl treatments over the course of the trial. Although not statistically significant, the AX 
treatment also produced numerically heavier birds (126g and 128g) and a reduction in FCR compared 
both the control and AX + Xyl treatments. 
Table 3.7 - Cumulative performance results for birds supplemented with AX or AX pre-treated with 
xylanase compared to a control diet mean (±SE)  
Diet D0-35 BWG (g/bird) D0-35 FI/bird (g) D0-35 FCR 
Con 1862 (48.1) 3577 (63.6)b 1.85 (0.035) 
AX 1988 (52.5) 3794 (72.0)a 1.83 (0.087) 
AX + Xyl 1860 (44.2) 3516 (47.1)b 1.90 (0.032) 
P value 0.117 0.008 0.406 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
3.3.5 Weekly Performance 
There was no significant difference in average body weight at day 7. By day 14 the average body 
weight is numerically increased, with a trend (p=0.056; average extra weight 31g) that the AX 
treatment was  higher than the AX + Xyl and  the control (33g extra BW). At D21 there was no 
significant difference in average bird weight, however, once again the AX treatment was numerically 
higher. This pattern continues for the remainder of the trial, with the AX treatment consistently 
performing numerically better than the other two treatments (a trend for increased body weight was 
recorded at D28) (table 3.8). 
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Table 3.8 - Weekly bird weights for birds supplemented with AX or AX pre-treated with xylanase pre-
treated xylanase compared to a control diet (±SE)  
Diets D7 BW (g/bird) D14 BW (g/bird) D21 BW (g/bird) D28 BW (g/bird) D35 BW (g/bird) 
Con 137 (2.6) 356 (11.4) 735(21.8) 1254 (29.3) 1908 (48.2) 
AX 145 (2.4) 388 (9.3) 770 (19.6) 1343 (30.9) 2034 (52.4) 
AX+Xyl 140 (2.9) 357 (9.8) 738 (20.6) 1250 (30.4) 1906 (44.2) 
P Value 0.130 0.056* 0.449 0.063* 0.116 
Trend AX > (p=0.06) day 14 and 28 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
Body weight gain results reflect the average body weight results with the AX treatment consistently 
performing better than the other two treatments, although BWG was only significantly increased in 
the fourth week (table 3.9). 
 
Table 3.9 - Body weight gain by week results for birds supplemented with AX or AX pre-treated with 
xylanase pre-treated xylanase compared to a control diet (± SE) 
Diets D0-7 BWG 
(g/bird) 
D7-14 BWG 
(g/bird) 
D14-21 BWG 
(g/bird) 
D21-28 BWG 
(g/bird) 
D28-35 BWG 
(g/bird) 
Con 91 (2.7) 221 (9.9) 371 (11.1) 520b (14.2) 654 (25.1) 
AX 99 (2.4) 244 (7.6) 391 (11.0) 560a (14.1) 709 (21.0) 
AX+Xyl 94 (2.9) 221 (7.6) 372 (10.3) 511b (11.4) 656 (16.5) 
P Value 0.139 0.112 0.856 0.033 0.140 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
There was no significant difference in feed intake between treatments during the first three weeks of 
the study. At day 28 there was a significant increase in feed intake for the AX treatment compared to 
the AX + Xyl treatment (p<0.001)  (table 3.10). There was also a trend towards increased feed intake 
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for this same diet during the period of day 28-35. There was no significant diet effect on FCR at any 
point of the trial (table 3.11). 
Table 3.10 – Weekly feed intake of birds supplemented with AX or AX pre-treated with xylanase pre-
treated xylanase compared to a control diet (± SE) 
Diet D0-7 FI 
(g/bird) 
D7-14 FI 
(g/bird) 
D14-21 FI 
(g/bird) 
D21-28 FI 
(g/bird) 
D28-35 FI 
(g/bird) 
Con 207 (12.4) 517 (21.6) 666 (27.7) 921 ab (23.3) 1257 (30.50) 
AX 205 (8.7) 539 (15.3) 687 (28.8) 1033a (35.4) 1341 (33.3) 
AX+Xyl 222 (7.2) 516 (16.0) 685 (10.3) 876b (11.3) 1226 (37.3) 
P value 0.420 0.601 0.846 <0.001 0.062 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
Table 3.11 – Weekly feed conversion ratio of birds supplemented with AX or AX pre-treated with 
xylanase pre-treated xylanase compared to a control diet (± SE) 
Diet D0-7 FCR D7-14 FCR D14-21 FCR D21-28 FCR D28-35 FCR 
Con 2.2 (0.15) 2.3 (0.13) 1.7 (0.05) 1.8 (0.08) 1.9 (0.09) 
AX 2.1 (0.14) 2.2 (0.12) 1.8 (0.08) 1.9 (0.09) 1.9 (0.05) 
AX+Xyl 2.2 (0.13) 2.3 (0.11) 1.8 (0.08) 1.7 (0.02) 1.9 (0.08) 
P value 0.860 0.763 0.567 0.362 0.970 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
3.4.6 Ileal weight  
There was no significant difference in ileum weight between treatments when full or empty (p=0.862 
and p=0.791) (table 3.12) 
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Table 3.12 - Day 35 Ileal weight full and empty for birds supplemented with AX or AX pre-treated with 
xylanase pre-treated xylanase compared to a control diet (± SE) 
Diet Ileal Weight Full (g) Ileal Weight Empty (g) 
Con 39.1 (1.6) 20.5 (0.7) 
AX 38.9 (1.6) 20.3 (0.7) 
AX+Xyl 41.6 (1.6) 20.7 (0.7) 
p value 0.862 0.791 
 
 
3.3.7 Caeca weight 
There was no significant difference in the caecal weights between treatments on either day 7 or 35 (see 
table 3.13). 
Table 3.13 - Day 35 caeca weight (mean of one ceca/bird) for birds supplemented with AX or AX pre-
treated with xylanase pre-treated xylanase compared to a control diet (± SE) 
Diet D7 Mean caeca weight (g) D35 Mean caeca weight (g) 
Con 3.6 (0.70) 9.4 (0.70) 
AX 3.7 (0.06) 9.6 (0.76) 
AX+Xyl 3.6 (0.03) 8.4 (1.60) 
p value 0.733 0.429 
 
3.3.8 Measurement of the thickness of the mucin layer 
There was no significant difference in the thickness of the mucin layer between treatments (table 3.14) 
Table 3.14 - Mucin Adherence D7 (µg of alcian blue released per gram of tissue) for birds supplemented 
with AX or AX pre-treated with xylanase pre-treated xylanase compared to a control diet (± SE) 
Diet D7 Mucin (µg/g) 
Con 22.4 (0.03) 
AX 21.8 (0.05) 
AX+Xyl 22.0 (0.02) 
p value 0.228 
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3.3.9 Measurement of Intestinal pH  
pH of the jejunum (taken at the jejunal side of the Meckel’s diverticulum) and caeca were measured on 
day 35 of the trial by taking 3 individual readings then calculating the mean per bird, and this mean was 
used for statistical analysis. There were no significant differences between treatments in either the 
caeca or the ileal pH measurements (table 3.15) 
Table 3.15 - Day 35 Caeca pH and Gut pH for birds supplemented with AX or AX pre-treated with 
xylanase pre-treated xylanase compared to a control diet (+/- SE) 
Diet Caeca pH D35 Jejunum pH D35 
Con 5.53 (0.113) 5.29 (0.060) 
AX 5.56 (0.135) 5.35 (0.098) 
AX+Xyl 5.54 (0.144) 5.26 (0.109) 
p value 0.979 0.773 
 
3.3.10 Digestibility of AME, AMEn and Ni retention 
There was no significant difference between treatments in apparent metabolizable energy (AME) of 
the diet, apparent metabolizable energy corrected for nitrogen (AMEn) or nitrogen retention (Ni ret) 
at d7 (table 3.16). At day 35 there was no significant difference in AME, however, there was a 
significant decrease in the nitrogen retention of the birds fed the AX treatment, as shown in table 
3.17. Interestingly, this did not have a significant effect on the AMEn result, as there was no 
significant difference in AMEn on day 35. 
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Table 3.16 – Day 7 digestibility for birds supplemented with AX or AX pre-treated with xylanase pre-
treated xylanase compared to a control diet (+/- SE) 
 
Diet 
AME D7 (MJ/kg) Ni ret D7 (g/kg diet) AMEn D7 (MJ/kg) 
Con 4.9 (0.50) 25.3 (0.48) 4.0 (0.49) 
AX 5.2 (0.50) 23.9 (0.54) 4.3 (0.50) 
AX+Xyl 5.3 (0.36) 24.4 (0.40) 4.4 (0.35) 
p Value 0.790 0.126 0.756 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
Table 3.17 - Day 35 digestibility for birds supplemented with AX or AX pre-treated with xylanase pre-
treated xylanase compared to a control diet (+/- SE) 
Diet AME D35 (MJ/kg) Ni ret D35 (g/kg diet) AMEn D35 (MJ/kg) 
Con 9.9 (0.66) 24.4b (0.32) 9.1 (0.65) 
AX 10.1 (0.50) 21.6a (0.30) 9.4 (0.40) 
AX+Xyl 9.9 (0.48) 25.3b (0.29) 9.1 (0.47) 
p Value 0.967 <0.001 0.862 
a-b Means within the same column that do not share a common superscript are significantly different (p<0.05) 
 
3.3.11 Immunoglobulins 
There was no significant difference in either Immunoglobulin A or M between treatments (table 3.18). 
Table 3.18 – Plasma immunoglobulin for birds supplemented with AX or AX pre-treated with xylanase 
pre-treated xylanase compared to a control diet (+/- SE). 
Diet D7 IGA (mg/ml) D35 IGA (mg/ml) D7 IGM (mg/ml) D35 IGM (mg/ml) 
Con 0.12 (0.012) 0.35 (0.064) 2.55 (0.137) 2.09 (0.255) 
AX 0.12 (0.007) 0.44 (0.080) 2.06 (0.105) 2.10 (0.307) 
AX+Xyl 0.16 (0.019) 0.40 (0.040) 2.06 (0.047) 2.11 (0.127) 
P Value 0.078 0.740 0.955 0.399 
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3.4 Discussion 
 The aim of this study was to investigate the effect of a DDGS derived AX extract in supporting the 
performance and gut health of broilers and to investigate whether pre-treating the AX with xylanase 
influenced efficacy. This study originally had four treatments, with the fourth treatment being AX + 
xylanase added directly into the diet, rather than as  a pre-treatment. Unfortunately, following the trial 
it was found that this diet was lacking phytase in the starter diet. Lack of phytase is widely recognized 
to inhibit bird growth and development as chicks are unable to access nutrients such as calcium, 
phosphorus and amino acids bound up in the phytate molecule (Oluyinka et al., 2007; Lelis et al., 2012). 
The poor start that this treatment received makes it not comparable to the other treatments. 
Therefore, this treatment was removed from the analysis.  
Despite the difficulties experienced, there are some interesting results. Overall, the final bird weight at 
d35 was lower than a typical mash trial at NTU (1.952kg compared to 2.181kg). The reason for this is 
unclear as the birds had constant access to feed that contained sufficient protein, energy, and essential 
nutrients for the duration of the trial. The study birds were from a 57-week flock, which has been shown 
to produce more bird weight variability and decreased bird performance, which may account for some 
of the decreased performance (Joseph and Moran, 2005). Extremes of temperature and humidity have 
been shown to negatively affect broiler performance, however there was little change in environmental 
conditions during the trial, which would therefore be unlikely to produce a reduction in body weight.  
 The AX extract continually performed at least as well as the control treatment, so it can be deduced 
that it did not have any deleterious effect on bird performance or health, and in fact showed positive 
effects at a number of measurement timepoints. During the first week of the trial both the 
experimental treatments showed numerical improvements in body weight gain, with the AX 
treatment gaining nearly 6% more weight than the control. Following the first week, the AX pre-
treated with Xyl no longer shows any improvements and performs in a very similar way to the control.  
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At day 14 the AX treatment continues to show increased performance compared to the other 
treatments, with the average bird weight (BW) becoming almost significantly increased at day 14 
(p=0.056). Likewise, at day 14 the body weight gain, although not significantly different, is 10% higher 
than the other two treatments. This effect seems to continue with the AX treatment consistently 
showing numerically increased BWG and BW compared to the other treatments. At day 28 the body 
weight gain becomes significantly increased for the AX treatment compared to the other two 
treatments (p=0.033) and there is a trend towards increased BW (p=0.063).  
The increased growth performance of the AX treatment shows that AX alone appears to be having a 
beneficial effect on bird growth compared to the other two treatments. The lack of enhanced 
performance for the AX+Xyl treatment was surprising as it could have been expected that the 
improvements seen for AX supplementation would be reflected in this treatment. It appears that 
either the pre-treatment process or the addition of xylanase acts to negate any benefit from AX 
supplementation.  
The routine use of exogenous xylanase in commercial broiler production has been widely shown to 
improve performance parameters by 2-4% (Enberg et al., 2004; Owens et al., 2008; Wu and 
Ravindran, 2004). Xylanase is considered to have four potential modes of action (Bedford, 2018).  
5. Viscosity effect – xylanase reduces the viscosity of digesta (Gonzalez-Ortiz, 2016) 
6. Cage effect (cell wall mechanism) – xylanase degrades the cell wall of cereal grains releasing 
encapsulated nutrients. This increases the diffusion of nutrients, substrates and enzymes 
enabling the host better utilize nutrients in the ration (Bedford and Autio, 1996) 
7. Pre-biotic effect – xylanase degrades AX present in the diet into oligosaccharides that can be 
used a nutrient source by saccharolytic microbes in the gut (Bedford, 2018; Craig, 2019) 
8. Signalling effect – xylanase stimulates microbes in the gut to produce xylanase in situ 
(Bedford, 2018).  
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However, the addition of distilled water during the pre-treatment process diluted the xylanase to the 
point where an enzyme recovery test could not determine a difference between the AX pre-treated 
with xylanase and the two treatment diets that did not contain xylanase. Therefore, it seems unlikely 
that there was enough xylanase present in the diet to exert any effect.  
Xylanase inhibitors are chemicals that inhibit the xylanase activity. Xylanases can also be subject to 
product inhibition, by some hydrolysis products of AX degradation, including xylose, arabinose and 
xylotrose (Dekker and Richards, 1976). Currently, three proteinaceous xylanase inhibitors have been 
identified in wheat. These include Triticum aestivum xylanase inhibitor (TAXI) (Debyser et al., 1999), 
xylanases inhibiting protein, (XIP) (McLauchlan, 1999), and thaumatin like xylanase inhibitor (TLXI) 
(Fierens, 2007). The quantity of these xylanase inhibitors is considered high in wheat compared to 
other cereal grains (Gebruers et al., 2010). Likewise, the quantity and type of xylanase inhibitors can 
vary by cultivar. Soerensen et al., (2004) demonstrated that endogenous xylanase inhibitors can 
reduce the effectiveness of xylanase inclusion in pig and poultry diets. Therefore, it is possible that 
the wheat used in this study may have been particularly high in xylanase inhibitors, thus accounting 
for the lack of xylanase effect. 
AX on its own would generally be considered deleterious to broiler production, as the larger 
polysaccharides would generally be thought to form gels and increase viscosity (Bedford, 2002). In 
commercial production, exogenous xylanase is fed with diets containing high levels of AX to 
counteract its effects (Bedford 2018). However, in the current study the AX treatment fed on its own 
seems to improve most performance parameters, this may support the theory that xylanase is being 
produced in vivo by the microbial population of the intestinal tract. It is generally believed that 
broilers do not possess the ability to produce endogenous xylanase (Bedford, 2018; Salah et al., 
2019). However, studies have shown that a number of bacterial species often found in the intestinal 
tract of broilers are capable of producing xylanase (Asem et al., 2017; Bhardwaj et al., 2019). Asem et 
al. (2017) demonstrated that of 29 bacterial isolates collected from the intestinal tract of a pig, 13 
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species had the capacity to produce xylanase with the capacity to hydrolyse xylan. Likewise, Latorre et 
al. (2015) demonstrated the ability of three different Bacillus.spp strains to produce xylanase in an in 
vitro digestive model. Bedford, (2018) suggests that when saccharolytic microbes produce xylanase, 
the AX present in the diet is degraded, providing more fermentable substrate for the caeca. VFA’s are 
the primary products of caecal fermentation (Annison et al., 1968). From the caeca, VFA’s are 
transferred to the blood and can contribute energy to the host (Annison et al., 1968; Svihus et al., 
2013). From the studies reviewed, there seems to be a consensus that broiler caeca generally contain 
acetic acid, butyric acid and propionic acid in varying amounts and on some occasions a small amount 
of lactic acid was detected (Choct et el., 1999; Jamroz et al., 2002; Jozefiak et al., 2006;, Jozefiak et al., 
2011). VFA production in the caeca is associated with an increase in the population of beneficial 
bacteria in the GIT (Enberg et al., 2004). Volatile fatty acids have been shown to enhance the 
performance of broilers, with butyrate in particular resulting in increased energy availability for the 
bird (Ravangard et al., 2017). Butyrate has also been shown to have anti-inflammatory properties and 
act as fuel for epithelial cells – consequently improving the integrity of the epithelial barrier (Duncan 
et al., 2004; De Maesschalck et al., 2015). 
When trying to determine possible reasons for the lack of AX effect in the AX pre-treated with 
xylanase treatment, there are several possibilities. One possibility is the effect of the method used for 
pre-treating the AX with xylanase. Distilled water was added to the powdered xylanase and the AX 
extract before this mixture was mixed with the diet. Arabinoxylans have been shown to have the 
ability to absorb up to 10 times their weight in water, forming a highly viscous, gel-like solution 
(Choct, 1997). It is possible that the AX extract when mixed with water became bound up in the 
viscous solution and the amount of xylanase present was insufficient to decrease this viscosity. If this 
occurred, the increased viscosity may have cancelled out any of the positive effect of the AX.  
In vitro pre-treatment with xylanase was performed in the hope of initiating the AX to break down 
into oligosaccharides prior to feeding the diet, rather than in situ. However, as xylanase is typically 
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added to the diet as a dry powder as part of the vitamin and mineral premix to ensure adequate 
mixing, another possibility is that the wet addition caused the AX to cluster, preventing even 
distribution and potentially making the diet unpalatable to the birds. Particle size has been shown to 
have a profound effect on palatability in broilers, and although they typically prefer the particle size to 
be around 800-1000µm (Mingbin et al., 2015), wet clusters of feed are likely to exceed this. Another 
possibility is that if the AX coagulated, it may have produced clusters of AX that would have been 
limited in number. This could mean that some birds in the pen were able to consume AX and others 
not. Finally, there is a possibility that adding exogenous xylanase directly to the AX extract may have 
depolymerised the AX into monosaccharides, rather than the desired, xylobiose and xylotriose (Kiran 
et al., 2013). Biose and triose are of particular interest as they are readily utilized by probiotic 
microorganisms (Bailey et al., 1992; Yamada et al., 1993). XOS with a degree of polymerisation of (2-3) 
present faster fermentation kinetics and therefore contribute to a favourable microbiome (Gullon et 
al., 2011). 
 The cumulative feed intake for the AX treatment is significantly increased compared to the other two 
treatments. When looking at the weekly feed intake, there is no significant difference until D28 
(p<0.001) and by D35 there was only a trend that birds fed the AX treatment ate more (p=0.062). As 
the AX treatment birds were also larger at these time points, it could be expected that FI would 
increase. A number of authors that reviewed broiler feed intake have deduced that feed intake is 
inextricably linked to growth rate (Nitsan, 1995; Ferket, 2002; Ferket and Gernat, 2006). Likewise, 
Ferket and Gernat (2006) state that digesta motility is a key influence on feed intake. As before, if the 
bacteria in the gut are producing in situ xylanase, it is plausible that the digesta viscosity may have 
been reduced and therefore gut motility was increased allowing increased feed intake. Unfortunately, 
digesta viscosity was not measured on this trial, so it is not possible to confirm that this affected feed 
intake. It has also been suggested that birds, rather than eating to satisfy hunger, just consume 
enough to satisfy their energy and protein requirements (Kamran et al., 2008). Therefore, it could be 
expected that larger birds would eat more to fulfil these requirements. However, there was no 
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significant difference in ileal weight when full between treatments, this suggests that there may not 
have been a difference in digesta viscosity as if one treatment produced decreased digesta viscosity, a 
difference in ileal weight when full, may have been expected. 
The digestibility results show that there was no significant difference in AME and AMEn between 
treatments at either day 7 or 35. There was no significant difference between treatments for nitrogen 
retention at day 7, but by day 35, the AX treatment shows significantly reduced nitrogen retention. 
This directly contrasts with other studies that found feeding xylose (the pentose sugar portion of 
xylans) caused increased nitrogen retention (Peng et al., 2004). As the AMEn was not affected, it is 
unlikely that any reduction in nitrogen retention is affecting the bird to any substantive degree. 
Furthermore, Morgan et al., (2019), found that supplementing broilers with AXOS significantly 
increased nitrogen retention when fed a wheat/soy diet and supplemented AXOS at a 2% inclusion 
rate. It is possible that this result may just be a statistical error, however, if it is a genuine reduction in 
nitrogen retention, this raises the concerns of protein or amino acid utilisation and additional 
excretion of nitrogenous waste.  
No significant differences were found between treatments in analysed plasma immunoglobulin G or 
M. It is possible that the birds in this trial were not placed under any immune challenge. 
Immunoglobulin levels have been found to increase under immunological challenge. This could 
potentially be due to the nature of the experimental unit at NTU. As the unit is kept very clean and a 
high level of biosecurity is observed, the chances of pathogenic challenge are greatly reduced. 
Likewise, environmental stress is likely to be lower due to reduced stocking density, easier access to 
feed and water and less social hierarchy (Marsteller et al., 1980; Estevez et al., 1997; Marino, 2017). 
Immunoglobulin levels rise in line with antibody production when the host undergoes an immune 
response (Painter, 1998). If the birds were not immunologically challenged, levels typically remain 
unchanged. The IgM results concur with that of Alsudani, (2018), where no difference was found 
when supplementing broilers with lactobacilli probiotic. The levels of IgM also concur with Lebacq et 
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al. (1974) who performed the original quantification and distribution of chicken immunoglobulins and 
found IgM levels to be an average of 2.55mg/ml and IgA to be an average of 0.33mg/ml.   
There was no significant difference in the mucin layer thickness between treatments, and the levels 
reported on this study are substantially (50%) lower than other authors have found. The mucin 
adherent layer lines the intestinal tract, providing a vital barrier function, lubrication and protection to 
the mucosal surface from mechanical injury and enteric pathogen entry (Tsirtsikos et al., 2012). 
Secreted from goblet cells in the lining of the gut epithelium, mucin is thought to effect nutrient 
absorption, if the adherent layer is too thick. If the layer is not thick enough, barrier integrity can be 
compromised. This may imply that intestinal barrier function was impaired for all treatments, 
potentially causing systemic infiltration of gut microbiota. The lack of difference between treatments 
seen in the current study, imply that any effect of mucin layer thickness was universal across all 
treatments. Impaired intestinal barrier function, also called leaky gut, has been widely reported to 
inhibit broiler performance (Bischoff et al., 2014; Gilani et al., 2016; Barekatain et al., 2019). Therefore, 
it is possible that all treatments were experiencing a degree of leaky gut, consequently reducing the 
overall performance seen in this study.  
There was also no difference in caeca weight or intestinal pH. This may suggest that there were not 
substantial differences in the bacterial make-up of the caecal contents. Jozefiak et al. (2007) looked at 
the effect of xylanase supplementation on diets of either, triticale, rye, or wheat. The authors found a 
significant increase in the weight of the caeca from birds fed rye-based diets, but despite this could not 
detect a significant difference in caecal pH between treatments. The same study analysed caeca 
content and found a significant increase in acetate and lactic acid production in the triticale and wheat 
treatments, despite the caecas for this treatment weighing significantly less. This may suggest that 
caecal pH measurement is not sensitive enough to detect differences in VFA production and that 
changes in caecal weight may not always indicate changes in microbial activity. The work of Olnood et 
al., (2015) seems to support this theory. These authors looked at supplementing broilers with different 
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strains of lactobacillus as a potential probiotic. When feeding a wheat, sorghum and mung bean-based 
ration, these authors found no significant differences in caeca pH or concentrations of VFA between 
treatments. As no pH differences were seen in either of these studies although VFA concentrations 
were altered it seems likely that either caecal pH is not substantially changed by differences in VFA 
concentration, or that the measuring procedure is not precise enough to detect differences, or that the 
dissection process and exposure to the environment affects the caecal pH. Therefore, looking at VFA 
concentration and 16S metagenomic profiling should be considered as a more accurate method to 
quantify changes in future studies.  
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3.5 Conclusion 
The AX extract produced from distillers’ wet grains does seem to have a beneficial effect on 
performance when fed without any xylanase pre-treatment. However, the mode of action is still unclear 
from the parameters investigated in this study.  
Pre-treating the AX extract appears to negate any performance improvements and does not seem to 
have any effect on other measures. It is unclear whether the benefits seen for AX supplementation are 
negated by the addition of xylanase or the pre-treatment process not allowing sufficient incorporation 
of the supplement into the diet. 
Unfortunately, from the parameters measured on this trial, pinpointing the mechanism of AX benefits 
is difficult. However, this study adds further weight to the suggestion that whilst broilers cannot 
produce endogenous xylanase, bacteria present in the gut, may be able to do so.  In future studies, 
measuring the viscosity of digesta and exploring the potential of a microbial effect in the caeca may 
help to further determine the mechanism for the beneficial effects of AX supplementation. 
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Chapter 4 - Comparing the efficacy of a corn derived XOS to a sugar 
cane bagasse XOS on the performance and gut health of broilers 
 
4.1 Introduction 
 
As the AX extract used in chapter 3 was successful in supporting bird performance, a second trial was 
designed to try to determine whether specifically manufacturing a xylo-oligosaccharide rather than 
simply an AX extract would enhance the performance benefits seen in the first study.  
XOS supplementation has been shown to have numerous benefits for broiler production, on both 
performance and physiological parameters. In 2006, Wu et al. found that XOS inclusion (1,2 and 4 
g/kg) significantly reduced cumulative mortality and feed conversion ratio over a 7-week broiler 
study. These authors also report that supplementing at 2g/kg, XOS increased the quantity of 
lactobacillus in the ileum. Furthermore, Maesschalck et al. (2015) demonstrated that birds fed a 
wheat/rye-based diet supplemented with XOS at 0.2% over 39 days  experienced significantly 
ireduced FCR and increased numbers of lactobacilli present in the hind gut as well as significantly 
increased the length of ileal villi, thus increasing the surface area and absorptive capacity of the ileum 
compared to the control birds. Subsequently, this led to increased concentrations of SCFA. Ribeira et 
al. (2018) found that XOS supplementation at 0.1g/kg increased the microbial populations of bifido 
bacterium and lactobacilli.This study demonstrated that a lower XOS inclusion rate (0.1g/kg) produced 
higher levels of beneficial bacterium.  
The chemists at The University of Huddersfield developed an arabino-xylan oligosaccharide derived 
from sugar cane bagasse. It was proposed to compare this novel bagasse XOS to a commercial corn 
based XOS (Longlive Biotechnology, Shandong, China) to elucidate if the material from which a XOS 
was extracted played a role in its efficacy as a feed supplement. 
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Global sugar cane production is approximately 1.9 billion tonnes a year (Campbell et al., 2019) and 
results in around 570 million tonnes of waste product wet bagasse. Therefore, bagasse represents a 
major waste stream.  Bagasse is the fraction of biomass resulting from the extraction of sugar cane 
juice (Santos et al., 2015). Bagasse is primarily fibre based and has three main components: cellulose 
(30-40%), hemicellulose (25-35%) and lignin (20-30%). With a xylose content of approximately 10.5% 
and an arabinose content of approximately 1.5%, it is a viable base for deriving arabino xylo-
oligosaccharides. As a low value by-product, it has the potential to be a sustainable source of XOS. 
The University of Huddersfield tested a number of base materials before performing a comparison 
study on wheat bran and bagasse. The AX from both substances was extracted via both chemical and 
enzyme extraction (figure 4.1). Bagasse was chosen as most appropriate because although bagasse 
has a comparable quantity of AX to wheat bran (20-30%), bagasse has a lower arabinoxylan 
substitution on the xylan backbone (A:X ratio of 0.2 compared with 0.6 for wheat bran). Therefore, 
the bagasse derived AX is likely to be less soluble and more susceptible to enzyme activity (Campbell 
et al., 2019). Additionally, bagasse can produce a wider range of molecular weight sugars (Campbell et 
al., 2019).  
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Figure 4.1 - Procedure for chemical extraction of AX from wheat bran or sugarcane bagasse, yielding 
either high or low cut-off fraction following either chemical or enzyme-assisted extraction (used with 
permission fromA.B. Vista 2020). 
 
The corn XOS was derived from corn cobs, contained 35% oligosaccharides and at the time of the 
study was readily commercially available as a functional feed ingredient for monogastrics.  
As the xylanase pre-treatment used in the first study had not been successful, this study was designed 
to examine the effect of both XOS products both with and without exogenous xylanase added directly 
to the diet to determine whether this affected the efficacy of the XOS. 
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The key aims of this study were as follows: 
• To directly compare the efficacy on bird performance of two XOS products derived from 
different plant materials (corn and sugar cane bagasse) compared to a control 
• To examine the effect of the two XOS products on bird performance both with and without 
an exogenous xylanase added directly to the diet compared to a control. 
• To determine whether any XOS and/or xylanase addition has any effect on anatomical or 
physiological parameters associated with gut health 
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4.2 Trial Procedure 
4.2.1 Husbandry Conditions 
400 day old male Ross 308 broilers were sourced from PD Hook from a flock aged 43 weeks. Birds 
were feather sexed on the day of hatch and any poor birds were discarded on arrival. Chicks were 
individually weighed on arrival, then randomly assigned to 48 mesh sided pens, littered with a wood 
shavings substrate. Food and water were provided ad libitum and care taken to ensure chicks were 
eating and drinking as soon as possible. Husbandry guidelines were followed as described in chapter 2 
and adhered to the institutional and national guidelines for the care and use of animals (Animal 
Scientific Procedures Act, 1986). Ethical approval was obtained as is recorded as NTU school ethics 
committee approval ARE798. 
 
4.2.2 Diet formulation and condition of animals 
 
6 dietary treatments were utilized in this study (table 4.1) with three phases (starter d0-14, grower 
d14-28 and finisher d28-42).  The bagasse XOS was manufactured by chemists at The University of 
Huddersfield and the corn XOS was commercially manufactured by Longlive Biotechnology, Shandong, 
China. The Longlive XOS is a mixed product containing 35% XOS with a degree of polymerisation 
between 2 and 7 and contains 65% maltodextrin. 
As in the previous chapter, the Huddersfield team used the GUNTCE-640 bio-ethanol unit to produce 
the xylan extract. The bagasse AX was subsequently treated with xylanase to produce xylo-
oligosaccharides from the xylan fraction. Following the previous production, the Huddersfield team 
developed a method to measure the oligosaccharide content of raw materials. The bagasse XOS was 
found to only contain 10% oligosaccharides, so the quantity fed was multiplied up to balance the oligo 
content of the commercial XOS (35% measured oligosaccharides), to ensure a like for like comparison.  
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 Exogenous xylanase (Econase XT) was provided by A.B. Vista and added at 100g per tonne (16000 
BXU). Quantum Blue 5G phytase was added to all diets at 0.01% inclusion rate to provide 
approximately 500FTU. Diets were formulated by a commercial poultry nutritionist (table 4.2) and 
proximate analysis was performed to confirm composition (Table 4.3). 
 
Table 4.1 - Study Treatments for XOS comparison trial 
Diet Treatment 
Con Control – standard broiler diet 
Corn XOS Control + Corn derived XOS (100g/t) 
Bag XOS Control + bagasse derived XOS (402 g/t) 
Con + Xyl Control + xylanase (100g/tonne) 
Corn + Xyl Control + corn XOS  (100g/t) + xylanase (100g/tonne) 
Bag + Xyl Control + bagasse (402g/t) + xylanase (100g/tonne) 
 
Two basal mash diets for each phase were manufactured by RDS in The Netherlands, based on a 
wheat, soy corn base. The first basal was a standard broiler diet (table 4.2) and the second was an 
identical standard diet with the addition of xylanase at 100g/t. 40kg of each starter diet was mixed 
and weighed into 4kg, individually labelled bags. The XOS products were added to the micro 
ingredients then sequentially mixed with increasing volumes of feed to ensure homogenous mixing. 
Individual bags were then weighed into labelled bags for each pen to allow feed intake to be 
calculated weekly. 90kg of each grower and 140kg of each finisher were mixed and weighed into 
individual pen bags. Birds were fed from their designated bag throughout to ensure they only 
consumed their correct treatment.  
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Table 4.2 - Control Diet formulations for XOS comparison trial 
Ingredient Starter Grower Finisher 
Wheat 35 35 35 
Corn 23.91 26.58 29.18 
Soybean meal 34.37 31.06 27.55 
Soya oil 2.76 3.85 4.96 
Salt 0.3 0.31 0.31 
Limestone 0.1 0.06 0.03 
Dicalcium Phos, 18%P 2.26 2 1.84 
Sodium Bicarbonate 0.1 0.1 0.1 
Lysine HCl 0.23 0.18 0.18 
DL-Methionine 0.31 0.27 0.26 
Threonine 0.13 0.09 0.08 
Vitamin & Mineral premix 0.5 0.5 0.5 
Quantum Blue 5G 0.01 0.01 0.01 
TOTAL 100 100 100 
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Table 4.3 - Diet proximate analysis for the two basal diets (standard broiler diet and standard broiler 
diet + xylanase) for XOS comparison trial 
Diet Starter Starter + Xyl Grower Grower +Xyl Finisher Finisher + Xyl 
DM (%) 87.37 87.62 87.34 87.34 87.14 87.07 
Ash (g/kg 5.91 4.95 5.69 5.93 4.50 5.12 
Protein (g/kg DM) 21.60 22.48 21.53 22.45 21.67 20.14 
Total P (g/kg DM) 7.45 7.55 7.58 7.58 6.78 7.39 
Total Ca (g/kg DM) 8.40 8.28 8.16 8.11 6.00 7.32 
Fat (g/kg) 2.80 2.79 3.88 4.25 4.49 4.62 
Ti (g/kg) 4.37 4.95 4.72 4.93 4.31 4.40 
GE (mj/kg) 16.27 16.30 16.20 16.28 16.31 16.47 
Phytase FTU/kg* 716 678 819 651 477 489 
Xylanase BXU/kg* <2000 14900 <2000 15000 <2000 16700 
*Enzymes were analysed by an external lab (ESC, Cardiff, UK) 
DM = dry matter, P=phosphorus, Ca = calcium, Ti = titanium, GE = gross energy 
 
4.2.3 Treatment Schedule / randomisation plan / condition of animals 
A replicate consisted of a pen containing 8 birds (individually weighed) and only birds weighing 
between 40g and 50g were placed on trial. The combined weight of each pen was recorded on day 0 
and randomly allocated around the trial room to reduce any possible effect of ventilation and room 
differences. Pen allocation is shown in table 4.4 and a plan of the experimental room is shown in 
appendix B. 
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Table 4.4 -  Diet allocations for the XOS comparison trial 
Pen  Diet Pen  Diet 
1 A 25 E 
2 B 26 F 
3 C 27 A 
4 D 28 B 
5 E 29 A 
6 F 30 B 
7 A 31 C 
8 B 32 D 
9 C 33 E 
10 D 34 F 
11 E 35 A 
12 F 36 B 
13 A 37 C 
14 B 38 D 
15 A 39 E 
16 B 40 F 
17 C 41 A 
18 D 42 B 
19 E 43 A 
20 F 44 B 
21 A 45 C 
22 B 46 D 
23 C 47 E 
24 D 48 F 
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4.2.4 Study observations  
Bird observations were performed a minimum of twice daily to ensure bird welfare and 
environmental comfort. Temperature and/or ventilation were adjusted accordingly. Bird and room 
observations were recorded by unit staff twice daily in the trial diary. Dead birds were removed and 
weighed, and any unfit birds were culled and removed from trial. Bird feed intake was calculated as 
per the method detailed in section 2.4.1. Birds were weighed weekly by pen on days 0, 7, 14, 21, 28, 
35 and 42, as per section 2.4.1.  Each week, remaining feed was weighed by pen to calculate feed 
intake. Feed intake and bird weight were used to calculate weekly feed conversion ratio (FCR). 
4.2.5 Sample Collection 
On day 7, birds were sequentially fed fresh diet for a minimum of 30 minutes to ensure adequate gut 
fill prior to euthanasia. Two birds per pen were humanely euthanized by cervical dislocation. Post 
mortem blood samples were collected into tubes containing EDTA as an anti-coagulant (as per section 
2.4.2) for post-trial immunoglobulin analysis (section 2.5.10). The blood was centrifuged at 3000RPM 
for 10 minutes and plasma removed and stored at -20°C.  Ileal digesta (defined as gut content located 
between the Meckel’s diverticulum and the ileal-caecal-colonic junction) was collected (as per section 
2.4.3) from all three birds and pooled per pen.  
Digesta was freeze dried and ground with a pestle and mortar. Diets and ileal digesta were analysed 
for gross energy by bomb calorimetry and protein content by external labs (PAS, Shropshire, UK and 
DM Scientific, Thirsk, UK respectively). Titanium dioxide content of the diet and digesta was measured 
using the method of Short et al., 1996 (section 2.5.5). Calcium and phosphorus content of the diets 
and digesta was determined by ICP-OES (section 2.5.6). Ash and dry matter were analysed as per 
sections 2.5.4, and 2.5.1. Digestibility of calcium and phosphorus were calculated using the formulas 
shown in section 2.5.7. 
Both caeca were removed and weighed as a pair then individually snap frozen for potential VFA and 
16S analysis at a later date (as per section 2.5.14). 1cm of ileal tissue was removed from the Meckel’s 
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end of the ileum for mucin analysis (see section 2.5.9). 2cm of jejunum (taken from directly proximal 
to the Meckel’s diverticulum) was removed and placed in Bouin’s fixative for 6 hours, before being 
moved into 70% IMS for later histology analysis (as per section 2.5.18). 
On day 21, and 42 the following measures were taken from a single weighed bird. One bird per pen 
was culled, though only if six birds remained in the pen, to ensure balanced performance data was 
collected. The culled bird was individually weighed.  
Blood samples were collected (as per section 2.4.2) and placed into tubes containing EDTA as an 
anticoagulant. The blood was centrifuged at 3000RPM for 10 minutes and plasma removed and 
stored at -20°C . The left tibia from each bird was excised and stored at -20C for bone morphometric 
and strength analysis (see section 2.5.11).  
On d42, one bird per pen was culled and individually weighed. Blood was taken (as described above) 
for immunoglobulin A analysis (section 2.5.13). Ileal digesta was taken and stored in the manner 
described above for Ca digestibility analysis.  A 1cm section of ileum was removed closest to the 
Meckel’s diverticulum was taken for mucin analysis (section 2.5.9). 2cm of jejunum (taken from 
proximal to the Meckel’s diverticulum) was removed and placed in Bouin’s solution for 8 hours, 
before being moved into 70% IMS for later histology analysis (section 2.5.18). 
4.2.5 Statistical Analysis of data 
Outliers were removed from data if they fell either two standard deviations above or below the 
average. Statistical analysis was performed using SPSS v.23. KS testing was used to determine data 
normality, followed by one-way ANOVA, Kruskal Wallis or Univariate analysis as appropriate. Tukey 
post hoc tests were used to elucidate differences in treatment. Correlations were analysed by 
bivariate correlation using Pearson correlation, chosen because it computes based on true values and 
depicts linear relationships. Multiple linear regressions were used to determine the unique 
contribution and relatedness of factors. Interpretations of the strength between relationships was 
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based on those of Cohen (1988): small r = 0.1-0.29, medium r = 0.30-0.39 and large r = 0.50 to 1.0. 
Statistical significance was declared at p<0.05.  
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4.3 Results 
4.3.1 Environment 
No environmental abnormalities occurred during this trial in terms of temperature or weather 
changes. 
4.3.2 Health and Condition 
During the whole 42d study, mortality was 4.17% which is considered standard for trials conducted at 
the NTU unit and approximately the same as might be expected in a commercial setting.  There was 
no apparent effect of treatment on mortality as can be seen in table 4.5 which splits the mortality by 
week and dietary treatment. 
 
Table 4.5 - Mortality for XOS comparison trial 
Treatment d0-7 d7-14 d14-21 d21-28 d28-35 d35-42 total 
A Con 0 0 0 1 0 0 1 
B) Corn XOS 2* 1 0 0 0 1 4 
C) Bag XOS 1 2 0 0 0 0 3 
D) Con + Xyl 1 0 0 0 1 2 4 
E) Corn + Xyl 0 0 1 0 1 1 3 
F) Bag + Xyl 0 1 0 0 0 0 1 
*runt bird culled 
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4.3.3 Bird Uniformity 
Birds were individually weighed and only birds between 40 to 50g were placed. Start weights for each 
treatment are shown in table 4.6. There was no significant difference in start weights between 
treatments. 
Table 4.6 - Start weights for chicks for XOS comparison trial (+/- S.E) 
Diet D0 bird wt (g) 
A) Con 44 (0.6) 
B) Corn XOS 44 (0.7) 
C) Bag XOS 44 (0.8) 
D) Con + Xyl 44 (0.8) 
E) Corn + Xyl 44 (0.6) 
F) Bag + Xyl 44 (0.6) 
p value 0.978 
 
4.3.4 Performance 
Cumulatively, there was no significant difference in body weight gain (p=0.828), feed intake 
(p=0.413), or feed conversion ratio (p=0.828) between treatments for the duration of the trial (table 
4.7). Likewise, there was no significant difference for any individual week of the trial for any 
performance parameter (table 4.8). There was no interaction seen between XOS and xylanase. 
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Table 4.7 - Cumulative performance for XOS comparison trial (+/- S.E) 
Diet D0-42BWG (g/bird) (±SE) D0-42 FI (g/bird) (±SE) D0-42 FCR (±SE) 
Con 3022 (31.0) 4938 (49.3) 1.63 (0.065) 
Corn XOS 3007 (40.2) 4864 (68.8) 1.61 (0.078) 
Bag XOS 2997 (42.1) 4966 (73.8) 1.66 (0.064) 
Con + Xyl 3003 (37.4) 5055 (95.7) 1.69(0.081) 
Corn + Xyl 2985 (68.6) 4867 (65.6) 1.62 (0.029) 
Bag + Xyl 3077 (37.6) 5008 (58.8) 1.65 (0.051) 
P value* 0.885 0.337 0.720 
P-Xyl 0.778 0.357 0.503 
P-XOS 0.768 0.133 0.477 
P-Interaction 0.599 0.708 0.673 
*p-value from ANOVA analysis 
 
Table 4.8 - Weekly body weight gain for XOS comparison trial (g/bird, +/- S.E.)  
Diet D0-7 
BWG/bird 
D7-14 
BWG/bird 
D14-21 
BWG/bird 
D21-28 
BWG/bird 
D28-35 
BWG/bird 
D35-42 
BWG/bird  
Con 88 (2.8) 243 (5.8) 467 (8.5) 670 (11.8) 740 (9.0) 815 (44.2) 
Corn XOS 86 (3.1) 231 (9.3) 482 (10.6) 663 (17.0) 772 (19.2) 798 (32.9) 
Bag XOS 90 (2.2) 254 (7.3) 477 (10.6) 655 (16.5) 757 (24.0) 770 (77.7) 
Con + Xyl 88 (2.3) 250 (9.3) 454 (13.9) 681 (20.1) 779 (14.5) 751 (33.7) 
Corn + Xyl 88 (2.2) 249 (7.8) 452 (10.4) 659 (10.0) 750 (23.1) 788 (44.8) 
Bag + Xyl 89 (2.9) 255 (10.3) 463 (21.7) 672 (10.0) 786 (14.5) 812 (23.7) 
P value* 0.973 0.408 0.627 0.958 0.590 0.795 
P-Xyl 0.704 0.236 0.110 0.642 0.358 0.718 
P-XOS 0.762 0.253 0.781 0.778 0.830 0.956 
P-interaction 0.929 0.640 0.819 0.859 0.300 0.360 
*p-value from ANOVA analysis 
 
There was no significant difference in feed intake between treatments until week 5 of the trial when 
the birds fed bagasse + Xyl consumed significantly more than those fed the other treatments (table 
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4.9). By week 6 there was once again no significant difference in feed intake between treatments. 
There is a significant increase in feed intake for the diets containing XOS (p=0.030). There is also a 
trend towards an interaction between XOS and xylanase (p=0.059). When xylanase is added to the 
bagasse XOS the feed intake increase,  however when xylanase is added to the corn XOS the feed 
intake decreases.  
 
Table 4.9  - Weekly feed intake for XOS comparison trial (g/bird, +/- S.E.) 
Treatment D0-7 
FI/bird (g) 
(±SE) 
D7-14 
FI/bird (g) 
(±SE) 
D14-21 
FI/bird (g) 
(±SE) 
D21-28 
FI/bird (g) 
(±SE) 
D28-35 
FI/bird (g) 
(±SE) 
D35-42 
FI/bird (g) 
(±SE) 
Con 158 (7.0) 368 (11.5) 650 (11.0) 1020 (16.4) 1268b (13.2) 1474 (17.6) 
Corn XOS 169 (10.3) 367 (17.0) 692 (46.4) 962 (56.0) 1284b (25.5) 1469 (26.1) 
Bag XOS 148 (6.7) 384 (14.4) 650 (15.0) 967 (39.8) 1303ab (21.2) 1505 (24.2) 
Con + Xyl 139 (5.0) 390 (12.5) 709 (38.3) 947 (38.5) 1356ab (53.2) 1515 (56.7) 
Corn + Xyl 151 (5.6) 382 (11.4) 680 (40.5) 944 (23.0) 1235b  (70.6) 1469 (24.9) 
Bag + Xyl 147 (8.4) 400 (14.7) 690 (40.0) 973 (35.0) 1391a (47.0) 1421 (26.3) 
p-value* 0.099 0.495 0.767 0.528 0.017 0.408 
p-Xyl 0.038 0.115 0.295 0.263 0.132 0.584 
p-XOS 0.184 0.414 0.987 0.605 0.030 0.560 
p-
Interaction 
0.403 0.962 0.691 0.407 0.059 0.162 
a-b Means within the same row that do not share a common superscript are significantly different by one-way 
ANOVA (p=<0.005) 
*p-value from ANOVA analysis 
 
 
There was a trend towards decreased feed conversion ratio for the control +xyl treatment in the first 
week (table 4.10). There is also a significant decrease in FCR for the diets containing xylanase during 
the first week, compared to those without. There were no other significant differences between 
treatments for the remainder of the trial. 
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Table 4.10 - Feed Conversion Ratio by week D0-D42 for XOS comparison trial (+/- S.E.) 
Treatment D0-7 FCR D7-14 FCR D14-21 FCR D21-28 FCR D28-35 FCR D35-42 FCR 
Con 1.82 
(0.111)b 
1.51 
(0.040) 
1.39 
(0.012) 
1.53 
(0.036) 
1.73 
(0.069) 
1.84 
(0.074) 
Corn XOS 1.97 
(0.116)b 
1.59 
(0.061) 
1.45 
(0.097) 
1.44 
(0.084) 
1.67 
(0.017) 
1.86 
(0.073) 
Bag XOS 1.66 
(0.076)ab 
1.52 
(0.046) 
1.36 
(0.015) 
1.48 
(0.058) 
1.74 
(0.110) 
1.98 
(0.777) 
Con + Xyl 1.58 
(0.085)a 
1.57 
(0.066) 
1.49 
(0.015) 
1.39 
(0.037) 
1.74 
(0.064) 
1.93 
(0.161) 
Corn + Xyl 1.72 
(0.083)ab 
1.56 
(0.073) 
1.50 
(0.110) 
1.44 
(0.035) 
1.64 
(0.111) 
1.75 
(0.140) 
Bag + Xyl 1.65 
(0.093)ab 
1.48 
(0.127) 
1.50 
(0.079) 
1.49 
(0.126) 
1.79 
(0.057) 
1.79 
(0.031) 
P Value 0.069 0.767 0.544 0.736 0.452 0.378 
p-Xyl 0.037 0.905 0.084 0.426 0.843 0.299 
p-XOS 0.122 0.440 0.779 0.773 0.127 0.514 
p-
Interaction 
0.364 0.637 0.857 0.465 0.780 0.194 
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4.3.5. Mucin layer thickness 
There was no significant difference in mucin adherence between treatments at days 7, 21 or 42 (table 
4.10) There was no significant interaction between XOS and xylanase.  
` 
Table 4.11 - Mucin layer thickness D7, D21 and D42 for XOS comparison trial (µg of alcian blue 
released per gram of tissue, +/- S.E.) 
 
 
 
 
 
 
 
 
 
 
 
Table 4.12 - Mean Mucin layer thickness across all treatments by age for XOS comparison trial (±SE 
Age Mean Mucin Layer Thickness (µg/g) 
7 days 53.02 (28.49) 
21 days 35.31 (15.30) 
42 days 47.05 (27.50) 
p-value age 0.006 
 
 
 
Treatment 
D7 Mucin 
(µg/g) 
D21 Mucin 
(µg/g) 
D42 Mucin 
(µg/g) 
Con 58.32 (12.888) 33.10 (8.150) 46.27 (7.029) 
Corn XOS 57.93 (13.946) 35.28 (4.857) 40.71 (7.029) 
Bag XOS 46.41 (7.774) 37.22 (5.802) 54.16 (15.004) 
Con + Xyl 41.39 (4.990) 44.06 (6.155) 64.20 (6.760) 
Corn + Xyl 76.79 (13.270) 40.59 (5.143) 52.91 (7.503) 
Bag + Xyl 75.20 (28.541) 38.51 (5.919) 52.76 (6.587) 
p-Value 0.486 0.849 0.093 
p-Xyl 0.422 0.270 0.596 
p-XOS 0.525 0.992 0.187 
p-XOS/Xyl 0.309 0.731 0.501 
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4.3.6 Caeca weight 
There was no significant difference in caeca weight at day 21 or 42, however, the addition of xylanase 
seems to numerically increase the weight of the caeca at day 42 (table 4.13).  
Table 4.13 - Caeca Weight (Pair) D21 and D42 for XOS comparison trial (g +/- S.E.) 
Treatment D21 Caeca weight (g) D42 Caeca Weight (g) 
Con 7.02 (0.641) 18.22 (2.037) 
Corn XOS 6.41 (0.393) 16.95 (2.314) 
Bag XOS 7.07 (1.033) 16.35 (1.625) 
Con + Xyl 6.62 (0.698) 20.14 (3.383) 
Corn + Xyl 7.20 (1.146) 19.74 (0.957) 
Bag + Xyl 5.53 (0.668) 22.49 (2.974) 
p- Value 0.787 0.488 
p-Xyl 0.615 0.100 
p-XOS 0.826 0.912 
p-Interaction 0.471 0.726 
 
 
4.3.7 Immunoglobulin A 
There was no significant difference in the IgA levels between treatments on D7, D21 and D42 (Table 
4.14). IgA levels for all treatments increase with age from day 7 to day 21 and then seem to maintain 
at around that level until day 42. 
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Table 4.14 - IgA D7, D21 and D42 for XOS comparison trial (ng/ml of plasma, +/- S.E.) 
Treatment D7 (ng/ml) D21 (ng/ml) D42 (ng/ml) 
Con 0.535 (0.0116) 1.771 (0.2535) 2.052 (0.4512) 
Corn XOS 0.691 (0.0252) 2.692 (0.6482) 1.731 (0.4467) 
Bag XOS 0.564 (0.0911) 1.975 (0.3684) 2.011 (0.5959) 
Con + Xyl 0.462 (0.0121) 1.765 (0.2268) 2.161 (0.3696) 
Corn + Xyl 0.494 (0.0119) 2.149 (0.3222) 1.875 (0.4101) 
Bag + Xyl 0.677 (0.032) 2.845 (0.5252) 2.148 (0.3189) 
p-Value 0.349 0.236 0.916 
p-Xyl 0.105 0.405 0.562 
p-XOS 0.684 0.714 0.826 
p-Interaction 0.395 0.527 0.464 
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4.3.8 Bone parameters 
There was no significant difference between individuals  diets for tibial morphometrics at either day 
21 (Table 4.15). However, there is a significant increase in tibial strength for the diets containing 
xylanase at day 21 (p=0.037). There were no significant differences in tibial morphometrics on day 42, 
however there is a statistical trend towards increased tibial length at day 42 (p=0.084) (table 4.16). 
Table 4.15 - Tibia Morphometrics at d21 for XOS comparison trial +/- SE 
Treatment Tibial Strength 
(N/kg of BW) 
Tibial Weight 
(g) 
Tibial Width 
(mm) 
Tibial Length 
(mm) 
Con 193.87 (33.265) 6.60 (0.160) 5.97 (0.110) 74.32 (0.960) 
Corn XOS 164.42 (37.435) 6.60 (0.125) 5.90 (0.216) 74.27 (1.382) 
Bag XOS 114.03 (44.074) 7.12 (0.434) 6.07 (0.130) 74.86 (1.462) 
Con + Xyl 199.22 (30.273) 6.66 (0.262) 5.71 (0.124) 74.27 (0.929) 
Corn + Xyl 222.55  (11.426) 6.39 (0.264) 5.81 (0.109) 73.10 (0.899) 
Bag + Xyl 222.45 (11.345) 6.89 (0.187) 5.90 (0.137) 75.14 (0.797) 
p-Value 0.121 0.500 0.657 0.782 
p-Xyl 0.037 0.665 0.193 0.732 
p-XOS 0.572 0.283 0.407 0.503 
p-Interaction 0.187 0.708 0.910 0.805 
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Table 4.16 - Tibia Morphometrics D42 for XOS comparison trial 
Treatment Tibial Strength 
(N/kg BW+/- SE) 
Tibial Weight 
(g +/- SE) 
Tibial Width 
(mm+/- SE) 
Tibial Length 
(mm+/- SE) 
Con 128.20 (9.212) 23.64 (0.803) 7.83 (0.304) 109.80 (1.171) 
Corn XOS 127.94 (9.941) 22.78 (0.583) 7.91 (0.240) 110.05 (0.884) 
Bag XOS 113.05 (9.622) 23.59 (0.543) 8.13 (0.203) 112.28 (0.884) 
Con + Xyl 120.55 (7.816) 22.61 (0.675) 7.81 (0.215) 110.22 (1.251) 
Corn + Xyl 107.47 (7.718) 22.09 (0.354) 7.79 (0.227) 109.07 (1.447) 
Bag + Xyl 112.47 (3.234) 23.65 (0.938) 8.39 (0.239) 111.01 (1.109) 
p-Value 0.157 0.641 0.415 0.471 
p-Xyl 0.617 0.175 0.843 0.356 
p-XOS 0.369 0.164 0.210 0.084 
p-Interaction 0.308 0.154 0.443 0.147 
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4.3.9 Calcium and phosphorus digestibility – Day 42 
There was no significant difference in the quantity of calcium or phosphorus digested between 
treatments, however, there was a significant increase in the amount of calcium digested for the 
treatments containing xylanase compared to those without (Table 4.17). 
Table 4.17 – Day 42 Calcium and phosphorus digestibility for XOS comparison trial (±SE) 
Apparent ileal digestibility coefficient                    Amount of Mineral digested 
Treatment Calcium  Phosphorus  
Calcium 
(g/day) 
Phosphorus 
(g/day) 
Con 0.61 (0.032) 0.84 (0.023) 0.03 (0.001) 0.07 (0.008) 
Corn XOS 0.58 (0.030) 0.82 (0.024) 0.03 (0.002) 0.07 (0.008) 
Bag XOS 0.52 (0.042) 0.78 (0.032) 0.023 (0.004) 0.07 (0.009) 
Con + Xyl 0.60 (0.042) 0.81 (0.028) 0.036 (0.005) 0.06 (0.034) 
Corn + Xyl 0.61 (0.045) 0.81 (0.028) 0.044 (0.004) 0.08 (0.085) 
Bag + Xyl 0.55 (0.076) 0.82 (0.058) 0.037 (0.007) 0.07 (0.012) 
P Value 0.712 0.851 0.14 0.115 
p-Xyl 0.637 0.808 0.039 0.690 
p-XOS 0.308 0.806 0.222 0.722 
p-Interaction 0.885 0.510 0.549 0.872 
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4.3.10 16S Sequencing - Microbiota Diversity 
There was no significant difference in the taxonomic diversity of microbiota between dietary 
treatments at either day 7 or day 42 (p= 0.260 and p=0.325) (figure 4.2 and 4.3). However, there was 
a significant composition change in the type of microbes present between day 7 and day 42 (p=0.018) 
(figure 4.4, 4.4 and 4.6) 
 
Figure 4.2 - Taxonomic diversity between dietary treatments D7 as follows; 1= Control, 2= Corn XOS, 
3= Bagasse XOS, 4= Con+ Xyl, 5= Corn XOS + XYL, 6= Bagasse + Xyl 
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Figure 4.3 - Taxonomic diversity between dietary treatments D42 (A-F represents treatments 1-6 as 
follows) treatments as follows; 1= Control, 2= Corn XOS, 3= Bagasse XOS, 4= Con+ Xyl, 5= Corn XOS + 
XYL, 6= Bagasse + Xyl Day 42 
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Figure 4.4 - Taxonomic diversity of microbiota for XOS comparison trial days 7 and 42 
 
Figure 4.5 - Taxonomic diversity of microbiota for XOS comparison trial days 7 and 42 
 
Figure 4.6 Taxonomic diversity by class for XOS comparison trial days 7 and 42 
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4.3.11 Gut Histology 
There were no significant differences in either villus height or crypt depth in the jejunum between 
treatments (Table 4.18) 
Table 4.18 – Gut Histology for XOS comparison trial- day 7 and 42 
Treatment D7 Villi Height 
(µm) 
D7 Crypt Depth 
(µm) 
D42 Villi Height 
(µm) 
D42 Crypt Depth 
(µm) 
Con 1488.8 (45.17) 68.0 (5.41) 2588.4 (73.51) 57.9 (6.25) 
Corn XOS 1415.3 (58.23) 69.8 (4.10) 2595.7 (65.7) 60.5 (6.33) 
Bag XOS 1427.6 (32.32) 73.3 (3.16) 2625.7 (91.52) 74.1 (16.66) 
Con + Xyl 1507.0 (39.50) 75.9 (1.03) 2610.4 (70.77) 54.6 (3.73) 
Corn + Xyl 1482.1 (55.26) 66.6 (3.081) 2662.8 (114.39) 51.3 (2.47) 
Bag + Xyl 1483.1 (53.91) 68.6 (2.86) 2482.4 (80.77) 58.15 (5.22) 
p-Value 0.719 0.448 0.757 0.465 
p-Xyl 0.238 0.993 0.619 0.233 
p-XOS 0.541 0.573 0.681 0.327 
p-
Interaction 
0.868 0.175 0.475 0.649 
 
 
 
 
 
 
 
 
 
129 
 
4.4 Discussion 
The aims of this study were to directly compare the efficacy of two XOS products derived from 
different plant materials in supporting the performance and health of broilers. Additionally, the study 
aimed to determine whether the addition of xylanase would affect efficacy of these XOS products. 
Due to structural differences in the xylan backbone, it was hypothesised that the plant matter from 
which a XOS was derived would affect the efficacy in supporting broiler performance, as one plant 
XOS maybe more accessible to gut microbiota than another. It was expected that xylanase might 
enhance any beneficial effects of the XOS as xylanase would hydrolyse AX /X present in the diet and 
potentially therefore increase the levels of XOS. 
 The performance results of this trial are essentially unremarkable with the cumulative results 
showing no significant differences. Numerically there is a 54g (nearly 2%) increase in body weight gain 
for birds fed the Bag + Xyl diet at day 42 compared to the other treatments. Both the Corn and Corn + 
Xyl treatments produced the lowest feed intake and FCR, which could suggest that the corn XOS is 
improving the efficiency of converting feed into body weight (Figure 4.4 and 4.5). Whilst these results 
are not statistically significant, these small improvements may represent financial gains – particularly 
on a commercial scale where margins are tight and tiny savings per bird are meaningful.  
When considering weekly performance, the feed intake for the Bag + Xyl diet is significantly increased 
(p=0.017) during week 5. This result is unexpected as this increase cannot be seen either before or 
after this point, even numerically. It is possible therefore, that a feed spillage or weighing error 
occurred at this time point, accounting for the loss of feed, rather than a true effect of the birds 
consuming more. The only other significant performance effect is the decrease in week 1 FCR for the 
Con + Xyl diet. Unfortunately, this result is almost certainly due to feed spillage as the feed type 
(mash) and feed system (open troughs) encourages the chicks to climb in the feeders, spill feed and 
dust bathe. The Ross 308 performance objectives state that typical FCR for a day 7 male Ross 308 
should be in the region of 0.821 (Aviagen, 2020) (Figure 4.19). The results of the current study are 
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approximately  8% lower than The Ross 308 performance objectives, likely due to the provision of a 
mash diet. It is of note that a day 7 FCR for a good trial at NTU is around 1.2.  As the day 7 FCR’s of the 
current trial are far above this any significance should probably be discounted.  
 
Table 4.19 - Comparison of Ross 308 Broiler objectives FCR with the mean results of the XOS 
comparison trial. 
Age Ross 308 objective for FCR Current study FCR 
Day 7 0.821 1.733 
Day 14 1.057 1.538 
Day 21 1.201 1.448 
Day 28 1.336 1.462 
Day 35 1.473 1.718 
Day 42 1.611 1.858 
 
Having found a positive effect for AX supplementation in the previous trial, it was expected that this 
trial may show similar effects. The AX content of bagasse has a low ratio of arabinose to xylose units 
(A:X =0.2:0.6) compared to wheat (A:X=0.5:0.6) and corn (A:X=0.59:0.6) (Kurakake et al., 2005). This 
“cleaner” xylan backbone with less arabinose substitutions are thought to make the AX less soluble 
(more likely to transit the GIT intact) and potentially more susceptable to enzyme activity (Campbell 
et al., 2019). Therefore, it was expected that the bagasse XOS used in the current study would be 
more effective than the wheat derived DDGS AX extract used in the previous study. The latter 
supplemented the birds with whole arabinoxylans (long-chain polysaccharides), whereas this study 
investigated the effect of hydrolysing the AX and depolymerising the polysaccharides down into 
oligosaccharides prior to feeding. This approach was taken as there was robust literature 
demonstrating the benefits of directly supplementing broilers with shorter-chain polysaccharides (De 
Maesschalck et al., 2015). Therefore, it was quite disappointing that there was very little to be seen in 
terms of performance effects. However, other authors have found similar results.  
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The performance effects of XOS appear to be variable with some studies reporting performance 
enhancement (De Maesschalck et al., 2015; Ribeiro et al., 2018), and others reporting little or no 
performance effects at all (Li et al., 2017; Craig et al., 2019; Morgan et al., 2019).  This may be due to 
differences in the base products from which XOS supplements were derived. As previously mention, 
the substitution of arabinose and xylose on the xylan backbone varies both by plant type and variety. 
Likewise, external factors such as housing, welfare, and pathogenic challenge may all play significant 
roles in affecting efficacy.  
Both De Maesschalck et al. (2015) and Craig et al. (2019) performed studies using the same 
commercial XOS as used in this study, though the results were conflicting between these two studies. 
Craig et al. (2019) performed a 29-day study with Ross 308 broilers fed a wheat soy diet. The diets 
were slightly deficient in protein (by 20g/kg) and energy (by 1MJ/kg) and supplemented with Longlive 
XOS (Corn XOS in the study in this chapter) at 0.25 g/kg and 1g/kg. No performance effects were 
found over the duration of the study. The authors suggest that the lack of growth performance may 
have been due to the use of low protein or energy diets. As the current study fed wheat/corn/soy 
diets that were sufficient in essential nutrients, to the same strain of birds, it seems unlikely that this 
was a factor in the lack of XOS response found in this study.  
 De Maesschalck et al., (2015), studied Ross 308 broilers fed a wheat and rye diet for 39 days. They 
supplemented the birds with 0.2% XOS from day 0-13 followed by 0.5% XOS from day 14-39. This 
study showed significant improvements in FCR for the birds supplemented with XOS compared to a 
control diet. The authors attribute the positive performance effect of XOS to a microbial shift in the 
GIT, leading to increased production of beneficial VFA’s including butyrate. Exogenous butyrate has 
been shown to enhance broiler growth performance, and to modulate intestinal microbiota and the 
metabolic activity of the microbiota (De Maesschalck et al.,2015).  In addition to the regulatory role 
that butyrate plays in trans-epidermal fluid transport, amelioration of mucosal inflammation and 
oxidative stress (Canani et al., 2011), butyrate has been shown to fuel epithelial cells, increasing 
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intestinal epithelium integrity and consequently preventing leaky gut (Guilloteau et al., 2010; Canani 
et al., 2011).  
De Maesschalck et al., (2015) also performed some in vitro work as part of the same study and 
demonstrated that when the Longlive corn XOS used in this study was fermented in vitro, cross-
feeding between L.crispatus and A.butytaricus occurred. L.crispatus produced lactate as a 
fermentation product, that was consequently used by butyrate producing anaerostipes species, thus 
increasing butyrate production. Butyrate has also been shown to enhance non-specific intestinal 
defence mechanisms against pathogens such as clostridium perfringens (Willemsen et al., 2003; 
Gantois et al., 2006; Timbbermont et al., 2010). This raises the possibility that the reduced 
performance of the birds in the current study may have been due to a clostridium perfringens 
overgrowth in the GIT, leading to subclinical necrotic enteritis. Necrotic enteritis is an enteric 
condition of broilers that can lead to malabsorption and nutrient deficiencies (Klyne, 2013). The 
subclinical form of this condition is highly prevalent in broilers, characterized by poor digestion, body 
weight gain and increased FCR. The birds on this study were unfortunately not scored for lesions in 
the GIT, so it impossible to rule this out,  although it is of note, that no lesions were noted during the 
sampling process. In future work, it is important to measure fermentation products in the caeca to 
elucidate whether butyrate production was increased, but unfortunately this was beyond the scope of 
this project. 
 Hydrolyses of AX into XOS has been shown to vary both by raw material derivation and by different 
xylanases. Kiran et al., (2013), showed that XOS production from various lignocellistic waste 
biomasses varied according to the type of xylanase used for hydrolyses. Likewise, these authors found 
that different xylanases produced varying quantities of products with differing degrees of 
polymerisation. Xylobiose and triose are considered preferable as they can be readily utilized by pro-
biotic microbiota, consequently proliferating these beneficial microbes and improving gut health 
(Bailey et al., 1992; Yamada et al., 1993). As such it is possible that the lack of performance effect 
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seen was due to the production of hydrolyses products that were either too small or not small 
enough. Interestingly, Craig et al. (2019), used both the same corn XOS and xylanase (Econase XT) 
used on this study and likewise showed no performance effect.  
There was no significant effect of xylanase on growth performance on this study. The effect of 
xylanase seems to be variable with some studies demonstrating significant performance 
improvements (Enberg et al., 2004; Owens et al., 2008; Wu and Ravindran, 2004; Masey O’Neil et al., 
2012; Zhang et al., 2014) and other studies showing nothing (Singh et al., 2012.; Azhar et al., 2018). 
The type of diets used seems to be one factor that may affect the efficacy of xylanase (Cardoso et al., 
2018; Azhar et al., 2018). Of the 3 or 4 suggested mechanisms of xylanase, the reduction of digesta 
viscosity is probably the most demonstrated  (Bedford, 2019). However, Cardoso et al., (2018) 
reported that exogenous xylanase only reduced the viscosity of digesta in wheat-based diets, if the 
wheat used had high levels of extract viscosity (>14.8cP). Similarly, Azhar et al., (2018) reports that 
xylanase only improved AME in wheat cultivars that had a high level of NSP to act as a substrate for 
enzyme activity.  Unfortunately, the viscosity of digesta was not measured on this study as it was felt 
that the literature conclusively demonstrated that xylanase reduced digesta viscosity in wheat/soy 
diets (Enberg et al., 2004; Owens et al., 2008; Wu and Ravindran, 2004). Therefore, it is possible that 
the experimental diets did not have sufficient NSP content to provide a substrate for xylanase activity. 
Alternatively, as mentioned above, it is also possible that the xylanase may have either not hydrolysed 
the AX sufficiently, or indeed have hydrolysed the AX into undesirable monosaccharides (Bailey et al., 
1992; Yamada et al., 1993). 
The increased calcium digestibility for the xylanase treatments seems to suggest that xylanase is 
increasing the availability of calcium in the diet. As the calcium coefficients of digestibility do not show 
any differences between treatments, the increase in digested calcium appears to occur in vivo. A 
plausible explanation of how calcium digestibility is being increased is possibly via reduction of a cell 
wall effect, whereby the hydrolysis of the non-starch-polysaccharide fraction of the diet in the upper 
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digestive tract, results in the release of nutrients that had previously been encapsulated in the endo-
sperm cell wall of the grain structure (Choct et al., 2004; Vandeplas et al., 2010; Knudsen, 2014). This 
theory is supported by Dong et al. (2018) who reported similar results from xylanase supplementation 
in pigs. The authors report that a 28 study of weanling pigs fed a wheat-based diet with varying 
amount of xylanase demonstrated increased calcium digestibility in pigs supplemented at 500 and 
1000BXU/kg compared to pigs supplemented at 0, 2000 and 4000BXU/kg. These authors suggest that 
increased calcium digestibility may be due to xylanase decreasing the cell wall effect and releasing 
trapped nutrients. Li et al. (2018) found increased calcium digestibility in laying hens supplemented 
with XOS. This is interesting as the current study found no effect for XOS on calcium digestibility. Li et 
al., (2018) attribute the increased calcium digestibility to the XOS altering mineral absorption rates by 
altering the metabolic activity of microbiota. Roberfroid (2000), describes an osmotic mechanism, 
whereby the provision of non-digestible carbohydrates such as inulin-type fructans, trigger the 
transfer of water into the hindgut, this increase in fluid allows minerals to further dissolve.  
Xylanase has long been suspected of having a potential prebiotic effect, whereby xylanase hydrolyses 
AX in to XOS and AXOS (Craig et al., 2019). Consequently, it is possible that the increased calcium 
digestibility seen for the xylanase treatments on this trial are a result of xylanase acting as a prebiotic 
and hydrolysing enough AX to trigger an osmotic response.  
Interestingly, the current trial showed increased tibial strength at day 21 for all the treatments 
containing xylanase, however, by day 42 there was no significant difference in tibia strength between 
treatments. This raises the possibility that the increased calcium digestibility seen for the xylanase 
treatments, may have contributed to increased mineralisation of the tibias at day 21. Unfortunately, 
calcium digestibility was not measured at 21, so it is impossible to know if calcium digestibility was 
increased for the entire duration of the study, or only towards to the end. However, this theory is 
supported by  Muszynski et al., (2019), who found similar results and report increased tibial strength, 
ash percentage and tibial mineralisation at day 42 with xylanase supplementation.  Unfortunately, 
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bone mineralisation was not measured on this study, so increased mineralisation cannot be 
confirmed. This result is in agreement with Latorre et al., (2014) who showed that feeding turkey 
poults with a Bacillus Subtilis direct fed microbial that produced significant levels of xylanase 
increased bone mineralization in diets high in NSPs. Neither author explains a mechanism for this, but 
once again, it is possible that a reduction in the cell wall mechanism as a result of xylanase 
supplementation could be increasing the availability of encapsulated minerals (Bedford, 2019).   It is 
interesting that the increased tibia strength does not continue to day 42 as it did in the study of 
Muszyynski et al. (2019), and the reason for this is unclear. These authors supplemented xylanase at 
200mg/kg (15% inclusion rate) compared to the current study that used 100g/t (100mg/kg). It is 
therefore possible that the xylanase inclusion rate was insufficient in the current study to exert a 
significant effect by day 42. It is also possible that when measuring bone strength at day 21 
differences between treatments are able to be detected due to being in an active growth phase, and 
the xylanase is increasing the rate of bone maturity. Therefore, as all treatment groups increase in 
body mass, bones are strengthened in response to body weight, causing all treatments to have similar 
bone breaking strength.  
Whilst this study did not show any significant differences in mucin layer thickness between dietary 
treatments at any time point, it did show a significant effect by age. For the majority of treatments, 
the mucin layer seems to drop at day 21 then start to recover by day 42. When compared to the 
findings of other trials (table 4.20), the results are variable. The day 7 and 42 results from the current 
study appear to be in the same range as the other studies. Alsudani (2018), shows a similar mean 
thickness at day 28 to the day 21 results for the current study. Afrin et al., (2018), are also roughly 
similar to the current study, in that the mucin layer thickness seems to start thicker and initially 
decrease with age. It is unfortunate that Afrin et al., did not measure at day 42, to assess whether 
their results would have started to increase again by day 42. 
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The varying results of xylanase and XOS trials within the literature make drawing conclusions from the 
evidence difficult. This is potentially due to the different types of xylanase and/or XOS used as well as 
variation in dose. However, the weight of the literature reviewed suggests that more beneficial effects 
may be obtained from xylanase supplementation, as opposed to XOS. This however, does not 
consider the potential effect of combining both additives and whether this may have a synergistic 
effect. 
 
Table 4. 20 - Mean Mucin layer thickness across various studies by age (Mean mucin layer thickness 
(µg Alcian Blue/g tissue) (adapted from Alsudani, 2018 and Amir et al., 2018) 
Age Current 
trial 
Alsudani 
(2018) 
Afrin et al., 
(2019) 
7 days 53.02 N/A 66 
21 days 35.31 N/A 41 
28 days N/A 38.04 30 
42 days 47.05 N/A N/A 
 
The mucin layer that covers the lining of the intestinal tract is an essential component of gut barrier 
function, acting as a lubricant and providing protection to the mucosal surface from physical injury 
and enteric pathogen entry (Tsirtsikos et al., 2012). Likewise, the mucus layer represents the primary 
barrier limiting contact between the host tissue and commensal microbiota and preventing the 
translocation of microbes (McGuckin et al.,2011). Mucin is secreted from the goblet cells lining the 
gut epithelium and the thickness of the mucin layer is generally expected to affect nutrient absorption 
and gut barrier function (Tsirtsikos et al., 2012). As such a balance must be achieved, if the mucin 
layer is too thick, nutrient absorption can be inhibited, but if it is not thick enough, barrier integrity 
can be compromised. The results of the current study did not show any difference in mucin layer 
thickness at and time point (D7, 21 and 42). Other authors have found mixed mucin responses. 
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Tsirtsikos et al., (2012), did not find any difference in mucin layer thickness when supplementing 
broilers with a dietary phytogenic. However, Alsudani, (2018), showed significant changes in mucin 
layer thickness when supplementing broilers with a pro-biotic. One possibility is that the birds were 
not immunologically challenged. Whilst mucin is continually secreted to support normal gut function, 
the quantity and composition of the mucin changes in response to pathogenic challenge (McGuckin et 
al., 2011). Antimicrobial peptides and glycoproteins are produced throughout the intestinal tract. 
These molecules target different classes of pathogens in an effort to maintain the sterility of the 
mucus layer (McGuckin et al., 2011). Therefore, if the birds in the current study were not exposed to 
pathogenic challenge, it is logical that there may not have been differences in mucin layer thickness. 
 There was also no significant difference in the immunoglobulin A levels between treatments. As 
before, we know that immunoglobulins increase in line with antibody production when the host 
undergoes an immune/inflammatory response (Painter, 1998). IgA is a class of antibody that is of 
particular importance in diseases involving mucus membrane lined tissues (Cotter, 2007). IgA 
originates as a secretary product of B-cells in the bursa of Fabricius. It is produced with the aid of 
intestinal dendritic cells that sample microbiota associated with the epithelium and interact with B 
and T cells in Peyer’s patches to produce specific IgA for microbiota-derived antigens (Macpherson 
and Uhr, 2004). As such, if the birds were not immunologically challenged, they may not have 
increased production of IgA. The lack of differences between dietary treatments for mucin layer 
thickness also reflect this.  
 The blood IGA levels found in this study are in the same range as other broilers studies (Zhang et al., 
2015, Alsudani, 2018). Whilst there is not any specific literature that looks at mucin or IgA levels of 
broilers supplemented with XOS, Komura et al., (2014), looked at the effect of fructo-oligosaccharides 
(FOS) on mucin and IgA levels in rats. These authors found that FOS supplementation increased mucin 
and IgA concentrations in rat caeca. Zhang et al., (2015), studied the development with age of mucin 
and IgA in broilers and pekin ducks. 
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It is of note that other studies have measured secretory IgA, which is the prevalent form of IgA found 
in mucin and levels highly correlates to mucin production. Secretory IgA is a dimer of two IgA bound 
by a J chain and attached to a secretory piece (Genova Diagnostics, 2008). As such, measuring 
secretary IgA is considered more accurate and maybe something to consider in future studies. The 
current trial took place under experimental conditions, that whilst trying to emulate commercial 
conditions, lack the high stocking density that can allow pathogenic disease to spread quickly and 
easily. 
16S analysis was undertaken to determine whether the microbial diversity of the caeca was affected 
by XOS/xylanase supplementation. The results showed that there was no significant difference in the 
microbial diversity at either day 7 or 42 between treatments, but that there was a significant 
(p=0.018) change in the microbial composition between time points. These results reflect those 
reported by Glendinning et al., (2019), who similarly found a profound change in the diversity of the 
microbiota in broiler caeca with age. These authors extracted microbial DNA from various points 
(including the caeca) of Ross 308 broilers at day 1, 3, 7, 14, and 35. Glendinning et al., (2019) do not 
provide any information on what the birds were fed or how they were housed. The authors found 
significant changes in composition, diversity, and richness at every sampling point. Awad et al., 2016 
looked at age related microbiota changes in broilers from day 1-28 post-hatch. Again, these authors 
found significant age-related changes in microbiota composition. In birds less than 14 days of age, the 
most predominant phyla were Proteobacteria, however birds over 14 days of age showed 
predominantly Firmicutes and Tenericutes. 
Whilst in mammals, the microbiota can be transmitted to the foetus via the maternal placenta, uterus 
and vagina, in avian species the embryo develops in isolation. Ding et al. (2017), explored the 
establishment of chicken microbiota. The authors performed 16S microbial sequencing on embryonic 
chickens. The study showed that by as early as 4 days of incubation, gut microbiota were present in 
chicken embryos. They also observed that the composition of the embryonic chick’s microbiota 
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changed fundamentally with age. Whilst in the early embryonic stages, proteobacteria were most 
abundant (86%) followed by firmicutes (5%). However, by day 19 of incubation firmicutes became 
most prevalent (88%) (Ding et al., 2017).  
The reason for the lack of differences in microbial diversity by treatment is not clear. The population 
of commensal microbiota within the gut is thought to play a profound role in regulating the immune 
system (Belkaid and Hand, 2014). The microbiota interacts with both the adaptive and innate immune 
systems, selecting, calibrating and terminating immune responses (Kamada et al., 2013). As both 
pathogens and commensal microbiota require similar conditions and ecological niches in order to 
colonize and proliferate in the GIT, a competition mechanism has evolved, allowing microbes to 
compete for colonization space in the gut (Kamada et al., 2013).  Therefore, as a direct consequence 
of pathogenic infection, the microbiota responds with protective mechanisms such as the production 
of bacteriocins, to try and inhibit growth of pathogenic microbes. The lack of differences in the 
microbial diversity seen in this study, could therefore suggest that the birds were either not exposed 
to pathogenic challenges and therefore, the microbiota was able to remain relatively stable. Likewise, 
this could also indicate that all the birds were all exposed to the same pathogenic challenges and 
therefore experienced similar shifts in microbiota diversity. The experimental setting used for this 
study, has the benefit of allowing numerous dietary treatments to be explored in one room and 
therefore, one environment. This of course has a number of limitations. The proximity of birds on 
different treatments means that if one set of birds was exposed to pathogenic infection, then all 
treatments are likely to become infected. At the same time, this also ensures that all the subjects are 
kept in like-for-like conditions and are therefore comparable. The nature of an experimental setting 
and the regulations they must adhere to, also means that by definition these facilities have to be kept 
clean and biosecure, potentially cleaner than a commercial broiler setting. This obviously reduces the 
bird’s exposure to environmental pathogens. Repeating this study in a commercial setting in the 
future would be very interesting to see if differences in microbial diversity could be detected. 
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Initially, there was concern over the validity of the 16S results for this trial as there were no 
Bacteroidetes microbes present. However, a second NTU trial revealed identical findings. Glendinning 
et al., (2019), also found no Bacteroidetes, which coupled with similar findings in the microbiota 
change with age adds weight to the findings of this study. 
 By day 42  the microbes found in this study are predominantly firmicutes, which again agrees with 
the findings of Glendinning et al. (2019). Interestingly, low levels of Bacteroidetes and predominant 
Firmicutes are associated with obesity in humans and mice due to Firmicutes ability to harvest energy 
from the diet (Ley et al., 2005; Faintuch and Faintuch, 2019).  Firmicutes can be split into two major 
groups: clostridium coccides (Clostridum cluster XIVa) and Clostridium leptum (Clostridium cluster IV).  
The bacteria in the Clostridum Coccoides groups play a large part in the fermentation of 
carbohydrates within the gut (Faintuch and Faintuch, 2019). Butyrate is the primary metabolite of 
firmicutes (Besten et al., 2013).   It therefore seems possible that the microbial diversity results of this 
trial (and others) would show predominant Firmicutes and lower levels of Bacteroidetes as high levels 
of phyla that are proficient in extracting energy from the diet would be beneficial, if not vital to 
maintain the high levels of growth efficiency required of modern broilers. 
The histology results of this study revealed no significant differences between treatments at either 
day 7 or days 42. This is  somewhat unexpected as De Maesschalck et al., (2015), found that 
supplementing broilers with the same corn XOS used in this study (0.2% day 0-13 and 0.5% day 14-39) 
resulted in significantly longer villi in the ileum (section closest to the Meckel’s diverticulum), at 26 
days of age. In the current study the intestinal samples were taken from the jejunum, however the 
samples were collected from the section closest to the Meckel’s diverticulum, so similar results may 
have been expected. As the current study measured at day 7 and day 42, it remains possible that 
taking measurements at different time points could have accounted for this lack of differences. Luo et 
al., (2009), demonstrated increased villus height in the jejunum of birds fed wheat-based diets, 
supplemented with xylanase at 1000BXU/kg. These authors showed that supplementing broilers with 
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either no xylanase or xylanase at 5000BXU/kg significantly reduced villus height in comparison to the 
1000BXU/kg dose. As the birds in the current study were supplemented with xylanase at either 0 or 
1600BXU/kg it is possible that the dose was either insufficient or too large to see increased villus 
height. When the villus height is correlated to mucin (day 42), there is no positive correlation 
(R2=0.0221) (Figure 4.6). When a Pearson correlation was performed the relationship is r=0.141 
showing there is no indication that longer villi are related to increased mucin secretion/mucin layer 
thickness.  
 
 
Figure 4.6 – Correlation between villi height and mucin layer thickness at day 42 
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4.5 Conclusion 
The results of this trial were unexpected, as following the initial study it was thought that directly 
supplying a XOS product might enhance the beneficial effects seen with AX supplementation. The 
results of this study showed no real effect of XOS supplementation; therefore, it is difficult to 
draw conclusions as to whether the base material from which a XOS is extracted can affect 
efficacy. 
  This study did, however, show a number of beneficial effects for xylanase supplementation. The 
treatments containing xylanase showed increases in tibial strength at day 21 and calcium 
digestibility at day 42. The mechanism by which xylanase is improving these parameters remains 
unclear, but a reduction in the cell wall effect, increasing the availability of encapsulated nutrients 
seems plausible.  
The lack of differences in immune and gut health parameters seems to suggest that the birds 
were not exposed to any immune challenges and therefore no response was observed. Upscaling 
this study to a commercial would be interesting, as the birds are more likely to be exposed to 
environmental and pathogenic challenges, due to increased stocking density, reduced 
environmental control and lack of experimental legislation. It would also be interesting to 
examine other areas of bird health, to determine whether differences between treatments can be 
detected in an experimental setting. Oxidative stress is an emerging field in animal production 
that has been shown to have profound effects on downstream meat quality. Looking at whether 
differences in oxidative stress can be detected between dietary treatments may be a more 
precise measure of bird health. Looking at the dose of XOS and/or xylanase may also further 
elucidate their effect. When comparing the results of this study to others in the literature, there 
was a broad variation in dose of both XOS and xylanase. Therefore, a dose response study may 
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provide further information into the mode of action and efficacy of XOS and xylanase 
supplements. 
 
 
 
 
 
 
 
 
 
 
Chapter 5 was appended during the viva and can be found at the end 
of this document 
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Chapter 6 – Optimizing the dose of a commercial xylo-
oligosaccharide/xylanase supplement 
6.1 Introduction 
After the initial work on this project the corn based XOS used in chapter 4 was marketed as a 
supplement containing both the corn XOS and xylanase (Signis ®). As the previous studies had shown 
results for both AX and xylanase independently, but had raised questions over whether the dose of 
xylanase in particular, may have affected efficacy, it was decided that a dose response study may further 
elucidate both the mode of action and effects of XOS and xylanase when provided together. 
As other studies had provided varied results in response to the dose of XOS supplied, gaining some 
more insight on this seemed important. Courtin et al. (2008) complemented a wheat-based diet with 
XOS at 0.25 and 0.5g/kg and reports that fourteen days of XOS supplementation (extracted from wheat 
flour) resulted in significantly increased quantities of Bifido bacteria inbroiler ceacas, however the 
authors did not find any significant changes in the numbers of Lactobacilli present. Furthermore, a study 
by Pourabedin et al. (2015) reports similar results with significant increases in beneficial bacteria in the 
caeca of birds supplemented with XOS at 2g/kg, however, in this case it was Lactobacillus genus 
bacterium that flourished. In some cases, both Bifido and Lactobacillus bacteria have been found to 
proliferate with XOS inclusion. Ribeira et al. (2018) found that XOS supplementation at 0.1g/kg 
increased the microbial populations of Bifido bacterium and Lactobacilli. As was found in the 
performance data from this study, a lower XOS inclusion rate (0.1g/kg) produced higher levels of 
beneficial bacterium. The results of Ribeira et al. (2018) suggest that there is likely to be an optimal 
dosage, however, whether this may vary by the base material from which the XOS is extracted is 
unclear. 
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 As such, a 35-day bird trial was designed to compare a control diet to Signis® at both the commercially 
recommended dose and at double the recommended dose. Several studies had used considerably 
higher doses of both XOS and xylanase with no ill effects to the birds (Courtin et al., 2008; Zhenping et 
al., 2012; Ribeira et al., 2018) and therefore no negative effects of doubling the dose were expected.  
The results of the previous studies in chapters 3 and 4, had revealed some benefits to feeding an AX 
supplement in terms of significantly improving body weight gain during the finisher phase and 
numerically increasing final bird weight by 6%. Likewise, feeding xylanase revealed increased bone 
breaking strength at day 21 and increased calcium digestibility at day 42. As such, the previous results 
had not shown a clear effect of the combination of XOS and xylanase, so measures were repeated to 
try and obtain more conclusive data.  
The main aims of the trial were as follows: 
• Investigate the effect of Signis® (XOS/Xyl) on the performance of broilers 
• Determine whether any effects of Signis® were altered by doubling the recommended dose 
• Determine whether any performance enhancement derived from the supplementation of 
XOS/Xyl is down to a viscosity effect 
• Undertake a range of analyses to add information into how this product may be working 
mechanistically. 
 
6.2 Trial procedure 
6.2.1 Husbandry Conditions 
240-day old male Ross 308 broilers were sourced from PD Hook Cote hatchery from a flock aged 44 
weeks. Birds were feather sexed on the day of hatch and any poor birds were discarded on arrival. 
Chicks were individually weighed on arrival, then randomly assigned to 48 mesh sided pens (5 birds 
per pen), littered with a wood shavings substrate. Food and water were provided ad libitum and care 
taken to ensure chicks were eating and drinking as soon as possible. Husbandry guidelines were 
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followed as described in chapter 2 and adhered to the institutional and national guidelines for the 
care and use of animals (Animal Scientific Procedures Act, 1986). Ethical approval was granted by the 
University ARES Ethics Committee and was logged as project ARE906.  
6.2.2 Diet formulation and condition of animals 
Signis® was provided by A.B. Vista. The trial used three treatments (table 6.1) with three phases 
(starter, grower, and finisher). Three basal diets (one per phase) were commercially manufactured by 
Target Feeds (Shropshire, UK). Diets were formulated by a commercial nutritionist to meet the age 
and strain of the bird (table 6.2). Each basal diet was divided into three treatments inhouse and 
Signis® was added to treatments B and C at either 0.1g/kg (diet B) or 0.2g/kg (diet C). Quantum Blue 
5G phytase was added to all diets at the time of manufacture at 0.01% inclusion rate to provide 
approximately 500FTU. Proximate analysis was performed to confirm composition (table 6.3) 
Table 6.1 – Dietary treatments for dose response trial 
Diet Treatment 
Control Standard broiler diet 
Control + 0.1g/kg Signis® Standard broiler diet + 0.1g/kg Signis® 
Control + 0.2g/kg Signis® Standard broiler diet + 0.2g/kg Signis® 
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Table 6.2 – Diet Formulations and rate of inclusion (Roi) for dose response trial (g/kg) 
Ingredient RoI Starter Roi Grower Roi Finisher 
Wheat 615 635 670 
Extruded Soy A 324.3 291.3 252.9 
Soya oil 15.8 29.4 38.9 
Salt 3.8 5 3.8 
Limestone 1.6 3.8 1 
Dicalcium Phos, 18%P 21.7 19.1 17.4 
Lysine HCl 2.8 2.2 2.3 
DL-Methionine 3.2 2.7 2.6 
Threonine 1.6 1.2 1.2 
Vitamin & Mineral premix 5 5 5 
Quantum Blue 5G 0.1 0.1 0.1 
Signis® 0 0 0 
Titanium 5 5 5 
 
 
Table 6.3 - Proximate analysis of basal diets for dose response trial  
 
 
 
Diet Starter   Grower  Finisher  
DM (g/kg) 879 874 875 
Ash (g/kg) 58 46 52 
Protein (g/kg DM) 224 186 208 
Total P (g/kg DM) 55 60 78 
Total Ca (g/kg DM) 49 47 67 
Fat (g/kg) 24 33 48 
Ti (g/kg) 4.96 4.02 5.15 
GE (MJ/kg) 15.91 16.24 16.40 
Phytase (FTU/kg) 491 617 981 
Xylanase (BXU/kg) (0.1g/kg) 13900 14800 16400 
Xylanase (BXU/kg) (0.2g/kg) 24200 30600 28700 
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6.2.3 Treatment Schedule / randomisation plan / condition of animals 
 
A replicate consisted of a pen containing 5 birds (individually weighed) and only birds weighing 
between 40g and 50g were placed on trial. The combined weight of each pen was recorded on day 0. 
Treatments were randomly allocated via, an online randomisation tool (random.org) by block (one 
block of 3 pens) to reduce any effect of ventilation and temperature differences within the room. Pen 
allocation is shown in table 6.4 and a plan of the experimental room is shown in appendix B 
Table 6.4 - Diet allocation for dose response trial 
pen 
diet 
allocation 
  pen 
diet 
allocation 
pen 1 A   pen 25 B 
pen 2 B   pen 26 C 
pen 3 C   pen 27 A 
pen 4 B   pen 28 A 
pen 5 A   pen 29 B 
pen 6 C   pen 30 C 
pen 7 C   pen 31 C 
pen 8 A   pen 32 B 
pen 9 B   pen 33 A 
pen 10 B   pen 34 A 
pen 11 C   pen 35 C 
pen 12 A   pen 36 B 
pen 13 C   pen 37 B 
pen 14 B   pen 38 A 
pen 15 A   pen 39 C 
pen 16 C   pen 40 A 
pen 17 A   pen 41 B 
pen 18 B   pen 42 C 
pen 19 A   pen 43 B 
pen 20 C   pen 44 C 
pen 21 B   pen 45 A 
pen 22 A   pen 46 C 
pen 23 B   pen 47 A 
pen 24 C   pen 48 B 
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6.2.4 Study observations 
Bird observations were performed a minimum of twice daily (generally more) to ensure bird welfare 
and environmental conditions were maintained. Temperature and/or ventilation were adjusted 
depending on bird behaviour. Dead birds were removed and weighed, and any unhealthy birds 
(defined as any bird displaying discomfort or distress) were culled and recorded. Bird feed intake was 
calculated as per the method detailed in section 2.4.1. Birds were weighed weekly by pen on days 0, 
7, 14, 21, 28 and 35, as per section 2.4.1.  Additionally, birds were weighed individually on days 28 
and 35 to assess flock variability. Feed intake and bird weight were used to calculate weekly feed 
conversion ratio (FCR). 
On day 35, birds were sequentially fed fresh diet for a minimum of 30 minutes to ensure adequate 
gut fill prior to euthanasia. One bird per pen was humanely euthanized by cervical dislocation. Post 
mortem blood samples were collected and split into tubes containing EDTA as an anti-coagulant for 
post-trial immunoglobulin analysis (as per section 2.4.2) or into serum tubes for antioxidant analysis 
(section 2.5.10). The blood was centrifuged at 3000RPM for 10 minutes (Thermo Scientific, Megafuge 
8, Fisher, UK) and plasma/serum removed and stored at -20°C.  
 The ileum and jejunum were excised from the end of the duodenal loop to the ileal-caecal-colonic 
junction then split at the Meckel’s diverticulum. Ileal and jejunal digesta were collected from each 
bird by gentle digital pressure. Jejunal digesta was aliquoted into Eppendorf tubes and immediately 
centrifuged at 15000RPM for 5 minutes (Sigma 1-14 micro centrifuge, Sigma-Aldrich, UK)  for viscosity 
analysis as described in section 2.5.22.  
Ileal digesta was pooled into one pot per pen. Digesta was frozen at -20oC before being freeze dried 
and ground with a pestle and mortar. Diets and ileal digesta were analysed for gross energy by bomb 
calorimetry at an external lab. Protein was analysed via Dumatherm (Gerhardt, UK) as described in 
section 2.5.2. Titanium dioxide content of the diet and digesta was measured using the method of 
Short et al., 1996 (section 2.5.5). Calcium and phosphorus content of the diets and digesta was 
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determined by ICP-OES (section 2.5.6). Ash and dry matter were analysed as per sections 2.5.4, and 
2.5.1. Digestibility of calcium and phosphorus were calculated using the formulas shown in section 
2.5.7. Both caeca were removed and weighed as a pair then individually snap frozen for potential VFA 
and 16S analysis in a later project (as per section 2.5.14). The bursa of Fabricius was excised from 
each bird and weighed. The left breast fillet and thigh were excised and later split for drip loss (section 
2.5.24) and texture analysis, both fresh and cooked(section 2.5.23). Variation was assessed using the 
percentage coefficient of variation (C.V). This was calculated using the following equation:    
  Standard deviation of treatment body weight X 100 
              Average body weight of treatment                                                
 
  
 
6.2.5 Statistical analysis of data 
Outliers were removed from data if they fell either two standard deviations above or below the mean. 
Statistical analysis was performed using SPSS v.23 (IBM statistics). KS testing was used to determine 
data normality, followed by one-way ANOVA and Univariate analysis as appropriate. Bonferroni post 
hoc tests were used to elucidate differences in treatment. Correlations were analysed by bivariate 
correlation using Pearson correlation, chosen because it computes based on true values and depicts 
linear relationships. Interpretations of the strength between relationships was based on those of 
Cohen (1988): small r = 0.1-0.29, medium r = 0.30-0.39 and large r = 0.50 to 1.0. Statistical 
significance was declared at p<0.05.  
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6.3 Results 
6.3.1 Environment 
This trial was carried out in winter, during a cold and wet period of weather. On Day 29 of the trial, a 
power cut caused loss of heating, causing temperatures to drop to 11°C. The system reset and raised 
temperatures to 14°C. The following day, the system failed again, causing temperatures to drop to 
10°C. The room was immediately heated up using portable heaters and the extraction system 
disabled to aid heating. By the afternoon check the room was up to temperature and the extraction 
system was restarted. Due to the heat fluctuations combined with high external humidity and low 
temperatures, the bedding quality was recorded as poor, and was capped by day 34 (figure 6.1). 
 
Figure 6.1- Temperature record for dose response trial 
 
 
6.3.2 Health and Condition 
Mortality data is shown in table 6.8. During the whole 35d study, mortality was 3.3% which is 
considered standard for trials conducted at the NTU unit and lower than would be expected in a 
commercial setting which would be typically in excess of 4%.  There was no apparent effect of 
treatment on mortality as can be seen in table 6.5 which splits the mortality by week and dietary 
treatment. 
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Table 6.5 - Bird mortality for dose response trial 
Treatment d0-7 d7-14 d14-21 D21-28 D28-35 Total 
Control 2 0 0 1 1 4 
0.1g/kg Signis® 1 0 0 1 1 3 
0.2g/kg Signis® 1 0 0 0 0 1 
 
6.3.3 Bird Uniformity 
Upon arrival at the research unit, all chicks were individually weighed and only birds weighing 
between 38 and 46g were placed. The mean start weights for each treatment are shown in table 6.5.  
There was no statistical difference in the start weight of the chicks between treatments. 
Table 6.6 - Average start weight for chicks for dose response trial 
Treatment d0 BW/bird (g) 
Control 41 (0.7) 
0.1g/kg Signis® 41 (0.8) 
0.2g/kg Signis® 41 (0.7) 
P value 0.469 
 
 
6.3.4 Cumulative Performance 
Cumulatively there was a significant increase in body weight gain during the periods of day 0-7, 0-14, 
and 0-21 for the higher dose of Signis® (0.2g/kg) compared to the other two treatments. From d0-28 
there was a significant increase in body weight gain for the higher dose of Signis compared to the 
lower dose and also a significant increase body weight gain for the low dose compared to the control. 
Between day 0 and35 there was a significant increase in body weight gain for both Signis® treatments 
compared to the control (table 6.6). 
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Table 6.7 - Cumulative body weight gain for dose response trial (g +/- SE) 
Treatment D0-7 BWG  D0-14 BWG  D0-21 BWG  D0-28 BWG  D0-35 BWG  
Control 72 (2.9)b 266 (11.3)b 633 (24.4)b 1161 (35.4)ab 1819 (54.1))b 
0.1g/kg Signis® 74 (2.5)b 280 (8.7)b 685 (16.6)b 1282 (27.1)b 1987 (53.8)a 
0.2g/kg Signis® 83 (3.3)a 321 (8.3)a 750 (15.1)a 1350 (22.8)a 2089 (31.9)a 
P Value 0.019 <0.001 <0.001 <0.001 0.001 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p<0.05) 
 
From days 0-7, 0-14, and 0-21 there was no significant difference in feed intake between treatments 
and between day 0-28 and 0-35 there was a significant increase in feed intake for both Signis® 
treatments compared to the control (table 6.7).  
Table 6.8 - Cumulative feed intake for dose response trial (+/- S.E.) 
Treatment D0-7 FI (g)  D0-14 FI (g)  D0-21 FI (g)  D0-28 FI (g)  D0-35 FI (g)  
Control 246 (12.9) 458 (22.5) 1022 (34.5) 1932 (34.2)b 3046 (50.8)b 
0.1g/kg Signis® 254 (16.09) 438 (50.6) 1013 (54.3) 2033 (35.4)a 3214 (47.7)a 
0.2g/kg Signis® 259 (18.3) 418 (22.5) 1003 (24.2) 2055 (39.9)a 3234 (51.6)a 
P Value 0.850 0.709 0.945 0.050 0.020 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
During day 0-7 there was no significant difference in FCR between treatments. During day 0-14, 0-21, 
0-28, and 0-35 there was a significant reduction in FCR for the birds fed the higher dose of Signis® 
compared to the other two treatments (table 6.8). These FCR values are high due to feed spillages 
typically seen in the first weeks of bird trials at NTU. 
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Table 6.9 - Cumulative feed conversion ratio for dose response trial +/- SE 
Treatment D0-7 FCR D0-14 FCR D0-21 FCR D0-28 FCR D0-35 FCR 
Control 2.19 (0.125) 1.79 (0.131)b 1.68 (0.046)b 1.65 (0.086)b 1.68 (0.033)b 
0.1g/kg Signis® 2.19 (0.123) 1.56 (0.155)b 1.59 (0.030)b 1.48 (0.060)b 1.63 (0.040)b 
0.2g/kg Signis® 2.08 (0.158) 1.31 (0.080)a 1.52 (0.020a 1.34 (0.040)a 1.55 (0.020)a 
P Value 0.812 0.036 0.007 0.008 0.002 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
 
6.3.5 Weekly bird body weight gain  
By day 7, there was a significant increase in bodyweight for the birds fed the higher dose of Signis®, 
with birds weighing on average over 10g more than the control (table 6.10). For the next two weeks 
(day 14 and 21) this trend continues, with the higher dose of Signis® consistently showing a significant 
increase in average bird weight. At day 14, the higher dose treatment weigh 22.7% more than the 
control and by day 21 this treatment weighs 22.3% more than the control (p= 0.001 and p <0.001). 
However, by day 28 both Signis treatments showed a significant increase in average bird weight 
compared to the control. Whilst the higher dose has a mean average bird weight of nearly 70g more 
than the lower dose, this difference was not statistically significant (p=0.985). During the final week of 
the trial, both Signis® treatments significantly increase average bird weight compared to the control 
birds. There was no significant difference between the two Signis® treatments at day 35 although 
numerically, the higher dose yields birds at slaughter age that weigh 100g (5%) more than the lower 
dose and nearly 15% higher than the control.  
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Table 6.10 - Weekly Body Weight Gain (g) for dose response trial (g) (+/- S.E.) 
Diet D0-7 
BWG/bird  
D7-14 
BWG/bird  
D14-21 
BWG/bird  
D21-28 
BWG/bird  
D28-35 
BWG/bird  
Control 72b  (3.0) 194b (9.0) 367b (15.5) 529b (18.0) 657 (30.4) 
0.1g/kg Signis® 74b (2.5) 206b (7.7) 404b (10.4) 597a (13.6) 705 (35.6) 
0.2g/kg Signis® 83a (3.3) 238a (5.4) 429a  (9.4) 600a (10.7) 739 (18.7) 
P value 0.019 <0.001 0.003 0.001 0.148 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
6.3.6 Weekly average bird weight   
By day 7, there was a significant increase in bodyweight for the birds fed the higher dose of Signis®, 
with birds weighing on average over 10g more than the control (table 6.10). For the next two weeks 
(day 14 and 21) this trend continues, with the higher dose of Signis® consistently showing a significant 
increase in average bird weight. At day 14, the higher dose treatment weigh 22.7% more than the 
control and by day 21 this treatment weighs 22.3% more than the control (p= 0.001 and p <0.001). 
However, by day 28 both Signis treatments showed a significant increase in average bird weight 
compared to the control. Whilst the higher dose has a mean average bird weight of nearly 70g more 
than the lower dose, this difference was not statistically significant. During the final week of the trial, 
both Signis® treatments significantly increase average bird weight compared to the control birds. 
There was no significant difference between the two Signis® treatments at day 35 although 
numerically, the higher dose yields birds at slaughter age that weigh 100g (5%) more than the lower 
dose and nearly 15% higher than the control.  
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Table 6.11 - Weekly Average Bird Weight for dose response trial (g ±SE)   
Diet D0 BW  D7 BW  D14 BW  D21 BW D28 BW D35 BW 
Control 42 (0.7) 113b (3.2) 307b (11.6) 674b (24.6) 1208b (37.7) 1860b (54.3) 
0.1g/kg Signis® 42 (0.8) 116b (2.6) 322b (8.9) 727b (16.9) 1323a (27.4) 2029a (54.0) 
0.2g/kg Signis® 41 (0.7) 125a (3.4) 363a (8.3) 791a (15.2) 1392a (22.9) 2131a (32.0) 
P value 0.469 0.029 0.001 <0.001 <0.001 0.001 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
6.3.7 Weekly Feed Intake 
There was no significant difference in feed intake between treatments during the first 4 weeks of the 
study. During the final week, the two Signis treatments both show significantly increased feed intake 
compared to the control diet (table 6.11)  
Table 6.12 - Weekly feed Intake for dose response trial (±SE) 
Diet D0-7 FI (g)  D7-14 FI (g)  D14-21 FI (g)  D21-28 FI (g)  D28-35 FI (g)  
Control 246 (3.2) 326 (11.8) 554 (19.1) 826 (17.8) 1114 (27.8) 
0.1g/kg Signis® 254 (64.0) 356 (8.9) 566 (15.0) 857 (14.9) 1181 (23.2) 
0.2g/kg Signis® 259 (18.3) 349 (11.7) 576 (14.1) 872 (15.1) 1179 (16.7) 
P value 0.85 0.248 0.639 0.126 0.075 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
 
6.3.8 Weekly Feed Conversion Ratio 
There was no significant difference in FCR by D7 (table 6.12), However, on D14 and 21 the higher 
dose of Signis® has a significantly reduced FCR of 1.46 and 1.35 respectively (D14, p=0.02,day 21 
p=0.039) when compared to the other two treatments. By D28, the FCR for the lower dose of Signis® 
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is no longer significantly different to the higher dose, and both Signis® treatments have significantly 
reduced FCR compared to the control. During the final week of the trial, there was no significant 
difference in FCR between treatments, though the numerical difference between the control diet and 
1g.kg Signis and the 2g/kg Signis diet is substantial (14 points of FCR). 
Table 6.13 - Weekly FCR for dose response trial (+/- S.E.) 
Diet D0-7    FCR  D7-14 FCR  D14-21 FCR  D21-28 FCR  D28-35 FCR  
Control 2.18 
(0.125) 
1.72b (0.078) 1.54b (0.081) 1.58b (0.052) 1.75 (0.084) 
0.1g/kg Signis®  2.19 
(0.123) 
1.75b (0.095) 1.41b (0.04) 1.44a (0.027) 1.74 (0.110) 
0.2g/kg Signis® 2.08 
(0.158) 
1.46a 
(0.044) 
1.35a  (0.04) 1.45a (0.017) 1.61 (0.031) 
P value 0.812 0.02 0.039 0.013 0.384 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
6.3.9 Variability 
There was a large difference in the standard deviation of weights between the three treatments, with 
variability being considerably lower for the higher dose of Signis® (table 6.13). The highest dose of 
Signis® produced the lowest coefficient of variation (12.4%) (table 6.14). 
Table 6.14 – Flock Variability (standard deviation from individual bird weights (S.D.)) for dose 
response trial 
Treatment Min wt 
(g) D28 
Max wt 
(g) D28 
Min wt 
(g) D35 
Max wt 
(g) D35 
S.D. (g) 
D28 
S.D.  (g) 
D35 
Control 567 1669 1009 2555 249 217 
0.1g/kg Signis® 750 1756 1181 2727 223 216 
0.2g/kg Signis® 954 1774 1476 2641 192 128 
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Table 6.15 - Coefficient of variation percentages for each treatment for the dose comparison trial 
Treatment Coefficient of variation D28 Coefficient of variation D35 
Control 20.6% 17.6% 
0.1g/kg Signis® 16.9% 15.9% 
0.2g/kg Signis® 13.8% 12.4% 
 
6.3.10 Digesta Viscosity 
There was no significant difference in the viscosity of the jejunal digesta on day 35 (p=0.103), though 
numerically, the viscosity reduced with Signis inclusion (table 6.15). 
Table 6.16 - Digesta viscosity (cP) for dose response trial (±SE) 
Treatment Digesta Viscosity (cP)  
Control 1.869 (0.1719) 
0.1g/kg Signis® 1.537 (0.0979) 
0.2g/kg Signis® 1.485 (0.1238) 
P Value 0.103 
 
6.3.11 Bursa Weight 
There was no significant difference in bursa weights on day 35 between treatments (p=0.815; table 
6.16) 
Table 6.17 - Bursa weight D35 for dose response trial (±SE) 
Treatment Bursa Weight (g/kg bird wt)   
Control 2.16 (0.111) 
0.1g/kg Signis® 2.01 (0.131) 
0.2g/kg Signis® 1.95 (0.130) 
P Value 0.815 
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6.3.12 Caeca Weight 
There was no significant difference in caeca weight between treatments on day 35 (p=0.496) (table 
6.17). 
Table 6.18 - Mean caeca weight per treatment on day 35 for dose response trial (per pair - g/kg bird 
wt; ±SE)   
Treatment Caeca weight (pair) 
Control 12.40 (1.455) 
0.1g/kg Signis® 12.21 (2.285) 
0.2g/kg Signis® 10.97 (0.836) 
P- Value 0.496 
 
6.3.13 Texture Analysis 
There was no significant difference between treatments in the force required to depress breast meat 
by 10mm when uncooked (p=0.682), though there was a numerical decrease with increasing SIgnis® 
dose. There was no significant difference between treatments in the force required to depress meat 
by 10mm when cooked (p=0.776) (table 6.18). 
Table 6.19 - Texture analysis for breast meat for dose response trial (±SE) 
Treatment Force required to depress 
10mm (N) Raw 
Force required to depress 
10mm (N) Cooked 
Control 47.73 (11.246) 13.63 (4.080) 
 0.1g/kg Signis® 35.36 (5.501) 13.31 (3.446) 
 0.2g/kg Signis® 33.69 (7.061) 18.62 (5.103) 
P Value 0.682 0.776 
 
6.3.14 Drip Loss 
There was no significant difference in breast meat drip loss percentage between treatments at either 
48 hours or 120 hours post slaughter (p=0.811 and p=0.824) (table 6.19). There was no significant 
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difference in thigh meat drip loss percentage between treatments at either 48 hours or 5 days post 
slaughter (p=0.286, p=0.711). 
Table 6.20 - Drip loss values between treatments on D35 for dose response trial (±SE) 
Treatment Breast drip loss 
48 h (%) 
Breast drip loss 
120 h (%) 
Thigh drip loss 
48 h (%) 
Thigh drip loss 
120 h (%) 
Control 0.14 (0.009) 3.35 (0.316) 0.10 (0.006) 0.19 (0.018) 
 0.1g/kg Signis® 0.14 (0.016) 3.36 (0.262) 0.13 (0.014) 0.23 (0.024) 
 0.2g/kg Signis® 0.14 (0.018) 3.59 (0.360) 0.11 (0.020) 0.22 (0.029) 
P Value 0.811 0.824 0.286 0.711 
 
6.3.15 Total Antioxidant Capacity 
There was no significant difference in the total antioxidant capacity of the blood between treatments 
(table 6.21)  
Table 6.21 - Total Antioxidant capacity for dose response trial 
Treatment Total antioxidant capacity (VEA µmol/L (±SE) 
Control 755.71 (35.192) 
Control + 0.1g/kg Signis® 799.87 (29.076) 
Control + 0.2g/kg Signis® 748.89 (28.342) 
P- Value 0.457 
 
6.3.16 Day 35 Digestibility 
There was a significant decrease in apparent metabolizable energy, apparent metabolizable energy 
corrected for nitrogen and nitrogen retention between the higher dose of Signis and the other two 
treatments (table 6.22). When AME is corrected for feed intake by dividing AME per kg feed intake, 
there is still a significant difference between each of the treatments (table 6.23).   
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Table 6.22 - Day 35 Digestibility for dose response trial 
Treatment AME (MJ/kg) AMEn (MJ/kg) Ni ret (g/kg) 
Control 16.57 (0.500)b 15.73 (0.516)b 28.13 (0.165)b 
0.1g/kg Signis® 15.19 (0.605)b 14.24 (0.599)b 27.57 (0.231)b 
0.2g/kg Signis® 13.71 (0.413)a 12.95 (0.398)a 26.88 (0.241)a 
P Value 0.001 0.001 0.002 
a-b Means within the same column that do not share a common superscript are significantly different by one-
way ANOVA (p=<0.05) 
 
6.3.17 Calcium and phosphorus digestibility  
There were no significant differences in either the apparent ileal digestibility coefficient for calcium 
or phosphorus between treatments, or between the amount of calcium or phosphorus digested 
between treatments (table 6.23). 
Table 6.23 - Calcium and Phosphorus digestibility for dose response trial (+/- S.E.) 
 Apparent ileal digestibility coefficient                        Amount of Mineral digested (g/) 
Treatment Calcium Phosphorus Calcium  Phosphorus 
Control 0.69(0.01) 0.79 (0.019) 0.04 (0.003) 0.06 (0.001) 
0.1g/kg Signis® 0.69 (0.00) 0.78 (0.340) 0.04 (0.004) 0.06 (0.002) 
0.2g/kg Signis® 0.68 (0.02) 0.75 (0.027) 0.04 (0.003) 0.06 (0.002) 
P Value 0.948 0.274 0.571 0.386 
 
6.3.18 Immunoglobulin Y 
There was no significant difference in the quantity of immunoglobulin Y present in the blood between 
the dietary treatments (table 6.24). However, there was an apparently linear numerical decrease in 
IgY (including a decrease in standard error) in line with increase in Signis dose. 
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Table 6.24 - Levels of immunoglobulin Y present in the blood on day 35 (±SE) 
Treatment Immunoglobuline Y (ug/ml)  
Control 1151.4 (197.26) 
0.1g/kg Signis® 1113.6 (101.60) 
0.2g/kg Signis® 953.1 (85.80) 
P Value 0.553 
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6.4 Discussion 
The main aim of this study was to determine whether Signis® (a combined corn XOS and xylanase 
supplement) was beneficial in supporting the performance of broilers and elucidating the 
mechanisms behind its action. A second aim was  and to try and determine to investigate the effect of 
increasing the commercially recommended dose.  
The performance data from this trial indicates that, from the parameters measured, there appears to 
be no deleterious effect of feeding Signis® at either 0.1g/kg or 0.2g/kg as mortality was not 
significantly different between treatments. As birds were fed identical basal diets, it can be assumed 
that any beneficial effects seen are a result of the Signis® supplement and not due to discrepancies in 
nutritional provision. 
All cumulative measuring points up to day 28 show significantly increased BWG for the higher dose of 
Signis® compared to the other two treatments. From days 0-35 (the full trial length) both Signis® 
treatments show significantly increased BWG compared to the control. 
Interestingly, there was no significant difference in cumulative feed intake between treatments until 
day 28. However, from day 0-28 and day 0-38 there was a significant increase in feed intake for both 
Signis® diets. This may be explained by the fact that the birds are over 15% (high dose) and 9% (low 
dose) heavier respectively and therefore need more energy to support their growth and maintenance 
(Kleyn, 2013). The higher dose of Signis® shows a significantly reduced FCR for days 0-7, 0-14, 0-21, 0-
28 and 0-35 compared to both other treatments. In the first two weeks of the study the lower dose of 
Signis® and control treatments produced similar FCR results, however, from the third week onwards, 
the lower dose of Signis start to improve and the FCR decreases until the end of the study. 
During the first week, the higher dose of Signis® produced a significant increase in body weight gain, 
average bird weight and significantly reduced FCR compared to the other two treatments. The first 
week BWG is increased by 12g (almost 15%) on average compared with the control treatment and 
increased by 9g compared to the lower dose of Signis®. This differs from the results of Craig et al. 
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(2019) who studied the effects of XOS and xylanase individually. These authors fed a wheat and soya-
based diet with the addition of wheat bran (to increase AX levels) over 29 days. The study only found 
BWG increases at day 14 and 21 with xylanase and the inclusion of XOS showed no performance 
enhancing effects. It is possible that it is the combination of XOS and xylanase together that is 
required in order to produce a performance effect to the level seen in the current study. This may be 
due to the provision of xylanase stimulating hydrolysis of AX in the diet, in addition to the provision of 
XOS already in a fermentable form for the gut bacteria. 
 By day 14, birds fed the higher dose treatment gained significantly more weight than those fed the 
other two treatments and on average has gained 45g (nearly 20%) more than the control and 32g 
(6%) more than the lower dose Signis®. Likewise, average bird weight is significantly increased by 
approximately 15% and FCR is significantly reduced. There was no significant difference in feed intake 
at this point. Whilst these FCR results are still slightly higher than the Aviagen Ross 308 objectives, the 
birds in the current study were fed mash diets as opposed to pelleted diets used for the Aviagen 
objectives, possibly accounting for the difference. The FCR results for the current study are also 
considerably improved compared to the two previous animal studies in this project (table 6.24). 
 
 
Table 6.25 - Comparison of Aviagen Ross 308 FCR objectives with the FCR of the 0.2g/kg Signis® 
treatment in the dose response trial 
Age Ross 308 objective for FCR Current study FCR (0.02g/kg Signis®) 
Day 7 0.821 2.08 
Day 14 1.057 1.31 
Day 21 1.201 1.52 
Day 28 1.336 1.34 
Day 35 1.473 1.55 
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On day 21, the higher dose treatment shows significantly increased BWG, higher average bird weight 
and significantly reduced FCR compared to both the other diets. By this point the high dose birds 
weigh approximately 20% more than the control and 10% more than the lower dose birds. Once 
again, there was no significant difference in feed intake between treatments. By day 28, both Signis® 
treatments show significantly increased BWG and average bird weight and significantly reduced FCR 
compared to the control. During the final week of the study, there was no significant difference in 
BWG, however, both Signis® treatments still show significantly increased average bird weight and 
feed intake compared to the control. There was no significant difference in FCR between treatments 
at day 35.  
The results of this study seem to indicate that Signis® is not merely causing the birds to eat more feed 
in order to gain extra body weight. With the exception of the final weeks of the study, there is a 
significant improvements in performance for Signis® fed birds, but no difference in feed intake (Table 
6.8, 6.9 and 6.10). This suggests that Signis® is causing the birds to convert feed into energy more 
efficiently than the control. Whilst we do see an increase in feed intake towards the end of the study, 
it is likely that by this stage the supplemented birds were so substantially bigger, that they actually 
required additional feed purely for maintainance. 
Unfortunately, there was a campus wide power cut on day 28 of the trial which caused room 
temperature to fall to 10°C (figure 6.2) overnight and the birds were chilled and demonstrating 
huddling behaviours. Unfortunately, the next day, the environmental controls reset to the start of trial 
setting and the room heated overnight to over 30°C. The following morning the birds were heat 
stressed. Extremes of temperature have been reported to negatively affect bird performance 
(Olanrewaju et al., 2010). As far back as 1968, Deaton et al., demonstrated a negative effect of 
temperature on broiler performance, reporting that 8-week-old broilers kept at average 
temperatures over  27°C showed significantly reduced growth compared to equivalent birds kept at 
average temperature below 27°C. Lott et al. (1998) looked the effect of temperature and drinker type 
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on broiler performance. This study showed that birds kept at temperatures over 30°C demonstrated 
significantly reduce body weight gain. These authors suggested that birds may be utilizing energy to 
reduce their core body temperature via cooling behaviours such as panting, thus reducing available 
energy for growth. Likewise, Abu-Dieyeh (2006) ran a study that kept half the birds at 35°C and half at 
20°C and found that body weight gain, feed intake and feed conversion ratio were negatively 
impacted by keeping birds at 35°C. 
Cold stress can have equally profound effects on performance. Ipek and Sahan (2006) report that 
birds exposed to cold stress (29°C at placement, 26.4°C week two then 21°C to 6 weeks of age) 
displayed significantly reduced bird weight, body weight gain and significantly increased FCR and feed 
intake. These authors suggest that energy is being expended to retain heat, thus reducing 
performance. Therefore, it is possible that the lack of significant BWG and FCR improvement between 
treatments recorded in the final week of the study could be due to the severe fluctuations in 
temperature deleteriously effecting feed intake and weight gain.  
However, it is also possible that the lack of significant differences for the performance parameters in 
week 5 could be due to the supplement being more beneficial during the early stages of production. 
Rubio (2019) reports in a review paper that early stimulation of beneficial bacteria is vital as it 
profoundly affects the health and performance throughout the life of the bird. Kim et al. (2011) 
looked at supplementing broilers with fructo-oligosaccharides (FOS) and mannan-oligosaccharides 
(MOS) for 4 weeks. They found that 0.25 g/kg of FOS and MOS produced significant increases in BWG 
and numeric reductions in FCR compared to the control diet in the first two weeks of the study. 
However, by the third week and for the remainder of the study, there were no significant differences 
between treatments. These authors suggested that early benefits may have been due to stimulation 
and establishment of beneficial microbiota in the GIT. Contrary to this, Bautil et al. (2019) studied the 
ability of broilers to ferment AX in wheat-based diets. These authors found that although within the 
first two weeks of life broilers were able to partially ferment a small amount of the AX present, this 
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ability increased with age and age-related establishment of a more mature microbial community. This 
seems to suggest that the drop-in performance results during the last week of the current study, may 
be down to the temperature fluctuations rather than an early fermentation effect. Although this 
would need to be confirmed by further studies, it is possible that under different environmental 
circumstances that the longevity of the beneficial response may have continued. 
The differences in uniformity of body weight seen between treatments is very interesting. Uniformity 
is the measure of the amount of body weight variation within a flock. At day 28 of the current study 
the standard deviation in mean body weight for the high dose of Signis® is nearly 60g lower (25%) 
than the control and the reduction shows a  linear response in line with Signis® dose (figure 6.2). 
Likewise, at day 35, this result is more pronounced with the higher dose reducing the standard 
deviation by approximately 90g - (40%) lower than the control. This suggests that the inclusion of 
Signis® is having a profound positive effect on the uniformity of growth of the birds in line with dose 
rate. 
 
 
Figure 6.2 - Flock uniformity for Signis® dose response trial 
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Flock uniformity is vital for optimal production, and poor uniformity is correlated to delayed growth, 
increased rejects and down-grading at processing, and poor FCR results (Corzo et al., 2004; Toudic, 
2007). Vasdal et al. (2019) suggests that flock uniformity (measured as co-efficient of variability) can 
be a reliable indicator of animal welfare. In a study of 45 commercial flocks of Ross 308 broilers, the 
authors found that poor flock uniformity was highly associated with first week mortality, increased 
total mortality, increased FCR, reduced growth rates and increased rejection rate at slaughter. 
 Modern broiler processing requires uniform flocks with as little deviation as possible to conform to 
the distribution network. Uniformity is considered an important measure of performance as it allows 
optimization of feed and feeding programmes for a given population of broilers, allowing the profit 
margins to be enhanced (Berhe and Gous, 2008). If Signis® supplementation can improve uniformity 
profoundly, the benefits to the broiler industry, both in terms of animal welfare and reduced financial 
losses are likely to be substantial. This could also potentially improve the sustainability of the industry 
by reducing the number of birds lost to downgrading and rejections at the processing plant, 
consequently improving food security by reducing waste. 
There was no significant difference in feed intake between treatments until day 28, which suggests 
that birds were not simply eating additional feed to gain more weight and that they were potentially 
more efficient than the control. The increased feed intake seen in the final two weeks was expected 
as the treatment birds weighed around 20% more than the control, so would require more feed for 
maintenance. The lack of difference in feed intake between treatments seen in the final week, is likely 
to be an artefact of the temperature fluctuations. 
Whilst Signis supplementation indisputably improved growth performance in this study, identifying 
the mode/modes of actions is still difficult. Xylanase fed at the recommended inclusion rate (16000 
BXU/kg) has been shown to improve performance by 2-4% (Enberg et al., 2004; Owens et al., 2008; 
Wu and Ravindran, 2004; Masey O’Neill et al., 2012; Zhang et al., 2014). However, previous xylanase 
results have been variable, with some studies showing no effect (Singh et al., 2012; Azhar et al., 
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2018). Possibly the most demonstrated effect of xylanase is a reduction in digesta viscosity from 
hydrolysis of the NSP fraction of the grain (Bedford, 2019). In the current study it appears that this 
may not be involved as there was no significant difference in digesta viscosity between treatments. 
The type of diet and indeed the cultivar of grain used in the ration has been shown to affect the 
efficacy of xylanase. Cardoso et al. (2018) report that exogenous xylanase only reduced digesta 
viscosity in wheat-based diets, if the wheat used had high levels of NSP and therefore, extract 
viscosity (>14.8cP). Similarly, it is reported that Azhar et al., (2018) found that xylanase only improved 
AME in wheat cultivars that had a high level of NSP to act as a substrate for enzyme activity. As such, 
it supports the theory that the wheat included in the diets of the current study were likely to be very 
low in NSP content and that a viscosity effect does not seem to be the mechanism for improved bird 
performance.. The control diet measured 1.869cP which is low, but similar to some other studies. 
Wheat viscosity was measured in vitro by Ayers et al., (2019), who report that their wheat sample 
measured 2.02cP following grinding and digestion simulation. Likewise, Saki and Alipana (2005) report 
measuring jejunal digesta viscosity ranging from 1.5-1.7cP with wheat-based diets. However, other 
authors have reported considerably higher viscosity.  Cowieson et al., 2002 report a wheat viscosity of 
13.7cP following in vitro digestion simulation. Likewise, Bedford, 1995 found the viscosity of foregut 
digesta of broilers fed a wheat diet without NSPases to be in the region of 12cP. Dusel et al., (1997) 
compared the viscosity of different wheat varieties and found that viscosity varied from 4-22cP in 
jejunal digesta. As these values are so much higher than found in the current study, it must be 
considered that the viscometer may have been incorrectly calibrated and potentially reading low. The 
varied results of these studies suggest a wide variation in the digesta viscosity of wheat-based diets.  
 It is also possible that the xylanase (whether supplied with the diet, or produced by endogenous 
bacteria) could have reduced a potential cell wall effect, allowing incapsulated nutrients to be 
released from within plant cells and consequently metabolized by the birds  (as discussed in detail in 
chapter 3), or, a potential signalling effect may have occurred on this study. Bedford, (2018) reports 
that xylanase supplementation can stimulate the microbes in the gut in produce xylanase in situ. As 
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described in the previous chapters, a number of studies have demonstrated the ability of various 
microbial species found in the GIT to produce endogenous xylanase (Asem et al., 2017; Bhardwaj et 
al., 2019). Bedford, (2018) suggests that when saccharolytic microbes produce xylanase, the AX 
present in the diet is degraded, providing more fermentable substrate for the caeca. This in turn 
enables the production of fermentation products (VFAs) within the caeca (Annison et al., 1968). VFAs 
subsequently enter the blood stream via active diffusion and provide energy sources for a number of 
bodily functions (Annison et al., 1968; Svihus et al., 2013). VFAs produced in the chicken caeca include 
butyrate, which is the primary energy source of colonocytes and epithelial cells, consequently 
improving the integrity of the gut epithelium (Duncan et al., 2004; Ravangard et al., 2017; De 
Maesschalck et al., 2015). Likewise, acetate has been shown to be the primary energy source for the 
liver. Ruminants obtain approximately 75% of their energy from VFA produced by bacteria in the 
rumen, which demonstrates the potential value of increasing VFA production in other species (Penn, 
2014). 
Energy harvested from sources other than the primary feed can produce an energy sparing effect, 
providing additional energy for growth and other essential functions (Penn, 2014). As such, if a 
signalling effect did occur in this study, it could account for the increased performance and 
particularly the improved feed conversion efficiency. This theory is supported by the work of Bautil et 
al. (2019), who performed a study looking at the ability of broilers to digest AX from wheat-based 
diets. The study collected digesta on days 5, 10, 15, 21, and 35 of age and analysed the digesta for AX 
content, AV digestibility and microbial xylanase production. This study showed that by 2 weeks of age, 
birds had some ability to solubilize AX and although xylose units were able to enter the caeca, only 
very limited quantities were fermented. However, by day 35 the birds were able to achieve a total 
tract digestion of 24%. Bedford, (2019) suggests that the presence of xylanase can stimulate further 
microbial production, thus increasing AX digestibility and subsequent fermentation, with the down-
stream benefits of VFA production. 
171 
 
Increased hydrolysis of AX present in the diet is also another possible reason for the performance 
effects found in this trial. When xylanase hydrolyses AX, it decreases the degree of polymerisation, 
producing AXOS, xylobiose and xylose (Courtin et al., 1999). Hydrolysis products can vary both by raw 
material (plant type) and depending on variety of xylanase used. Kiran et al. (2013) demonstrated this 
by in vitro hydrolysis of different waste biomasses using various types of xylanase. The results showed 
significantly different quantities of products with varying degrees of polymerisation. The degree of 
polymerisation has been shown to have a significant effect on whether the hydrolysis products can be 
fermented by microbiota in the gut. Several authors report that xylo-biose and xylo-triose are 
preferable as they can be readily fermented by pro-biotic microbiota, resulting in proliferation of 
these beneficial species and consequently improving gut health and maximising the nutritive value of 
the ration (Bailey et al. 1992; and Yamada et al.,1993) . Therefore, it is plausible that some of the 
performance effects seen on this study are a result of successful depolymerisation of AX in the ration, 
subsequently providing a nutrient source for beneficial bacteria. This project had intended to measure 
both VFAs and carry out 16s metagenomic profiling for this study, but unfortunately this was not 
possible in the timeframe of the project due to external influences which limited the project scope. It 
is important that these measures are completed in the future to further elucidate the performance 
enhancing mechanism seen in this study. 
The linear increase in performance effect, seen in line with the increase in dose in the early weeks, 
suggest that the dose of supplement is significant, and that performance improves in line with dose 
until day 28. This is in agreement with Craig et al. (2019), who compared Ross 308 broilers 
supplemented with xylanase at different doses. The study ran for 29 days and compared a control diet 
to 16000BXU/kg xylanase and 32,000BXU/kg xylanase. The authors found significantly reduced FCR at 
day 14 and 29 for the high dose of xylanase compared to the control and low dose of xylanase. 
However, other studies have found contrasting results. Kolln et al. (2017) investigated the effect of 
xylanase at different inclusion rates in broilers. They used doses varying from 0-250g/t in a wheat and 
soya diet. Whilst these authors did find a significant decrease in digesta viscosity at the highest dose 
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of xylanase, they did not observe performance effects at any inclusion rate. Yan et al. (2016) 
investigated powdered xylanase at 250BXU/kg and 500BXU/kg and liquid xylanase supplemented at 
250BXU/kg and 500BXU/kg in a wheat-based diet. Whilst these authors did find increased body 
weight at day 21 for all xylanase treatments, the dose did not alter the response. Likewise, Luo et al., 
2009) supplemented broilers with doses of 0, 500, 1000 and 5000U/kg of xylanase, fed in a wheat-
based diet. These authors found a significant improvement in FCR for all doses of xylanase compared 
to the control, but no differences between doses. They also found that the 500U/kg and 1000U/kg 
doses increased Villus height and crypt depth in the small intestine. A dose of 5000U/kg significantly 
increased the height of villi in the ileum; however, this dose also showed a tendency to induce 
proliferation of E. coli and total aerobes. The authors conclude that supplementing boilers with 
xylanase at 500U/kg and 1000U/kg is beneficial for broilers, but excess xylanase does not produce 
further improvements and may have negative effects on microbiota.  
Dose responses to xylanase can seem to be highly variable, and in future it would be interesting to 
add more treatments to investigate the effects of xylanase at both high and low doses without XOS to 
allow the beneficial mechanisms to be further clarified, as currently it is impossible to discern the 
effect of xylanase, from XOS and XOS + xylanase together.  Other studies have demonstrated varying 
performance effects with XOS supplementation. De Maesschalck et al. (2015) investigated the effect 
of a corn derived XOS without the addition of xylanase. This study used Ross 308 broilers fed a wheat 
and rye-based diets over 39 days. Study results showed significantly improved FCR, increased villus 
height in the ileum and the number of gene copies encoding the key bacterial enzyme for butyrate 
production were significantly increased in the caeca. A further study looked at supplementing Arbor 
Acres broilers with either XOS or flavomycin (an antibiotic complex) (Yuan et al. 2018). The authors 
found that XOS significantly improved performance compared to the control and produced 
performance results comparable to the flavomycin. XOS supplementation also significantly increased 
production of acetate and butyrate in the caeca. Likewise, Vasudevan et al., (2019) compared the 
effect of XOS to a control. The study used Cobb 400 broilers fed a maize and soya-based diet and 
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compared doses of 0.2, 0.5, 0.75 and 1.00% XOS. The author found significantly increased body 
weight for 0.5 and 0.75% doses of XOS compared to the other doses and the control at both 35 and 
42 days of age. Interestingly, this study found similar results to the current study in that during the 
first 3 weeks body weights increased in line with the inclusion of XOS, but the lower dose made 
considerable gains by week 4 and 5 nearing the body weights for the higher dose. This suggests that 
increased levels of XOS in the first 3-4 weeks of production improves BWG, however by the end of 
production, lower doses of XOS achieve the same benefit. As such it may be financially beneficial to 
feed the lower dose rate in practice to reduce supplement costs for the same ultimate effect.  
In addition to performance, this study looked at several anatomical and metabolic parameters to try 
and elucidate any mechanisms of Signis® action. The bursa of Fabricius is a lymphoid organ found in 
birds that plays a primordial role in poultry immunity. A number of papers have suggested that the 
bursa weight reflects the hosts ability to provide lymphoid cells during an immune response and that 
it increases in line with response to a specific immune challenge (Heckert et al., 2002; Al-Mayah et al., 
2010). McMullin (2004) suggests that a typical bursa should weigh approximately 0.2- 0.3% of the 
bird’s total body weight, which agrees with the measures taken in the current study. Bursas weighing 
less than 0.1% of total bodyweight are thought to be indicative of infectious bursa disease, a highly 
contagious immunosuppressive disease (Kasanga et al., 2008; Al-Mayah et al.,2010).  Rathgeber et al., 
(2008) looked at the effect of feeding beta-glucan and virginiamycin (antimicrobial) on bursa weight. 
Their results were in a similar weight range to the current study but showed that bursa was 
significantly smaller in birds fed an antibiotic. This supports the theory that bursa size increases with 
exposure to pathogenic challenge, as the birds fed a prophylactic antibiotic were given significant 
protection from infection. The results of the current study seem to suggest that the bursas were 
within normal weight range, but that the birds were not subject to an immune challenge. Due to 
legislation and restrictions surrounding animal experiments, the trial facility used for the current 
study is kept clean, reducing the potential for pathogen exposure. 
174 
 
The IgY results are in the same range as other broiler studies (Kulkarni et al., 2007; Agrawal et al., 
2016). As with the bursa weight, the lack of significant differences seen in IgY levels between dietary 
treatments suggests that the birds are not under immunological stress. Kulkarni et al. (2007) 
performed a study looking at IgY antibody titres in response to vaccination for necrotic enteritis 
caused by C.Perfringens . That study showed that IgY levels increased in line with pathogenic exposure 
to mount a protective response. The results of the current study agree with a number of other studies 
where livestock were supplemented with either pre or pro-biotics (Franklin et al., 2002; Huang et al., 
2004; Midilli et al., 2008) who also found no significant differences in immunoglobulin levels.  
When bursa weight is correlated to Immunoglobulin Y (IgY) via Pearson correlation, there is no 
positive correlation (r=0.083) (figure 6.5). 
 
 
Figure 6.3- Correlation between bursa weight (g/kg of bird weight) to immunoglobulin Y for XOS dose 
response trail 
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of the final week, when both Signis® treatments show significantly increased feed intake. Increased 
feed intake has been associated with increased intestinal transit time (Watson et al., 2006). This in 
turn may reduce the amount of time that the digesta is available in the GIT for uptake of nutrients, 
thus reducing AME and also having a similar detrimental effect on AMEn and Ni retention. The level of 
titanium (the inert marker) recovered from the ileal digesta was lower than expected in the 2g/kg 
SIgnis treatment, which may suggest that there was increased density of feed material at the end of 
the ileum, consequently diluting the marker. This may in turn suggest reduced digestion or increased 
feed passage, leading to reduction in nutrient disappearance. The high temperatures experienced 
during the final week are likely to have increased water intake. Increased water intake has also been 
shown to increase tract transit time (Johnson, 2019) which may have exacerbated this effect. As there 
was no difference in analysed gross energy between diets, it seems unlikely that the birds fed 0.2g/kg 
of Signis® would grow significantly better than the other treatments, and yet report significantly 
reduced levels of AME and AMEn. Titanium oxide (Ti) was used as an inert digestibility marker in all 
treatments. As the AME, AMEn and NI all reduce in a linear fashion in line with Signis®, it may be 
possible that there is some type of detrimental interaction between the Ti and the Signis®. If the Ti 
somehow binds to the Signis®, it could potentially be producing an artificial reduction in these 
parameters.  
Breast meat texture analysis, drip loss and the peroxynitrite TAC (total antioxidant capacity) assays 
were performed to explore the effect of Signis® on oxidative stress measures, particularly in respect 
to the muscle meat myopathies such as white stripe and woody breast. Chapter 5 had demonstrated 
that the corn XOS included in Signis® had substantial antioxidant properties, so it was hoped 
differences between treatments would be measured in these assays. It is possible that the birds from 
the current trial were not mature enough to show muscle effects. Woody breast is particularly 
prevalent in larger birds (Lorenzi et al., 2014). Likewise, Bauermeister et al., (2009) report that a 
higher incidence in muscle meat myopathies in broilers processed at 8 weeks of age compared to 6 
weeks of age. As the birds in the current study were only 5 weeks old, it is possible that had the study 
176 
 
continued, we may have seen increased incidence of muscle myopathies. There were no significant 
differences between treatments in the total antioxidant capacity either, however, the peroxynitrite 
assay results agreed with the results of the previous trial, with no differences being seen between 
dietary treatments. This may suggest that the birds were not experiencing sufficient levels of 
oxidative stress to be detected, or that there was no antioxidant effect of the supplement.  
The TAC for peroxynitrite assay had been chosen as it was a precursor to lipid peroxidation (Knight, 
2002), which is thought to be a contributory factor in the muscle meat myopathies. However, the 
antioxidant value of the corn XOS was measured for its capacity to quench singlet and halogenated 
oxygen species. It is therefore possible that the XOS may not be a good antioxidant against 
peroxynitrite radicals, and therefore no differences in TAC scores were found.  
There were no significant differences between treatments for drip loss percentage after either 24 or 
120 hours. After 24 hours breast meat drip loss was 0.14% and after 120 hours was around 3.5% for 
all dietary treatments. Drip loss is essentially a measurement of the water loss of meat over time in 
storage. It is commercially important as the visual appearance of meat seeping is undesirable to 
consumers and implies an inferior product (Warner, 2017).  
 Suo et al., 2015 looked at the effect of Longlive XOS on Arbor Acre broilers fed a corn-soya diet over 
42 days. Whilst they didn’t find any performance or breast meat drip loss effect from supplementing 
XOS at 25, 50, 75 and 100 mg/kg, they did report a linear reduction in thigh drip loss percentage in 
line with quantity of XOS inclusion after 24 hours. In the current study there was a small linear 
increase in drip loss percentage in line with Signis® dose for the breast meat at 5 days. However, this 
result was not statistically significant and drip loss was identical for breast meat at 24 hours. Likewise, 
there was no significant difference in thigh meat drip loss at either time point, so it seems unlikely 
that there is cause for concern. Once again, the study by Suo et al., (2015) was 42 days long. As 
previously mentioned, muscle meat myopathies have been reported to increase with age and size of 
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the birds (Bauermeister et al., 2009; Lorenzi et al., 2014). Therefore, it is possible that had the current 
trial ran for an extra week, more differences may have been detected.  
The percentage of drip loss found after 24 hours on this trial are similar to other studies in the 
literature. Albrecht et al., (2019), investigated the effect of supplementing Ross 308 broilers fed a 
corn, soy, and pea-based diet with different sources and concentrations of methionine. This study 
showed drip loss percentage after 24 hours to range from 0.175% to 0.34%. A further study looked at 
the effect of combined BHT (200ppm /0.02%) and vitamin E (500Iu) compared to a diet containing 
oxidised oil and a control (Zhang et al., 2011). This study showed the breast meat drip loss ranged 
from 0.42% for the control to 0.6% for the oxidised oil at 24 hours. As the results of the current study 
fall on the low side of this range, it may suggest that the birds were not experiencing high levels of 
oxidative stress, consequently accounting for the lack of differences observed in all the oxidation 
measures explored in this study. 
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6.5 Conclusion 
The results of this study clearly show enhanced bird performance with Signis® supplementation, with 
birds fed a dose of 0.2g/kg weighing approximately 20% more than the control and 5% more than the 
lower dose (0.1g/kg). Whilst there were no significant differences in BWG and BW between the two 
Signis® treatments by the end of the trial, the higher dose does show significantly reduced cumulative 
FCR (1.55) compared to both the other treatments. This reduction in FCR as well as the substantial 
improvement in bird uniformity seen are likely to represent substantial financial gains on a 
commercial scale, indicating the potential for use of Signis® at 0.2g/kg compared to the 0.1g/kg 
currently recommended dose. 
The significant reduction in AME, AMEn and nitrogen retention, need further investigation, as 
although these results may be explained to an extent by the increased feed intake seen with the 
higher dose of Signis®, the negative implications of increased nitrogen excretion and subsequent 
environmental effects must be explored.  
Due to external influences preventing the VFA and 16s metagenomic analysis, the mechanism behind 
the performance enhancement observed in this study is still unclear, however the results of this study 
seem to suggest that performance enhancement is not purely due to a reduction in digesta viscosity. 
Likewise, the lack of significant differences in calcium and phosphorus digestibility may suggest that 
an increase in the availability of encapsulated nutrients is also not entirely responsible for 
performance effects observed. Therefore, investigating a potential microbial effect is indicated in 
future work.   
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Chapter 7: Conclusion, and recommendations 
7.1 Introduction 
This chapter has been split into four sections to discuss the potential benefits of AX, xylanase and 
xylo-oligosaccharides as supplements to support the performance and physiological function of 
broiler chickens. Initially, the results of the studies undertaken as part of this project will be discussed 
alongside their key findings. Secondly, the impacts of these conclusions on global poultry production 
and food security will be considered. Subsequently, key areas for future research and development 
are outlined and finally, key recommendations based on this work will be provided. 
Global population growth and its impact on food insecurity places intense pressure on the poultry 
industry to optimize production (Shahbandeh, 2019). The 2006 EU ban on the use of non-therapeutic 
antimicrobials due to concerns over antibiotic resistance has increased the challenge of producing 
plentiful chicken meat, while supporting health and boosting bird performance (Hajati and Rezaei, 
2010). This has led to increased research into alternative methods of supporting bird performance 
and health, including understanding that managing the microbiome could have beneficial effects. In 
the absence of antibiotics, producers must try and minimise the possibility of pathogenic infection by 
optimising the hosts microbiome. Likewise, there is not a universal solution of an ideal microbiome as 
this will vary depending on the environmental conditions in which a bird is raised (Bedford, 2020). 
This project began in response to a theory that exogenous xylanase may have some pre-biotic 
mechanisms due to hydrolysis of arabinoxylans (AX) present in feed materials. This would produce to 
xylo-oligosaccharides (XOS) that could be used as a potential nutrient source for beneficial bacteria in 
the gastro-intestinal tract (Bedford, 2019). Prebiotic, probiotic and symbiotic supplements have all 
demonstrated the ability to provide a beneficial effect both in humans and animals. One of the 
primary benefits of these supplements is the capacity to modulate gut microbiota. In broiler chickens, 
proliferation of bacteria that can ferment non-digestible carbohydrates from the diet can be highly 
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beneficial for growth performance and bird health. Fermentation products of these bacteria (VFA) can 
directly control pathogenic growth due to the reduced pH resulting from increased production of 
VFAs. However, almost more importantly, some VFAs can have antimicrobial and/or anti-
inflammatory properties or be used as energy sources within the body. As such, proliferation of these 
bacteria can maximise the nutritional value of the diet, gaining nutritional benefit from feed fractions 
that the animal would otherwise be unable to utilize. This not only reduces waste in terms of excreted 
nutrients, but also allows low value waste and by-products to be profitably utilized by the industry, 
thus increasing sustainability.  The hypothesis that exogenous xylanase was reducing the degree of 
polymerisation of AX into AXOS and XOS led to the investigation of whether the direct provision of an 
AX extract or XOS supplement could enhance this potential pre-biotic effect.  
Through the course of this project the industry began to focus on the issue of poultry muscle meat 
myopathies such as woody breast and spaghetti meat. Preliminary work indicated that lipid 
peroxidation and oxidative stress could be involved in the aetiology of these syndromes (Petracci et 
al., 2019). The genetic selection for growth performance and efficiency has led to birds that have 
improved feed conversion efficiency, reach slaughter weight at an earlier age and are subject to more 
intensive production processes than their counterparts  from as little as 50 years ago (Bradshaw et al., 
2002; Julian, 1998; Havenstein et al., 2003). This trajectory is predicted to continue with some experts 
predicting that broilers will be reaching slaughter weight by 29 days of age by the year 2034 (Tavarez 
and Solis, 2016). This all raises the likelihood of broilers to be subjected to oxidative stress (Fellenburg 
and Speisky, 2006), increasing the possibility of these muscle meat myopathies. As there was 
evidence that oligosaccharides could have antioxidative properties, this project developed to included 
looking at some measures of oxidative stress. Therefore, the overarching objectives of this project 
were: 
1. To determine whether AX, XOS and/or xylanase can effectively support the performance of 
broilers 
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2. Investigation of the effect of AX, XOS and/or xylanase on various anatomical or physiological 
parameters of broilers 
3. To validate and assess a novel assay for measuring oxidative stress in broilers and to 
investigate the potential antioxidant properties of AX, XOS and/or xylanase 
4. To gather evidence to further elucidate the mode(s) of action of AX, XOS and/or xylanase 
 
7.2 Conclusions and Critiques 
7.2.1 Effect of AX, XOS and/or xylanase on broiler performance  
The results of the studies undertaken as part of this thesis show that AX, XOS and/or xylanase can all 
have beneficial effects on the performance of broilers. However, there was some variation within the 
results. The first animal study looked at the effect of a novel DDGS derived AX extract (chapter 3). The 
results showed that the AX extract treatment consistently numerically improved body weight gain 
compared to the control and a pre-treated AX treatment. Body weight gain was significantly improved 
for the AX during days 21-28 of the study. At the end of the study, the AX fed birds weighed on 
average 100g more than birds fed either of the other treatments.  
Pre-treating the AX extract with xylanase seemed to negate any of the performance benefits seen 
with AX supplementation alone. It is unclear whether the benefits seen for AX supplementation are 
negated by the addition of xylanase or by the pre-treatment process. It may be that the liquid mixing 
and homogenising of this treatment may have caused problems when combining into the basal diet. 
Whether this issue was particle size related or due to over/under hydrolysation of the AX extract is 
still unclear. This study had to discount one treatment due to incorrect diet formulation. This 
treatment was the AX extract with xylanase added directly to the diet (rather than pre-treated). Had 
this data been comparable, it would have clarified the effect of XOS + xylanase and determined 
whether the lack of performance response for the AX pre-treated with xylanase was due to the 
process of pre-treating, or the synergistic relationship between the AX extract and xylanase. It was 
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originally thought that a negative control was not necessary, as the effects of xylanase in a wheat/soy 
diet was well established. However, with hindsight, this study would have been more robust with the 
addition of a negative control treatment (control + xylanase). This would have allowed the effect of 
the xylanase to be assessed in direct comparison to the other treatments and would have added 
evidence to clarify why the AX pre-treated with xylanase did not perform as well as the AX alone. 
The second study compared two different novel XOS supplements derived from different base 
materials (corn and sugar cane bagasse), both fed with and without the addition of exogenous 
xylanase (chapter 4). This study showed very little difference in performance effects between 
treatments, which was not expected as it was felt that directly supplying the shorter chain 
polysaccharides as a XOS product would have enhanced the beneficial effects seen with AX 
supplementation in the previous study. There could be several reasons for this. It is possible that the 
hydrolysis products of the xylanase activity were either too large or too small to be fermentable by 
gut bacteria. Likewise, the cereals used in the ration may have been high in xylanase inhibitors, 
preventing enzyme activity. Finally, there is the possibility that the birds were sub-clinically 
pathogenically challenged, resulting in poor performance. 
The final animal study (chapter 6) explored the response to different doses of a commercial corn 
based XOS combined with xylanase (commercially available as Signis®). Cumulatively, this study 
showed significantly increased body weight gain for both doses of Signis® (1 and 2g/kg) compared to 
the control, with the higher dose birds weighing over 20% more than the control and 5% more than 
the  lower dose. Cumulatively, the FCR was significantly reduced for birds fed 0.2g/kg Signis® 
compared to the other two treatments. This study also revealed that Signis® inclusion was 
significantly beneficial in reducing flock variability, particularly in the final week of the study, where 
the standard deviation of bodyweight is almost halved in the higher dose treatment.  
In conclusion, the quantitative analysis of these studies shows that AX extract and Signis® (XOS + xyl) 
are both effective at improving broiler performance to varying degrees. There are however factors 
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that may have prevented optimal information gathering in these studies, including incorrect diet 
manufacture and possible homogenization issues when attempting to pre-treat XOS with xylanase.  
7.2.2 Effect of AX, XOS and/or xylanase on gut health, immune, or physiological parameters 
of broilers 
The initial study (chapter 3) showed very little effect on any of the physiological parameters 
examined. However, in the second study, where very little performance effect was observed, there 
were physiological differences. Xylanase inclusion increased tibial bone breaking strength at day 21 
and calcium digestibility at day 42, though neither of these measures were assessed in the first study. 
Improved calcium digestibility and bone mineralisation have both been reported when supplementing 
xylanase or XOS and is generally attributed to a reduction in cage effect, increasing the availability of 
encapsulated nutrients (Nortey et al.,2008; Li et al., 2016; Muszynski, 2019). Interestingly, the final 
study in this project (chapter 6) did not find any significant difference in calcium digestibility at day 35. 
As the final study included a treatment with double the dose of xylanase used in chapter 4, a calcium 
digestibility response may have been expected.  Therefore, the mechanism for improved digestibility 
may be multifactorial and not as simple as a reduction in cage effect alone.   
The final animal study (chapter 6) revealed reduced AME, AMEn and nitrogen retention for the higher 
dose of Signis®. As a reduction in nitrogen retention was also seen in chapter 3 when birds were 
supplemented with an AX extract, there is a strong indication that this area requires further 
investigation. Whilst to an extent these results may be explained by the increased feed intake 
observed in both these treatments, consequently increasing gut throughput and reducing the time 
available for digestion. If AX or XOS are indeed genuinely increasing nitrogen excretion, there are 
environmental concerns regarding nitrogenous waste and pollution. Unfortunately, the bone 
parameters measured in chapter 4 were not analysed until after the final study was completed, 
otherwise they would have been included in the analysis for chapter 6.  
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Throughout this project there has been a possibility that the experimental facility in which these 
studies were conducted may have precluded an immune or gut health response to the various 
treatments. The enhanced biosecurity and husbandry are one of the accepted shortcomings of using 
an experimental setting compared to a commercial facility. Although this enables precise 
measurements to be obtained, ensures optimal welfare and allows preliminary work to be performed 
inexpensively, there are likely to be substantial differences between experiments this setting 
compared with a commercial barn. The sheer quantity of birds raised in a single commercial facility 
provide huge statistical power that can enable small differences to be detected. However, a 
commercial setting can also increase the exposure to disease challenge, as there may be a risk of 
cross contamination between flocks and poor biosecurity between houses can promote the spread of 
pathogenic disease. Likewise, the higher stocking density, reduced access to food and water and 
proximity in which commercial birds are kept can all increase the incidence of physiological stress and 
disease. Therefore, the environmental conditions of a study and the particular effects being 
investigated should be considered, both when undertaking an animal study, or indeed, extrapolating 
results. 
7.2.3 Effect of XOS on the microbiome of broilers 
In chapter 4 it was shown that the microbial community of the gastrointestinal tract changes 
significantly with age, but no differences were found in microbial diversity between dietary 
treatments at either day 7 or 42. As such a profound performance effect was seen in chapter 6, VFA 
and 16S analysis may have contributed to explaining the mechanism behind the performance effect. 
Unfortunately, this was outside the scope of this project, however, biological samples were collected 
for this purpose in a future project, which may fully elucidate the mode of action of XOS. 
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7.2.4 Validation and assessment of novel oxidative assays 
The pilot studies for the novel oxidative assays investigated in chapter 5 revealed a number of 
preliminary recommendations. The results suggest that running the TAC for peroxynitrite assay on 
broiler serum, rather than plasma collected with either EDTA or heparin, allows higher antioxidant 
capacity to be detected from the sample. It also showed that the assay should be run using fresh 
blood rather than blood stored at -20°C. When looking at the euthanasia method, the results were 
less clear. The birds euthanised via cervical dislocation showed greater capacity to scavenge 
peroxynitrite radicals compared to those dispatched via captive bolt. However, it is still unclear 
whether either of these results equate to the levels of antioxidative capacity experienced during life.  
When examining the antioxidant capacity of feed and feed ingredients, the results showed that the 
broiler diets used in chapter 4, demonstrated very limited antioxidant capacity, however, they were 
not prooxidant and therefore were not increasing potential oxidative stress. The various commercial 
XOS products investigated all showed some ability to quench singlet and halogenated oxygen species. 
The corn XOS used in chapter 4 and later included in the Signis® product showed moderate 
antioxidant ability to quench singlet and halogenated oxidative species. Again, none of the XOS 
products showed pro-oxidative properties for the species of reactive oxygen investigated.  
Considerably more work is required to fully determine the optimal methodologies required for these 
assays and to clarify the usefulness of these methods in broiler production, and whether they 
correlate to health of the birds and meat quality 
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7.2.5 Investigating the mode of action for AX, XOS and/or xylanase 
The possible modes of action for xylanase have been suggested to include: 
9. Viscosity effect – xylanase reduces the viscosity of digesta (Gonzalez-Ortiz, 2016) 
10. Cage effect (cell wall mechanism) – xylanase degrades the cell wall of cereal grains releasing 
encapsulated nutrients. This increases the diffusion of nutrients, substrates and enzymes 
enabling the host better utilize nutrients in the ration (Bedford and Autio, 1996) 
11. Pre-biotic effect – xylanase degrades AX present in the diet into oligosaccharides that can be 
used a nutrient source by saccharolytic microbes in the gut (Bedford, 2018; Craig, 2019) 
12. Signalling effect – xylanase stimulates microbes in the gut to produce xylanase in situ 
(Bedford, 2018).  
Whilst this project has not further elucidated the mode of action for AX, XOS and/or xylanase, the 
studies have added weight to various theories surrounding their mechanisms. The initial study 
showed a beneficial performance effect of feeding AX without xylanase, particularly in terms of body 
weight gain. This may suggest that the birds develop the ability to ferment xylan with age, which 
supports the findings of Bautil et al., (2019) who demonstrated that broilers develop the ability to 
ferment AX with age and that by day 35, broilers could ferment up to 24% of xylan in the diet. This 
study provides evidence that whilst broilers may not be able to produce endogenous xylanase 
themselves, microbes residing within the GIT may well be able to.  
Whilst the second study (chapter4) did not reveal any performance effect of XOS and/or xylanase, it 
showed that xylanase inclusion increased the mineral digestibility and bone strength, which may 
indicate that xylanase is reducing the cell wall effect and releasing encapsulated nutrients.  
Chapter 6 revealed the most substantial performance effect with a combined XOS and xylanase 
inclusion. The lack of effect on digesta viscosity suggests that other mechanisms may be responsible 
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for this effect. Likewise, no significant differences were found for calcium or phosphorus digestibility, 
which suggest that a potential cell wall effect may not be entirely responsible for the enhanced 
performance. This indicates the mechanism may involve either a potential prebiotic or signalling 
effect. Therefore, it was unfortunate that the VFA and 16S analysis were outside the scope of this 
project as they may have been able to elucidate this effect.  
 
7.3 Future work 
This project has highlighted the need for future work. All of these studies could be upscaled to a more 
commercial setting as this is more representative of industry and birds are likely to be exposed to 
increased physiological and pathogenic challenges. This may provide further confidence in the results 
and ensure that results are repeatable in a non-research setting. However, there is also substantial 
potential for future work in both commercial and experimental settings, expanding on the current 
findings, the key areas of which are explained below. 
7.3.1 Performance effects of arabinoxylans, xylanase and/or xylo-oligosaccharides 
When looking at the performance effects of these studies, separating the performance effects of AX, 
XOS and xylanase both independently and in combination is the next logical step. Repeating the initial 
study from chapter 3 with the addition of an AX treatment where xylanase is included in the diet and 
with a negative control would provide more information in regard to the mechanisms of action. It 
would also be useful to include some of the other measures in this trial, such as digesta viscosity, VFA 
and microflora analysis.  
Although the industrial partner for this project purchased the corn XOS from chapter 4 for use in 
Signis®, the AX extract used in the initial study could still merit further investigation. The reduced 
processing required to manufacture an AX extract verses a XOS product (no enzyme extraction 
required), may possibly reduce the production costs making a low cost AX supplement viable – 
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particularly as the AX is derived from a low value by-product so could have a potential sustainability 
angle for bioethanol or sugarcane production.  
It would be necessary to repeat the dose response study from chapter 6 due to the environmental 
issues experienced and extend it to 42 days or beyond to large bird size (usually 49 days). From the 
results of the current study it looks as if the lower dose of Signis® begins to show similar growth 
benefits to the higher dose, which may be an artefact from the conditions, so extending this study 
may allow any effects to be clarified. The flock variability measures were undertaken in response to a 
visual difference between pens. Although the process was labour intensive and time consuming, it 
would be interesting to see whether these beneficial results are repeatable on a commercial scale. 
Likewise, it would be interesting to look at individual bird weights over an entire study. Following this 
study, it has become routine practice to individually weigh birds at NTU and exploring the degree of 
variation over all age ranges would provide insight into the point at which Signis® starts to reduce 
flock variability.  
7.3.2 Other effects of arabinoxylans, xylanase and/or xylo-oligosaccharides 
It was unfortunate that the scope of the project meant that two of the animal studies (ones which 
showed significant performance results) were unable to look at gut microbial effects or VFA 
production. Performing 16S metagenomic profiling on a repeat of the AX extract study and Signis ® 
study would provide information on whether a microbial effect was the mechanism for improved 
performance. Likewise, VFA analysis of the caeca contents would allow the fermentation products to 
be quantified and further elucidate the mechanism(s) behind XOS and/or xylanase supplementation.  
As previously mentioned, the lack of immune response seen during this study, may be due to a lack of 
physiological or pathogenic challenge. Testing these supplements during exposure to pathogenic 
challenge may elucidate any effect on the immune response.  
In the second animal study, there was a significant increase in tibial breaking strength found at day 21 
and significantly increased calcium digestibility found at day 42. Measuring the calcium digestibility at 
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day 21 in future studies would be informative to look at whether increased calcium digestibility  may 
play a role in the mechanism for improving tibial breaking strength. Likewise, upscaling sampling in 
terms of tibia collection from trials would improve statistical power and potentially reveal further 
effects.  
In future work it would be enlightening to look at the arabinoxylan content, hydrolysis, and 
fermentation within the GIT of the AX extract used in chapter 3. Bautil et al. (2019) measured the 
total and water-unextractable AX content of feed and digesta by gas chromatography in a method 
described by Olaerts et al. (2016). This allowed the authors to measure hydrolysis and fermentability 
of AX at various points in the GIT and may elucidate the mechanism of breakdown of the AX extract.   
Outside the poultry sector, it is possible that XOS may have applications for human or other species. 
Other oligosaccharides have been shown to have pre-biotic properties in humans and pigs (Tian et al., 
2018; Yang et al., 2020), so it is possible that XOS may have beneficial effects on the microbiome in 
other species. In the current global situation of food insecurity maximising the nutritive value of food 
is becoming more important. Whilst hypothetical, if XOS products can improve the nutritive value of 
plant-based feed for monogastrics such as chickens and pigs, it may do the same for humans. With 
more of the population moving over to plant-based diets for, optimizing the nutritional value of these 
diets will become increasingly important. XOS has been shown to proliferate bifidobacteria in the 
human gut by as much as 8-18% after two weeks, improving gut motility and immune function (Flavia 
et al., 2013). Proliferation of beneficial bacteria can aid recovery from gastrointestinal dysbiosis, 
particularly following antibiotic treatment. Likewise, galacto-oligosaccharides have been used as a 
pre-biotic in human infant formula to improve gut health and reduce diarrhoea and infant colic 
(Vandenplas, 2003). Therefore, XOS has potential cross-over value in both human, livestock and pet 
markets which could be explored in further work.   
Oligosaccharides have been used as artificial sweeteners and sugar replacers. XOS have a sweetness 
level around 50% of sucrose (Belorkar and Gupta, 2016), however, only a very small proportion of XOS 
190 
 
is digested, so is much less calorific. As such, there may be potential for XOS to be used in diabetic 
and low-calorie foods as an alternative sweetener.  
 The increased bone strength and calcium digestibility seen in chapter 4 has potential in a number of 
species. If the mechanism of how these are being improved can be fully understood, this could have 
far reaching benefits in supporting bone health. Both meat and egg laying chickens are prone to 
skeletal issues; whilst broilers are prone to leg abnormalities, laying strains suffer from osteomalacia 
and osteoporosis. Human and animal athletes such as horses and agility dogs could also benefit from 
improved mineral digestibility and bone strength. The incidence of microfractures from heavy 
exercise strain, and recovery from bone injuries are important areas which could be considered in the 
future. Likewise, these ingredients may aid post-menopausal women suffering from osteoporosis. 
Osteoporotic fractures cost the NHS over £2.1 billion per year - a figure that is likely to increase 
without an effective preventative intervention (Burge et al., 2001).  
 
7.3.3 Further oxidative stress work 
Further work is required in validating the novel antioxidant assays used in chapter 5. The assays need 
to be tested on birds that are habituated to blood samples to try and gain an accurate baseline for 
broilers. Once this is complete, capture, restraint and euthanasia method can be quantified with more 
precision. The blood storage also needs further investigation. Storing blood at -80°C is recommended 
for any work looking at DNA/RNA, and therefore a lower temperature may be more suitable for 
storage of blood samples for these assays. It is clear from the initial validation that the sample tubes 
effect the results in these assays and care needs to be taken to be consistent in sample collection 
going forward. 
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7.4 Contribution to knowledge 
The results of this project contribute to current knowledge in a number of ways. The results of the 
initial AX study demonstrate that broilers can gain beneficial effects from AX supplementation, which 
adds weight to the suggestions that broilers can ferment AX  and whilst broilers may not be able to 
produce endogenous xylanase, the microbiota within the gut may be able to.  
XOS combined with xylanase (Signis®) is a new product to market and this project has shown that it 
can significantly enhance broiler performance, improving body weight gain, average bird weight and 
feed conversion ratios. Whilst a dose of 0.1g/kg does significantly improve the later performance, a 
dose of 0.2g/kg is indicated to be optimal for optimal final body weight and feed conversion ratio. 
Likewise, a dose of 0.2g/kg substantially increases the uniformity of a flock compared to a dose of 
0.1g/kg or a control. The performance effects observed in the final study may not be due to 
decreased digesta viscosity or a cell wall effect and as such a potential prebiotic or signalling effect is 
indicated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
192 
 
References 
 
ALAM, M.N., BRISTI, N.J., RAFIQUZZAMAN, M. 2013, Review on in vivo and in vitro methods 
evaluation of antioxidant activity, Saudi Pharmaceutical Journal, 21(2):143-152 
AACHARY, A.A., PRAPULLA, S.G. 2008, Corncob-induced endo-1, 4-beta-D-xylanase of Aspergilus 
oryae: Production and characterization of xylobiose from glucuronoxylan. Journal of Agriculture, Food 
and Chemistry, 56:3981-3988 
ABASHT, B., MUTRYN, M.F., MICHALEK, R.D., LEE, W.R. 2016, Oxidative stress and metabolic 
perturbations in wooden breast in chickens. PLOS ONE, 11(4) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838225/ 
ABDELMALEK, B.E., DRISS, D., KALLEL, F. 2015, Effect of xylan oligosaccharides generated from 
corncobs on food acceptability, growth performance, haematology and immunological parameters 
of dicentrarchus labrax fingerlings. Fish Physiology and Biochemistry, 41(6):1587-1596 
ABU-DIEYEH, Z. 2006, Effect of High Temperature Per se on Growth Performance of Broilers. 
International Journal of Poultry Science. 5(10):3923 
AEBI, H. 1984, Catalase in vitro. Methods in Enzymology, 105(1984):121-126 
AGRAWAL, R., HIRPURKAR, S. D., SANNAT, C., GUPTA, A. K. 2016, Comparative study on 
immunoglobulin Y transfer from breeding hens to egg yolk and progeny chicks in different breeds of 
poultry. Veterinary world, 9(4), 425–431. https://doi.org/10.14202/vetworld.2016.425-431 
AKELAINEN, H., JUNTUNEN, M., HASSELWANDER, O. 2009, Prebiotic Potential of Xylo-
Oligosaccharides. In: Charalampopoulos D., Rastall R.A. (eds) Prebiotics and Probiotics Science 
and Technology. Springer, New York, NY 
AL-MAYAH, A., MUDHAR, A.S., TABEEKH, A. 2010, Investigation on bursa fabricius and body weights in 
broiler and local chicks with two types of infectious bursal disease vaccines. International Journal of 
Poultry Science, 9(5):464-467  
ALAM, M.N., BRISTI, N.J., RAFIQUZZAMAN, M. 2013, Review on in vivo and in vitro methods 
evaluation of antioxidant activity. Saudi Pharmaceutical Journal, 21(2):143-152 
ANDERSON, J.M., VAN ITALLIE, C.M. 1995, Tight junctions and the molecular basis for regulation of 
paracellular permeability. American Journal of Physiology, 269:467-475 
ANNISON, G., CHOCT, M. 1991, Anti-nutritive activities of cereal non-starch polysaccharides in broiler 
diets and strategies minimizing their effects. World’s Poultry Science Journal, 47(3):232-242 
AMERAH, A.M. 2015, Interactions between wheat characteristics and feed enzyme supplementation 
in broiler diets. Animal Feed Science and Technology, 199(2015):1-9 
AO, Z., CHOCT, M. 2013, Oligosaccharides affect performance and gut development of broiler 
chickens. Asian-Australasian journal of animal sciences, 26(1), 116–121. 
https://doi.org/10.5713/ajas.2012.12414 
ARTHUR, J.R. 2000, The glutathione peroxidases, Cellular and Molecular Life Sciences, 57(13-14):1825-
1835 
ASEM, D., LEO, V.V., PASSARI, A.K., TONSING, M.V., JOSHI, J.B., UTHANDI, S. 2017, Evaluation of 
gastrointestinal bacterial population for the production of holocellulose enzymes for biomass 
deconstruction. PLoS ONE 12(10): e0186355. https://doi.org/10.1371/journal.pone.0186355 
193 
 
AVIAGEN 2014, Ross 308 broiler: Nutrition specifications. Available at: 
http://en.aviagen.com/assets/Tech_Center/Ross_Broiler/Ross308BroilerNutritionSpecs2014-EN.pdf  
[Accessed on 27/05/19] 
AWAD, W.A., GHAREEB, K., ABDEL-RAHEEM, S., BOHM, J. 2009, Effects of dietary inclusion of 
probiotic and symbiotic on growth performance, organ weight and intestinal histomorphology of 
broiler chickens. Poultry Science, 88(1):49-56 
AWAD, W.A., MANN, E., DZIECIOL, M., HESS, C., SCHMITZ-ESSER, S., WAGNER, M., HESS, M. 2016, 
Age-Related Differences in the Luminal and Mucosa-Associated Gut Microbiome of Broiler Chickens 
and Shifts Associated with Campylobacter jejuni Infection. Frontiers in cellular and infection 
microbiology, 6(154).  
AYERS, V.E, BROOMHEAD, J.N., LI, X., RAAB, R.M., MORRITZ, J.S. Viscosity and growth response of 
broilers fed high fibre diets supplemented with a corn-produced recombinant carbohydrase, Journal 
of Applied Poultry Research, 28(4): 826-836, 
AZHAR, R., ROSE, S.P., MANSBRIDGE, S.C., BEDFORD, M.R., PIRGOZLIEV, V.R. 2018, Growing site 
influences wheat apparent metabolizable energy value for broiler chickens. British Poultry Abstracts, 
14(1):1-35 
BAILEY, M.J., BIELY, P., POUTANEN, K. 1992, Interlaboratory testing of methods for assay of xylanase 
activity. Journal of Biotechnology,1: 257-270 
BAREKATAIN, R., CHRYSTAL, P.V., HOWARTH, G.S., MCLAUGHLAN, C.J., GILANI, S., NATTRASS, G.S., 
2019.Performance, intestinal permeability, and gene expression of selected tight junction proteins in 
broiler chickens fed reduced protein diets supplemented with arginine, glutamine, and glycine 
subjected to a leaky gut model, Poultry Science, 98(12): 6761-6771 
BAREKATAIN, R., CHRYSTAL, P.V., HOWARTH, G.S., MCLAUGHLAN, C.J., GILANI, S., NATTRASS, G.S., 
2019.Performance, intestinal permeability, and gene expression of selected tight junction proteins in 
broiler chickens fed reduced protein diets supplemented with arginine, glutamine, and glycine 
subjected to a leaky gut model, Poultry Science, 98(12): 6761-6771 
BEDFORD, M.R., APAJALAHTI, J.H.A. 2018, “Exposure of a broiler to a xylanase for 35d increases the 
capacity of caecal microbiome to ferment soluble xylan.” Poultry Science 97(1):3263-3274 
BEDFORD, M.R. 2000, Removal of antibiotic growth promotors from poultry diets: Implications and 
strategies to minimise subsequent problems. Worlds Poultry Science Journal, 56: 347-365 
BEDFORD, M.R. 2018, The evolution and application of enzymes in the animal feed industry: the role 
of data interpretation, British Poultry Science, 59(5): 486-493 
https://www.tandfonline.com/doi/full/10.1080/00071668.2018.1484074 
BEDFORD, M.R., CAMPBELL, G.L., CLASSEN, H.L. 1991, The effect of pelleting, salt, and pentosanase 
on the viscosity of intestinal contents and the performance of broilers fed rye, Poultry Science, 70: 
1571-1577 
BEDFORD, M.R., CLASSEN, A. 1992, Reduction of intestinal viscosity through manipulation of dietary 
rye and pentosanase concentration is effected through changes in the carbohydrate composition of 
the intestinal aqueous phase and results in improved growth rate and food conversion efficiency of 
broiler chicks. Journal of Nutrition, 122:560-569 
BEDFORD, M.R., COWIESON, A.J., 2012, Exogenous enzymes and their effects on intestinal 
microbiology. Animal Feed Science and Technology, 173:76-85 
194 
 
BEDFORD, A., GONG, J. 2018, Implications of butyrate and its derivatives on gut health and animal 
production. Animal Nutrition, 4(2):151-159 
BEDFORD, M.R., MORGAN, A.J. 1996, The use of enzymes in poultry diets. Worlds Poultry Science 
Journal. 52:61-68 
BEDFORD, M.R., SCHULZE, H. 1998, Reduction of intestinal viscosity through manipulation of dietary 
rye and pentosanase concentrations is effected through changes in the carbohydrate composition of 
the intestinal aqueous phase and results in improved rates and food conversion efficiency of broiler 
chicks. Nutrition Research Reviews, 11:91-114 
BELORKAR, S.A., GUPTA, A.K. 2016, Oligosaccharides: a boon from nature's desk. AMB Express. 
6(1):82. doi:10.1186/s13568-016-0253-5 
BENZER, F., YILMAZ, S. 2009, Effects on oxidative stress and antioxidant enzyme activities of 
experimentally induced Ornithobacterium rhinotracheale infection in broilers. Journal of Animal and 
Veterinary Advice, 8, 548–553. 
BERG, E.L., FU, C.J., PORTER, J.H., KERLEY, M.S. 2005, Fructo-oligosaccharide supplementation in 
yearling horses: effects on faecal pH, microbial content and volatile fatty acid concentrations. 
Journal of Animal Science, 7(1):1549-1553 
BERLETTE, B.S., STADTMAN, E.R. 1997, Protein oxidation in aging, disease and oxidative stress. Journal 
of biochemistry, 272(33):20313-20316 
BERNARDES, S.S., SOUZA-NETO, F.P., RAMALHO, L.N. 2015, Systemic oxidative profile after tumour 
removal and the tumour microenvironment in melanoma patients, Cancer Letters 361(2):226-232 
BETTERIDGE, D.J. 2000, What is oxidative stress? Metabolism, 49(2):3-8 
BHARDWAJ, N., KUMAR, B., VERMA, P. 2019, A detailed overview of xylanases: an emerging 
biomolecule for current and future prospective. Bioresources and Bioprocessing, 6(40) 
https://link.springer.com/article/10.1186/s40643-019-0276-2 
BISCHOFF, S.C., BARBARA, G., BUURMAN, W., OCKHUIZEN, T., SCHULZKE, J.D., SERINO, M., TILG, H., 
WATSON, A., WELLS, J.M. 2014. Intestinal permeability – a new target for disease prevention and 
therapy. BMC Gastroenterology, 14(2):189 
BIRBEN, E., SAHINE$R, U.M., SACKESEN, C., ERZURUM, S., KALAYCI, O. 2012, Oxidative stress and 
antioxidant defence, The World Allergy Organization Journal, 5(1):9-19 
BHARDWAJ, N., KUMAR, B., VERMA, P. 2019, A detailed overview of xylanases: an emerging 
biomolecule for current and future prospective. Bioresources and Bioprocessing, 6(40) 
https://link.springer.com/article/10.1186/s40643-019-0276-2 
BIOTECH. 2018 Source accessed on Jan 14th, 2018 : https://www.biotek.com/resources/application-
notes/enzymatic-digestion-of-polysaccharides-part-ii/ 
BOUAYED, J., BOHN, T. 2010, Exogenous antioxidants – Double edge swords in cellular redox state. 
Health beneficial effects at physiological doses versus deleterious effects at high does. Oxidative 
Medicine and Cellular Longevity, 3(4):228-237 
BOUHNIK, Y.K., VAHEDI, K., ACHOUR, L., ATTAR, A., SALFATI, J., POCHART, P., MARTEAU, P., FLOURIE, 
B., BORNET, F., RAMBAUD, J. 1999, Short-chain fructo-oligosaccharide administration dose-
dependently increases fecal bifido bacteria in healthy humans. Journal of Nutrition, 129:113-116 
BRADSHAW, R.H., KIRKDEN, R.D. BROOM, D.M. 2002, A review of the aetiology and pathology of leg 
weakness in broilers in relation to welfare. Avian and Poultry Biology Reviews, 13(2):45-103. 
195 
 
BRIARD, J.G., POISSON, J.S., TURNER, T.R., CAPICCIOTTI, C.J., ACKER, J.P., BEN, R.N. 2016,  Small 
molecule ice recrystallization inhibitors mitigate cell lysis during freezing, transient warming and 
thawing, Scientific Reports, 6(23619) https://www.nature.com/articles/srep23619#citeas 
BRITISH NUTRITION FOUNDATION. 2020, Types of fibre and dietary sources 
https://www.nutrition.org.uk/nutritionscience/nutrients-food-and-ingredients/dietary-
fibre.html?start=2 accessed 14/4/2020 
BROEKAERT, W.F., COURTIN, C.M., VERBEKE, K., VAN DE WIELE, T., VERSTRAETE, W., DELCOUR, J.A. 
2011, Prebiotic and other health-related benefits of cereal derived arabinoxylans, arabinoxylan-
oligosaccharides and xylooligosaccharides. Critical Reviews of Food Science and Nutrition, 51:178-194 
BURTON, G.J., JAUNIAUX, E. 2011, Oxidative Stress, Best Practice and Research, Clinical Obstetrics and 
Gynaecology, 25(3): 287-299  
BURTON, E.J., GATCLIFFE, J., MASEY O’NEIL, H., SCHOLEY, D.V. 2016, Sustainable Poultry Production I 
in Europe. CABI Publishing, UK. 
BUSSE-WICHER, M., GOMES, T.C.F., TRYFONA, T., NIKOLOVSKI, N., STOTT, K., GRANTHAM., N.J., 
BOLAM, D.N., SKAF, M.S. 2014, The pattern of xylan acetylation suggests xylan may interact with 
cellulose microfibrils as a twofold helical screw in the secondary plant cell wall of Arabidopsis thaliana. 
The Plant Journal, 79:492-506 
BUSTANY, Z.A. 1996, The effect of pelleting an enzyme-supplemented barley-based broiler diet. 
Animal Feed Science Technology, 58(1996): 283-288 
CABEL, M.C., WALDROUP, P.W., SHERMER, W.D. and CALABOTTA, D.F. 1988, Effects of Ethoxyquin 
Feed Preservative and Peroxide Level on Broiler Performance. Poultry Science. 67: 1725-1730 
CALEFI, A.S. FONSECA, J.G., COHN, D.W.H., HONDA, B.T.B., COSTOLA-DE-SOUZA, C., TSUGIYAMA, L.E., 
2016, The gut-brain axis interactions during heat stress and avian necrotic enteritis, Poultry Science. 
95(5):1005-1014 
CAMPBELL, G., MUSTAC, N.C., ALYASSIN, M., GOMEZ, L.D., SIMISTER, R., FLINT, J., PHILIPS, D.J., 
GRONNOW, M.J., WESTWOOD, M.J. (2019). Arabinoxylans – the key to numerous benefits for 
biorefineries, the food industry and the animal feed industry. Biochemical Engineering Journal, 146: 
https://www.researchgate.net/publication/331601964_Integrated_processing_of_sugarcane_bagass
e_Arabinoxylan_extraction_integrated_with_ethanol_production 
CANANI, R.B., COSTANZO, M.D., LEONE, L, PEDATA, M., MELI, R., CALIGNANO, A. 2011, Potential 
beneficial effects of butyrate in the intestinal and extra-intestinal diseases. World Journal of 
Gastroenterology, 17:1519-1528 
CARABOTTI, M., SCIROCCO, A., MASELLI, M.A., SEVERI, C. 2015, The gut-brain axis: interactions 
between enteric microbiota, central and enteric nervous systems, Annals of Gastroenterology, 
28(2):203-209 
CARDOSO, V., FERNANDES, E., SANTOS, H., MACAS, B., LORDELO, M., TELO DE GAMA, L., FERREIRA, 
L.M.A., FONTES, C.M.G.A., RIBEIRO, T. 2018, Variation in levels of non-starch polysaccharides and 
endogenous endo-1,4-ß-xylanases affect the nutritive value of wheat for poultry. British Poultry 
Science, 59(2):218-226 
CARTNER, S & BARLOW, S., NESS, T. 2008, Loss of cortical function in mice after decapitation, cervical 
dislocation, potassium chloride injection, and CO2 inhalation. Comparative medicine, 57(570):3. 
196 
 
CHANUTIN, A., CURNISH, R.R. 1966, Effect of freezing red blood cells and hemolyzates at different 
temperatures: Electrophoretic and methemoglobin studies. Archives of Biochemistry and Biophysics, 
113(1):114-121 
CHATTERJEE, D., ZHUANG, H., BOWKER, B.C., RINCON, A.M., SANCHEZ-BRAMBILA, G. 2016, 
Instrumental texture characteristics of broiler pectoralis major with the wooden breast condition. 
Poultry Science, 95(10):2449-2454 
CHEN, J., ZHU, Y., LIU, S. 2017, Functional carbohydrates: Development, Characterization, and Bio 
manufacture. CRC Press, 1st edition 
CHEN, H., YAN, X., ZHU, P., LIN, J. 2006, Antioxidant activity and hepatoprotective potential of agaro-
oligosaccharides in vitro and in vivo. Nutrition journal,  5(31)  
CHOCT, M. 1997, Feed non-starch polysaccharides: Chemical Structure and Nutritional Significance. 
Feed Milling International, 1997: 13-26 
CHOCT, M. 1998, The effect of different xylanases on carbohydrate digestion and viscosity along the 
intestinal tract in broilers, Proceedings of the Australian Poultry Science Symposium, 1998 (10):111-
115 
CHOCT, M., HUGHES, R.J., BEDFORD, M.R. 1999, Effects of a xylanase in individual bird variation, 
starch digestion throughout the intestine, and ileal and caecal volatile fatty acid production in 
chickens fed wheat. British Poultry Science, 40:419-422 
CHOCT, M., 2006, Enzymes for the feed industry: past, present and future. Worlds Poultry Science 
Journal, 62:5-16 
CHOCT, M., HUGHES, R.J., BEDFORD, M.R. 1999, Effects of a xylanase on individual bird variation 
throughout the intestine, and ileal and caeca volatile fatty acid production in chickens fed wheat. 
British Poultry Science, 40:419-422 
CHOCT, M., HUGHES, R.J., BEDFORD, M.R. 1999, Effect of xylanase on individual bird variation, starch 
digestion throughout the intestine, and ileal and caecal volatile fatty acid production in chickens fed 
wheat. British Poultry Science, 1(40):419-422 
CHUNG,C.H., DAY, D.F. 2004, Efficacy of Leuconostoc mesenteroides (ATCC 13146) 
isomaltooligosaccharides as a poultry prebiotic. Poultry Science, 83(8):1302-1306 
COLLINS, T., GERDAY, C., FELLER, G. 2005, Xylanases, xylanase families and extremophilic xylanases. 
FEMS Microbiology Reviews, 29(1):3-23 
CORZO, A., MCDANIEL, C. D., KIDD, M. T., MILLER E. R., BOREN, B. B., FANCHER B. I. 2004, Impact of 
dietary amino acid concentration on growth, carcass yield, and uniformity of broilers. Australian 
Journal of Agricultural Research, 55, 1133-1138. 
COTTER, P.F. 2000, Quantitative and qualitative heterogeneity of bile IgA in commercial laying hens. 
In: Current Progress in Avian Immunology Research. Proceedings of the 6th Avian Immunology 
Research Group Meeting (K.A. Schat, ed). Cornell University, Oct. 8-10, pp. 78-82. 
COURTIN, C.M., BROEKAERT, W.F., SWENNEN, K., LESCROART, O., ONAGBESAN, O., BUYSE, J., 
DECUYPERE, E., VAN DE WIELE, T., MARZORATI, M., VERSTRAETE, W. 2008, Dietary inclusion of wheat 
bran arabinoxylo-oligosaccharides induces beneficial nutritional effects in chickens. Cereal Chemistry, 
85: 607-611 
COWIESON, A.J., MASEY O’NEILL, H. 2013, Effects of exogenous xylanase on performance, nutrient 
digestibility and caeca thermal profiles of broilers given wheat-based diets. British Poultry Science, 
54(3):346-354  
197 
 
COWISON, A.J., HRUBY, M., FAURSCHOU ISAKSEN, M. 2002, The effect of conditioning temperature 
and exogenous xylanase addition of wheat-based diets and the performance of broiler chickens. 
https://www.cabi.org/Uploads/animal-science/worlds-poultry-science-association/WPSA-hungary-
2005/269-272Cowieson.pdf 
CRAIG, J.V., TOTH, A. 1969, Productivity of pullets influenced by genetic selection for social 
dominance ability and by stability of flock membership. Poultry Science 5(1):1729-1736 [online] 
accessed on April16th 2020 https://academic.oup.com/ps/article-abstract/48/5/1729/1518596 
CRAIG, A., KHATTAK, F., HASTIE, P., BEDFORD, M.R., OLUKOSI, O.A. 2020, The similarity of the effect of 
carbohydrase or prebiotic supplementation in broilers aged 21 days, fed mixed cereal diets and 
challenged with coccidiosis infection, Plos One, 15(2) 
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229281 
CRAIG, A.D., BEDFORD, M.R., HASTIE, P., KHATTAK, F.M., OLUKOSI, O.A. 2019, the effect of 
carbohydrases or prebiotic oligosaccharides on growth performance, nutrient utilisation and 
development of small intestine and immune organs in broilers fed nutrient-adequate diets based on 
either wheat or barley. Journal of the Science of Food and Agriculture, 99(7):3246-3254 
CRAIG, A., KHATTAK, F., HASTIE, P., BEDFORD, M.R., OLUKOSI, O.A. 2019, Xylanase and xylo-
oligosaccharides prebiotic improve the growth performance and concentration of potentially 
prebiotic oligosaccharides in the ileum of broiler chickens. British Poultry Science, 
https://www.tandfonline.com/doi/full/10.1080/00071668.2019.1673318 
CRESSMAN, M.D., YU, Z., NELSON, M.C., MOELLER, S.J., LILBURN, M.S. and ZERBY, H.N. 2010, 
Interrelations between the microbiotas in the litter and in the intestines of commercial broiler 
chickens. Applied and Environmental Microbiology, 76 (19), 65726582.  
CZECZOT, H., SCIBIOR, D., SKRZYCKI, M., PODSIAD, M. 2006, Glutathione and GSH-dependant enzymes 
in patients with liver cirrhosis and hepatocellular carcinoma, Acta Biochimica Polonica, 53(1):237-242 
DANG, G.H. 2004, Effects of dietary xylo-oligosaccharides on performance of broilers and layers. 
Master thesis, Nanjing Agricultural University 
DEBYSER,W., PEUMANS, W.J., DAMME, E.J.M., DELCOUR, J.A. 1999, Triticum aestivum xylanase 
inhibitor (TAXI), a new class of enzyme inhibitor affecting breadmaking performance. Journal of Cereal 
Science, 30:39-43. 
DEPARTMENT FOR ENVIRONMENTAL AND RURAL AFFAIRS, 2020. UK poultry and poultry meat 
statistics, March 2020. 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file
/879535/poultry-statsnotice-16apr20.pdf 
DEKKER, J., RICHARDS, G.N. 1976, Hemicellulose: their occurrence, purification properties and mode 
of action. Advanced Carbohydrate Chemistry and Biochemistry. 32:277-352. 
DE LANGE, C.F.M., PLUSKE, J., GONG, J., NYACHOTI, C.M. 2010, Strategic use of feed ingredients and 
feed additives to stimulate gut health and development in young pigs. Livestock Science, 134(1-
3):124-134 
De MAESSCHALK, C., EECKHAUT, V., MAERTENS, L., DE LANGE, L., MARCHAL, L., NEZER, C., CROUBELS, 
S., DAUBE, G., DEWULF, J., DUCATELLE, R., TAMINAU, B., VAN IMMERSEEL, F. 2015, Effects of xylo-
oligosaccharides on broiler chicken performance and microbiota. Applied Environmental 
Microbiology, 81(17):5880-5888 
198 
 
DE MARCHI, U., BIASUTTO, L., TONINE, A., ZORATTI, M. 2009, Quercetin can act either as an inhibitor 
or an inducer of the mitochondrial permeability transition pore: A demonstration of the ambivalent 
redox character of polyphenols. Biochemica et Biophysica Acta (BBA) – Bioenergetics, 1787 (12):1425-
1432 
DENBOW, M., 2000, Gastrointestinal anatomy and physiology, Sturkies avian physiology. Fifth edition, 
Academic Press, London, UK 
DEATON, J.W.,REECEW, F.N., VARDAMAN, T.H. 1968, The effect of temperature and density on broiler 
performance. Poultry Science, 47(1):293-300 
DETTMER, K.., ALMSTETTER, M.F., APPEL, I.J., NURNBERGER, N., SCHLAMBERGER, G., GRONWALD, 
W., MEYER, H.H.D., OEFNER, P.J.  2010, Comparison of serum versus plasma collection in gas 
chromatography – Mass spectrometry-based metabolomics. Electrophoresis, 31: 2365-2373. 
doi:10.1002/elps.200900778 
DIBAISE, J.K., FRANK, D.N., MATHUR, R. 2012, Impact of the gut microbiota on the development of 
obesity: current concepts. The American Journal of Gastroenterology Supplements, 1(2012): 22-27 
DIBNER, J.J., RICHARDS, J.D. 2005, Antibiotic growth promoters in agriculture: history and mode of 
action. Poultry Science, 84(4):634-643 
DING, J., DAI, R., YANG, L., HE, C., XU, K., LIU, S., ZHAO, W., XIAO, L., LUO, L., ZHANG, Y., MENG, H. 
2017, Inheritance and Establishment of Gut Microbiota in Chickens, Microbiology, 10, 2017 [Online] 
https://www.frontiersin.org/articles/10.3389/fmicb.2017.01967/full 
DING, X.M., LI, D.D., BAI, P., WANG, J.P., ZENG, Q.F., SU, W., XUAN, Y., ZHANG, K.Y. 2018, Effect of 
dietary xylooligosaccharides on intestinal characteristics, gut microbiota, cecal short-chain fatty acids, 
and plasma immune parameters of laying hens. Poultry Science, 97:874-881 
DING, J., DAI, R., YANG, L., HE, C., XU, K., LIU, S., ZHAO, W., XIAO, L., LUO, L., ZHANG, Y., MENG, H. 
2017, Inheritance and Establishment of Gut Microbiota in Chickens, Microbiology, 2017(8):1967-1974,  
[Online] https://www.frontiersin.org/articles/10.3389/fmicb.2017.01967/full 
DONALDSON, A.E., LAMONT, I.L. 2013, Biochemistry Changes That Occur after Death: Potential 
Markers for Determining Post-Mortem Interval. PLOS ONE 8(11): 
e82011. https://doi.org/10.1371/journal.pone.0082011 
DONG, H., ROWLAND, I., YAQOOB, P. 2012, Comparative effects of six probiotic strains on immune 
function in vitro. British Journal of Nutrition, 108:459-470 
DONG, B., LIU,S., WANG, C., CAO, Y. 2018, Effects of xylanase supplementation to wheat-based diets 
on growth performance, nutrient digestibility and gut microbes in weanling pigs. Asian-Australasian 
Journal of Animal Science, 31(9):1491–1499. doi:10.5713/ajas.17.0867 
DUKE, G.E. 1986a, Alimentary Canal: anatomy, regulation of feeding and motility. Avian Physiology, 4th 
edition, (ed P.D. Sturkie) Springer Verlag, New York. 269-288) 
DUKE, G.E. 1986b, Alimentary Canal: secretion and digestion, special digestive functions and 
absorption. Avian Physiology, 4th edition (ed. P.D. Sturkie) Springer Verlag, New York. 289-302) 
DUMITRESCU, L., POPESCU-OLARU, I., COZMA, L., TULBA, J., HINESCU, M.E., CRISTINA, L., 
GHERGHICEANU, M., POPESCU, B.O. 2018, Oxidative stress and the microbiota-gut-brain axis. 
Oxidative Medicine and Cellular Longevity, 2018(2406594) [Online] 
Cas.ntu.ac.uk/d2lcas_cloud/copyright/copyright.aspx?TARGET 
199 
 
DUMONCEAUX, J., HILL, J.E., HEMMINGSEN, S.M., VAN KESSEL, 2006, Characterization of intestinal 
microbiota and response to dietary virginiamycin supplementation in the broiler chicken, Applied 
Environmental Microbiology, 72:2815-2823 
DUNCAN, S.H., FLINT, H.J., LOUIS, P. 2004, Lactate-utilizing bacteria, isolated from human faeces that 
produce butyrate as a major fermentation product. Applied Environmental Microbiology, 70:5810-
5817 
DUSEL G., KLUGE H., GLASER, K., 1997, An investigation into the variability of extract viscosity of 
wheat-relationship with the content of non-starch-polysaccharide fractions and metabolisable energy 
for broiler chickens. Arch Tierernahr., 50(2):121–135. 
EECKHAUT, V., VAN IMMERSEEL, F., DEWULF, J., PASMANS, F., HAESEBROUCK, F., DUCATELLE, R., 
COURTIN, C.M., DELCOUR, J.A., BROEKAERT, W.F., 2008. Arabinoxylanoligosacchrides from Wheat 
Bran Inhibit salmonella Colonization in Broiler Chickens. Poultry Science, 87(11):,, 2329-2334 
EGE, M.J., MAYER, M., NORMAND, A.C., GENUNEIT, J., COOKSON, W.O., BRAUN-FAHRLANDER, C., 
HEEDERIK, D., PIARROUX, R., PIARROUX, R., VON MUTIUS, E., GABRIELA, T. 2011, Exposure to 
environmental microorganisms and childhood asthma. New England Journal of Medicine, 364(2011): 
701-709 
ELLMAN, G.L. 1959, Tissue sulfhydryl groups, Archives of Biochemistry and Biophysics, 82(1):70-77 
ENGBERG, R.M., HEDEMANN, M.S., STEENFELDT, S., JENSEN, B.B. 2004, Influence of Whole Wheat 
and Xylanase on Broiler Performance and Microbial Composition and Activity in the Digestive Tract. 
Poultry Science, 83:925-938 
ENKVETCHAKUL, B., BOTTJE, W., ANTHONY,N., MOORE, R., HUFF, W. 1993, Compromised Antioxidant 
Status Associated with Ascites in Broilers. Poultry Science, 72(12):2272–2280 
ESTEVEZ, I., NEWBERRY, R., ARIAS DE RAYNA, L. 1997, Broiler Chickens: A tolerant social system? 
Etologia, 5(5):19-29 
ESTERBAUER, H., CHEESEMAN, K.H. 1990, Determination of aldehydic lipid peroxidation products: 
malonaldehyde and 4-hydroxynonenal. Methods in Enzymology, 186:407-421 
ESTEVEZ, M. 2015, Oxidative damage to poultry: from farm to fork. Poultry Science, 94(6):1368-1378 
EUROPEAN COMMISSION. 2005, Ban on antibiotics as growth promoters in animal feed comes into 
effect, 2006. https://ec.europa.eu/commission/presscorner/detail/en/IP_05_1687 
FAINTUCH, J., FAINTUCH, S. 2019, Microbiome and metabolome in diagnosis, therapy and other 
strategic applications. Elsevier, USA, 
https://www.sciencedirect.com/book/9780128152492/microbiome-and-metabolome-in-diagnosis-
therapy-and-other-strategic-applications#book-info 
FALKEBORG, M., CHEONG, L., GIANFICO, C., SZTUKIEL, K.M., KRISTENSEN, K., GLASIUS, M., XU, X., 
GUO, Z. 2014, Alginate oligosaccharides: Enzymatic p[reparation and antioxidant property evaluation. 
Food Chemistry, 164(1):185-194 
FARYAR, R., LINARES-PASTEN, J.A., IMMERZEEL, P., MAMO, G., ANDERSSON, M., STALBRAND, H., 
MATTIASSON, B., NORDBERG KARLSSON, E. 2014, Production of prebiotic xylooligosaccharides from 
alkaline extracted wheat straw using the K80R-Varient of a thermostable alkali-tolerant xylanase. Food 
and Bioproducts Processing, 93,:1-10 
FARAHAT, M., ABDALLAH, F., ABDEL-HAMID, T., HERNANDEZ-SANTANA, A. 2016, Effect of 
supplementing broiler chicken diets with green tea extract on the growth performance, lipid profile, 
antioxidant status and immune response, British Poultry Science, 57(5):714-722 
200 
 
FIERENS, E. 2007. TLXI, athaumatin-like xylanase inhibitor: isolation, characterisation and comparision 
with other wheat (Triticum aestivum L.) xylanase inhibiting proteins. Katholieke Universiteieit Leuven 
Ph.D., Katholiele Universiteit, Leuven, Belgium. 
FELLENBURG, M.A., SPEISKY, H. 2006, Antioxidative stress and its meat oxidative stability. World’s 
Poultry Science Journal, 62(1):53-70 
FIGUEIREDO, A.A., CORREIA, B.A., RIBEIRO, T., PONTE, P., FALCAO, L., PRATES, J.A., FERREIRA, L.M., 
FONTES, C.M., LORDELO, M.M. 2012, The effects of restricting enzyme supplementation in wheat-
based diets to broilers. Animal Feed Science Technology, 172:194-200 
FELLENBURG, M., SPEISKY, H. 2006, Antioxidants: Their effects on broiler oxidative stress and its meat 
oxidative stability. World’s Poultry Science Journal, 62(1):53-70 
FLAVIA, A., CARVALHO, A., DE OLIVA NETO., DA SILVA, D., PASTORE, G.M. 2013, Xylo-oligosaccharides 
from lignocellulosic materials: Chemical structure, health benefits and production by chemical and 
enzymatic hydrolysis, Food Research International, 51(1)75-85 
FONTES, C.M., PONTE, P.I., REIS, T.C., SOARES, M.C., GAMA, L.T., DIAS, F.M.V., FERREIRA, L.M.A. 2004, 
A family 6 carbohydrate-binding module potentiates the efficacy of recombinant xylanase used to 
supplement cereal-based diets for poultry. British Poultry Science, 45:648-656 
FOODS ETHICS COUNCIL. 2007, Meat Consumption: Trends and environmental implications. 
www.foodethicscouncil.org/system/files/businessforum201107.pdf Accessed 31st October 2018 
FRANKLIN, S.T., NEWMAN, K.E. NEWMAN, M.C. 2002, Evaluation of mannanoligosaccharide on the 
immune status of dairy cows and their calves. Journal of Animal Science, 80(192):766-788 
FREMPONG, N.S., NORTEY, T.N., PAULK, C., STARK, C. 2019, Evaluating the e4ffect of replacing fish 
meal in broiler diets with either soybean meal or poultry by-product meal on broiler performance and 
total feed cost per kilogram of grain. Journal of Applied Poultry Research, 28(4):912-918 
FUNG, S., REMPEL, H., FORGETTA, V., DEWAR, E.T.K., DIARRA, M.S. 2013, Caeca microbiome of 
mature broiler chickens fed with or without salinomycin. Gut Microbiome: The Effector/regulatory 
Immune Network Conference, Keystone Symposia on Molecular and cellular biology, Taos, New 
Mexico, USA, 2013 
GABRIEL, I., LESSIRE, M., MALLET, S., GUILLOT, J. 2006, Microflora of the digestive tract: Critical 
factors and consequences for poultry. World’s Poultry Science Journal, 62(3):499-511 
GAGNE, F. 2014, Oxidative stress, Biochemical Ecotoxicity, Principals and Methods. Academic Press, 
Oxford, UK 
GANGWAR, R., MEENA, A.S., SHUKLA, P., NAGARAJA, A.S., DORNIAK, P.L., PALLIKUTH, S., WATERS, C., 
SOOD, A., RAO, R. 2017, Calcium-mediated oxidative stress: a common mechanisms in tight junction 
disruption by different types of cellular stress. Biochemical Journal, 474(5):731-749 
GANTOIS, I., DUCATELLE, R., PASMANS, F., HAESEBROUCK, F., HAUTEFORT, I., THOMPSON, A., 
HINTON, J.C., VAN IMMERSEEL F. 2006, Butyrate specifically down-regulates Salmonella pathogenicity 
island 545 1 gene expression. Applied and Environmental Microbiology, 72:946-949. 546 59.  
GAUTIER, A.E., WALK, C.L., DILGER, R.N. 2017, Influence of dietary calcium concentrations and the 
calcium-to-non-phytate phosphorus ratio on growth performance, bone characteristics, and 
digestibility in broilers. Poultry Science, 96(8):2795-2803 
GEBRUERS ,K., DORNEZ,E., BEDO,Z., RAKSZEGI, M., COURTIN, C.M., DELCOUR, J.A. 2010, Variability in 
Xylanase and Xylanase Inhibition Activities in Different Cereals in the HEALTHGRAIN Diversity Screen 
201 
 
and Contribution of Environment and Genotype to This Variability in Common Wheat. Journal of 
Agricultural and Food Chemistry, 58:9362-9371. 
GIBSON, G.R., PROBERT, H.M., Loo, J.V., RASTALL, R.A., ROBERFROID, M.B. 2004, Dietary modulation 
of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews, 17 
(2004):259 
GILANI, S., HOWARTH, G., TRAN, C., BAREKATAIN, R., KITESSA, S., FORDER, R., HUGHES, R. 2018. 
Reduced fasting periods increase intestinal permeability in chickens. Journal of Animal Physiology and 
Nutrition, 102(3):486-492 
GIUSTARINI, D., DALLE_DONNE, I., TSIKAS, D., ROSSI, R. 2009, Oxidative stress and human diseases: 
origin, link, measurement, mechanisms and biomarkers. Critical Reviews in Clinical Laboratory 
Sciences, 46(5-6):241-281  
GOBINATH, D., MADHU, A.N., PRASHANT, G., SRINIVASAN, K., PRAPULLA, S.G. 2010, Beneficial effect 
of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats. British 
Journal of Nutrition, 104: 40-47 
GONZALEZ-ORTIZ, G., OLUKOSI, O., BEDFORD, M.R. 2016, Evaluation of the effect of different wheats 
and xylanase supplementation on performance, nutrient and energy utilisation of broiler chicks. 
Animal Nutrition, 2(3):173-179 
GRACE, J., NARENDHIRAKANNON, R.T. 2011, Detection of high-risk HPV and evaluation of antioxidant 
status in cervical carcinoma patients in Tamil state, India – a case controlled study. Asian Pacific 
Journal of Cancer Prevention, 12(10):2689-2695  
GRAHAM, H., GOMES, G.A., DOS SANTOS, T.T., TEN DOESCHATE, R.A. 2019, Xylo-oligosaccharides and 
xylanase improves the performance of broilers fed wheat based diets [Online] 
https://www.abvista.com/ABVista/media/WebsiteResources/PDFs/XYLO-OLIGOSACCHARIDES-AND-
XYLANASES-IMPROVE-THE-PERFORMANCE-OF-BROILERS-FED-WHEAT-BASED-DIETS.pdf Accessed 
222/03/2020 
GRAY, J.I., GOMAA, E.A., and BUCKLEY, D.J. 1996, Oxidative quality and shelf life of meats. Meat 
Science, 43:111S-123S 
GULLON, P, SALAZAR, N., MUNOZ, M.J., GUEIMONDE, M., RUAS-MADIEDO, P., DE LOS REYES-GAVILAN 
. C.J. 2011, Assessment on the fermentability of xylo-oligosaccharides from rice husks. 
Bioresources,6(3):3096-3114 
GUINANE, C.M., COTTER, P.D. 2013, Role of the gut microbiota in health and chronic gastrointestinal 
disease: understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology, 
6(4):295-308 
GUILLOTEAU, P., MARTIN, L., EECKHAUT, V., DUCATELLE, R., ZABIELSKI, R., VAN IMMERSEEL, F. 2010, 
From the gut to the peripheral tissues: the multiple effects of butyrate. Nutritional Research Reviews, 
23:366-384 
HAJATI, H., REZAEI, M. 2010, The Application of Prebiotics in Poultry Production. International Journal 
of Poultry Science, 9(3):298-304 
HALAS, V., BABINSZKY, L. 2014. Role of dietary polysaccharides in monogastric animal nutrition, 
Polysaccharides, Book chapter:4-18 accessed on April 22, 2020 
https://www.researchgate.net/publication/300428696_Role_of_Dietary_Polysaccharides_in_Monoga
stric_Farm_Animal_Nutrition/figures?lo=1 
202 
 
HALLIWELL, B., GUTTERIDGE, J.M. 1990, Role of free radicals and catalytic metal ions in disease: an 
overview. Methods in Enzymology,186:1-85 
HAVENSTEIN G.B., FERKET, P.R, QURESHI, M.A. 2003 Growth, livability, and feed conversion of 1957 
versus 2001 broilers when fed representative 1957 and 2001 broiler diets. Poultry Science, 
82(10):1500–1508.  
HECKERT, R.A., I. ESTEVEZ, E. RUSSEK-COHEN R. PETTIT-MORAES, H.L.S., SALLE, C.T.P., PADILHA, A.P., 
RILEY, R. 2002, Effects of density and perch availability on the immune status of broilers. Poultry 
Science, 81:451-457.  
HENNEKENS, C.H, MAYRENT, S.L., WILLETT, W. 1986, Vitamin A, carotenoids, and retinoids. Cancer, 
58(8):1837-1841 
HERNANDEZ-HERNANDEZ, O., MUTHAIYAN, A., MORENO, F.J., MONTILLA, A., SANZ, M.L., RICKE, S.C. 
2012, Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus. Food 
Microbiology, 30(2):355-361 
HILL, K.J. 1976, The anatomy and general physiology of the alimentary tract. In: Digestion in the fowl. 
(Eds K.N. Boorman and B.M. Freeman). Poultry Science Symposium, No.11. British Poultry Science Ltd. 
Edinburgh, 3-24.  
HILL, F.W., Anderson, D.L., 1958. Comparison of metabolizable energy and productive energy 
determinations with growing chicks. Journal of Nutrition, 64:587-603 
HOSSEINI, S.M., AFSHAR, M. 2017, Effects of feed form and xylanase supplementation on 
performance and ileal nutrients digestibility of heat-stressed broilers fed wheat–soybean diet. Journal 
of Applied Animal Research, 45:1, 550-556, DOI: 10.1080/09712119.2016.1224765 
HOU, Y., DING, X., HOU, W. 2015, Composition and antioxidant activity of water-soluble 
oligosaccharides from hericium erincues. Molecular Medicine Reports, 11(5):3794-3799 
HOWARD, M.D., GORDON, D.T., PACE, L.W, GARLEB, K.A., KERLEY, M.S. 1995, Effects of dietary 
supplementation with fructooligosaccharides on colonic microbiota populations and epithelial cell 
proliferation in neonatal pigs. Journal of Pediatric Gastrointestinal Nutrition, 21:297-303 
HSU, C.K., LIAO, J.W., CHUNG, Y.C., HSIEH, C.P., CHAN, Y.C. 2004, Xylo-oligosaccharides and fructo-
oligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. 
Journal of Nutrition, 34:1523-1528 
HU, X.F., GUO, Y.M. 2008, Corticosterone administration alters small intestinal morphology and 
function of broiler chickens. Asian-Australian Journal of Animal Sciences, 21(12):1773-1778 
HUA, X., AHN, D.U. 2018,The Incisence of Muscle Abnormalities in Broiler Breast Meat – A Review. 
Korean Journal of Food Science of Animal Resources, 38(5):835-850 
HUANG, M.K., CHOI, Y.J., HOUDE, R., LEE, J.W., LEE, B., ZHAO, X. 2004. Effects of Lactobacilli and an 
acidophilic fungus on the production performance and immune responses in broiler chickens. Poultry 
Science. 83, 788–795.  
HUNTER, J.O., TUFFNEL, Q., Lee, A.J. 1999. Controlled trial of oligofructose in the management of 
irritable bowel syndrome. Journal of Nutrition, 129:1451S-1453S 
HUSVETH, F. 2011, Physiological and Reproductional Aspects of Animal Production, First Edition. 
Debreceni Egyetem, Budapest, Hungary 
203 
 
IJI, P.A., SAKI, A.A., TIVEY, D.R. 2001, Intestinal structure and function of broiler chickens on diets 
supplemented with a mannan oligosaccharide. Journal of Science Food and Agriculture, 81: 1186-
1192. doi:10.1002/jsfa.925 
IMMERZEEL, P., FALCK, P., GALBE, M., ADLERCREUTZ, P., KARLSSON, E.N., STALBRAND, H. 2014, 
Extraction of water-soluble xylan from wheat bran and utilization of enzymatically produced 
xylooligosaccharides by Lactobacillus, Bifidobacterium and Weissella spp. LWT- Food Science and 
Technology, 56(2):321-327 
IPEK, A., SAHAN, U., 2006. Effects of cold stress on broiler performance and ascites susceptibility. 
Asian-Australasian Journal of Animal Science, 19(5):734-738 
ISMAIL, I.B., AL-BUSADAH, K.A., EL BAHR, S.M. 2013, Oxidative stress biomarkers and biochemical 
profile in broilers fed zinc bacitracin and ascorbic acid under hot climate. American Journal of 
Biochemistry and Molecular Biology, 3(2):202-21 
IUPAC-IUB Joint commission on biochemical nomenclature (JCBN), 1980, Abbreviated terminology of 
oligosaccharide chains. European Journal of Biochemical Nomenclature, 126 (3):433-437 
JACOBS, J., PESCATORE, T. 2013, Avian Digestive System. University of Kentucky College of Agriculture, 
Food and Environment. [Online] Available at: 
http://www2.ca.uky.edu/agcomm/pubs/asc/asc203/asc203.pdf 
JAMROZ, D., JAKONSEN, K., KNUDSEN, K.E.B., WILICZKIEWICZ, A., ORDA, J. 2002, Digestibility and 
energy value of non-starch polysaccharides in young broiler chickens, ducks and geese, fed diets 
containing high amounts of barley. Comparative Biochemistry and Physiology, 131A:657-668 
JOSEPH, N.S., MORAN, E.T. 2005, Effect of flock age and postmergent holding in the hatcher on broiler 
live performance and further processing yield. ,  Journal of Applied Poultry Research 14: 512-520. 
JOZEFIAK, D., RUTKOWSKI, A., JENSEN, B.B., ENGBERG, R.M. 2006, The effect of ß-glucanase 
supplementation of barley and oat-based diets on growth performance and fermentation in broiler 
chicken gastrointestinal tract. British poultry Science, 51:546-557 
JOZEFIAK, D., RUTKOWSKI, A., JENSEN, B.B., ENGBERG, R.M. 2007.Effects of dietary inclusion of 
triticale, rye and wheat and xylanase supplementation on growth performance of broiler chickens and 
fermentation in the gastrointestinal tract, Animal Feed Science and Technology,132 (1–2):79-93 
JOZEFIAK, D., SIP, A., RAWSKI, M., RUTKOWSKI, A., KACMAREK, S., HOJBERG, O., JENSEN, B.B., 
ENBERG, R.M. 2011, Dietary divercin modifies gastrointestinal microbiota and improves growth 
performance in broiler chickens. British Poultry Science, 52:492-499 
JUGE, N., PAYAN, F., WILLIAMSON, T. 2004, XIP-I, a xylanase inhibitor protein from wheat: a novel 
protein function, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1696(2):203-211 
JULIAN, R.J., 1998, Rapid growth problems: ascites and skeletal deformities in broilers. Poultry 
Science, 77(12):1773-1780. 
KAMRAN, Z., M. SARWAR, M. NISA, M. A. NADEEM, S. MAHMOOD, M. E. BABAR, and S. AHMED. 2008, 
Effect of Low Protein Diets Having Constant Energy-To- Protein Ratio on Performance and Carcass 
Characteristics of Broiler Chickens from One to Thirty- Five Days of Age. Poultry Science 87:468–474. 
doi:10.3382/ps.2007-00180. 
KANAUCHI, O., FUJIYAMA, Y., MITSUYAMA, K., ARAKI, Y., ISHII, T., NAKAMURA, T., HITOMI, Y., AGATA, 
K., SAIKI, K., ANDOH, A., TOYONAGA, A., BAMBA, T. 1999, Increased growth of bifidobacterium and 
eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in 
healthy volunteers. International Journal of Molecular Medicine, 3(2):1107-3756 
204 
 
KASANGA, C.J., YAMAGUCHI, T.,  WAMBURA, P.N., MUNANGANDU, H.M., OHYA, K., FUKUSHI, H. 
2008, Detection of infectious bursal disease virus (IBDV) genome in free-living pigeon and guinea fowl 
in Africa Suggests involvement of wild birds in the epidemiology of IBDV. Journal of Virus Genes, 36: 
521-529. 
KATARIA, Y., DEATON, R.J., ENK, E. 2016, Retinoid and carotenoid status in serum and liver among 
patients at high-risk for liver cancer. BMC Gastroenterology, 16(1):30-32  
KNIGHT, J. 2005, Pholasis-based antioxidant assays for cosmetics, cosmeceutical and nutraceutical 
product development. https://www.knightscientific.com/uploads/2/2/4/6/22464150/kslksl-article---
cosmetic-science-conference-2005_2.pdf Accessed 18/04/2020 
KILKENNY, C., BROWNE, W., CUTHILL, I.C., EMERSON, M. and ALTMAN, D.G. 2010, Animal research: 
Reporting in vivo experiments: the ARRIVE Guidelines. British Journal of Pharmacology, 160(7):1577-
1579 
KIM, G.B., SEO, Y.M., KIM, C.H., KIM, I.K., PAIK, I.K. 2011, Effect of dietary prebiotic  supplementation 
on the performance, intestinal microflora and immune response of broilers. Poultry Science, 90(1):75-
82 
KIM, J.C., SIMMINS, P.H., MULLAN, B.P., PLUSKE, J.R. 2005, The effect of wheat phosphorus content 
and supplemental enzyme digestibility and growth performance of weaner pigs. Animal Feed Science 
Technology, 118(2005):139-152 
KNUDSEN, K.E.B. 2014, Fibre and Non-Starch Polysaccharide Content and Variation in Common Crops 
Used in Broiler Diets. Poultry Science 93:2380–2393. doi:10.3382/ps.2014-03902.  
KOGUT, M.H. 2013, the gut microbiota and host innate immunity: Regulators of host metabolism and 
metabolic diseases in poultry? The Journal of Applied Poultry Research. 22(3):637-646 
KOLLN, M., WEIB, H., HANKEL, J. KAMPHUES, J. 2017, Effects of a carbohydrase complex added in 
different inclusion rates in feeds for broilers on growth performance, digesta viscosity and foot pad 
health. Journal of Animal Physiology and Animal Nutrition, 101: 105-109. doi:10.1111/jpn.12701 
KNIGHT, J., GANDERTON, M., HOTHERSALL, J. NOUROOZ-ZADEH, J. 2002, The ABEL® peroxynitrite 
antioxidant test with Pholasin® measures the antioxidant capacity of plasma to protect against 
peroxyl radical attack. Luminescence, 17, 95-96.  
KNIGHT, J, GANDERTON, M, ARMSTRONG, K and LARKINS, N. 2003, The use of Pholasin®-based assays 
to evaluate anti- and pro- oxidant capacity of extracts of certain functional foods: the effect of these 
foods on leucocytes in blood. Free Radical Biology & Medicine, 35(1) S39 (92)  
KNIGHT, J., LARKINS, N.J. 2003, Antioxidant status of horses quantified by ABEL® wide-range 
assay. British Equine Veterinary Association 42nd Congress: Handbook of presentations & Free 
Communications, Equine Veterinary Journal Ltd. 193-294. 
KNIGHT, J. 2005. Pholis-based antioxidant assays for cosmetics, cosmeceutical and nutraceutical 
development. https://www.knightscientific.com/uploads/2/2/4/6/22464150/kslksl-article---cosmetic-
science-conference-2005_2.pdf 
KOMURA, M., FUKUTA, T., GENDA, T., HINO, S., AOE, S., KAWAGISHI, H., MORITA, T. 2014, A short-
term ingestion of fructo-oligosaccharides increases immunoglobulin A and mucin concentrations in 
the rat cecum, but the effects are attenuated with the prolonged ingestion. Bioscience, Biotechnology, 
and Biochemistry, 78(9):1592-1602  
205 
 
KRONENBERG, F., TRENKWALDER, E., KRONENBERG, M.F., UTERMANN, G. 1998, Influence of 
haematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein 
(a). Kidney International. 1998;54:1385–1389 
KULKARNI, R. R., PARREIRA, V. R., SHARIF, S., PRESCOTT, J. F. 200,. Immunization of broiler chickens 
against Clostridium perfringens-induced necrotic enteritis. Clinical and vaccine immunology, 14(9): 
1070–1077. https://doi.org/10.1128/CVI.00162-07 
KUMAR, S., CHEN, C., INDUGU, N., WERLANG, G. O., SINGH, M., KIM, W. K., THIPPAREDDI, H. 2018, 
Effect of antibiotic withdrawal in feed on chicken gut microbial dynamics, immunity, growth 
performance and prevalence of foodborne pathogens. PloS one, 13(2), e0192450. 
https://doi.org/10.1371/journal.pone.0192450 
KUTTAPPAN, V.A., SHIVAPRASAD, H.L., SHAW, D.P., VALENTINE, B.A., HARGIG, B.M., CLARK, F.D., 
MCKEE, S.R., OWENS, C.M. 2013, Pathological changes associated with white striping in broiler breast 
muscles. Poultry Science, 92(2):331-338 
LABACQ-VERHEYDEN, A.M., VAERMAN, J.P., HEREMANS, J.F. 1974, Quantification and distribution 
of chicken immunoglobulins, IgA, IgM and IgG in serum and secretions. Immunology, 27(4):683-692 
LARBIER, M., LECLERCQ, R. 1994, Nutrition and Feeding of Poultry. Nottingham University Press. 
Translated by Julian Wiseman. INRA, Nottingham. 
LATORRE, J., ADHIKARI, B., PARK, S.H., TEAGUE, K.D., GRAHAM, L.E., MAHAFFEY, B.D., BAXTER, M.F., 
HERNANDEZ-VELASCO, X., KWON, Y.M., RICKE, S.C., BIELKE, L.R., HARGIS, B., TELLEZ, G. 
2018,Evaluation of the epithelial barrier function and ileal microbiome in an established necrotic 
enteritis model in broiler chickens. Frontiers in Veterinary Science, 10(5):199 
LEE, K.W., LI, G., LILLEHOJ, H.S., LEE, S.H., JANG, S.I., BABU, U.S., LILLEHOJ, E.P., NEUMANN, A.P. and 
SIRAGUSA, G.R. 2011, Bacillus subtilis-based direct-fed microbials augment macrophage function in 
broiler chickens. Research in Veterinary Science, 91 (3), e87 
LEE, J.E., KIM, S.Y., SHIN, S.Y. 2015, Effect of repeated freezing and thawing on biomarker stability in 
plasma and serum. Osong Public Health and Research Perspectives, 6(6):357-362 
LEE, S. A., APAJALAHTI, J. VIENOLA, K GONZALEZ-ORTIZ, G. FONTES, M.G.A.BEDFORD, M.R. 2017, Age 
and Dietary Xylanase Supplementation Affects Ileal Sugar Residues and Short Chain fatty Acid 
Concentration in the Ileum and Caecum of Broiler Chickens. Animal Feed Science & 
Technology, 234: 29–42. 
LEVINE, R.L., GARLAND, D., OLIVER, C.N., AMICI, A., CLIMENT, I., LENZ, A.G., AHN, B.W., SHALTIEL, S., 
STADTMAN, E.R. 1990, Determination of carbonyl content in oxidatively modified proteins. Methods 
in Enzymology, 186:464-478 
LEY,E., BACKHED, F.,TURNBAUGH, P., LOUZUPONE, K., KNIGHT, R., GORDON, J. 2005,Obesity alters gut 
microbial ecology. Proceedings of the National Academy of Sciences , 102(31)11070-
11075; DOI: 10.1073/pnas.0504978102 
 
LI, D.D., DING, X.M., ZHANG, K.Y., BAI, S.P., WANG, J.P., ZENG, Q.F., SU, Z.W., KANG, L. 2018, Effects of 
dietary xylooligosaccharides on the performance, egg quality, nutrient digestibility and plasma 
parameters of laying hens. Animal Feed Science and Technology, 225(2017):20-26 
LIN, C.F., ASGHAR, A., GRAY, J.I., BUCKLEY, D.J., BOOREN, A.M., CRACKEL, R.L., FLEGAL, C.J. 1989, 
Effects of oxidised dietary oil and antioxidant supplementation on broiler growth and meat stability. 
British Poultry Science, 30:855-864 
206 
 
LIN, J., HUNKAPILLER, A.A., LAYTON, A.C., CHANG, Y.J. and ROBBINS, K.R. 2013, Response of intestinal 
microbiota to antibiotic growth promoters in chickens. Foodborne Pathogens and Disease, 10(4), 331-
337. 
LORENZONI, G. 2010, Poultry Diseases Influenced by Gastrointestinal Health. Pg 3-4, Nottingham 
University Press, Nottingham UK 
LOTT, B.D., SIMMONS, J.D., MAY, J.D. 1998, Air velocity and high temperature effects on broiler 
performance. Poultry Science, 77(3):391-393. 
LORENZI, M., MUDALAL, S., CAVANI, C., PETRACCI, M. 2014, Incidence of white striping under 
commercial conditions in medium and heavy broiler chickens in Italy. Journal of Applied Poultry 
Research, 23:754–758. doi: 10.3382/japr.2014-00968. 
LUO, D., YANG, F., YANG, X., YAO, J. 2009, Effects of xylanase on performance, blood parameters, 
intestinal morphology, microflora and digestive enzyme activities of broilers fed wheat-based diets. 
Asian-Australasian Journal of Animal Science, 22(9):1288-1295 
LU, S.C. 2009, Regulation of glutathione synthesis. Molecular Aspects of Medicine, 30(1-2):42-59 
LUO, D., YANG, X., YAO, J., SHI, B., ZHOU, Z. 2009, Effects of xylanase on performance, blood 
parameters, intestinal morphology, microflora and digestive enzyme activities of broiler fed wheat-
based diets. Asian-Australasian Journal of Animal Science, 22(9):1288-1295. 
LV, M., YAN, L., WANG, Z., AN, S., WU, M., LV, Z. 2015, Effects of feed form and particle size on growth 
performance, carcass characteristics and digestive tract development of broilers. Animal nutrition, 
1(3):252-256 
MACPHERSON, J., UHR, T. 2004, Induction of protective IgA by intestinal dendritic cells carrying 
commensal bacteria. Science, 303:1662-1665 
MADSEN, C.K., PETTERSSON, D., HJORTSHOJ, R., KATHOLM, A., BRINCH-PEDERSON, H. 2018, Superior 
growth rates in broilers fed wheat with low in vitro feed-xylanase inhibition. Journal of Agriculture and 
Food Chemistry, 66(16):4044-4050 
MAGDELAINE, P., SPIESS, M.P., VALCESCHINI, E. 2008, Poultry meat consumption trends in Europe. 
World’s Poultry Science Journal, 64:53-63 
MALOMO, G.A., BOLU, S.A., MADUGU, A.S., USMAN, A.S. 2017, Nitrogen emissions and mitigation 
strategies in chicken production. [online] https://www.intechopen.com/books/animal-husbandry-
and-nutrition/nitrogen-emissions-and-mitigation-strategies-in-chicken-production, Accessed 
30/04/2020 
MANILLA, H.A., and HUSVETH, F. 1999, N-3 fatty acids enrichment and oxidative stability of broiler 
chicken. Acta Alimentaria, 28:235-249 
MARCO, F., BUCAJ, E., FOPPOLI, C., FIORINI, A., BLARZINO, C., FILLIPI, K., GIORGI, A., SCHININA, M.E., 
DI DOMENICO, F., COCCIA, R., BUTTERFIELD, D.A., PERLUIGI, M. 2012, Oxidative Stress in HPV-Driven 
Viral Carcinogenesis: Redox Proteomics Analysis of HPV-16 Dysplastic and Neoplasitic Tissues. PLoS 
One, 7(3):e34366 
MARKLUND, S., MARKLUND, G., 1974, Involvement of superoxide anion radical in the autoxidation of 
pyrogallol abd a convenient assay for superoxide dismutase. European Journal of Biochemistry, 
47(3):469-474 
MARSTELLER, F.A., SIEGEL, P.B., GROSS, W.B. 1980, Agonistic behaviour, the development of the 
social hierarchy and stress in genetically diverse flocks of chickens. Behavioural Processes, 5(4):339-
354 
207 
 
MARINO, L.2017, Thinking Chickens: a review of cognition, emotion, and behaviour in the domestic 
chicken. Animal Cognition, 20(2):127-147 
MARTIN, J., SANDILANDS, V., SPARREY, J., BAKER, L., DIXON, L. M., MCKEEGAN, D. E. F. 2019. Welfare 
assessment of novel on-farm killing methods for poultry. PLoS ONE, 14(2):463-472 
[e0212872]. https://doi.org/10.1371/journal.pone.0212872 
MASEY O'NEILL, H., LIU, N., WANG, J., DIALLO, A, HILL, S. 2012, Effect of Xylanase on Performance and 
Apparent Metabolisable Energy in Starter Broilers Fed Diets Containing One Maize Variety Harvested 
in Different Regions of China. Asian-Australasian Journal of Animal Sciences. 25: 515-23. 
MATHLOUTHI, N, MALLET, S, SAULNIER, L, QUEMENER, B and LARBIER, M.  2003, Effect of xylanase 
and β-glucanase addition on performance, nutrient digestibility, and physico-chemical condition in 
the small intestine contents and caecal microflora of broiler chickens fed a wheat and barley-based 
diet. Journal of Animal Research, 51:395–406. 
MAZZONI, M., PETRACCI, M., MELUZZI, A., CAVANI, C., CLAVENZANI, P., SIRRI, F. 2015, Relationship 
between pectoralis major muscle histology and quality traits of chicken meat. Poultry Science, 
94(1):123-130 
MCLAUCHLAN, W.R., GARCIA-CONESA, M.T., WILLIAMSON, G., ROZA, M., RAVENSTEIN, P., MAAT, J. 
1999, A novel class of protein from wheat which inhibits xylanases. Biochem Journal 338:441-446. 
Megazyme International. endo-1,4-ß-D-Xylanase assay procedure. Megazyme International . Available 
at http://secure.megazyme.com/downloads/en/data/T-XAX200.pdf 
MCGUCKIN, A., LINDEN, S.K., SUTTON, P., FLORIN, T.H. 2011, Mucin dynamics and enteric pathogens. 
Nature Reviews Microbiology, 9(2011):265-278 
MCMULLIN, P. 2004, Infectious bursal disease, IBD, Gumboro. A pocket guide to poultry health and 
disease. 5th Edn. 
MIDILLI, M., ALP, M., KOCABAGLI, N., MUGLAH, O.H., TURAN, N., YILMAZ, H., CAKIR, S. 2008, Effects of 
dietary probiotic and prebiotic supplementation on growth performance and serum IgG 
concentration of broilers. South African Journal of Animal Science, 38(1):21-27 
MIN, B., AHN, D.U. 2005, Mechanism of lipid peroxidation in meat and meat products, Food Science 
Biotechnology, 14(1):152-163 
MIN, B., CORRAY, J., AHN, D.U. 2008, Endogenous factors affecting oxidative stability of beef loin, pork 
loin and chicken and thigh meats, Journal of Food Science, 73:C439-C446 
MORGAN, N.K., WALL, C.L., BEDFORD, M.R., BURTON, E.J. 2014, The effect of dietary calcium inclusion 
on broiler gastrointestinal pH: Quantification and method optimization. Poultry science, 93:354-363 
MIRONCZUK-CHODAKOWSKA, I., WITKOWSKA, A.M., ZUJKO, E. 2018, Endogenous non-enzymatic 
antioxidants in the human body. Advances in Medical Sciences, 63(1):68-78 
MORRIS, JD & FERNANDEZ, JM & CHAPA, A.M., & GENTRY, L., THORN, K.E., WEICK, T.M. 2002, Effects 
of sample handling, processing, storage, and haemolysis on measurements of key energy metabolites 
in ovine blood. Small Ruminant Research. 43(2):157-166. 10.1016/S0921-4488(01)00266-8. 
MUDALAI, S., LORENZI, M., SOGLIA, F., CAVANI, C. 2015, Implications of white striping and wooden 
breast abnormalities on quality traits of raw and marinated chicken breast. Animal, 9(4):728-734 
MUIR, W.M., AGGREY, S.E. 2003, Poultry genetics, breeding and biotechnology. First Edition, CABI, 
Oxfordshire, UK 
208 
 
MUTUCUMARANA, R.K., RAVINDRAN, V., RAVINDRIN, G. and COWIESON, A.J. 2014, Measurement of 
true ileal digestibility and total tract retention of phosphorus in corn and canola meal for broiler 
chickens. Poultry Science, 93(2):412-419 
MUSSATTO, S.I., MANCIHA, I.M. 2007, Non-digestible oligosaccharides: A review. Carbohydrate 
Polymers, 68(3):587-597 
MUSZYNSKI, S., ŚWISTKIEWICZ, A., ARCZEWSKA-WTOSEK, P., DOBROWOLSKI, J.L., VALVERDE-PIEDRA, 
M.B., ARCISZEWSKI, S., SZYMANCZYK, S., ZACHARKO-SIEMBIDA, A., KOWALIK, S., HUTAS-STASIAK, M., 
TOMCZYK-WARUNEK, A., SCHWARZ, T., TOMASZEWSKA,E. 2019, Analysis of mechanical properties of 
bones and tendons shows that modern hybrid rye can be introduced to corn-wheat based diet in 
broiler chickens as an alternative energy source irrespective of xylanase supplementation, Poultry 
Science, 98(11): 5613-5621 
NEETESON-VAN_NIEUWENHOVEN, A.M., KNAP, P., AVENDANO, S. 2013, The role of sustainable 
commercial pig and poultry breeding for food security. Animal Frontiers, 3(1):52-57 
NIME, SA. PAL,B. DILIPKUMAR,S. 2015, Free radicals, antioxidants and their reaction mechanisms. 
Review for the Royal Society of Chemistry [Online]: 
https://pubs.rsc.org/en/content/articlehtml/2015/ra/c4ra13315c Accessed 11/01/2020 
NISHIDA, N., ARIZUMI, T., TAKITA, M., KITAI, S., HAGIWARA, S., MINAMI, Y., UESHIMA, K., SAKURAI, T., 
KUDO, M. 2013, Reactive oxygen species induce epigenetic instability through formation of 8-
hydroxydeoxyguanosine in human hepatocarcinogenesis. Digestive Diseases, 31(5-6):459-466 
NOGUES, M.R., GIRALT, M., CERVELLO, I. 2002, Parameters related to oxygen free radicals in human 
skin: a study comparing healthy epidermis and skin cancer tissue. The Journal of Investigative 
Dermatology, 119(3):645-652 
NOGUCHI, T., CANTOR, A.H., SCOTT, M.L. 1973, Mode of action of selenium and vitamin E in 
prevention of exudative diathesis in chicks. Journal of Nutrition, 103:1502-1511 
NORTEY, T.N., PATIENCE, J.F., SIMMONS, P.H., TROTTIER, N.L., ZIJLSTRA, R.T. 2007, Effects of 
individual or combined xylanase and phytase supplementation on energy, amino acid and phosphorus 
digestibility and growth performance on grower pigs fed wheat-based diets containing wheat millrun. 
Journal of Animal Science, 85(6):1432-1443 
OCK, C.Y., KIM, E.H., CHOI, D.J., LEE, H.J., HAHM, K.B., CHUNG, M.H. 2012, 8-hydroxydeoxyguanosine: 
not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal 
diseases. World Journal of Gastroenterology, 18(4):302-308 
OLNOOD, C.G., SLEMAN, BESKI, S.M., CHOCT, M., IJI, J. 2015. Novel probiotics: Their effects on growth 
performance, gut development, microbial community and activity of broiler chickens, Animal 
Nutrition, 1(3)184-191 
OLUYINKA AO, COWIESON AJ, ADEOLA O. 2007, Energy utilization and growth performance of broilers 
receiving diets supplemented with enzymes containing carbohydrase or phytase activity individually 
or in combination. British Journal of Nutrition,99:682-690 
ONRUST, L., DUCATELLE, R., DRIESSCHE, K., MASSCHALCK, C., VERMEULEN, K., HAESEBROUCK, F., 
EECKHAUT, V., IMMERSEEL, F. 2015, Steering endogenous butyrate production in the intestinal tract 
of broilers as a tool to improve gut health. Veterinary Science, 2(75)[online] 
https://www.frontiersin.org/articles/10.3389/fvets.2015.00075/full Accessed 22/04/2020 
OWENS, B., TUCKER, L., COLLINS M.A., McCRACKEN, K.J. 2008, Effects of different feed additives alone 
or in combination on broiler performance, gut microflora and ileal histology. British Poultry Science, 
49(2):202-212 
209 
 
PADAYATTY, S., KATZ, A., & WANG, Y., ECK, P., KWON, O., LEE, J., CHEN, S., CORPE, C., DUTTA, A., 
DUTTA, S., LEVINE, M. 2003, Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention. 
Journal of the American College of Nutrition, 22:18-35. 10.1080/07315724.2003.10719272. 
PALFRAMAN, R.J., GIBSON, G.R., RASTALL, R.A. 2003, Carbohydrate preferences of Bifidobacterium 
species isolated from the human gut. Current Issues in Intestinal Microbiology, 4:71-75 
PAN, D., YU, Z. 2014, Intestinal microbiome of poultry and its interaction with host and diet. Gut 
microbes, 5(1):108–119. https://doi.org/10.4161/gmic.26945 
PARRTY, A., LUOTO, R., KALLIOMAKI, M., SALMINEN, S., ISOLAURI, E. 2013, Effects of early prebiotic 
and probiotic supplementation on the development of gut microbiota and fussing and crying in 
preterm infants. Journal of Paediatrics, 163(5):1272-1277 
PENG, Y.L., GUO, Y.M., YUAN, J.M. 2004, Effects of feeding xylose on the growth of broilers and 
nutrient digestibility as well as the absorption of xylose in the portal-drained viscera. Asian-
Australasian Journal of Animal Science, 14(8):1123-1130 
PENNER, G. 2014, Mechanisms of volatile fatty acid absorption, metabolism and maintenance of a 
stable rumen environment. University of Saskatchewan http://edfman.it/images/speakers/Greg-
Penner-2014---Mechanisms-of-VFA-Absorption-metabolism-and-mainten_.pdf 
PETRACCI, M., SOGLIA, F., MADRUGA, M., CARVALHO, L., IDA, E., ESTEVEZ, M. 2019, Wooden breast, 
white striping and spaghetti meat: causes, consequences and consumer perception of emerging 
broiler meat abnormalities. Comprehensive reviews in Food Science and Food Safety. 18(2):565-583 
PETERSON, C.T., SHARMA, V., ELMEN, L., PETERSON, S.N. 2015, Immune homeostasis, dysbiosis and 
therapeutic modulation of the gut microbiota. Clinical and Experimental Immunology, 179(3):363-377 
PIRGOZLIEV, V., ROSE, S.P., PELLNY, T., AMERAH, A.M., WICKRAMASINGHE, M., ULKER, M., RAKSZEGI, 
M., BEDO., Z., SHEWRY., P.R., LOVEGROVE, A.. 2015, Energy utilization and growth performance of 
chickens fed novel wheat inbred lines selected for different pentosan levels with and without xylanase 
supplementation. Poultry Science, 94(2):232-239 
PIZZINO, G., IRREA, N., CUCINOTTA, M., PALLIO, G., MANNINO, F., ARCORACI, V., SQUADRITO, F., 
ALTAVILLA, D., BITTO, A. 2017, Oxidative stress: Harms and benefits for human health. Oxidative 
Medicine and Cellular Longevity. 2017(2017) [Online] 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551541/#B26 Accessed 07/04/2020 
PODMORE, I.D., GRIFFITHS, H.R., HERBERT, K.E., MISTRY, N., MISTRY, P., LUNEC, J. 1998, Vitamin C 
exhibits pro-oxidant properties. Nature, 392(559) 
POPULATION REFERENCE BUREAU 2019, population data sheet [online]: 
https://www.prb.org/worldpopdata/ 
POURABEDIN, M., GUAN, L., ZHAO, X. 2015, Xylo-oligosaccharides and virginiamycin differentially 
modulate gut microbial composition in chickens, Microbiome, 2015(3):15 
PRYOR, W.A. (1986) Oxy-radicals and related species: their formation, lifetimes and reactions, Annual 
Review of Physiology, 48(1):657-667 
RAMKRISHNA, D.S., BANERJEE, J., ARORA, A. 2015, Prebiotic potential of oligosaccharides. Bioactive 
Carbohydrates and Dietary Fibre, 5(1):19-30 
RANA, M. 2018, Impact of stocking density, dietary supplementation of optifeed and veopremium on 
the behaviours of broiler chicks. 11th Asia Pacific Poultry Conference, (APPC, 2018, Bangkok). 
https://www.researchgate.net/publication/325987100_IMPACT_OF_STOCKING_DENSITY_DIETARY_S
210 
 
UPPLEMENTATION_OF_OPTIFEED_AND_VEOPREMIUM_ON_THE_BEHAVIOR_OF_BROILER_CHICKS_1
1th_Asia_Pacific_Poultry_Conference_APPC_2018_Bangkok 
RAO R. 2008. Oxidative stress-induced disruption of epithelial and endothelial tight 
junctions. Frontiers in bioscience : a journal and virtual library, 1(13): 7210–7226. 
https://doi.org/10.2741/3223 
RATHGEBER, B.M., BUDGELL, K.L., MACLSAAC, J.L., MIRZA, M.A., DONCASTER, L. 2008, Growth 
performance and spleen and bursa weights of broilers fed yeast beta-glucan. Canadian Journal of 
Animal Science, 88:469-473 
RAVN, J.L., THOGERSEN, J.C., EKLOF, J., PETTERSSON, D., DUCATELLE, R., IMMERSEEL, F., PEDERSEN, 
N.R. 2017, GH11 xylanase increases prebiotic oligosaccharides from wheat bran favouring butyrate-
producing bacteria in vitro. Animal Feed Science and Technology, 226(2017):113-123 
RAZA, A., BASHIR, S., TABASSUM, R. 2019, An update on carbohydrases: growth performance and 
intestinal health of poultry. Heliyon, 5(4), e01437. https://doi.org/10.1016/j.heliyon.2019.e01437 
REECE, J.B., URRY, L.A., CAIN, M.L., MINORSKY, P.V., JACKSON, R.B. 2014, Campbell’s Biology, 10th 
edition, Pearson, USA 
RIBEIRA, T., CARDOSO, L.M.A., FERREIRA, L.M.A., LORDELO, M.M.S., COELHO, E., MOREIRA, A.S.P., 
DOMINGUES, M.R.M., COIMBRA, M.A., BEDFORD, M.R., FONTES, C.M.G.A. 2018, Xylo-
oligosaccharides display a prebiotic activity when used to supplement wheat or corn-based diets for 
broilers. Poultry Science, 97(1):4330-4341[online] https://academic.oup.com/ps/advance-
article/doi/10.3382/ps/pey336/5067930 
ROBERFROID, M.B., GIBSON, G.R., HOYLES, L., McCARTNEY, A.L., RASTALL, R., ROWLAND, I. 2010, 
Prebiotics effects: metabolic and health benefits. British Journal of Nutrition, 104(2):s1-63 
ROBERFROID, M., SLAVIN, J. 2000., Nondigestible Oligosaccharides. Critical reviews in Food Science 
and Nutrition, 40 :461-480 
ROSICKA-KACZMAREK, J., TKACZYK, M., MAKOWSKI, B., KOMISARCZYK, A., NEBESNY, E. 2017, The 
influence of non-starch polysaccharide on the thermodynamic properties of starches from facultative 
wheat varieties, European Food Research and Technology, 243(1):2243-2253 [Online] Available at: 
https://link.springer.com/content/pdf/10.1007%2Fs00217-017-2926-y.pdf 
ROEDIGER, W.E.W. 1982, Utilization of nutrients by isolated epithelium-cells of the rat colon. 
Gastroenterology, 83:424-429 
ROOS, E., SUNDBERG, C., TIDAKER, P., STRI, I., HANSSON, P., 2013. Cab carbon footprint serve as an 
indicator of the environmental impact of meat production. Ecological Indicators, 2013(24):573-581 
RUBIO, L.,2019. Possibilities of early life programming in broiler chickens via intestinal microbiota 
modulation, Poultry Science, 98(2):695-706 
RYCROFT, C.E., JONES, M.R., GIBSON, G.R., RASTALL, R.A. 2001, A comparative in vitro evaluation of 
the fermentation properties of prebiotic oligosaccharides. Journal of Applied Microbiology, 91:878-
887 
SAKI, A.A., ALIPANA, A. 2005, Effect of dietary wheat screening diet on broiler performance, intestinal 
viscosity and ileal protein digestibility. International Journal of Poultry Science, 4(1):16-20 
SAKO, T., MATSUMOTO, K., TANAKA, R. 1999, Recent progress on research and applications of non-
digestible galacto-oligosaccharides. International Dairy Journal, 9:69-80  
211 
 
SALAMI, S. A., MAJOKA, M. A., SAHA, S., GARBER, A., GABARROU, J.F. 2015, Efficacy of Dietary 
Antioxidants on Broiler Oxidative Stress, Performance and Meat Quality: Science and Market. Avian 
Biology Research, 8(2), 65–78. https://doi.org/10.3184/175815515X14291701859483 
SALEH, A.A., KIRRELLA, A.A., ABDO, S.E., MOUSA, M.M., BADWI, N.A., EBEID, T.A., NADA, A.L., 
MOHAMED, M.A. 2019, Effects of dietary xylanase and arabinofuranosidase combination on growth 
performance, lipid oxidation, blood constituents and immune response of broilers fed low energy 
diets. Animals, 9(7):467-479 
SALLES, G.B.C., BOIAGO, M.M., SILVA, A.D., MORSCH, V.M., GRIS, A., MENDES, R.E., BALDISSERA, M.D., 
DA SILVA, A.S. 2019, Lipid Peroxydation and protein oxidation in broiler breast fillets with white 
striping myopathy. Journal of Food Biochemistry, 43(4): 
https://www.ncbi.nlm.nih.gov/pubmed/31353592 
SANTOS, F., BOREM, A., CALDAS, C. 2015, Sugarcane, Agricultural production, Bioenergy and ethanol. 
Elsevier, USA. https://www.sciencedirect.com/book/9780128022399/sugarcane 
SEBASTIAN., S., TOUCHBURN, S.P., CHAVEZ, E.R., LAGUE, P.C. 1996, The effects of supplemental 
microbial phytase on the performance and utilization of dietary calcium, phosphorus, copper and zinc 
in broiler chickens fed corn and soybean diets. Poultry Science, 75(6):729-736 
SCANES. C.G. 2007, The Global Importance of Poultry. Poultry Science, 86(6): 1057-1058 
SCHELLER, H.V., ULVSKOV, P. 2010, Hemicelluloses. Annual Review of Plant Biology, 61:263-289 
SCHEPPACH, W., BARTRAM, H.P., RICHTER, F. 1995, Role of short-chain fatty acids in the prevention of 
colorectal cancer. European Journal of Cancer, 31A:1177-1080 
SCHOLEY, D.V. 2012, Optimisation of distillery co-products for poultry feed. PhD Thesis. [Online] 
Available at: http://irep.ntu.ac.uk/id/eprint/144/1/211222_Dawn.Scholey-
2012%20incl.3rdpartycopyright.pdf 
SCOTT, K.P., MARTIN, J.C., DUNCAN, S.H., FLINT, H.J. 2014, Prebiotic stimulation of human colonic 
butyrate-producing bacteria and bifidobacteria, in vitro. Nutritional research and reviews, 87: 259-275 
SELL-KUBIAK, E., WIMMERS, K., REYER, H., SZWACZKOWSKI, T. 2017, Genetic aspects of feed 
efficiency and reduction of environmental footprint in broilers: a review. Journal of Applied Genetics, 
58(4):487-498 
SELLE, P.H., RAVINDRAN, G., PITTOLO, P.H., BRYDEN, W.L. 2003, Influence of phytase and Xylanase 
supplementation on growth performance and nutrient utilisation of broilers offered wheat-based 
diets. Asian-Australian Journal of Animal Science, 16(3):394-402 
SELL-KUBIAK, E., WIMMERS, K., REYER, H., SZWACZKOWSKI, T. 2017, Genetic aspects of feed 
efficiency and reduction of environmental footprint in broilers: a review. Journal of Applied Genetics, 
58(4):487-498 
SHAW, A.L., BLAKE, J.P. and Moran, E.T. 2010, Effects of flesh attachment on bone breaking and 
phosphorus concentration on performance of broilers hatched from young and old flocks. Poultry 
Science, 89(2):295-302 
SHENDARE, R.C., GONGLE, M.A., RAJPUT, A.B., WANJARI, B.V., MANDLEKAR, S.M. 2008, Effect of 
supplementation of manno-oligosaccharides and b-glucans on maize based meal on commercial 
broilers. Veterinary World, 1(1):13-15 
SHERMER, W.D. and CALABOTTA, D.F. 1985, Oxidation of feed: How much has occurred? Feedstuffs, 
4, 19–20. 
212 
 
SHORT, F.J., GORTON, P., WISEMAN, J. and BOORMAN, K.N. 1996, determination of titanium dioxide 
added as an inert marker in chicken digestibility studies. Animal Feed Science and Technology, 
59(4):215-221 
SIES, H. (1996) Oxidative stress: oxidants and antioxidants. Experimental Physiology, 82:291-295 
SIHVO, H.K., IMMONEN, K., PUOLANNE, E. 2013, Myodegeneration with fibrosis and regeneration in 
the pectoralis major muscle of broilers. Veterinary Pathology, 51(3):619-623 
SILVERSIDE, F.G., BEDFORD, M.R. 1999, Enzymes may improve energy digestibility. Feedstuffs, 
71(9):15-17 
SIMON, D. 2000, Non starch polysaccharides (NSP) hydrolysing enzymes as feed additives: mode of 
action in the gastrointestinal tract. 
https://pdfs.semanticscholar.org/80f4/785df2ce5d85d31652e570b9893875e71292.pdf?_ga=2.13687
1536.1773285532.1587567546-1326316333.1587567546 Accessed on 22/04/2020 
SINGH, R., MANDAL, A.B., SHRIVASTAV, A.K. 2019, Amelioration of aflatoxin in coloured broiler 
chickens by dietary butylated hydroxytolulene. Engormix, 
https://en.engormix.com/mycotoxins/articles/amelioration-aflatoxicosis-coloured-broiler-
t43357.htm Accessed 22/03/2020 
SINGER, R.S., HOFACRE, C.L. 2006, Potential Impacts of Antibiotic Use in Poultry Production. Avian 
Diseases, 50(2):161-172 
SIRAGUSA, G.R., HAAS, G.J., MATTHEWS, P.D., SMITH, R.J., BUHR, R.J., DALE, N.M., 2008. Antimicrobial 
activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and 
caecum. The Journal of Antimicrobial Chemotherapy, 61 (4), 853-858. 
SLAVIN, J., 2013, Fibre and prebiotics: mechanisms and health benefits. Nutrients,5(4):1417-1435 
SMIRICKY-TJARDES, M.R., FLICKINGER, E.A., GRIESHOP, C.M., BAUER, L.L., MURPHY, M.R., FAHEY, G.C. 
2003, In vitro fermentation characteristics of selected oligosaccharides by swine fecal microflora. 
Journal of Animal Science, 81:2505-2514 
SOERENSEN,J.F., KRAGH, K.M., SIBBESEN, O., DELCOUR, J.A., GOESAERT, H., SVENSSON, B., TAHIR, T., 
2004, Potential role of glycosidase inhibitors in industrial biotechnological applications. Biochimica et 
Biophysica Acta (BBA) - Proteins & Proteomics, 1696:275-287. 
SOGLIA, F., MUNDALAL, S., BABINI, E., DI NUNZIO, M., MAZZONI, M., SIRRI, F., CAVANI, C., PETRACCI, 
M. 2016, Histology, composition and quality traits of chicken pectoralis major muscle affected by 
wooden breast abnormality. Poultry Science, 95(3):651-659 
SOHAIL, S.S., ROLAND, D.A. 1999, Influence of supplemental phytase on performance of broilers four 
to six weeks of age. Poultry Science, 78(4):550-555 
SOLIS de los SANTOS, F., FARNELL, M.B., TELLEZ, G., BALOG, J.M., ANTHONY, N.B., TORRES-
RODRIGUEZ, A., HIGGINS, S., HARGIS, M., DONOGHUE, A.M. 2005, Effect of prebiotic on gut 
development and ascites incidence of broilers reared in a hypoxic environment. Poultry Science, 
84(7):1092-1100 
STANLEY, D., KEYBURN, A.L., DENMAN, S.E., MOORE, R.J. 2012, Changes in the caecal microflora of 
chickens following Clostridium perfringens challenge to induce necrotic enteritis. Veterinary 
Microbiology, 159(1-2):155-162. 
STURKIE, P.D. 1965, Avian Physiology, Fourth edition. Springer-Verlag, New York, USA 
213 
 
SUN, Z., Lv, W., YU, R., LI, Y., LUI, H., SUN, W., WANG, Z., LI, J., SHAN, Z., QIN, Y. 2013, Effect of a straw 
derived xylooligosaccharide on broiler growth and performance, endocrine metabolism, and immune 
response. Canadian Journal of Veterinary Research, 7(2): 105-109 
SUO,A., LU,L., XU,G., XIAO,L., CHEN,X., XIA,R., ZHANG,L., LUO,X. 2015, Effectiveness of dietary xylo-
oligosaccharides for broilers fed a conventional corn-soybean meal diet. Journal of Integrative 
Agriculture, 14(10):2050-2057, 
TAVEREZ, D.D., BOLER, K.N., BESS, J., ZHAO, F., YAN, A.C., DILGER, F.K. MCKEITH, J., KILLEFER, J., 2011, 
Effect of antioxidant inclusion and oil quality on broiler performance, meat quality, and lipid 
oxidation. Poultry Science, 90(4): 922-930 
TAVEREZ, M.A., SOLIS, F. 2016. Impact of genetics and breeding on broiler production performance: A 
look into the past, present, and future of the industry. Animal Frontiers, 6 (4):37-41 
TENG, P.Y., KIM, W.K. 2018, Review: Roles of prebiotics in intestinal ecosystem of broilers, Frontiers of 
Veterinary Science, 5(1):245 
THE WORLD HEALTH ORGANIZATION. 2012, Guidelines for evaluation of probiotic food. 
https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf Accessed 02/04/2020 
TIAN, S., WANG, J., YU, H., WANG, J., ZHU, W. 2018, Effects of galacto-oligosaccharides on growth and 
gut function of newborn suckling piglets. Journal of Animal Science and Biotechnology, 9(75) [online] 
https://jasbsci.biomedcentral.com/articles/10.1186/s40104-018-0290-9 Accessed 01/05/2020 
 TIMBERMOUNT, L., LANCKRIET, A., DEWULF, J., NOLLET, N., SCHWARZER, K., HAESEBROUCK, F., 
DUCATELLE, R., VAN IMMRSEEL, F. 2010, Control of Clostridium perfringens-induced necrotic 548 
enteritis in broilers by target-released butyric acid, fatty acids and essential oils. Avian Pathology, 549 
(39):117-121.  
TOBLER, M., SANDELL, M., CHIRIAC, S., HASSELQUIST, D. 2013, Effects of prenatal testosterone 
exposure on antioxidant status and bill colour in adult zebra finches. Physiological and Biochemical 
Zoology, 86(3):333-345 
TOBLER, M., SANDELL, M. 2009, Sex-specific effects of prenatal testosterone on nestling plasma 
antioxidant capacity in the zebra finch. Journal of Experimental Biology, 212(1):89-94 
TONA, K., BAMELIS, F., COUKE, V., BRUGGEMAN, V., DECUYPERE, E. 2001, Relationship between 
broiler breeders age and egg weight loss and embryonic mortality during incubation in large scale 
conditions. Journal of Applied Poultry research, 10:221-227 
TSIRTSIKOS, P., FEGEROS, K., KOMINAKIS, A., BALASKAS, C., MOUNTZOURIS, K. 2012, Modulation of 
intestinal mucin composition and mucosal morphology by dietary phytogenic inclusion level in 
broilers. Animal, 6(7):1049-1057 
VALLS, C., PASTOR, F., VIDAL, T., RONCERO, M.B., DIAZ, P., MARTINEZ, J., VALENZUELA, S.V. 2018, 
Antioxidant activity of xylooligosaccharides produced from glucuronoxylan by xyn10A and Xyn30D 
xylanases and eucaliptus autohydrolysates. Carbohydrate Polymers, 194(2018):43-50 
VAN DER HULST, R.R.W.J. VON MEYENFELDT, M.F., VAN KREEL, B.K., THUNNISSEN, F.B., BRUMMER, 
R.J., ARENDS, J.W., SOETERS, P.B. 1998, Gut permeability, intestinal morphology, and nutritional 
depletion. Nutrition, 14(1998):1-6  
VANDECASTEELE, B., REUBENS, B., WILLEKENS, K. 2014, Composting for Increasing the Fertilizer Value 
of Chicken Manure: Effects of Feedstock on P Availability. Waste Biomass Valor, 5:491–503 (2014). 
https://doi.org/10.1007/s12649-013-9264-5 
214 
 
VANDENPLAS, Y. 2002, Oligosaccharides in infant formula. British Journal of Nutrition, 87(S2):293-296 
VANDEPLAS, S., DAUPHIN, R.D., THONART, P., THEWIS, A., BECKERS, Y. 2010, Effect of bacterial or 
fungal origin of exogenous xylanases supplemented to a wheat-based diet on performance of broiler 
chickens and nutrient digestibility of the diet. Canadian Journal of Animal Science, 90(2):22   
VANNONI, V., LYNCH, M., GOLDSTEIN, S., SATO, P. 1974, A rapid determination for the determination 
of ascorbic acid in plasma and tissues. Biochemical Medicine, 11(1):41-48  
VASDAL, G., GRANQUIST, E.G., SKJERVE, E., JONG, I., BERG, C., MICHEL, V., OPPERMANN MOE, R. 
2019, Associations between carcass weight uniformity and production measures on farm and at 
slaughter in broiler flocks. Poultry Science, 98(10):4261-4268 
VIVEROS, A., BRENES, A., PIZARRO, M., CASTANO, M. 1994, Effect of Enzyme supplementation of a 
diet based on barley and autoclave treatment, on apparent digestibility, growth performance and gut 
morphology of broilers. Animal Feed Science& Technology, 48:237-251 
VORAGEN, A.G.J. 1998, Technological aspects of functional food-related carbohydrates. Trends in 
Food Science and Technology, 9(1998):328-335 
WALDROUP, P.W., DOUGLAS, C.R., MCCALL, J.I. and HARMS, R.H. 1960, The effects of santoquin on 
the performance of broilers. Poultry Science 39: 1313-1317.  
WALK, C.L., BEDFORD, M.R., McELROY, A.P. 2012, Influence of limestone and phytase on broiler 
performance, gastrointestinal pH, and apparent ileal nutrient digestibility. Poultry Science, 91(6):1371-
1378 
WANG, S.Y., BOTTJE, W., MAYNARD, P., DIBNER, J., SHERMER, W. 1997, Effect of Santoquin ® and 
Oxidized Fat on Liver and Intestinal Glutathione in Broilers. Poultry Science, 76: 961-967.  
WARNER, R. 2017, The eating quality of meat -IV Water holding capacity and juiciness. Lawrie’s Meat 
Science (Eighth edition), Woodhead Publishing Series in Food Science, pp419-459 
WATSON, B.C., MATTHEWS, J.O., SOUTHERN, L.L., SHELTON, J.L. 2006, The effects of phytase on 
growth performance and intestinal transit time of broilers fed nutritionally adequate diets and diets 
deficient in calcium and phosphorus. Poultry Science,85(3):493–497.  
WITKO-SARSAT, V., FRIEDLANDER, M., CAPEILLERE-BLANDIN, C. 1996, Advanced oxidation protein 
products as a novel marker of oxidative stress in uremia. Kidney International, 49(5):1304-1313 
WHITE, C.C., VIERNES, H., KREJSA, C.M., BOTTA, D., KAVANAGH, T.J. 2003, Fluorescence-based 
microtiter plate assay for glutatamate-cysteine ligase activity. Analytical Biochemistry, 318(2):175-180 
WICHIENCHOT, S., CHINACHOTI, P. 2011, Prebiotic oligosaccharides: Origins and production, health 
benefits, Properties and Applications. [online] 
https://www.researchgate.net/publication/281750231_Prebiotic_oligosaccharides_Origins_and_prod
uction_health_benefits_and_commercial_applications Accessed 11/04/2020 
WILLEMSEN, L., KOETSIER, M.A., VAN DEVENTER, S.J.H. 2003, Short chain fatty 551 acids stimulate 
epithelial mucin 2 expression through differential effects on prostaglandin E-1 and 552 E-2 production 
by intestinal myofibroblasts. Gut, 52:1442-1447. 553 61  
WONG, K.K., TAN, L.U., SADDLER, J.N. 1988, Multiplicity of B-1, 4-Xylanase in Microorganisms: 
Functions and Applications. Microbiological Reviews, 52(3):305-317 
WU, Y.B., RAVINDRAN, V. 2004, Influence of whole wheat inclusion and xylanase supplementation on 
the performance, digestive tract measurements and carcass characteristics of broiler chickens. Animal 
Feed Science and Technology, 116(1-2):129-139 
215 
 
WU. Y.B., RAVINDRAN, V., THOMAS, D.G., BIRTLES, M.J., HENDRIKS, W.H. 2004, Influence of phytase 
and xylanase, individually or in combination, on performance, apparent metabolisable energy, 
digestive tract measurements and gut morphology in broilers fed wheat- based diets containing 
adequate level of phosphorus. British Poultry Science, 45(1): 76-84 
WU, Y., YUMING, G., ZHONG, W., WEI, N. 2006, Effect of XOS on growth performance, intestinal 
physiology and morphology of broilers. Journal of China Agricultural university, 6(9):784-792 
WONG, K.K., TAN, L.U., SADDLER, J.N. 1988, Multiplicity of B-1, 4-Xylanase in Microorganisms: 
Functions and Applications. Microbiological Reviews, Sept. 52(3): 305-317 
YAMADA, H., ITOH, K., MORISHITA, Y., TANIGUCHI, H. 1993, Structure and properties of 
oligosaccharides from wheat bran. Cereal Foods World, 19(3):490-492 
YAN, F., LICHTENSTEIN, D., VAZQUEZ-ANON, M. 2016, Evaluation of xylanase form and dose in broilers 
fed wheat-based diets. Novus International https://en.engormix.com/poultry-
industry/articles/evaluation-xylanase-form-dose-t39257.htm Accessed 07/02/2020 
YANG, K., ZHANG., Y., CAI, M., GUAN, R., NENG, J., PI, X., SUN., X. 2020. In vitro prebiotic activities of 
oligosaccharides from the by-products in Ganoderma Lucidum spore polysaccharide extraction. Royal 
Society of Chemistry Advances, 2020(10):14794-14801 
 YEGANI, M., KORVER, D.R. 2008, Factors affecting intestinal health in poultry. Poultry Science, 
87(10):2052-2063 
YARANDI, S.S., PETERSON, D.A., TREISMAN, G.J., MORAN, T.H., PASRICHA, P.J 2016, Modulatory 
effects of gut microbiota on the central nervous system: How gut could play a role in neuropsychiatric 
health and diseases. Journal of Neurogastroenterology and Motility, 22(2):201-212 
YUAN, L., HUO, Q., DU, C., WANG, Z., YI, B., WANG, M. 2018, Effects of xylo-oligosaccharide and 
flavomycin on the immune function of broiler chickens. PeerJ 6: e4435 
https://doi.org/10.7717/peerj.4435 
ZHANG, W., XIAO, S., LEE, E.J., AHN, D. 2011, Consumption of oxidized oil increases oxidative stress in 
broilers. Journal of Agricultural and Food Chemistry, 59(3):969-974 
ZHANG, Q., EICHER, S.D., APPLEGATE, T.J. 2015, Development of intestinal mucin 2, IgA and polymeric 
Ig receptor expressions in broiler chickens and pekin ducks. Poultry Science, 94(2):172-180 
ZHANG, W.F., LI, D.F., LU, W.Q., YI, G.F. 2003, Effects of isomalto-oligosaccharides on broiler 
performance and intestinal microflora. Poultry Science, 82(4):657-663, 
ZHAO, N., WANG, X., LIU, H., LV, C., LU, J. 2020, Structural characterization and antioxidant activity of 
oligosaccharides from Panax ginseng C. A. Meyer. International Journal of Biological Macromolecules, 
150:737-745 
ZHONGHAO, Y., KASTENMULLER, G., HE, Y, BELCREDI, P., MOLLER, G. 2011, Differences between 
human plasma and serum metabolites profiles. PLoS One,6(7):e21230 
ZHOU, T., XUE, Y., REN, F., DONG, Y. 2018, Antioxidant activity of xylooligosaccharides prepared from 
thermotoga maritima using recombinant enzyme cocktail of b-xylanase glucuronidase. Journal of 
Carbohydrate Chemistry, 37(4):210-22 
ZUIDHOF, M. J., SCHNEIDER, B. L., CARNEY, V. L., KORVER, D. R.,ROBINSON, F. E. 2014, Growth, 
efficiency, and yield of commercial broilers from 1957, 1978, and 2005. Poultry science, 93(12), 2970–
2982. https://doi.org/10.3382/ps.2014-04291 
 
216 
 
 
 
Appendix 
 
Appendix A: Room plan for study 1 
      
19  20 41  42 
18  21 40  43 
17  22 39  44 
16  23 38  45 
15  24 37  46 
14  25 36  47 
13  26 35  48 
12  27 34   
11  28 33   
10  29 32  1 
9  30 31  2 
8      
 (pilot birds) 7 6 5 4 3 
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Appendix B: Room plan for study 2 and 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
     48 
     47 
01  23 24  46 
02  22 25  45 
03  21 26  44 
04  20 27  43 
05  19 28  42 
06  18 29  41 
07  17 30  40 
08  16 31  39 
09  15 32  38 
10  14 33  37 
11  13 34  36 
12     35 
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Appendix C: Vitamin and mineral pre-mix formulation for all studies 
 
CONSTITUENT VOLUME/KG DIET 
Calcium 10g 
Phosphorus 4.5g 
Sodium 1.5g 
Potassium 4.0g 
Chloride 1.5g 
Magnesium 0.6g 
Manganese 60mg 
Zinc 50mg 
Iron 80mg 
Copper 6mg 
Iodine 0.5mg 
Molybdenum 0.2mg 
Selenium 0.15mg 
Retinol 2.25mg 
Cholecalciferol 37.5g 
Tocopherol 10mg 
Menadione 3.0mg 
Thiamin 3.0mg 
Riboflavin 5.0mg 
Pantothenic acid 10mg 
Pyroxidine 4.0mg 
Niacin 30mg 
Cobalamin 10g 
Folic acid 1.5mg 
Biotin 0.15mg 
Choline 1.3g 
Amprolium 125mg 
Antioxidant 125mg 
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Appendix D: Diet allocation for study 1 
 
pen 
diet 
allocation   pen 
diet 
allocation 
pen 1 D   pen 25 D 
pen 2 C   pen 26 C 
pen 3 B   pen 27 B 
pen 4 A   pen 28 A 
pen 5 D   pen 29 D 
pen 6 C   pen 30 C 
pen 7 B   pen 31 B 
pen 8 A   pen 32 A 
pen 9 D   pen 33 D 
pen 10 C   pen 34 C 
pen 11 B   pen 35 B 
pen 12 A   pen 36 A 
pen 13 D   pen 37 D 
pen 14 C   pen 38 C 
pen 15 B   pen 39 B 
pen 16 A   pen 40 A 
pen 17 D   pen 41 D 
pen 18 C   pen 42 C 
pen 19 B   pen 43 B 
pen 20 A   pen 44 A 
pen 21 D   pen 45 D 
pen 22 C   pen 46 C 
pen 23 B   pen 47 B 
pen 24 A   pen 48 A 
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Appendix E: Diet allocations for Study 2 
Pen  Diet   Pen  Diet 
1 A   25 E 
2 B   26 F 
3 C   27 A 
4 D   28 B 
5 E   29 A 
6 F   30 B 
7 A   31 C 
8 B   32 D 
9 C   33 E 
10 D   34 F 
11 E   35 A 
12 F   36 B 
13 A   37 C 
14 B   38 D 
15 A   39 E 
16 B   40 F 
17 C   41 A 
18 D   42 B 
19 E   43 A 
20 F   44 B 
21 A   45 C 
22 B   46 D 
23 C   47 E 
24 D   48 F 
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Appendix F: Diet allocation for study 3 
pen 
diet 
allocation 
  pen 
diet 
allocation 
pen 1 A   pen 25 B 
pen 2 B   pen 26 C 
pen 3 C   pen 27 A 
pen 4 B   pen 28 A 
pen 5 A   pen 29 B 
pen 6 C   pen 30 C 
pen 7 C   pen 31 C 
pen 8 A   pen 32 B 
pen 9 B   pen 33 A 
pen 10 B   pen 34 A 
pen 11 C   pen 35 C 
pen 12 A   pen 36 B 
pen 13 C   pen 37 B 
pen 14 B   pen 38 A 
pen 15 A   pen 39 C 
pen 16 C   pen 40 A 
pen 17 A   pen 41 B 
pen 18 B   pen 42 C 
pen 19 A   pen 43 B 
pen 20 C   pen 44 C 
pen 21 B   pen 45 A 
pen 22 A   pen 46 C 
pen 23 B   pen 47 A 
pen 24 C   pen 48 B 
 
Appendix G: Original tables for study 1 with Removed diet and outliers included 
 
Table 3.1 – Dietary treatments for XOS/xylanase study 
Diet Treatment 
Control Standard broiler diet 
Control + XOS Standard broiler diet + 100g/t DDGS AX 
Control + XOS pre-treated 
with Xyl 
Standard broiler diet + 100g/t DDGS XAX Pre-treated with xylanase 
at 1g/kg 
Control + XOS + Xyl Standard broiler diet 100g/t DDGS AX + xylanase added at 1g/kg 
directly to diet 
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Table 3.4 Diet proximate analysis for AXOS 1 
Diet Start
er A 
Start
er B 
Start
er C 
Start
er D 
Grow
er A 
Grow
er B 
Grow
er C 
Grow
er D 
Finis
her A 
Finis
her B 
Finis
her C 
Finis
her 
D 
DM 
(%) 
87.3
1 
87.3
1 
87.6
4 
87.6
4 
87.2
2 
87.2
2 
87.4
7 
87.4
7 
87.13 87.13 87.07 87.07 
Ash 
(g/kg 
5.37 5.51 5.95 5.75 5.03 4.68 5.05 4.78 4.58 4.96 4.97 4.99 
Prot
ein 
(g/kg 
DM) 
21.4
2 
21.7
6 
22.1
6 
22.4
8 
20.2
1 
20.0
4 
20.8
1 
22.6
0 
19.02 18.55 20.72 19.00 
Total 
P 
(g/kg 
DM) 
8.80 7.93 8.39 8.32 7.29 8.06 7.58 7.50 6.88 6.45 6.72 7.43 
Total 
Ca 
(G/K
G 
DM) 
9.84 9.28 9.03 9.06 8.03 8.83 8.61 8.24 7.43 6.90 6.93 7.91 
Fat 
(g/kg
) 
4.41 4.21 4.04 4.11 5.48 5.83 5.01 4.93 5.85 5.69 5.66 5.87 
Ti 
(g/kg
) 
4.98 4.95 4.72 4.94 N/A N/A N/A N/A 5.01 4.84 4.40 4.27 
GE 
(mj/k
g) 
16.2
7 
16.3
0 
16.2
0 
16.2
8 
16.5
5 
16.4
5 
16.3
1 
16.4
7 
16.69 17.03 16.97 17.05 
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Table 4 – Performance results for the effect of birds supplemented with XOS either with or without 
xylanase added at 1g/kg compared to a control diet 
Diet D0-35 BWG 
(g/bird) 
D0-35 FI/bird (g) D0-35 FCR 
Control 1917 (42.8) 3499 (72.5)b 1.83 (0.035) 
Control + 100G/t XOS 1860 (44.2) 3533 (52.7)b 1.91 (0.087) 
Control + 100g/t XOS pre-treated with Xyl 1988 (52.5) 3873 (95.4)a 1.97 (0.087) 
Control +100g/t XOS +Xyl in diet 1862 (48.1) 3624 (69.9)ab 1.96 (0.077) 
P value 0.195 0.004 0.406 
Values in the table denote mean (standard error) 
 
Table 5 - Body weight gain by week results for the effect of birds supplemented with XOS either with 
or without xylanase compared to a control diet 
Diets D0-7 BWG 
(g/bird) 
D7-14 BWG 
(g/bird) 
D14-21 BWG 
(g/bird) 
D21-28 BWG 
(g/bird) 
D28-35 BWG 
(g/bird) 
Control 85 (206)b 222 (8.6) 380 (14.7) 533 (17.1) 696 (25.1) 
Control + XOS 92 (3.3)ab 228 (10.1) 372 (10.3) 511 (11.4) 656 (25.9) 
Control + XOS 
pre-treated Xyl 
100 (2.7)a 248 (8.4) 389 (14.4) 559 (14.1) 691 (16.5) 
Control + XOS + 
Xyl 
89 (3.1)ab 220 (9.9) 380 (13.3) 519 (14.2) 654 (13.6) 
P Value 0.007 0.140 0.856 0.103 0.335 
Trend control + 100g/t AXOS > (p=0.06) 
Values in the table denote mean (standard error) 
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Table 6 – Weekly feed intake of birds supplemented with XOS either with or without xylanase added 
at 1g/kg compared to a control diet 
Diet D0-7 FI 
(g/bird) 
D7-14 FI 
(g/bird) 
D14-21 FI 
(g/bird) 
D21-28 FI 
(g/bird) 
D28-35 FI 
(g/bird) 
Control 200 (13.4) 512 (25.9) 654 (21.9) 895 (22.7)b 1224 (40.1) 
Control + 
100G/T XOS 
213 (10.8) 535 (23.3) 685 (29.2) 876 (11.3)b 1225 (37.3) 
Control + 100g/t 
XOS pre treated 
with Xyl 
213 (10.5) 557 (22.3) 687 (28.8) 1032 (35.4)a 1341 (33.5) 
Control +100g/t 
XOS +Xyl in diet 
214 (12.3) 517 (21.6) 687 (33.1) 921 (23.3)b 1286 (40.5) 
P value 0.800 0.530 0.801 <0.001 0.116 
Values in the table denote mean (standard error) 
 
Table 7 – Immunoglobulin results for of birds supplemented with XOS either with or without xylanase 
added at 1g/kg to a control diet 
Diet D7 IGA D35 IGA D7 IGM D35 IGM 
Control 0.12 (0.012) 0.35 (0.064) 0.05 (0.000) 0.09 (0.005) 
Control + XOS 0.12 (0.007) 0.44 (0.080) 0.06 (0.005) 0.10 (0.007) 
Control + XOS pre-treated with Xyl 0.16 (0.019) 0.40 (0.040) 0.06 (0.007) 0.11 (0.007) 
Control +XOS +Xyl in diet 0.21 (0.050) 0.40 (0.050) 0.06 (0.007) 0.10 (0.004) 
P Value 0.078 0.740 0.955 0.399 
Values in the table denote mean (standard error) 
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at 1g/kg compared to a control diet 
 
Diet 
AME diet 
D35 
Ni ret diet 
D35 
AMEn 
D35 
AME  D7 Ni ret diet 
D7 
AMEn D7 
Control 10.3 (0.72) 25.5 (0.27) 9.4 (0.71) 6.1 (0.81) 24.6 (0.57) 5.3 (0.79) 
Control + XOS 11.1 (0.45) 23.0 (0.25) 10.4(0.44) 6.2 (0.55) 25.3 (0.47) 5.3 (0.55) 
Control + XOS pre treated 
with Xyl 
10.9 (0.65) 25.9 (0.26) 9.9(0.64) 4.6 (0.54) 23.5 (0.62) 3.8 (0.52) 
Control +XOS +Xyl in diet 11.3 (0.60) 24.9 (0.32) 10.4(0.59) 4.9 (0.41) 24.4 (0.27) 4.1 (0.40) 
p Value 0.713 0.000 0.668 0.145 0.134 0.145 
Values in the table denote mean (standard error) 
 
Table 9 - D35 Ileum and caeca weights of birds supplemented with XOS either with or without 
xylanase added at 1g/kg compared to a control diet 
Diet Illeal 
Weight Full (g) 
Illeal Weight 
Empty (g) 
Caeca weight 
Full (g) 
Control 39.1 ab (2.03) 20.5 (0.72) 8.9 (0.54) 
Control + 100G/t XOS 38.9 ab (1.74) 20.3 (0.66 8.9 (0.42) 
Control + 100g/t XOS pre-treated with Xyl 43.8 a (1.39) 22.6 (0.85) 9.7 (0.58) 
Control +100g/t XOS +Xyl in diet 37.1 b (1.64) 20.7 (0.91) 8.9 (0.43) 
P value 0.049 0.187 0.554 
Values in the table denote mean (standard error) 
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Chapter 5 was appended to a supplementary chapter at the viva 
Chapter 5 - Novel antioxidant methodologies 
5.1 Introduction 
 
It has been demonstrated that some oligosaccharides may have antioxidant properties (Zhao et al., 
2020). Emerging literature has indicated that oxidative stress, and particularly lipid peroxidation may 
be responsible for damaging the integrity of the tight junctions in the gut epithelium (Rao, 2008). In 
addition to this, an ongoing problem with breast muscle myopathies has been identified which may 
be linked to oxidative stress. Following an approach from Knight Scientific, the use of novel 
antioxidant assays was discussed in order to quantify any antioxidant properties of the XOS products 
used in this project. Knight Scientific have developed a number of assays for quantifying the total 
antioxidant capacity of a substance, or the ability of a substance to quench various reactive oxygen 
species (singlet and halogenated oxygens and peroxynitrite radicals). 
 These assays were demonstrated to be highly sensitive and accurate in humans and were entirely 
novel in the poultry sector. These assays use Pholasin™, a substance extracted from the light organs 
of a marine mollusc. Pholasin™ emits light when exposed to free radicals. This can then be used to 
compare the quenching ability of unknown substance as the quenching reduces light emitted and/or 
time to maximum light peak. The assays use the reaction between super oxide and nitric oxide 
released simultaneously and continually from a solution of 3-morpholino-sydnonimine HCl to release 
reactive oxygen species in situ, thus allowing changes in the light emitted by the Pholasin™ to be 
measured by a chemiluminescent plate reader. These novel methods had been validated in horses 
(Knight and Larkins, 2003), humans ( Knight et al.,2002) and wild birds (Tobler and Sandell, 2009; 
Tobler et al., 2013), but to date had not been assessed in broilers.  
Initially, the aim was to determine the oxidative status of Ross 308 commercial broilers and to 
compare this to a backyard ‘pet’ bird to determine from the relative levels of oxidative stress present. 
The hypothesis was that the commercial birds would be experiencing high levels of oxidative stress 
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compared to an average backyard housed bird. The intense genetic selection for enhanced increased 
growth rate and enhanced commercial performance have been reported to place the birds under 
high levels of oxidative stress (Fellenburg and Spiesky, 2006). This together with the environmental 
conditions that broilers experience (high stocking density and high ammonia levels) are reported to 
increase the risk of oxidative stress (Fellenburg and Speisky, 2006). For the first part of this study, 
blood samples analysed were from the broiler trial described in chapter 4. These were used to 
determine a base level of oxidative stress in broilers and compare it to that of a backyard raised pet 
chicken. Secondly, the feed samples from the broiler trial described in chapter 4 and a number of 
commercially available XOS samples were analysed to assess their antioxidant capacity. A pilot 
collection study was performed to ensure that the optimal method of blood collection and storage 
were determined for the peroxynitrite assay. Additionally, we hypothesized that the method of 
euthanasia may affect the levels of peroxynitrite that could be detected, due to potential stress to the 
bird during this process, so this was also investigated. Peroxynitrite was selected as an appropriate 
measure for these assessments it is the major pre-cursor to lipid peroxidation. Lipid peroxidation is of 
particular relevance to the poultry industry as it is thought to be the primary cause of the common 
poultry muscle meat myopathies such as woody breast (Huang and Ahn, 2018). It was hoped that this 
particular assay would be a good prediction marker for these muscle meat myopathies. The 
antioxidant properties of broiler diets and commercial XOS products were also investigated to assess 
whether an in vitro measure of antioxidant status could be valid for feed and supplements, to allow 
selection of new antioxidant feed ingredients in the future. 
Exogenous Antioxidants 
Antioxidants have been defined as “substances that, when present in low concentrations compared 
to an oxidizable compound (e.g., DNA, proteins, lipids or carbohydrates), delay or prevent oxidative 
damage caused by the presence of reactive oxygen species” (Gutteridge, 1990).  Endogenous and 
exogenous antioxidants are able interact synergistically in order to maintain homeostasis (Bouayed 
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and Bohn, 2010). Exogenous antioxidants are found in numerous foods and as such, intake can aid the 
prevention of oxidative stress. Antioxidants exist as nutrients such as vitamins or phytochemicals such 
as polyphenols. Dietary antioxidants contribute to the reinforcement of the human/animal 
antioxidant systems by removing excess oxygen metabolites. Complete foods containing naturally 
occurring antioxidants have been widely recommended for humans and animals in an effort to 
prevent the deleterious effect of oxidative stress (Bouayed and Bohn, 2010, The department of 
Health, 2008). Common dietary antioxidants include fruits vegetables and food preservation 
substances. Most synthetic antioxidants are derived from phenolic structures such as butylated 
hydroxyanisol, butylated hydroxytoluene. (Fellenburg and Speisky, 2006). Whilst many fruits and 
vegetables do indeed contain antioxidants, unfortunately they are not always bioavailable to animals 
and often cannot be synthesized (Bouayed and Bohn, 2010). Likewise, some plant-based antioxidants 
such as quercetin, when delivered in high quantities potentate super oxide radical production within 
isolated mitochondria and cultured cells (De Marchi et al., 2009, Bouayed and Bohn, 2010). As such 
the actual total antioxidant capacity for a given species must be considered in order to 
prevent/control oxidative stress. 
 The key aim of this work was to investigate the informative ability of novel antioxidant assays to 
accurately assess the oxidative status of broilers and antioxidant capacity of broiler feed. Secondly, 
this work aimed to assess the most appropriate sampling procedures for their use in broilers. The 
objectives were as follows : 
• To begin to quantify the oxidative status of Ross 308 commercial broiler  
• To determine optimal blood collection, storage and euthanasia methods for optimal sample 
analysis using the peroxynitrite assay 
• To determine whether a number of commercial xylo-oligosaccharides possess the ability to 
quench singlet or halogenated oxygen species  
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5.2 Materials and Methods 
 
The samples used in this chapter are from control birds taken from commercial studies. All birds were 
raised under trial conditions at the PRU therefore all husbandry information is as previously stated in 
section 2.2. All birds were fed commercial style mash diets formulated for the age and strain of the 
bird, and samples taken in addition to the required trial procedures. All studies were approved by the 
college ethics committee. 
 
5.2.1 Pilot study to determine whether euthanasia method affects the peroxynitrite levels in blood 
Twenty Ross 308, 35 day old  broilers were euthanized by either cervical dislocation (10) or captive 
bolt using a 0.22mm pellet to fire (Cash small animal tool, Frontmatec, UK) (10). The captive bolt was 
operated by a trained user and two handlers were used to restrain the bird in order to minimise 
stress.  Blood samples were collected immediately post-mortem (as described in section 2.4.2) and 
split in to either a serum, heparin or EDTA tube and serum or plasma analysed for peroxynitrite (as 
described in section 2.5.15). Results were also adjusted for body weight of the birds and calculated as 
VEA per kg BW (µmol/L).  
 
5.2.2 Pilot study to determine whether the type of blood tube/anticoagulant used to collect the blood 
sample effects the levels of peroxynitrite detected in the blood.  
Blood samples were collected from twenty Ross 308 male birds (all 35 days of age) and split in to 
three tubes containing, heparin, EDTA or plain serum tubes, respectively. The samples were 
centrifuged immediately after the final sample had been collected as described in section 2.4.2 and 
the plasma or serum aliquoted into fresh tubes. Each sample was analysed according to the 
procedure for the peroxynitrite assay (section 2.5.15). Results were also adjusted for body weight of 
the birds and calculated as VEA per kg BW (µmol/L).  
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5.2.3 Pilot study to determine whether freezing the samples effects the levels of peroxynitrite present 
in the sample.  
The 20 samples used in the previous pilot study (section 5.2.2) were analysed fresh on the same day 
as collection, then the samples were frozen at -20°C  for 1 week. Samples were then thawed at room 
temperature prior to reanalysis to determine whether freeze thaw cycles detrimentally affected the 
assay results. Results were also adjusted for body weight of the birds and calculated as VEA per kg BW 
(µmol/L).  
 
5.2.4 Pilot study to determine whether diet effects peroxynitrite levels in the blood 
The twenty birds used in sections 5.2.1, 5.2.2 and 5.2.3 were all taken from the control treatment of a 
commercial trial Birds were all fed a balanced, wheat/corn/soy diet fed in three phases formulated for 
the age and strain of bird. Results were adjusted for body weight of the birds and calculated as VEA 
per kg BW (µmol/L).  
 
5.2.5 Determination of oxidative status – ABEL TAC™ (peroxynitrite assay) - Blood 
The blood samples taken for animal study 2 (chapter 4) were used to determine oxidative status of 
birds fed trial diets. On day 42, blood samples from 48 birds (1 bird per pen) were centrifuged in 
serum tubes and the serum retained for the analysis. An ABEL TAC™ kit was used to analyse the 
serum fresh as described in section 2.5.16. Results were also adjusted for body weight of the birds 
and calculated as VEA per kg BW (µmol/L).  
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5.2.6 Determination of antioxidant capacity – ABEL TAC™ - Diet samples 
The treatment and control diets from the study described in chapter 4, and the vitamin and mineral 
premix and xylanase used in both previous studies (chapters 3 and 4) were assessed for their 
antioxidant capacity. This was to try and quantify the antioxidant value of these dietary components, 
and to ensure that these components were not pro-oxidant and therefore inhibiting any antioxidant 
activity of the diets or XOS. As the kit requires liquid samples (section 2.5.16) solubility was first 
assessed in ultra-pure water, 50% and 100% ethanol and 50% and 100% acetone. Solubility was 
visually determined by the quantity of substance that remains in dissolved in a vessel following 30 
minutes agitation on a roller. It was determined that maximum solubility was achieved with 50% 
acetone for the complete diets and with 50% ethanol for the premix and with ultra-pure water for the 
xylanase. The diets had all been stored at -20°C to prevent lipid oxidation, avoid bacterial overgrowth 
and maintain the nutritional profile as fed.  
 
5.2.7 ABEL test for halogenated oxygen 
The ABEL kit for halogenated oxygen was used as described in section 2.5.18 to quantify the ability of 
five commercially available XOS products (including the corn XOS used in chapter 4) to quench 
halogenated oxygen radicals (see table 5.1 for details of each product). Solubility was again assessed 
prior to analysis, as described in section 5.2.6. 
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Table 5.1 Commercial XOS products used in comparison of antioxidant properties assay 
Product Material extracted and/or manufacturer 
Corn XOS (Longlive) Corn cob, Shandong Longlive Bio-
Technology Co (China) 
Yuan Long  Corn cob, corn straw, cotton seed hull and 
peanut hull, Henan Biotechnology (China) 
Yatai Source material unknown, Yibin Yatai 
Biotechnology (China) 
Taixin Source material corn cob, Hebi Taixin 
Technology Co (China) 
Heagreen Source material unknown*, Henan 
Heagreen Biotechnology (China) 
* Derived from hemicellulose in biomass and is composed of pentose glycosyl 
 
5.2.8 ABEL test for singlet oxygen species 
The ABEL Tac™ kit for singlet oxygen species was performed as described in section 2.5.19 to measure 
the capacity of five commercial XOS products (table 5.1). As with the halogenated test, solubility was 
assessed and the XOS products were analysed in ultra-pure, 50% ethanol and 100% ethanol to ensure 
a complete picture was obtained. 
 
 
 
 
 
 
 
 
 
 
 
233 
 
5.3 Results 
5.3.1 Euthanasia method 
There was a significant increase in the total antioxidant capacity (TAC) for peroxynitrite for birds 
euthanised via cervical dislocation compared with those euthanised by captive bolt. When the TAC for 
peroxynitrite levels were adjusted for bird weight there was still a significant increase in TAC for 
peroxynitrite levels for the CD culled birds (Table 5.2) 
Table 5.2 TAC for Peroxynitrite scores for birds euthanised in different ways (mean VEA µmol/L ±SE) 
Euthanasia method VEA µmol/L VEA adjusted for body weight µmol/L 
Cervical dislocation 986.9a (35.84) 481.7a (21.89) 
Captive bolt 808.5b (35.28) 416.0b (22.90) 
p-value 0.002 0.015 
a-b Means within the same row that do not share a common superscript are significantly different 
(p=<0.005) 
 
5.3.2 Blood collection comparison 
 There was a significant increase in the TAC for peroxynitrite levels detected in blood collected into 
tubes containing no anti-coagulant (Table 5.3), however, it is of note that the standard error is 
substantially higher for this treatment. 
 
Table 5.3 Comparison of TAC for peroxynitrite scores for blood collected into different anticoagulant 
tubes VEA (vitamin E analogue) µmol/L (S.E.) 
Anticoagulant VEA µmol/L VEA per kg BW µmol/L 
EDTA 805.7b (29.17) 403.2b (20.40) 
Heparin 894.2b (30.51) 448.3b (22.02) 
None 1095.0a (66.49) 533.1a (38.92) 
p-value 0.001 0.004 
a-b Means within the same row that do not share a common superscript are significantly different 
(p=<0.005) 
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5.3.3 Blood sample storage 
There was a significant increase in the levels of peroxynitrite that could be detected in fresh blood 
samples compared to serum that had been frozen prior to analysis (Table 5.4). 
 
Table 5.4 Comparison of TAC for peroxynitrite scores detected in either fresh or frozen blood 
Storage method VEA µmol/L VEA adjusted for body weight µmol/L 
Fresh 1029.2a (41.59) 550.6a (24.24) 
Frozen 863.2b (34.59) 405.6b (20.39) 
p-value 0.003 <0.001 
a-b Means within the same row that do not share a common superscript are significantly different 
(p=<0.005) 
 
5.3.4 Peroxynitrite levels of birds fed different diets 
There was no significant difference between TAC for peroxynitrite in the blood (P=0.519) of the birds 
sampled in the XOS trial describe in chapter 4 (Table 5.5). Although not statistically significant, the 
control + corn XOS and control + bagasse XOS did produce a TAC score almost 20% higher than the 
other treatments. This suggests these diets may be conferring a 20% improved capacity to scavenge 
peroxynitrite radicals. 
 (Table 5.5) 
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Table 5.5 TAC for Peroxynitrite scores detected in the birds used for chapter 4 (VEA µmol/L +/- SE) 
Treatment Peroxynitrite (VEA µmol/L +/- 
SE) 
Control 863.20 (117.090) 
Control + Corn XOS 1029.38 (102.186) 
Control + bag XOS 1028.35 (129.307) 
Control + Xyl 816.49 (108.700) 
Control + corn XOS + Xyl 877.83 (122.790) 
Control + bag XOS + Xyl 848.62 (81.709) 
P Value 0.519 
a-b Means within the same row that do not share a common superscript are significantly different 
(p=<0.005) 
 
5.3.5 Antioxidant properties of diets and diet components 
 
All the broiler diets tested did have some degree of capacity to quench halogenated oxygen species. 
Likewise, both the xylanase and the vitamin and mineral pre-mix also possess a degree of antioxidant 
capacity (figure 5.2). However, when compared to grape seed extract – a known excellent quencher 
of halogenated oxygen radicals, the feed ingredients the feed did not have significant antioxidant 
capacity (figure 5.3).  
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Figure 5.2 - Comparison of the capacity of broiler diets used in chapter 4 and diet components to 
quench halogenated oxygen species 
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Figure 5.3 - The capacity of broiler diets used in chapter 4 and diet components to quench 
halogenated oxygen species compared to grapeseed oil as a known antioxidant 
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5.3.6 Antioxidant properties of commercial XOS products 
When analysed for the ability to quench singlet oxygen radicals, three of the five XOS products 
showed significant antioxidant properties. The Taixin showed outstanding ability to quench singlet 
oxygen with a score of ABEL score of 114966 (Figure 5.4). Both the corn XOS used in chapter 4 
and Yuan Long displayed very good levels of antioxidant activity against singlet oxygen. Yaitai XOS 
did not exhibit any antioxidant activity and Heagreen XOS only showed very low levels of activity. 
The ABEL-RAC score of ascorbic acid is shown as a comparison, being a known good antioxidant 
(figure 5.4). 
 
Figure 5.4 - Comparison of the ability of commercial XOS products to quench singlet oxygen species 
 
 
When analysed for antioxidant activity against halogenated oxygen species, results for the XOS 
products were very similar to those for singlet oxygen. The Taixin XOS achieved a score of  51,207 
compared to ascorbic acid that scored 21,000. The corn XOS showed reasonable ability to quench 
halogenated oxygen compared to the ascorbic acid. The Yuan Long XOS also performed moderately 
well, though it was consistently inferior to both the corn XOS and the Taixin. Both the Yatai and the 
Heagreen showed very little antioxidant activity against halogenated oxygen species (figure 5.5). 
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Figure 5.5 - Comparison of the ability of commercial XOS products to quench halogenated oxygen 
species 
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5.4 Discussion 
 
The assays used in this chapter are all commercially available from Knight Scientific, (Plymouth, UK) 
and validation procedures in broilers were carried out under their supervision and advice as experts in 
this field. The TAC assay for peroxynitrite had been validated in horses (knight and Larkins, 2003), 
humans (Knight et al., 2002), and wild birds (Tobler et al., 2013) but had never been used for broilers. 
In humans and horses (Knight and Larkins, 2003) the assay was validated to use either serum or 
plasma. Tobler and Sandell (2009) used plasma (unidentified anticoagulant) from Zebra Fiches to run 
the TAC assay, although the publication did not describe any particular rationale for this. As the assay 
had not previously been used in broilers, the initial pilot study looked at comparing the total 
antioxidant capacity for peroxynitrite levels detectable in both serum and plasma (using two common 
anticoagulants). The results showed that significantly higher capacity to scavenge peroxynitrite could 
be detected in serum compared to either of the two plasma samples (EDTA and heparin tubes). This 
result was unexpected as both serum and plasma had been shown to be equally accurate in other 
species (Knight, 2019). As the study by Tobler and Sandell (2009) did not provide any reason for using 
plasma, it is possible that this parameter was not considered. As they were using the assay as a direct 
comparison from one bird to another, it is possible that plasma may produce repeatable results, and 
that serum samples are just able to detect a higher level for antioxidant capacity.  With limited 
information from other studies, the fact that serum could repeatedly detect higher levels of 
antioxidant capacity was used as the rationale for selecting this method for further testing.  
Serum is defined as the fluid and solute component of blood without the fibrinogen (Reece et al., 
2014). Serum contains all blood proteins that do not play a role in clotting. As such it is possible that 
something in the clotting factors present in plasma, reduce the detectability of capacity to scavenge 
peroxynitrite. Zhonghao et al., (2011), reports that both collecting procedures and the coagulation 
cascade can influence the concentration of proteins and metabolites present in a human blood 
sample. Their study showed that metabolite concentration was generally higher in a serum samples 
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than in a corresponding plasma sample and that consequently, serum consistently showed higher 
sensitivity in biomarker detection. These authors suggest that this may be due to the volume 
displacement effect, whereby deproteinization of serum eliminates the volume fraction of proteins 
and consequently distributes any remaining low molecular weight constituents in a smaller volume, 
thus increasing the concentration. Likewise, Dettmer et al., (2010) found that some metabolites 
(citrate and lactate) in the cow blood differed significantly between serum and plasma samples. 
It is also possible that differences in avian blood physiology may cause reactions with the heparin or 
EDTA, resulting in lower detectable biomarkers. There are a few fundamental differences in avian and 
mammalian blood that may account for this result. Like humans, avian blood contains erythrocytes, 
however, unlike humans, avian erythrocytes are larger and possess a nucleus and mitochondria 
(Sturkie,2000). Whilst many other assays successfully use plasma, it is possible that peroxynitrite 
specifically is affected by the anticoagulants, and that the oxidation products are partially neutralized 
or changed by contact with them. Papp and Smits (2007) investigated another chemical luminescence 
assay which used lucigenin to assess the innate immune function of broilers and other animals. These 
authors found that consistent luminescence responses were found when blood was collected in 
heparin or EDTA, but when blood exposed to heparin, was mixed with EDTA, the chemical 
luminescence was dramatically inhibited. However, these authors did not assess serum for the assay, 
so no direct comparison can be made. This does suggest that collection of blood samples is important 
when carrying out this type of analysis and therefore at least consistency of tube type should be 
incorporated into future work. 
When the TAC for peroxynitrite (TAC) scores for broilers are compared to other species, there is some 
variation. Human TAC scores collected by the assay manufacturers varied from 275 to 625 (figure 
5.6). Whereas the TAC scores for horses are lower and vary between 80 and 300 (figure 5.7). The TAC 
levels for Zebra Finches aged 35 days were higher than humans and very similar to the levels found 
for broilers in this study, ranging between 758 and 840 (Tobler and Sandell, 2009). The variation by 
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species and the similarity of zebra finches to broilers suggests that the total antioxidant capacity for 
peroxynitrite of avian species may be similar, however, more avian species would need to be assessed 
to confirm this. 
 
 
 Figure 5.6 - TAC for peroxynitrite scores of 263 human subjects (Source, Knight Scientific, used with 
permission, 2019). 
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Figure 5.7 – TAC for peroxynitrite scores in horses (Source: Knight Scientific, used with permission 
2019) 
 
The method of euthanasia was assessed as it was hypothesised that the reflex flapping after cervical 
dislocation may alter the biochemistry and effect results, or that the procedure and handling of the 
bird may cause stress. Unfortunately, live blood samples could not be collected to compare results. 
However, as a captive bolt is one of the approved methods of humane slaughter, and that total brain 
decimation by the captive bolt may potentially stop metabolic and biochemical changes rapidly, it was 
used to compare to cervical dislocation. The results showed that there was a significant increase in 
the TAC for peroxynitrite score detected in birds that were euthanized via cervical dislocation 
compared to captive bolt. This may suggest that cervical dislocation produces results closer to those 
experienced during life. As the birds were taken from a control treatment and had experienced 
identical diets and lives until euthanasia, the loss of antioxidant capacity for the captive bolt group is 
more likely due to the euthanasia process, rather than oxidative status prior to death. 
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This was quite unexpected as it had been assumed that the complete decimation of the brain, caused 
by the captive bolt strike, may stop biochemical reactions quicker than just severing the spinal cord 
during cervical dislocation.  However, as two people are required to restrain birds during captive bolt 
euthanasia, and restraint must be firm, to ensure both human and animal safety, it is possible that 
this may increase stress on the bird, subsequently causing a high TAC score. 
Cartner et al., (2008), report that cortical function was disrupted within 10 seconds post-cervical 
dislocation. This suggests that biochemical changes may occur post-mortem, potentially skewing 
results. Donaldson and Lamont (2013) assessed post-mortem biochemical changes in humans, pigs 
and rats. The authors found that biochemical changes varied post-mortem between species. Martin et 
al., (2019), assessed different methods of euthanasia, time to unconsciousness, and the rate at which 
flapping, and leg paddling reflexes stopped. These authors found that manual cervical dislocation 
achieved unconsciousness more quickly, in an average of 2.6 seconds compared to captive bolt device 
(3.5 seconds). Reflex flapping was slightly shorter in the manual cervical dislocation treatment (134.8 
seconds compared to 138.0 seconds for captive bolt) and leg paddling reflex was also slightly reduced 
in the manual cervical dislocation group compared to captive bolt.  
Therefore, it is difficult to discern the results of the current study. On the one hand, cervical 
dislocation could genuinely cause less stress and produce a result closer to what the result may have 
been during the life of the bird. However, it is also possible, as discussed above, that in response to 
increased oxidative stress the birds produced increased levels of circulating antioxidants, thus 
increasing the capacity of the plasma to scavenge peroxynitrite radicals. It is also of note that the 
capture and restraint of the birds could also induce biochemical changes. This is very difficult to 
assess, as even collecting a live blood sample would involve capture and restraint of the bird. Without 
keeping a bird and habituating it to restraint and blood sampling, it is almost impossible to remove 
this bias. Although the birds used in this study were captured in the same manner, cervical dislocation 
only needs one operative, whilst captive bolt requires two handlers and an operative. It is also of note 
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that cervical dislocation is the standard method of euthanasia at NTU and as such, operatives are 
highly trained and rapid in dispatching birds. Captive bolt was a new method for the team and in 
ensuring it was carried out humanely, the dispatching process did take substantially longer than 
cervical dislocation. Therefore, the necessary variation between treatments makes forming 
conclusions difficult in this regard. 
As the birds used in this study were captured and restrained in the same manner prior to euthanasia, 
this study can at least compare like with like. Additionally, as results were consistent, over all 
replicates it can be concluded that birds euthanized via cervical dislocation had increased ability to 
scavenge peroxynitrite radicals. However, repeating this study under a Home Office Licence with live 
blood samples prior to euthanasia may help to confirm whether changes blood biochemistry are 
genuine and at what point peroxynitrite levels may change.  
The results of freezing broiler blood serum for a week showed that the TAC for peroxynitrite score 
was significantly reduced by freezing the serum sample at -20°C, compared to analysing a fresh 
sample. This result is not unexpected as the manufacturer’s instructions recommend storage at -80°C. 
However, there are a number of publications that investigate the effect of freezing on blood samples. 
Briard et al. (2016) report that ice recrystallization is a major cause of damage to proteins in frozen 
blood serum samples. Lee et al. (2015) looked at the effect of freezing and thawing plasma and serum 
and found that the stability of circulating proteins can be significantly affected by the freezing and 
thawing process. These authors found multiple biomarkers that were significantly affected by frozen 
storage including Interferon-y and tumour necrosis factor-α. Work in sheep also found that the effect 
of storage on ovine serum and plasma and also found significant changes in energy metabolites after 
frozen storage at -20°C (Morris et al., 2002). It is of note that some of these studies found that 
biomarkers were more stable when stored at -80°C rather than -20°C. Whilst some change still 
occurred, the changes were significantly smaller. Therefore, in cases where samples must be frozen, 
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freezing at -80oC may provide an alternative solution to allow this analysis to be carried out with least 
variability. 
Following the initial validation work on the TAC method, dietary effects were investigated using the 
TAC for peroxynitrite scores of the birds from the trial described in chapter 4. These samples 
however, had been stored for a number of months at -20°C, as originally no antioxidant analysis had 
been planned for this trial. Although this analysis did not show any significant differences in 
peroxynitrite levels between the 6 treatments used, there was a 20% increase in the ability of the 
birds fed the control + corn XOS and control + bagasse XOS treatments to scavenge peroxynitrite 
radicals compared to the other treatments. The TAC scores of these birds were still in the same range 
as the other broiler results from section 5.3.2, so the long-term storage did not seem to profoundly 
affect the TAC score, although subtle differences between treatments may be lost during storage.  
Knight scientific had previously validated an assay for measuring the ability of feed ingredients and 
nutraceuticals to quench peroxynitrite reactive oxygen species (Knight, 2005). Initially the diets used 
for the trial described in chapter 4 were assessed. These were commercial wheat/soy/corn-based 
broiler diets with the addition of two different XOS products both with and without xylanase. (Figure 
5.2). Whilst there were some apparent differences in antioxidant capacity between diets, when these 
diet scores were compared to a known antioxidant (grape seed oil), the antioxidant capacity of the 
diets was negligible. Figure 5.8 shows the ABEL RAC™- peroxynitrite scores for various other known 
antioxidant substances for comparison. 
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Figure 5.8 - Examples of ABEL RAC™ scores from other substances (adapted from Knight Scientific 
website –2020) 
 
 
What is interesting, is the repeatability in scores between the diets (figure 5.2). Both the control and 
the control + xylanase have very similar scores (431 and 381) likewise, the two corn XOS and the two 
bagasse XOS diets were also similar to one another. This does seem to infer a good level of precision 
and repeatability for this procedure; however, this also seems to suggest the corn XOS is somehow 
reducing the ability of that diet to quench peroxynitrite radicals. As the diets were manufactured as 
two basal diets (control and control + xylanase) then each split into three treatments before the 
various XOS products added; the two basal diets could only be detrimentally affected by the addition 
of XOS. The reduced anti-peroxynitrite capacity of the corn XOS treatments suggest this product is a 
potential pro-oxidant and therefore reducing the antioxidant capacity of the basal diet in the 
treatment. This result was unexpected as other authors have found alternative oligosaccharides to be 
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antioxidants (Zhao et al., 2020). However, some studies have found known antioxidants to be pro-
oxidants in some circumstances. 
 Podmore et al., (1998), investigated the antioxidant properties of vitamin C (ascorbic acid)  and found 
that, although vitamin C was an excellent antioxidant against some reactive oxygen species, it was 
actually pro-oxidative in some circumstances and could cause damage to lymphocyte DNA. Mandal, 
(2019) reports that although vitamin C is excellent at scavenging hydrogen peroxide, it also reduces 
metal ions that consequently generate free radicals. It is therefore possible that the corn XOS may 
have triggered a pro-oxidant effect, either directly, or indirectly. Likewise, this TAC assay measures 
the ability of a substance to scavenge peroxynitrite radicals specifically. Reactive oxygen species (ROS) 
can be split into two categories. Radical ROS possess an unpaired electron and therefore try to seek 
another electron (Lagunes and Trigos, 2015). Non-radical ROS have their full complement of electrons 
but possess very high energy making them extremely reactive. Most antioxidants act by donating an 
electron to stabilize the molecule, however as non-radical species cannot accept an electron, the only 
way for an antioxidant to stabilize them is by quenching – or trapping the non-radical. Therefore, it is 
possible that the corn XOS may be capable of quenching non-radical ROS but is not able to donate 
electrons to radical species (Lagunes and Trigos, 2015). This is supported by the results of the vitamin 
and mineral pre-mix. The ingredients specifically list an “antioxidant” in the ingredients list (appendix 
C). Whilst this is not identified by the commercial premix supplier, it would be expected to display 
measurable antioxidant activity. As the peroxynitrite assay found very little antioxidant activity in the 
premix, it again appears that whilst the pre-mix may possess antioxidant properties against some ROS, 
it appears to have little activity against peroxynitrite radicals. The xylanase showed numerically more 
peroxynitrite scavenging ability than the pre-mix. However, as the xylanase is added to the diet at a 
very low inclusion rate (0.01%), it was expected that the diets containing xylanase did not perform 
better than the diets without.  
249 
 
The results of the peroxynitrite assay led to further exploration of the corn XOS to attempt to 
determine any antioxidant properties. As part of this investigation, , four commercially available XOS 
products were purchased to act as direct comparisons. The ability of the five XOS products (including 
the corn XOS) to quench singlet and halogenated oxygen species was measured. These assays were 
selected as they measure the ability of the XOS to quench non-radical ROS, rather than the radical 
species tested previously. The results showed highly significant differences between the five XOS 
products in their ability to quench non-radical singlet and halogenated ROS. Whilst two of the 
commercial products showed very little quenching ability, the Taixin XOS demonstrated exceptional 
ability to quench both singlet and halogenated oxygen species. This XOS product (Taixin) is also 
produced from corn manufacturing, but the process used is not openly available, so may be a 
different product source to the other materials tested. The corn XOS used in the trial described in 
chapter 4 achieved an ABEL RAC™ score of 20288 for singlet ROS and 9224 for halogenated oxygen 
species. When compared with ascorbic acid which scored 42619 for singlet ROS and 20023 for 
halogenated ROS, the corn XOS demonstrates approximately 50% of the ability to quench these non-
radical ROS. As mentioned previously ascorbic acid is considered an excellent antioxidant (Padayatty 
et al., 2003), despite potentially negative side effects due to the reduction of metal ions increasing 
the production of free radicals (Mandal, 2019). This suggests that the corn XOS may have the added 
benefit of acting as a quencher of non-radical ROS. However, the inclusion rate in the complete diet 
may negate any major benefits. Further research on in vivo inclusion of corn XOS with monitoring of 
antioxidant effects both in the bird and in terms of meat quality is required to further assess any 
potential antioxidant effect. 
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5.5 Conclusion 
 
In conclusion, the methodology pilot study revealed that the TAC for peroxynitrite could detect higher 
levels of antioxidant capacity in broiler serum than in plasma collected using either heparin or EDTA 
tubes. Cervical dislocation demonstrated the highest antioxidant capacity; however, it is unclear if this 
really does provide a true reflection of the levels of oxidative stress a bird experiences during its life. 
The storage of blood samples clearly shows that the assay can detect higher levels of antioxidant 
scavenging ability in fresh samples, rather than those stored at -20°C for one week.  
The commercial broiler feed used as the control diet for chapter 4, demonstrates limited ability in 
scavenging free radicals and as such, supplementary antioxidants are indicated. Some commercial 
XOS products do have the ability to quench non-radical ROS. However, when the level of dietary 
inclusion is considered, the antioxidant benefits of XOS are unlikely to be significant. 
 
